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Abstract. 
The application of tetradentate aminoalcohol ligands to the KO
t
Bu-catalysed 
hydrogenation of benzophenone has been studied. Hydrogenation was found to 
proceed via a transfer hydrogenation process with the ligands acting as hydrogen 
donors. 
A series of bidentate and tetradentate ligands containing a variety of coordinating 
groups including amino, hydroxy, silyl, phosphine and amido functionalities have 
been prepared and applied to the transition metal-catalysed asymmetric transfer 
hydrogenation of ketones using iron, ruthenium and rhodium metals although none 
were found to be enantioselective for the hydrogenation of acetophenone. 
A series of asymmetric tethered ruthenium half sandwich complexes have been 
applied to the asymmetric pressure hydrogenation of ketones. Studies have 
investigated the effect of changing the sulfonamide group, halide and tether length 
on the activity of the catalysts. The application of an achiral tethered ruthenium half 
sandwich complex as a catalyst for the pressure hydrogenation of aldehydes is also 
reported. 
A novel synthesis of tethered ruthenium complexes using aryl substitution 
methodology has been developed and applied to the preparation of a series of novel 
complexes which were found to be highly active for asymmetric pressure 
hydrogenation of ketones. The application of the synthesis to the preparation of 
poly(methyl methacrylate) supported complexes is also discussed. Application of the 
supported catalysts to asymmetric pressure and transfer hydrogenation of 
acetophenone has shown potential for the development of an active heterogeneous 
catalyst for transfer hydrogenation of ketones in aqueous media. 
Development of catalysts for asymmetric hydrogenation                                                  Abbreviations 
v 
 
Abbreviations. 
 
[α]D    Optical rotation (alpha D) 
°C    Degrees celsius 
δC    Carbon chemical shift 
δH    Proton chemical shift 
νmax    Wavenumber (cm
-1
) 
Ǻ    Angstroms 
Ad    Adamantane 
aq.    Aqueous 
APH    Asymmetric pressure hydrogenation 
Ar    Aryl 
ATH    Asymmetric transfer hydrogenation 
atm.    Atmospheres 
BH3.DMS   Borane dimethylsulfide complex 
BINAP   2,2’-Bis(diphenylphosphino)-1,1’binapthyl 
Boc    tert-Butoxycarbonyl 
Bu    Butyl 
c    Concentration (g/100 cm
3
) 
CBS    Corey-Bakshi-Shibata 
CDCl3    Deuterated chloroform with 0.3% TMS 
CI    Chemical ionization 
cm
3
    Centimetres cubed 
13
C NMR   
13
Carbon nuclear magnetic resonance 
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1. Introduction. 
1.1 Chirality. 
Chirality, derived from the Greek word cheir meaning hand, is a form of 
stereoisomerism and is the structural characteristic of an object that can exist as one 
of two non-superimposable mirror images of itself. A molecule is said to be chiral if 
it can exist in a pair whereby both molecules have the same molecular formulae, but 
differ in their structural arrangement to the extent that the pair form mirror images of 
each other.
1
 Each mirror image of the compound is called an enantiomer. Chirality 
arises in a molecule when a central atom has a different atom or functionality as each 
of its substituent groups. The central atom is referred to as the chiral centre. 
It is particularly important within asymmetric synthesis to specify the absolute 
configuration of a chiral molecule at each of its chiral centres. Within a chiral 
compound each chiral centre has either ‘R’, from the Latin rectus meaning right, or 
‘S’, from the Latin sinister meaning left, configuration.2 These terms relate to the 
order in which substituent groups are arranged around the chiral centre and hence 
describe the configuration of the molecule at the chiral centre. An equal mixture of 
(R) and (S) enantiomers of the same compound is referred to as a racemate.  
An example of a chiral molecule is bromochlorofluoromethane 1 shown in Figure 1. 
The carbon atom at the centre of the molecule is bound to four different atoms, 
bromine, chlorine, fluorine and hydrogen, and is thus a chiral centre. To determine 
the absolute configuration of each enantiomer it is necessary to use the Cahn-Ingold-
Prelog system to assign priorities to each substituent group.
3
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Figure 1. Assignment of absolute configuration of stereochemistry in enantiomers of 
bromochlorofluoromethane 1. 
 
The priorities relate to the atomic number of each atom bound to the chiral centre. 
The atom having the highest atomic number has the highest priority. Where two 
atoms bound to the chiral centre have the same atomic number, the atomic number of 
the next atom to each in sequence is considered. When priorities have been assigned, 
the molecule is oriented with the lowest priority group pointing backwards. If the 
priorities then decrease in a clockwise manner around the chiral centre the 
configuration is R and if in an anti-clockwise manner the configuration is S. The 
enantiomeric purity of an asymmetric product is reported either as an enantiomeric 
ratio (er.) of R:S or as a percentage enantiomeric excess (ee.) using the equation: 
((proportion of most abundant enantiomer)-(proportion of least abundant 
enantiomer)/(R + S)) x 100. 
Enantiomers of a compound will have the same chemical and physical properties as 
each other, however they are optical isomers of each other. Each enantiomer will 
rotate the plane of polarised light in the opposite direction.
4
 If the light is rotated to 
the left the enantiomer is D, the dextro-rotatory enantiomer (+) and if the light is 
rotated to the right the enantiomer is L, the levo-rotatory enantiomer (-). Polarimetry 
is an analytical technique which measures the rotation of polarised light when passed 
through a chiral sample and can be used to determine which enantiomer of the 
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compound is present. The [α]D value obtained can be compared to literature 
measurements to confirm the R or S configuration of a compound. 
Many naturally occurring compounds are chiral including amino acids, sugars and 
natural products and almost all will possess the (L)-configuration in their natural 
states.
5
 Amino acids are the building blocks for proteins and enzymes within 
biological systems. Enzymes operate as biological catalysts, each exhibiting 
selectivity for a specific reaction or transformation within a biological system. The 
enzymes exhibit a preference for the reaction of one enantiomer of the starting 
material over the other to form an enantiopure product.
6 
 
1.1.1 Industrial importance of chiral compounds. 
Proteins and biological compounds are built from (L)-amino acids meaning that 
biological organisms operate within a chiral environment of a single handedness. 
This has a major impact on the design of drugs which must be compatible with this 
environment in order to work successfully. An example of this is the use of (L)-3,4-
dihydroxyphenylalanine 2 ((L)-DOPA) shown in Figure 2, which is used as a 
treatment for Parkinson’s Disease.7 
 
Figure 2. Structure of (L)-DOPA (2) 
 
The active compound dopamine is not able to cross the blood-brain barrier to reach 
the site of action. Dopamine is thus administered as DOPA which undergoes 
enzyme-mediated decarboxylation in the body to form dopamine. Due to the 
enantiomerically pure nature of the amino acids it is built from, the dopamine 
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decarboxylase enzyme is only active for conversion of (L)-DOPA to dopamine. 
Administering racemic DOPA to patients would lead to a dangerous build up of (D)-
DOPA in the body. It is thus important to synthesise and administer pure (L)-DOPA 
to patients. 
1.1.2 Preparation of chiral compounds. 
The need for enantiomerically pure compounds, particularly within the 
pharmaceutical industry, has made asymmetric and enantioselective synthesis an 
important area of chemical research. Many strategies discussed below have been 
used to achieve asymmetric synthesis. 
1.1.2.1 Biosynthesis. 
Biosynthesis involves the use of enzymes to perform chemical transformations. The 
enantioselectivity of enzymes leads to formation of enantiomerically pure products, 
either via kinetic resolution whereby the enzyme converts only one enantiomer of a 
racemic starting material to the product, or via a biocatalysed asymmetric synthesis 
where the stereochemistry of the enzyme allows formation of only one enantiomer of 
a product. An example of a biocatalysed asymmetric hydrogenation is the yeast 
mediated reduction of ethyl acetoacetate (3) reported by Smallridge et al. in 1993 
shown in Scheme 1.
8 
 
Scheme 1. Yeast-catalysed asymmetric hydrogenation of ethyl acetoacetate. 
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1.1.2.2 Chiral pool synthesis. 
Chiral pool synthesis is the use of enantiomerically pure starting materials in 
reactions to give enantiomerically pure products. Naturally occurring chiral 
compounds are almost always enantiomerically pure and can be used 
stoichiometrically to give enantiomerically pure products, as long as the chiral centre 
does not undergo racemisation during the reaction. An example of a successful 
approach is the preparation of Chiraphos (5) from naturally occurring (L)-tartaric 
acid (4) as shown in Scheme 2.
9
  
 
Scheme 2. Asymmetric synthesis of Chiraphos from (L)-tartaric acid. 
 
1.1.2.3 Chiral auxiliaries. 
A chiral auxiliary is an enantiomerically pure compound which is added to a reagent 
to create a chiral centre. Subsequent reaction at an additional chiral or pro-chiral 
centre in the molecule will give an enantiomerically enriched product at this centre 
due to the steric influence imposed by the auxiliary. After the reaction the auxiliary 
is removed to give the enantiomerically enriched product. 
A particularly well known and widely used family of oxazolidinone auxiliaries such 
as 6 was developed by David Evans in the mid 1980s.
10
 Initially the auxiliaries were 
used for asymmetric aldol reactions as shown in Scheme 3.
11 
 
Scheme 3. Use of Evans Auxiliary for asymmetric aldol reaction. 
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Evans auxiliaries have also been applied to the asymmetric synthesis of carboxylic 
acids,
12
 asymmetric Diels-Alder cylcoadditions
13
 and the synthesis of a range of 
antibiotics
14
 and pharmaceutical products including  Ezetimibe
15
 and Lipitor
16
 for 
treatment of high cholesterol and Tipranavir
17
 a HIV protease inhibitor. 
1.1.2.4 Asymmetric catalysis. 
A catalyst increases the rate of a reaction by decreasing the activation energy of the 
transformation but is not itself consumed in the reaction. Catalysts may be 
homogeneous (in the same phase as the reaction mixture) or heterogeneous (in a 
different phase to the reaction mixture) and may be metallic, often based on 
transition metals, or organic comprising of small C, H, N, O, S based molecules. The 
variable oxidation states and incomplete d-orbitals of transition metals gives good 
scope for their use as catalysts allowing variable coordination numbers for 
interaction with ligands and substrate and elimination of products. Catalysts 
possessing chirality, for example with coordinated enantiomerically pure ligands, 
can impose enantioselectivity upon the reaction they are catalysing.  
An achiral catalyst used in the reaction of a racemic or pro-chiral starting material to 
form a chiral product will give the product as a racemate. This is because the 
reaction pathway from either enantiomer of starting material to either enantiomer of 
product requires the same energy. Use of an asymmetric catalyst lowers the energy 
required for the formation of one enantiomer of product below that of the other 
enantiomer as shown in Figure 3. During the reaction this enantiomer of product is 
formed preferentially leading to an enantiomerically enriched product.
18
 
Development of a sufficiently active catalyst may decrease the activation energy to 
such an extent that an essentially enantiomerically pure product is formed. 
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Figure 3. Activation energies for transition state formation with and without an asymmetric catalyst. 
 
Asymmetric catalysis is advantageous as it allows both enantiomers of a starting 
material to react to give a single enantiomer of the product. Racemic starting 
materials can be used rather than expensive, less available, enantiomerically pure 
starting materials. It is also a more efficient process without the need for additional 
steps in the reaction for the addition and removal of an auxiliary for example. Some 
drawbacks of the process are that the metals used are often transition metals which 
may be toxic and not readily available leading to an increase in costs, thus catalysts 
need to be highly active to minimise the amount of them it is necessary to use. 
1.2 Hydrogenation.  
Hydrogenation is the addition of hydrogen to an unsaturated bond, often a C≡C, 
C=C, C=O or C=N bond. Transfer hydrogenation uses a hydrogen donor such as 
formic acid or 2-propanol to supply the substrate with hydrogen, whilst pressure 
hydrogenation uses pressurised hydrogen gas. A vast range of homogeneous and 
heterogeneous catalysts have been used for hydrogenation applications.
19 
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1.2.1 Pressure hydrogenation with transition metal catalysts. 
Pressure hydrogenation of unsaturated compounds is achieved with use of hydrogen 
gas. One of the earliest examples of a homogeneous transition metal catalyst for 
hydrogenation was reported by Wilkinson in 1966.
20
 [RhCl(PPh3)3] (7) as the 
catalyst precursor was used along with hydrogen gas under mild conditions for the 
hydrogenation of alkenes. The catalyst precursor 7 is formed from the reaction of 
RhCl3.3H2O with excess triphenylphosphine. The catalytic cycle for the 
hydrogenation of alkenes is shown in Scheme 4. 
 
Scheme 4. Mechanism of pressure hydrogenation of alkenes using Wilkinson's catalyst. 
 
The mechanism of catalysis
20
 proceeds with oxidative insertion of hydrogen to the 
16-electron Rh
+
 species 7 to give 18-electron dihydride Rh
3+
 complex 8. Loss of a 
triphenylphosphine ligand allows η2-coordination of the substrate to the rhodium to 
give complex 10. Migratory insertion into a Rh-H bond followed by reductive 
elimination yields the hydrogenated product. Coordination of triphenylphosphine 
reforms the 16-electron Rh
+
 species 7 for continuation of the catalytic cycle. 
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The system was found to show good selectivity for hydrogenation of alkene bonds 
with ketones, hydroxy, cyano, nitro, chloro, azo, ethers, esters and carboxylic acids  
each being stable to hydrogenation.
20
 Scheme 5 shows the hydrogenation of 
cyclohexene using Wilkinson’s catalyst 7. 
 
Scheme 5. Hydrogenation of cyclohexene using Wilkinson's catalyst. 
The study also investigated the scope of the reaction, finding that terminal alkenes 
underwent hydrogenation more readily than internal alkenes; alkenes with cis 
geometry were hydrogenated more readily than trans and an increase in hydrogen 
pressure was required to bring about hydrogenation of conjugated alkenes.
20 
1.2.2 Asymmetric pressure hydrogenation with transition metal catalysts. 
Asymmetric pressure hydrogenation (APH) is the addition of hydrogen to a pro-
chiral unsaturated bond to give a specific enantiomer of the chiral saturated product. 
The enantioselectivity in the reaction originates from the use of asymmetric ligands 
such diphosphines and diamines as shown in Figure 4.
 
 
Figure 4. Examples of asymmetric ligands. 
 
Early examples of APH took inspiration from Wilkinson’s catalyst, using 
enantiopure chiral phosphine ligands and a rhodium catalyst. An early example was 
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reported by Knowles in 1968.
21
 Reaction of (-)-methylpropylphenylphosphine (P) 
and RhCl3.3H2O gave the catalyst precursor [RhCl3P3] which was applied to the 
hydrogenation of prochiral compounds. Use of 0.15 mol% catalyst with 
benzene:EtOH 1:1 with Et3N (3.5 equiv. relative to Rh) at 60°C allowed the 
hydrogenation of phenylacrylic acid to phenylpropanoic acid with an optical purity 
of 15%. The reaction is believed to have proceeded via the same mechanism as 
Wilkinson’s catalyst and established the potential for asymmetric hydrogenation 
using rhodium-phosphine catalysts.  
Improvements to this system were reported by Kagan in 1971
22
 for the asymmetric 
pressure hydrogenation of unsaturated prochiral acids with an in situ formed catalyst 
comprising of rhodium and an asymmetric diphosphine ligand 16 shown in Figure 5, 
derived from (+)-ethyl tartrate. 
 
Figure 5. Structure of ligand 16 for use in the rhodium APH of unsaturated prochiral acids. 
 
In combination with [Rh(cyclooctene)2Cl]2 and benzene:EtOH 1:2 at room 
temperature and with atmospheric hydrogen, ligand 16 was used in the asymmetric 
hydrogenation of atropic acid giving the product in quantitative yield with an optical 
purity of 63%. The system was found to be particularly active for the asymmetric 
hydrogenation of α-acetamidocinnamic acid giving a quantitative yield of product 
with 72% optical purity.
22 
Knowles reported further improvements to the asymmetric hydrogenation of alkenes 
in 1986 with use of rhodium and an asymmetric diphosphine ligand ethane-1,2-
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diylbis[(2-methoxyphenyl)phenylphosphine] (DiPAMP) 17 shown in Figure 6, for 
the preparation of (L)-DOPA precursor 18 in 94% ee.
23 
 
Figure 6. Structure of (R,R)-DiPAMP 17 and (L)-DOPA precursor 18. 
 
More recently the use of rhodium with asymmetric diphosphine ligands such as C2-
symmetric EtDuPHOS 19 has proved to be an effective system for APH of alkenes. 
Burk has reported the hydrogenation of prochiral acetamidoacrylates and enol 
acetates
24
 at low temperature and hydrogen pressure and with short reaction times 
and low catalyst loadings to give high enantiomeric excesses as shown in Table 1. 
Table 1. Enantiomeric excesses achieved for APH of acetamidoacrylates and enol acetates. 
 
 
 
 
Entry Diphosphine ligand Substrate Ee.
a
 (%) 
1a (S,S)-14 
 
98 (S) 
1b (S,S)-20 99 (S) 
1c (S,S)-19 93 (S) 
2 (S,S)-20 
 
99 (S) 
3 (S,S)-19 
 
90 (R) 
4a (S,S)-14 
 
94 (S) 
4b (S,S)-19 >95 (S) 
a Determined by chiral HPLC. 
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The reaction mechanism was reported by Gridnev and Imamoto
25
 and is shown in 
Scheme 6.  
 
Scheme 6. Mechanism for rhodium-catalysed APH of acetamidoacrylates using asymmetric 
diphosphine ligands such as DuPHOS. 
 
The reaction involves initial coordination of the substrate 22 to the rhodium 
precursor 21 to give complex 23 which exists at a low concentration in a fast 
equilibrium with the substrate chelate complexes 24a and b. Complexes 24a and b 
were found to react slowly with hydrogen to form the product via complexes 25a and 
b whilst 23 reacts quickly with hydrogen. It was therefore proposed that once 
formed, complex 23 reacts quickly with hydrogen to give complex 26. The rhodium 
in 23 is activated to oxidative addition of hydrogen by electron donation from the 
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carbonyl group and also the process is sterically favoured. After oxidative addition 
of hydrogen, the double bond of the substrate coordinates to the rhodium to give 27 
which can exist as one of two diastereomers. Once the sterically favourable 
diastereomer of 27 forms, fast migratory insertion of the C=C bond into the Rh-H 
bond occurs fixing the stereochemistry of the product and giving complex 28. The 
favoured conformation is that which minimises steric clash between the diphosphine 
ligand and the substrate. The product 29 is released by reductive elimination. 
 
The use of rhodium and 2,2’-bis(diphenylphosphino)-1,1’-binapthyl (BINAP) as the 
asymmetric diphosphine has been reported by Noyori and co-workers however its 
scope is limited to the synthesis of amino acids as shown in Scheme 7.
26 
 
 
Scheme 7. Preparation of enantiomerically pure amino acids with rhodium BINAP complex 30. 
 
This system is reported to follow an analogous mechanism to that of the Rh-
DuPHOS system shown in Scheme 6.
26
 The system does not offer a significant 
improvement over the Rh-DuPHOS system, with Noyori reporting it as being 
relatively slow and the need for specific conditions to give a high degree of 
enantioselectivity.
27
 For example, the pressure of hydrogen gas used in the reaction 
must be carefully selected as too high a pressure leads to a reduction in the 
enantiomeric excess of the product. This is due to the relative reactivities of the 
chelate complex diastereomers (analogous to 24a and 24b in Scheme 6). Halpern 
and Ashby report that under low hydrogen pressures the formation of the chelate 
complex is reversible.
28
 The minor diastereomer is more reactive with hydrogen than 
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the major diastereomer. The reversibility of the reaction allows conversion of the 
less reactive major diastereomer to the highly reactive minor diastereomer which 
then determines the configuration of the product.  Increasing the hydrogen pressure 
reduces the reversibility of the process and hence the degree of interconversion 
between diastereomers. With increased hydrogen pressure the amount of the major 
diastereomer present and its reactivity increases which causes a reduction in the 
enantiomeric purity of the product.
28
 
The concentration of the reaction solution with respect to the substrate is also 
important in the reaction. Under high substrate concentrations, complexes containing 
two coordinated substrates each bound through their C=C bonds were observed
28
 and 
the ee. of the products obtained from these complexes was found to be lower than 
that obtained via the conventional mechanism. 
Improvements to this system were first reported by Noyori et al. in 1986 upon using 
ruthenium metal instead of rhodium.
29, 30
 This system was found to be highly 
enantioselective and have broad scope and high activity for a range of substrate 
types. The use of [Ru(BINAP)(carboxylate)2] complexes has been applied to the 
APH of allylic alcohols,
31
 isoquinolines
29
 and α,β-unsaturated carboxylic acids,32 
whilst use of [Ru(BINAP)(halide)2] complexes have been applied to the APH of 
ketones
33
 as illustrated in Figure 7. 
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Figure 7. Ruthenium BINAP-catalysed APH of a range of unsaturated substrates.30-33 
 
The mechanism for APH using the ruthenium BINAP catalyst is shown in Scheme 8. 
The mechanism differs to that of the rhodium BINAP catalyst in that it involves a 
ruthenium monohydride and that the ruthenium remains in its +2 oxidation state 
throughout the cycle. The mechanism for the APH of β-keto esters is shown 
below.
34,35 
Heterolytic cleavage of hydrogen allows formation of a ruthenium 
hydride complex 32. The C=O bonds of the β-keto ester substrate coordinate to the 
ruthenium to give complex 33. The C=O of the ketone then inserts into the Ru-H 
bond to give complex 34 before protonation of the Ru-O bond (35) gives the product 
and reforms catalyst pre-cursor (31). 
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Scheme 8. Mechanism for Ru-BINAP-catalysed APH of β-keto esters. 
 
More recently Wills and co-workers have reported an iridium-catalysed approach to 
the APH of ketones using IrCl3 and asymmetric diamine ligands.
36
 Of a range of 
metals tested, IrCl3 was shown to give excellent selectivity for hydrogenation of the 
C=O bond of acetophenone over hydrogenation of the aromatic ring using N-
alkylated TsDPEN ligands. A range of N-alkylated derivatives of TsDPEN were then 
employed as ligands with IrCl3 for the APH of acetophenone with ligand 36 giving 
the highest ee. of 60% as shown in Scheme 9.
36
  
 
Scheme 9. Iridium-catalysed APH of ketones using alkylated TsDPEN ligand 36. 
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The best performing ligands including 36 in Scheme 9 were successfully applied to 
the APH of a range of aromatic ketones. Further extension of this work was reported 
the synthesis and application of derivatives of ligand 36 with a variety of 
sulfonamide groups to iridium-catalysed APH of a range of ketones with the 2-
napthalene sulfonyl derivative was found to be most successful allowing 100% 
conversion of a large range of ketones with up to 85% ee.
37
 
1.2.3 Transfer hydrogenation of ketones with transition metal catalysts. 
Catalytic transfer hydrogenation provides a mild process for reduction of saturated 
compounds, often carbonyl compounds. It is generally considered to be safer than 
pressure hydrogenation as the use of hydrogen donors to supply hydrogen to the 
substrate removes the need to use pressurised hydrogen gas. As shown in Scheme 
10, hydrogen is donated from a donor molecule such as 2-propanol or formic acid, 
and is accepted by the substrate.  
 
Scheme 10. Asymmetric transfer hydrogenation of ketones. 
 
There are two general inner sphere mechanisms for transfer hydrogenation, a 
monohydride mechanism and dihydride mechanism as shown in Figure 8.
 38
 
The monohydride process involves substitution of the chloride in a metal chloride 
precursor for the hydrogen donor molecule. β-elimination generates a metal hydride 
complex and insertion of the unsaturated substrate into the metal hydride bond forms 
the saturated species. The product is displaced from the complex by a further 
hydrogen donor molecule which then allows continuation of the catalytic cycle. 
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The dihydride mechanism involves replacement of chloride in a metal dichloride 
complex with the hydrogen donor molecule and β-elimination to give a metal 
dihydride complex. Co-ordination of the substrate to the complex followed by 
insertion into the metal hydride bond forms the saturated compound which is 
displaced by reductive elimination to give the product. The hydrogen donor molecule 
re-coordinates to the metal complex via oxidative insertion forming a metal hydride 
complex. A further β-elimination then generates the second metal hydride bond with 
displacement of the now unsaturated donor molecule reforming the metal dihydride 
complex for further hydrogenation of the substrate molecule. 
 
Figure 8. Mono- and Dihydride mechanisms for ATH of ketones. 
An early example of transfer hydrogenation reported in the literature is the Meewein-
Schmidt-Ponndorf-Verley (MSPV) reduction which was reported by Meerwein and 
Schmidt 
39
, Ponndorf
40
 and Verley
41
 independently in the 1920s. Each reported the 
use of a stoichiometric aluminium alkoxide reagent (37) in 2-propanol for the 
transfer of hydrogen to aldehydes and ketones shown in Scheme 11. The reverse of 
this process was later reported by Oppenauer
42
 allowing the oxidation of alcohols.  
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Scheme 11. MSPV reduction of ketones. 
 
The ketone substrate and 2-propanol co-ordinate to the aluminium alkoxide and via a 
6-membered cyclic transition state hydrogen is transferred from 2-propanol to the 
ketone in a concerted manner as shown in Scheme 11.
43
  
Catalytic variations of the MSPV reaction have also been reported. The use of protic 
acids was first reported by Rathke in 1977
44
 where use of 2.5 mol% trifluoroacetic 
acid with 5 mol% Al(O
t
Bu)3 allowed the oxidation of cyclohexanol to 
cyclohexanone with 88% yield using benzaldehyde as the hydrogen acceptor. 
Akamanchi and Noorani later reported the reduction of a range of ketones and 
aldehydes using trifluoroacetic acid.
45 
Using a ratio of substrate:aluminium 
isopropoxide:TFA of 1:0.08:0.003, benzaldehyde was reduced to benzyl alcohol 
with 93% conversion. Rathke proposed that use of the protic acid with oligomeric 
aluminium isopropoxide allows replacement of one or more bridging isopropoxy 
ligands with an anion, increasing the Lewis acidity of the aluminium which improves 
coordination with the carbonyl. 
The use of ligands has also been found to improve the activity of the MSPV 
reduction of aldehydes and ketones as shown in Scheme 12. The use of 
tetraphenylporphyrin aluminium complex 38 was reported by Inoue
46
 and the use of 
binuclear aluminium complex 39 was reported by Maruoka.
47
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Scheme 12. Catalytic MSPV reduction of ketones using aluminium complexes. 
 
Kagan has reported the use of lanthanides as catalysts for the MSPV reduction of 
aldehydes. Use of 0.1 equiv. t-BuOSmI2 at 65°C gave 94% conversion of p-
nitrobenzaldehyde to p-nitrobenzyl alcohol with 2-propanol as the hydrogen donor.
48
 
In a later study, use of lanthanum and cerium iso-propoxides were also reported to be 
highly active for the MSPV reduction of 2-octanone with >98 and 95% yield 
respectively, however ytterbium iso-propoxide was less active.
49 
1.2.4 Asymmetric transfer hydrogenation with transition metal catalysts. 
A broad range of asymmetric transition metal catalysts have been developed for use 
in transfer hydrogenation reactions. 
1.2.4.1 Asymmetric MSPV transfer hydrogenation reactions. 
The MSPV reduction methodology has been expanded in recent years to allow 
asymmetric reduction of carbonyl compounds.  
Evans and co-workers have reported the application of samarium complexes with 
asymmetric tridentate aminoalcohol ligands for the asymmetric MSPV reduction  of 
a range of ketones.
50
 O-chloroaxetophenone was reduced with full conversion and 
Development of catalysts for asymmetric hydrogenation                                                     Introduction 
21 
 
97% (R) ee. in 24 hours at room temperature with 5 mol% catalyst using 2-propanol 
as the hydrogen donor. 
Maruoka has reported the use of (R)-phenyl ethanol as a chiral hydrogen source for 
MSPV-type ATH of α-chloroacetophenone achieving 82% yield and an ee. of 54%. 
Use of sterically encumbered (R)-o-bromophenyl ethanol as the hydrogen source 
showed an improved ee. of 82% although the yield of product was reduced to 51% as 
a result of increased steric hindrance.
51
 
In 2002, Nguyen reported the addition of enantiopure 2, 2’-dihydroxy-1, 1’binapthyl 
(BINOL) to the reduction of a range of ketones as shown in Table 2.
52 
Table 2. ATH of acetophenone derivatives using MSPV methodology. 
 
Entry BINOL R Yield
a
 (%) Ee.
a
 (%) 
1 (S) CH2Cl 99 80 (S) 
2 (R) CH2Cl 99 80 (R) 
3 (S) CH2Br 99 83 (S) 
4 (R) CH2CH3 30 50 (R) 
5 (R) CH3 54 30 (R) 
6 (S) CH(CH3)2 20 61 (S) 
   a
 Determined by GC analysis. 
 
Acetophenone was reduced with 54% yield and 30% ee. however this was seen to 
improve upon the reduction of α-chloroacetophenone achieving a yield of 99% and 
ee. of 80%.
52
 Increasing the number of equivalents of 2-propanol used increased the 
yield of product however enantioselectivity was reduced. 
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1.2.4.2 Ruthenium-catalysed ATH reactions. 
Ruthenium catalysts have also been applied to the ATH reactions. In 2006 Reetz and 
Li reported the use of BINOL derivatives as ligands for ruthenium-catalysed ATH of 
ketones. Ligand 40 (Figure 9) was found to be the most effective giving 91% 
conversion of acetophenone to (R)-phenyl ethanol with 97% ee. in 28 hours with 0.5 
mol% ruthenium using 2-propanol and KOH at 40°C.
53
 
 
Figure 9. Structure of BINOL derived ligand 40 used for ATH of ketones. 
 
Wills and co-workers have recently reported the first use of asymmetric tridentate 
triazole containing ligands, such as 41 in Scheme 13, with Ru3(CO)12 for the ATH of 
ketones.
54
 The reaction was found to proceed well with use of the ruthenium 
dodecacarbonyl precursor, other ruthenium sources gave low conversion to product 
with low enantioselectivity. Use of formic acid as the hydrogen source was 
detrimental to the reaction with no reaction taking place, whereas use of 2-propanol 
lead to high yields and enantioselectivities of product. 
 
Scheme 13. ATH of acetophenone using tridentate ligand 41. 
Development of catalysts for asymmetric hydrogenation                                                     Introduction 
23 
 
1.3 Hydrogenation via metal ligand bifunctional catalysis. 
The hydrogenation catalysts discussed thus far have primarily operated via inner 
sphere mechanisms involving interaction of the substrates with the metal centres 
themselves by co-ordination or insertion into metal hydride bonds. A development to 
this strategy was realised by Noyori who developed catalysts for pressure and 
transfer hydrogenation of ketones via an outer sphere mechanism in which the 
substrate does not bind directly to the metal centre and instead interacts with a metal 
coordinated hydride and protonated ligand on the catalyst.
55
 This allows selective 
hydrogenation of polar bonds such as C=O as the mechanism delivers both a 
negatively charged hydride and positively charged proton to the substrate for 
interaction with the δ+ C and δ- O of the C=O bond respectively. The process is 
referred to as metal ligand bifunctional catalysis as both the metal and ligand 
participate in the catalytic cycle.  
An example of this within the context of APH is the further development of the 
ruthenium-BINAP system (shown in Figure 7) by Noyori. The addition of a second 
asymmetric ligand in the form of an asymmetric diamine, to the ruthenium-BINAP 
to give complex 42 was reported by Noyori in 1998.
56
 This system offered 
significant advantages over the earlier system using just a BINAP ligand by allowing 
selective hydrogenation of C=O bonds in the presence of C=C functionality as 
shown in Scheme 14. 
 
 
 
 
 
 
Scheme 14. APH of 4,4-dimethyl-2-cyclohexen-1-one using ruthenium BINAP/DPEN catalyst 42. 
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Catalyst 42 uses an (S)-BINAP and (S,S)-DPEN ligand to impose asymmetry on 
substrates. This system is tolerant to low catalyst loadings (S:C 50,000:1) and low 
hydrogen pressures. The mechanism of hydrogenation has been widely studied.
57, 58
 
The chloride ligands in 42 are replaced with hydride ligands and a 6-membered 
cyclic transition state is then formed between the metal hydride and protonated 
diamine ligand with the ketone substrate (Figure 10 A). A hydride is then transferred 
to the δ+ carbon of the carbonyl group and the δ- oxygen coordinates with the proton 
on the nitrogen of the amino ligand eliminating the product as a specific enantiomer. 
Potassium alkoxide is also used in the reaction and is reported by Chen and 
Hartmann
59
 to act as a Lewis acid interacting with the nitrogen to properly position 
the alkoxide base to assist with cleavage hydrogen for formation of the active 
ruthenium dihydride complex as shown in Figure 10 B.  
 
 
 
Figure 10. Transition states for hydrogenation of ketones with catalyst 42. 
Wills has also reported the use of phosphine-diamine ruthenium complexes for the 
APH of ketones as shown in Scheme 15. Use of BINOL with DPEN to give complex 
43 was found to be the most effective complex.
60 
 δ 
  δ 
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Scheme 15. APH of acetophenone using ruthenium complex 43. 
The reaction is believed to proceed via the same transition state as with the 
BINAP/DPEN complex 42 reported by Noyori (Figure 10).
56 
Transition metal complexes have also been used for ATH of ketones via metal ligand 
bifunctional catalysis methodology. Noyori and Gao have reported the use of 
diimino/diaminodiphosphine ligands such as 44 and 45 below with ruthenium, 
rhodium and iridium metals.
61-64
 In 1996 and 2000, Noyori and Gao reported the use 
of ruthenium with ligand 45 to afford highly enantioselective hydrogenation of 
ketones.
61, 62
 Ligands 44 and 45 were also combined with [RuCl2(DMSO)4] and 
refluxed in toluene to form complexes 46 and 47 (Figure 11). 
 
 
Figure 11. Diimino/diaminodiphosphine ligands and ruthenium complexes used for ATH of ketones. 
 
The complexes were then applied to the ATH of a series of ketones with the results 
summarised in Table 3. 
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Table 3. Use of diimino/diaminodiphosphine ruthenium complexes for ATH of ketones. 
 
Entry R Catalyst 
Temp 
(°C) 
Time 
(hours) 
Yield
a
 
(%) 
Ee.
a
 
(%) 
1 H (S,S)-46 23 48 3 18 (R) 
2 H (S,S)-46 82 4 7 5 (R) 
3 H (R,R)-47 23 25 91 97 (S) 
4 H (S,S)-47 45 7 93 97 (R) 
5 o-Cl (S,S)-47 45 5 15 91 (R) 
6 m-Cl (S,S)-47 45 6 99 95 (R) 
7 p-Cl (S,S)-47 45 5 95 94 (R) 
8 p-CN (S,S)-47 45 6 99 89 (R) 
9 p-F (S,S)-47 45 6 97 80 (R) 
10 m-OCH3 (S,S)-47 45 6 74 95 (R) 
11 p-OCH3 (S,S)-47 45 6 67 58 (R) 
        a Determined by GLC analysis. 
 
The diiminodiphosphine complex 46 was found to be relatively inactive to transfer 
hydrogenation conditions (Table 3, entries 1 and 2), whilst the amine derivative 
(complex 47) was found to be highly active demonstrating the importance of the NH 
functionality in the reaction. The reaction is reported to proceed under kinetic control 
with a low level of reversibility and high level of differentiation between 
enantiomeric transition states leading to the high enantioselectivities observed. An 
increase in the concentration of base within the reaction was found to increase the 
rate of reaction but reduce the enantioselectivity, presumably by increasing the rate 
of reaction of the unfavoured enantiomeric transition state increasing the amount of 
the unwanted enantiomer present in the product.  
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These findings were mirrored in the application of the rhodium derivatives of 
complexes 46 and 47 to APH of ketones.
62, 63
 Ligands 44 and 45 were combined with 
[Rh(COD)Cl2]2 and an appropriate anion to give complexes 48-51 (Figure 12). These 
were then applied to the ATH of ketones and the results are shown in Table 4.
63 
 
Figure 12. Diaminodiphosphine rhodium complexes for ATH of ketones. 
 
Table 4. Application of rhodium complexes for ATH of ketones. 
 
Entry Catalyst 
Time 
(hours) 
Yield
a
 (%) Ee.
a
 (%) 
1 
[Rh(COD)Cl]2 +  
(R,R)-44 
9 56 36 (S) 
2 (R,R)-48 7 40 40 (S) 
3 (R,R)-49 7 97 91 (R) 
4 (R,R)-49
b
 24 85 89 (R) 
5 (R,R)-50 7 98 80 (R) 
6 (R,R)-51 9 87 86 (S) 
a Determined by GC. bSubstrate/catalyst 400/1 
Again the imine complex (48) was found to be less active to ATH than the amine 
complexes. Use of PF6 as the anion with the amine complex gave the best 
enantiomeric excess of product (complex 49). 
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In more recent studies, Gao has also applied iridium derivatives of the complexes to 
ATH of ketones shown in Scheme 16.
64 
 
Scheme 16. Application of iridium diaminodiphospine complex 52 to APH of propiophenone. 
 
Other examples of iridium catalysts for ATH applications include the use of 
[Ir(COD)Cl]2 with TsDPEN reported by Lamaire for the hydrogenation of β-keto 
esters, however yields and conversions obtained were low.
65
 
1.3.1 Metal ligand bifunctional catalysis with phosphine free catalysts. 
In the mid 1980s Shvo reported the use of a tetraphenylcylcopentadienyl ruthenium 
carbonyl dimer for hydrogenation and dehydrogenative applications.
66
 Initially the 
structure of the complex was assigned as [(η4-Ph4C4CO)(CO)2Ru]2 however 
1
H 
NMR analysis of the compound indicated the presence of a hydride with a signal at -
17.75 ppm.
67
 Replacing two of the phenyl groups with p-Cl-(C6H4) groups allowed 
an X-ray structure to be obtained showing the dimer to have the structure shown 
below with a bridging hydride between the two ruthenium centres and a bridging 
proton between the two oxygen atoms. Use of complex 53 in the dehydrogenation of 
an alcohol gave two complexes 54 and 55 which were presumed to form via 
fragmentation of the bridging hydrogen atoms. A catalytic cycle was proposed for 
complex involving interaction with hydrogen and hydrogen transfer between 
alcohols and ketones as shown in Scheme 17.
67
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Scheme 17. Interaction of Shvo catalyst 53 with hydrogen and transition state for transfer 
hydrogenation of ketones. 
 
In 1985 Shvo reported the application of complex 53 to the pressure hydrogenation 
of ketones however high pressures and temperatures were required.
68
 The 
hydrogenation of acetophenone is shown in Scheme 18. 
 
Scheme 18. Pressure hydrogenation of acetophenone with complex 53. 
 
Shvo also reported the application of the complex to transfer hydrogenation with 
formic acid as the hydrogen source as in Scheme 19. Addition of a small amount of 
water and sodium formate prevented formation of the formate adduct of the desired 
alcohol product.
69 
 
Scheme 19. Transfer hydrogenation of ketones with complex 53. 
 
1.3.1.1 Ruthenium half sandwich complexes. 
In 1995, Noyori reported the preparation and application to ATH of ketones of a new 
type of ruthenium half sandwich catalyst such as 54 shown in Figure 13.
70
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Figure 13. Ruthenium half sandwich complex 54 developed by Noyori. 
 
The catalyst consists of an η-6 bound arene, an asymmetric diamine (TsDPEN) and a 
chlorine ligand and is prepared from the reaction of [Ru(benzene)Cl2]2 dimer and 
TsDPEN with either 1 equivalent of KOH in DCM or with 2 equivalents of Et3N in 
2-propanol at 80°C. The catalyst can also be prepared in situ and in this manner was 
applied to the ATH of a range of ketones and the results are shown in Table 5.
70 
Table 5. In situ formation of ruthenium half sandwich complexes and application to ATH of ketones 
with 2-propanol as the hydrogen donor. 
 
Entry R
1
 R
2
 Time 
(hours) 
Yield
a
 
(%) 
Ee.
b
 
(%) 
1 H Me 15 95 97 (S) 
2 H Et 14 94 97 (S) 
3 o-Me Me 24 53 91 (S) 
4 m-Cl Me 2.5 98 98 (S) 
5 p-Cl Me 19 95 93 (S) 
6 m-OMe Me 16 96 96 (S) 
7 p-OMe Me 20 53 72 (S) 
 Substrate    
8 Tetralone 27 65 97 (S) 
9 1’-acetonapthone 62 92 93 (S) 
10 2’-acetonapthone 16 93 98 (S) 
           a
 Determined by GLC or 
1H NMR. b Determined by GLC or HPLC. 
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The use of 2-propanol as a hydrogen donor however has its drawbacks. It allows 
reversibility within the ATH reaction, as both the IPA and product are similar, both 
being secondary alcohols. The desired alcohol product can act as the hydrogen donor 
to the catalyst reforming the ketone substrate.
71
 This reverse reaction is detrimental 
to both the yield of product and its enantiopurity. It is therefore important to use the 
right concentration of substrate within an ATH reaction and also control the time of 
the reaction in order to limit the exposure of the reaction mixture to the catalyst.  
Noyori reported that the use of a 1 M substrate concentration in the reaction mixture 
showed an initial enantiomeric ratio for the product of (S):(R) 99:1 however at a 
conversion of 75% this had reduced to 97:3.
70
 The reverse reaction of the 
dehydrogenation of phenyl ethanol was found to be ~2 orders of magnitude faster for 
(S)-phenyl ethanol than for the (R) enantiomer with use of (S,S)-TsDPEN in the 
catalyst. This therefore means that as well as reducing the product yield the reverse 
reaction also reduces the enantiomeric excess of the remaining product. The reaction 
is enantioselective in both the forward and reverse direction and over time there is a 
tendency towards racemisation. The equilibrium composition of the reaction mixture 
with a 1 M concentration of acetophenone was found to be 80:20 phenyl 
ethanol:acetophenone thus under sufficient reaction time, full conversion is not 
theoretically possible in this system.
70 
In order to maximise the conversion and enantioselectivity of ATH with hydrogen 
donation by 2-propanol it is necessary to use low concentrations of substrate, 
typically ~ 0.1 M. 
The use of formic acid as the hydrogen donor offers a solution to the problem of 
reversibility in ATH reactions. Dehydrogenation of formic acid is irreversible thus 
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increased reaction concentrations, conversions and enantioselectivities are possible. 
Noyori reported the use of an azeotropic mixture of formic acid:triethylamine 5:2 for 
the ATH of a range of ketones and the results are shown in Table 6.
71 
Table 6. Application of complex 55 to ATH of ketones with formic acid as the hydrogen donor. 
 
Entry R
1
 R
2
 
Time 
(hours) 
Yield 
(%) 
Ee.
a
 (%) 
1 Ph Me 20 >99 98 (S) 
2
c Ph Me 1.5 >99 96 (S) 
3 m-Cl Me 21 >99 98 (S) 
4 p-Cl Me 24 >99 95 (S) 
5 p-CN Me 14 >99 90 (S) 
6 m-OMe Me 50 >99 98 (S) 
7 p-OMe Me 60 >99 97 (S) 
8 H Et 60 96 97 (S) 
9 H (CH2)3CO2Et 90 99 95 (S) 
 Substrate    
10 Tetralone 48 >99 99 (S) 
11
b Tetralone 6 >99 98 (S) 
12 1’-acetonapthone 60 93 83 (S) 
13 2’acetonapthone 22 >99 96 (S) 
aDetermined by GC bReaction carried out at 60°C. 
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The ATH of a range of acetylenic ketones has also been reported by Noyori. For 
example, the ATH of 4-phenyl-3-butyn-2-one proceeded with >99% conversion and 
97% (S) ee. as shown in Scheme 20.
72
 
 
Scheme 20. ATH of 4-phenyl-3-butyn-2-one using complex 55. 
 
The ATH of acetylenic ketones proceeds well with 2-propanol as the hydrogen 
donor. Although the reverse reaction is still possible, the product is favoured more at 
equilibrium than with aromatic ketones, therefore higher substrate concentrations can 
be used without the racemisation observed with aromatic ketones. Noyori reports the 
ATH of a 1 M solution of 4-phenyl-3-butyn-2-one using the 16 electron complex 56 
to give a 94% yield and 95% ee. of product and use of a 5 M solution was found to 
give an ee. of 94% although the yield was reduced to 58% in 41 hours (Figure 14).
72
  
 
Figure 14. Structure of 16 electron complex 56. 
 
Use of formic acid as a hydrogen donor was reported to give low conversions for the 
ATH of acetylenic ketones as shown in Figure 15. The p-cymene catalyst 57a was 
found to deactivate under the reaction conditions with irreversible coordination of 
the C≡C bond to the ruthenium to form complex 57b in Figure 15. This prevents 
interaction of the complex with hydrogen.
72 
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Figure 15. Deactivation of catalyst by irreversible coordination to alkyne bonds. 
 
Wills has also reported the use of Noyori-type ruthenium half-sandwich complexes 
as catalysts for ATH of α, β-unsaturated ketones such as shown in Scheme 21.73 
 
Scheme 21. ATH of 2-phenyl-2-cyclohexen-1-one using complex 57a. 
  
1.3.1.2 Structure of ruthenium half sandwich complexes. 
Noyori has reported X-ray structures for the catalyst the series of reaction 
intermediates
74
 – the catalyst precursor, the active catalyst and the ruthenium hydride 
complex shown in Figure 16. 
 
Figure 16. Ruthenium half sandwich catalyst pre-cursor (57a), 16 electron (56) and hydride (58) 
complexes. 
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The catalyst precursor 57a has 18 electrons and is reported to have a distorted 
octahedral structure with three chiral centres, two within the diamine and the third 
being the ruthenium. The coordination of the diamine to the ruthenium forms a 5-
membered ring and it is this that determines the configuration of the catalyst at the 
ruthenium. Use of (S,S)-TsDPEN gives an (R) configuration at the ruthenium. 
1
H 
NMR analysis found the complex to exist as a single diastereomer in CDCl3.
74 
The 16 electron complex 56 is formed from 57a via elimination of HCl by a base 
such as KOH. The length of the HN-Ru bond shown in the X-ray structure suggested 
a degree of double bond character making the nitrogen lone pair less available than 
in the 18 electron complex. The complex was found to dehydrogenate methanol, 
ethanol and 2-propanol to give complex 58 with a Ru-H bond and protonated 
amine.
73
 Complexes 56 and 58 were found to catalyse the ATH of acetophenone in 
IPA without the need for KOH, showing that the presence of KOH in the reaction 
mixture is necessary only for generation of the 16 electron complex 56.
74
 
1.3.1.3 Mechanism of asymmetric transfer hydrogenation using ruthenium 
half sandwich catalysts. 
The ATH mechanism is shown in Scheme 22.
75
 As mentioned previously, under 
ATH conditions with the presence of base, the 18 electron catalyst precursor (54 in 
Scheme 22) undergoes loss of HCl to form a 16 electron species (59 in Scheme 22). 
The 16 electron species then interacts with the hydrogen donor (2-propanol in 
Scheme 22) forming a 6-membered pericyclic transition state whereby hydrogen is 
transferred to the 16 electron species to again form an 18 electron species with a 
ruthenium hydride and protonated amine (60). The hydride and proton are 
transferred to the substrate via a further cyclic transition state to afford the desired 
product and reform the 16 electron species. 
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Scheme 22.Mechanism for ATH of ketones using ruthenium half sandwich complexes. 
 
Much evidence has been reported that supports this ATH mechanism
74,76,77
 however 
there are also reports that suggest an alternative mechanism. For example Xiao 
reported that the rate of the reaction increased with use of water and a co-solvent 
with the degree of acceleration of the reaction increasing with the polarity of the 
cosolvent.
78 
This suggests that transition states within the reaction must be polar and 
possess a dipole. The pericyclic mechanism proposed by Noyori would not show a 
solvent effect as both the catalyst and reactants possess a similar charge distribution. 
Meijer studied the molecular dynamics of the reaction and found that the concerted 
mechanism was predicted in a gas phase reaction, however in solution phase the 
reaction mechanism became sequential.
79,80
 In water, the hydride was found to 
transfer to the substrate with the proton being transferred by water at a later stage.  
Recently, Ikariya has published the results of further studies into the reaction 
mechanism and proposed a non-concerted mechanism shown in Scheme 23.
81
 After 
formation of the 16 electron species 59, the ruthenium initially coordinates with the 
2-propanol solvent and a proton is transferred to the amino nitrogen to form a 
ruthenium-alkoxide complex 62. The alkoxide is then displaced and the hydride is 
transferred to the ruthenium to form complex 60 and acetone. The hydride is then 
transferred to the substrate forming an alkoxide which first hydrogen bonds with the 
proton on the amino group of the ligand (64) and is then transferred to the ruthenium 
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to give complex 65. The substrate is then displaced with addition of a proton from 
the nitrogen (66) to again form the 16 electron species (59). 
 
Scheme 23. Mechanism of ATH using ruthenium half sandwich complex 59 proposed by Ikariya. 
 
In 2004 Ikariya reported insights into the mechanism of ATH of ketones using 
formic acid as the hydrogen with Noyori-type catalysts.
82
 The reaction of the 16 
electron complex 59 with formic acid first gave a formate complex which underwent 
decarboxylation to give ruthenium hydride complex 61 and CO2. This can then react 
with CO2 to reform the formate complex. The catalyst also promotes hydrogenation 
of CO2 to form formic acid and it is therefore important to remove CO2 from ATH 
reactions. 
1.3.1.4 Further derivatives of half sandwich complexes for ATH applications. 
The use of asymmetric amino alcohols as ligands in place of the TsDPEN in 
ruthenium half sandwich complexes has also been investigated. Noyori first reported 
the use of this type of catalyst in 1996
83 
showing high activity for the ATH of 
ketones as shown in Scheme 24. 
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Scheme 24. ATH of acetophenone using asymmetric amino alcohol ligands 67 and 68. 
 
More recently, Wills and co-workers have used asymmetric amino alcohol ligands 
with [Ru(p-cymene)Cl2]2 for the ATH of ketones as shown in Scheme 25.
84 
 
Scheme 25. Application of amino acid ligand 69 to ruthenium-catalysed ATH of acetophenone. 
 
Puntener and co-workers have since reported the use of a range of amino alcohol 
ligands demonstrating excellent activity for selective ATH of C=O bonds in the 
presence of C=C bonds.
85
 
Wills has reported results of investigations into the effects of N-substituents on the 
TsDPEN ligand of Noyori-type complexes.
87,88
 The use of N-benzyl-N’-tosyl-DPEN 
was reported to give an ineffective catalyst when p-cymene was used as the aryl 
ligand, however when benzene was used the activity of the system was increased 
achieving 97% conversion of acetophenone to (R)-phenyl ethanol with 95% ee. in 7 
days.
87
 Other N-substituted derivatives of TsDPEN were prepared and used with 
[Ru(benzene)Cl2]2 dimer to give complexes 54 and 70-75 which were applied to the 
ATH of acetophenone as shown in Table 7.
86 
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Table 7. ATH of acetophenone using N-alkylated ruthenium complexes. 
 
Entry Complex Time 
Yield 
(%) 
Ee.
a
 
(%) 
1 54 26 hours 99 95 (R) 
2 70 11 hours 99 96 (R) 
3 71 3 days 99 96 (R) 
4 72 3 days 99 96 (R) 
5 73 7 days 88 98 (R) 
6 74 7 days 97 95 (R) 
7 75 7 days 97 96 (R) 
         a Determined by GC. 
 
All N-substituted complexes showed excellent activity and enantioselectivity for the 
hydrogenation of acetophenone, with complex 70 giving the best results. A decrease 
in activity was seen for complexes 71-75 with increasing steric bulk of the 
substituent group. The complexes were also applied to the ATH of 6,7-dimethoxy-1-
methyl-3,4-dihydroisoquinoline giving full conversion and high enantiomeric 
excesses with complexes 54 and 70 providing the highest rate of reaction. Complex 
74 with increased steric hindrance gave the highest enantioselectivity of 85% ee. 
Further work looked at the effect of the degree of substitution on the aryl ligand of 
N-benzyl substituted complexes. Reactivity and enantioselectivity was found to 
decrease upon aryl substitution.
87
 
Wills et al. has also reported the use of a rhodium derivative of Noyori-type catalysts 
for the ATH of ketones. Use of [Rh(C5Me5)Cl2]2 with (R,R)-TsDPEN gave 
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contrasting results to use of [Ru(p-cymene)Cl2]2 for the ATH of chloro and hydroxy 
substituted acetophenone as shown in Scheme 26.
88
 
 
Scheme 26. Application of ruthenium and rhodium half-sandwich catalysts to ATH of α-chloro and 
α-hydroxy acetophenone. 
 
Interestingly, it was also reported that upon subjection of α-tosyloxyacetophenone 75 
to ATH conditions, the use of [Rh(C5Me5)Cl2]2 and (R,R)-TsDPEN gave (R)-2-
tosyloxy-1-phenylethanol 76 with 93% ee. whilst use of [Ru(p-cymene)Cl2]2 and 
(R,R)-TsDPEN gave a cyclic carbonate product 78 with 94% (S) ee.
88
 It was 
proposed that the carbonate formed via hydrogenation of the C=O bond followed by 
formation of phenacylformate 77 which cyclises to give 78 as shown in Scheme 27. 
 
Scheme 27. Reaction of -tosylacetophenone with rhodium and ruthenium catalysts under ATH 
conditions. 
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1.3.1.5 Aqueous ATH of ketones with ruthenium half sandwich complexes. 
The use of water as a solvent for ATH of ketones using Noyori-type complexes has 
also been investigated as a more economical and environmentally solvent than the 2-
propanol or formic acid/Et3N that has conventionally been used. The first report of 
this was by Xiao and co-workers in 2005.
89
 Initial attempts looked at the addition of 
water to the use of formic acid/Et3N azeotrope as the hydrogen source.
90
 
Improvements to the activity of the system were seen with use of aqueous formic 
acid/Et3N with the pH of the reaction solution maintained at 5-8 by addition of 
Et3N.
89
 Further studies were made using sodium formate as a water soluble 
alternative hydrogen source to formic acid/Et3N.
90
 Table 8 shows a comparison of 
the results for the ATH of acetophenone with a range of hydrogen sources.
70-71, 89-90 
Table 8. Comparison of the ATH of acetophenone in formic acid, 2-propanol and water solvents. 
 
 
 
Entry H2 source S/C Solvent 
Temp 
(°C) 
Time 
(hr) 
Conv. 
(%) 
Ee.
a
 
(%) 
1
 2-propanol/KOH 200/1 2-propanol RT 15 95 97 (S) 
2
 
Formic acid/Et3N 5/2 200/1 - 28 20 >99 98 (S) 
3
 
Formic acid/Et3N 5/2 100/1 Water 40 12 98 97 (R) 
4 Formic acid/Et3N 1.2/1 100/1 Water
b 
40 1.5 100 97 (R) 
5 Sodium formate 100/1 Water 40 0.5 76 95 (R) 
aDetermined by GC. bpH of reaction maintained at pH5-8 with addition of Et3N. 
 
Complex 57 showed a relatively slow rate of reaction for the ATH of acetophenone 
in 2-propanol
70
 and formic acid/Et3N
71
 compared to the reaction carried out in water 
(entry 3)
90
; in water with pH 5-8 (entry 4)
89
 and that carried out with sodium formate 
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and water (entry 5).
90
 To further understand the mechanism of the ATH reaction 
carried out in water, Xiao investigated the effect of pH on the reaction, and proposed 
two competing catalytic cycles.
89
 At low pH, the tosylamine of the diamine ligand is 
protonated leading to its partial dissociation from the ruthenium centre. This 
dissociation will reduce the rigidity and hence enantioselectivity of the complex, thus 
the pH of the reaction should be maintained at 5-8 for the duration of the reaction to 
achieve maximum activity and enantioselectivity. 
1.3.1.6 Asymmetric pressure hydrogenation of ketones with Noyori catalysts. 
Noyori has also reported the application of catalyst 57a to asymmetric pressure 
hydrogenation achieving high conversions and enantioselectivities of chromanones 
and α-chloro aromatic ketones as shown in Scheme 28.75, 91 
 
Scheme 28. APH of chromanone and α-chloroacetophenone with complex 57a. 
 
Use of the triflate form of the catalyst was found to give improved results over the 
chloride, and indeed Ohkuma developed a related catalyst based on an iridium 
triflate and it too was found to allow effective hydrogenation of ketones with 
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hydrogen gas.
92
 The application of the catalyst to the APH of α-
hydroxyacetophenone is shown in Scheme 29. 
 
Scheme 29. APH of α-hydroxyacetophenone using iridium catalyst 79. 
The enhanced activity of the triflate catalyst over its chloro derivative for APH of 
ketones is explained when the reaction mechanism for APH is considered. 
1.3.1.7 Mechanism of asymmetric pressure hydrogenation using ruthenium 
half sandwich catalysts. 
The mechanism of APH with ruthenium half-sandwich complexes is shown in 
Scheme 30. Under APH conditions the catalyst precursor undergoes loss of chloride 
by ionisation to give cationic complex 80 which possesses a vacant co-ordination 
site for interaction with molecular hydrogen. Heterolytic cleavage of the H-H bond 
then allows formation of the ruthenium hydride species 60 as with ATH. The 
hydrogenation of the substrate proceeds via a cyclic transition state as for ATH.
75, 93 
Scheme 30. Mechanism of APH of ketones using ruthenium half sandwich complexes. 
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The use of ruthenium triflate complexes as shown in Schemes 28 and 29 is believed 
to lead to an increased rate of ionisation in the first step of the mechanism and indeed 
an increased rate of catalyst activation. Silver salts, known to readily interact with 
halides, have also been used to improve the rate of ionisation and activation of the 
catalyst.
94 
1.3.1.8 Derivatives of half-sandwich metal complexes for APH applications. 
Xiao has reported the use of rhodium and iridium derivatives of Noyori-type 
catalysts for the APH of imines as shown in Scheme 31.
94, 95
 
 
Scheme 31. Application of rhodium and iridium complexes to APH of imines. 
 
1.3.2 Tethered ruthenium complexes for ATH and APH of ketones. 
In 2004, Wills and co-workers reported the synthesis and application of a new class 
of half-sandwich ruthenium complex to the hydrogenation of ketones incorporating a 
tether between the aryl and diamine ligand as shown in Scheme 32.
96
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Scheme 32. Synthesis of tethered ruthenium complex 88. 
 
Ruthenium complexes 87 and 88 were applied to the ATH of acetophenone as shown 
in Scheme 33. 
 
Scheme 33. Application of tethered ruthenium monomer 88 and dimer 87 to ATH of acetophenone. 
 
The dimeric (87) and monomeric (88) forms of the catalyst were found to be highly 
active for the ATH of acetophenone and a series of aromatic ketones.
96
 Recently 
Mohar has reported the preparation of a similar tethered catalyst and found excellent 
activity and enantioselectivity for the ATH of 1-napthyl ketones (Scheme 34).
97
 
 
Scheme 34.  ATH of 1-acetonapthone with catalyst 89. 
 
Development of catalysts for asymmetric hydrogenation                                                     Introduction 
46 
 
Wills and co-workers have reported an alternative synthesis for catalysts of type 88 
which avoids the hazardous Birch reduction for formation of the diene via a [4+2] 
cycloaddition.
98
 The synthesis of the analogous complexes (92a-d) is shown in 
Scheme 35. 
 
Scheme 35. Synthesis of tethered ruthenium catalysts 92a-d by an initial [4+2] cyclisation. 
 
The catalysts prepared were subjected to the ATH of acetophenone however each 
was less active than catalyst 88, with the best being 92a achieving 88% conversion, 
63% ee. in 96 hours with 0.25 mol% dimer in formic acid/Et3N 5/2 at 40°C.
98
 
Further investigations into the position of the tether within the complex by the Wills 
group found that tethering the aryl ligand to the amino rather than sulfonamide 
nitrogen gave a significantly more active catalyst as shown in Scheme 36.
99. 
Scheme 36. Synthesis of 'reverse tethered' ruthenium complex 97. 
Development of catalysts for asymmetric hydrogenation                                                     Introduction 
47 
 
Catalyst 97 was found to show high activity for ATH of ketones allowing the 
formation of (S)-phenyl ethanol with 100% conversion and 96% ee. in 3 hours at 
28°C with 0.5 mol% catalyst.  
Further tethered catalysts, including the use of cyclochexadiamine (98) and the 
incorporation of a benzene ring into the tether (99) as shown in Figure 17, were 
found to be less active than 97.
100 
 
Figure 17. Further derivatives of tethered catalysts. 
 
At 28°C with a catalyst loading of 0.5 mol% catalyst 98 gave only 43% conversion 
to (R)-phenyl ethanol in 66 hours however the ee. was high at 97%. Catalyst 99 was 
more active giving 100% conversion in 12 hours however the ee. was reduced 
slightly to 92% under the same conditions. The activity of catalyst 98 was improved 
with an increase in temperature to 40°C giving (R)-phenyl ethanol in 100% 
conversion and 95% ee.
100 
The incorporation of a tether within the aryl/diamine half sandwich ruthenium 
complexes has been found to give a more stable structure. Catalyst 88 gave full 
conversion of acetophenone to phenyl ethanol within 24 hours, upon which more 
acetophenone and formic acid/Et3N 5/2 was added and full conversion was achieved 
in 73 hours and upon further addition again full conversion was reached in 176 hours 
each time without a reduction in the ee.
99
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1.3.2.1 Structural and mechanistic insights for application of tethered 
ruthenium catalysts to ATH of ketones. 
The preparation of a range of catalysts with different tether lengths and a range of 
aryl substituent groups allowed for further insights into the structure and mechanism 
of action of the catalysts.
101,102
 The catalysts prepared are shown in Figure 18 and 
results of their application to the ATH of acetophenone are given in Table 9. 
 
Figure 18. Structures of tethered catalysts with a variety of tether lengths and aryl substituents. 
 
Table 9. Application of catalysts 97 and 100-104 to the APH of acetophenone. 
 
Entry Catalyst 
Time 
(hours) 
Conv. (%) Ee.
a
 (%)
 
1 100 15 19 92 (R) 
2 97 2 100 96 (R) 
3 101 1.25 100 96 (R) 
4 102 6 38 94 (R) 
5 103 4 100 96 (R) 
6 104 5 100 93 (R) 
    a
Determined by GC. 
 
Complex 101 was the most active of the catalysts both as the monomer shown above 
and also in its dimeric form. Kinetic studies revealed this increase in activity to be 
due to an increased rate of ruthenium hydride formation and ketone reduction. For 
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the other catalysts tested, the overall rate of the reaction was limited by their rate of 
hydride formation. 
Andersson has reported that the H-Ru-NH angle in Noyori-type catalysts is 
important for the catalytic process with a smaller angle giving an increase in reaction 
rate.
103
 It is thought that the smaller angle gives a catalyst that is better pre-organised 
for efficient hydrogen transfer. In catalyst 101 with a four-carbon tether, although an 
X-ray structure of the ruthenium-hydride complex has not been reported, inspection 
of the X-ray for the chloride complexes shows 101 to have the smallest Cl-Ru-N-H 
angle of 3.04° compared to 4.59° in the parent three carbon tethered catalyst 97. If 
this pattern is retained upon formation of the ruthenium hydride complexes then this 
would explain the high reactivity of catalyst 101. 
In addition to providing a more stable structure for the catalysts, the tether also 
prevents rotation of the aromatic ring. The addition of substituent groups to the 
aromatic ring could therefore be used to affect the selectivity or activity of the 
catalyst as their position within the catalyst would be fixed rather than existing in an 
equilibrium environment as in Noyori’s untethered catalysts due to rapid rotation of 
the aromatic ring. Reaction of the complexes with cyclohexyl methyl ketone showed 
complex 104 to give the highest ee. of 90%.
101
 It is believed that the additional 
methyl groups on the aromatic ring, fixed in position with the addition of the tether 
to the catalyst enhance the preference for the substrate to adopt the favoured 
transition state shown in Figure 19, in order to minimise steric clash between the 
cyclohexyl ring and the methyl groups. 
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Figure 19. Cyclic transition states for ATH of cyclohexylmethyl ketone with catalyst 104. 
 
1.3.2.2 O-Tethered ruthenium catalysts. 
In late 2011 and early 2012 both Ikariya 
104
 and Wills
105
 independently reported the 
synthesis and use of four atom ether tethered catalysts 105-107 as shown in Scheme 
37. The catalyst showed improved activity for ATH of ketones over the conventional 
carbon tethered catalysts. Another benefit offered by this catalyst is that its 
preparation is achieved by use of a [4+2] cycloaddition to afford the required diene 
as reported by Wills
98 
rather than the hazardous Birch reduction. 
 
 
 
 
 
 
Scheme 37. Application of ether tethered ruthenium catalysts to the APH of acetophenone. 
 
1.3.2.3 Tethered rhodium catalysts. 
In 2004, Wills and co-workers reported the use of a tethered rhodium catalyst for the 
ATH of ketones.
106
 Initially asymmetric amino alcohol ligands were used however 
later reports showed the use of asymmetric N-(p-tosyl)-1,2-cyclohexanediamine or 
TsDPEN as ligands gave improved enantioselectivity for product formation.
107, 108
 
The results are shown in Table 10. 
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Table 10. ATH of acetophenone with tethered rhodium catalysts 108, 109a and 109b. 
 
Entry Catalyst Base Solvent Time 
(hours) 
Conv.
a
 
(%) 
Ee.
b
 
(%) 
1 108 (5 mol%) KO
t
Bu 2-propanol 10 min. 95 68 (R) 
2 109a (0.5 mol%) - 
Formic 
acid/Et3N 5/2 
2 100 96 (R) 
3 109a (0.5 mol%) - 
Water/sodium 
formate 
3 100 96 (R) 
4 109b (0.5 mol%) - 
Formic 
acid/Et3N 5/2 
10 100 98 (R) 
aDetermined by 1H NMR. bDetermined by chiral HPLC. 
1.3.2.4 APH with tethered catalysts. 
Although Noyori-type untethered ruthenium catalysts have successfully been applied 
to the APH of ketones, there is little precedent in the literature for the application of 
tethered ruthenium catalysts to the APH of ketones. In 2007 Wills and Morris 
reported the application of the three carbon tethered catalyst 97 to the APH of α-
chloro acetophenone as shown in Scheme 38.
109 
 
Scheme 38. Application of catalyst 76 to APH of α-chloroacetophenone. 
 
In the more recent publication, Ikariya reported the application of the O-tethered 
catalyst 105 and the 4C tethered catalyst 106 to the APH of a range of ketones, 
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revealing 105 to be highly active for this application.
104
 Compared to O-tethered 
catalyst 105, the four carbon tethered catalyst 106 was found to be less active for 
APH at very low loadings. The results are summarised in Table 11. 
Table 11. Application of catalysts 105, 106 and 108 to APH of ketones. 
 
 
Entry R
1 
R
2 
Catalyst S/C 
Time 
(hours) 
Yield 
(%) 
Ee.
a
 
(%) 
1 Ph CH3 (R,R)-105 500/1 20 58 90 (R) 
2 Ph CH3 (R,R)-107 500/1 20 99 95 (R) 
3 Ph CH2OH (R,R)-105 5000/1 18 99 93 (S) 
4 Ph CH2OH (S,S)-106 5000/1 18 35 89 (R) 
 Substrate      
5 4-Chromanone (R,R)-105 1000/1 20 99 99 (R) 
6 4-Chromanone (R,R)-107 1000/1 20 99 97 (R) 
7 1-Indanone (R,R)-105 1000/1 18 59 98 (R) 
8 1-Indanone (R,R)-107 1000/1 18 97 98 (R) 
9 1-Tetralone (R,R)-105 1000/1 18 52 >99 (R) 
10 1-Tetralone (R,R)-107 1000/1 18 85 >99 (R) 
aDetermined by GC or HPLC. 
 
1.3.3 Polymer supported catalysts for hydrogenation of ketones. 
Supporting a catalyst on a polymer offers several advantages to a reaction, in 
particular the opportunity for facile and efficient recovery of the catalyst after the 
reaction. This not only reduces the costs involved in purifying reaction products to 
ensure residual catalyst is removed but also allows for the catalysts to be recycled 
and used in subsequent reactions.  
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The use of poly(ethylene glycol) (PEG) as a soluble polymer support for 
hydrogenation catalysts has been widely studied due to its solubility in a range of 
solvents, low toxicity and high stability.
 110, 111 
 
The first reported use of PEG-2000 as a support for a TsDPEN based hydrogenation 
catalyst was developed by Xiao in 2004.
112
 The PEG is linked to the TsDPEN via an 
ether linkage at the meta position of each of the phenyl substituents to give 
PTsDPEN 109 shown in Figure 20.  
 
Figure 20. Structure of PEG supported ligands and complexes. 
 
The reaction of [Ru(p-cymene)Cl2]2 with the supported ligand 109 in water at 40°C 
allowed the formation of polymer supported Noyori-type complex 110. Previous 
application of supported catalyst 110 to the ATH of acetophenone in formic acid 
gave good conversion and enantioselectivity however attempts to recycle the catalyst 
were unsuccessful.
113
 Use of catalyst 110 in water with five equivalents of sodium 
formate gave 99% conversion to (R)-phenyl ethanol with 92% ee. in only 1 hour 
(40°C, 1 mol% catalyst). The catalyst was successfully recycled and used in 
subsequent reactions with the no significant reduction in activity until after the 
fourteenth cycle of the reaction where a conversion of 87% was achieved. 
Chan and Li reported the synthesis and application of other PEG supported TsDPEN 
ligands, firstly with an ether link at the para-position of the benzenesulfonamide 
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group (PEG-BsDPEN 111)
114
 and secondly linked via the free amine (N-PEG-
TsDPEN 112).
115
 The structures of both supported ligands are shown in Figure 21. 
 
Figure 21. Structures of MsDPEN (111) and N-PEG-TsDPEN (112). 
 
When 111 (PEG-750) was combined with [Ru(p-cymene)Cl2]2 at a catalyst loading 
of 1 mol% in water with 5 equivalents of sodium formate, acetophenone was reduced 
to (S) phenyl ethanol with >99% conversion and 96% ee. in 2 hours at room 
temperature. The system was also found to give higher enantioselectivities than 110 
(PTsDPEN) for the ATH of a range of ketones.
114
 Use of ligand 112 (with PEG200-
PEG2000) under the same conditions as for 111 but at 40°C gave the reduction of 
acetophenone to (S)-phenyl ethanol with >99% conversion and 94-94.8% ee. in 15 
hours. Use of N-PEG2000-TsDPEN maintained high conversions and 
enantioselectivity for nine catalytic cycles. Lower molecular weight N-PEG200-
TsDPEN was found to be more soluble than N-PEG2000-TsDPEN and when used in 
hydrogenation reactions a decrease in activity was seen after three cycles possibly 
due to the ligand being too soluble causing leaching of the catalyst.
115
  
The use of pendant groups on a polymer chain as ligands for ruthenium-catalysed 
ATH has also been reported in the literature. Wills has reported the use of pendant 
chiral β-amino alcohols with a copolymer of PEG ethylether methacrylate and 
hydroxyethyl methacrylate (HEMA) for use in catalytic ATH of ketones.
116
 (1S, 2R)-
N-(4-bromobenzyl)norephedrine was coupled with the O-p-bromobenzene derivative 
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of the hydroxyethyl component of HEMA by Suzuki coupling to form a biphenyl 
spacer group and give polymer supported ligand 113 (Figure 22). The best result 
achieved for the ATH of acetophenone to phenyl ethanol was 85% conversion and 
81% ee. in 20 hours with a 0.5 mol% catalyst loading in 2-propanol/KOH.
116 
 
Figure 22. Structure of PEG ethylether methacrylate and hydroxyethyl methacrylate copolymer 
supported TsDPEN ligand 113. 
 
The use of insoluble polymers as supports for ligands has also been applied to the 
ATH of ketones offering convenient recovery of the catalyst from the reaction 
solution by filtration for regeneration and reuse and also allowing removal of traces 
of transition metals from reaction products. Polystyrene has commonly been used in 
this application due to its stability to a range of reaction conditions and wide scope 
for functionalisation. 
Polywka et al. reported the use of two polystyrene bound diamines (114 and 115) for 
the ATH of ketones using ruthenium.
117 
The ligands are bound to the polymer by an 
amide linkage at the para position of the aryl sulfonamide group. The application of 
the ligands to the ATH of acetophenone as shown in Scheme 39 showed ligand 114 
to be the more reactive of the two giving significantly higher conversions and 
enantioselectivities than 115. 
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Scheme 39. Application of polystyrene supported TsDPEN ligand to ATH of acetophenone. 
 
Use of formic acid/Et3N 5/2 increased the activity of ligand 115 to give 95% 
conversion, 96.7% ee. for the ATH of acetophenone although the activity of 114 was 
decreased. The enantioselectivity of the reaction with ligand 115 was unchanged 
over two reaction cycles. 
Itsuno has reported the first application of polystyrene supported TsDPEN in 
aqueous ATH of ketones using polymer supported ligands.
118
 Use of ligand 116 
(Figure 23) with [RuCl2(p-cymene)]2 gave a conversion and enantiomeric excess for 
the ATH of acetophenone of 100% and 97% (R) ee. respectively in only three hours 
using 1 mol% catalyst at 40°C with water and sodium formate. The catalyst was 
recycled five times with conservation of the enantiomeric excess. 
 
Figure 23. Structure of polystyrene supported TsDPEN ligand 116. 
 
1.4 Non-Precious metal catalysts for asymmetric hydrogenation. 
Within synthetic chemistry, particularly on an industrial scale, there is an ever 
growing need to develop more viable preparations of desirable products in order to 
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develop a more environmentally friendly approach, to reduce costs or increase 
efficiency. Of particular interest is the development of non-precious metal catalysts 
for key transformations. Although highly active as catalysts, many transition metals 
are a limited resource making them expensive and many are also toxic making 
expensive and stringent purification methods to ensure their removal from reaction 
products essential. Much research has and is therefore being carried out in this field. 
1.4.1 Base-catalysed hydrogenation of ketones using potassium tert-butoxide.  
One of the earliest reports of non-transition metal-catalysed pressure hydrogenation 
of ketones was reported by Walling and Bollyky in 1964 using KO
t
Bu to catalyse the 
hydrogenation of benzophenone to benzhydrol as shown in Scheme 40.
119
 
 
Scheme 40.  Hydrogenation of benzophenone to benzhydrol using KOtBu catalyst. 
 
The reaction required high temperatures of up to 210°C and hydrogen pressures of 
up to 135 atm. to generate high product yields as shown in Table 12. With low 
loadings of KO
t
Bu the rate of reduction was slow with reactions requiring up to 25 
hours to form high product yields. Using an excess of KO
t
Bu improved this allowing 
slightly reduced temperatures, pressures and time to give an almost quantitative yield 
of product (Table 12, entry 2).
119 
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Table 12. Base-catalysed reduction of benzophenone. (0.43-0.46 M benzophenone). 
Entry Solvent Catalyst 
Moles 
catalyst 
H2 
(atm.) 
Temp 
(°C) 
Time 
(hours) 
Benzhydrol 
(%) 
1 
t
BuOH None - 102 170 28 0 
2 
t
BuOH
 t
BuOK 0.086 102 170 18 63 
3 
t
BuOH
 t
BuOK 0.093 102 153 50.5 47 
4 
t
BuOH 
t
BuOK 0.093 135 210 25 98 
5
a tBuOH 
t
BuOK 0.333 96 150 14.5 98 
6 Benzene 
t
BuOK 0.093 125 204 23 98 
7 Diglyme 
t
BuOK 0.093 100 170 18 52 
8
b Diglyme 
t
BuOK 0.283 78 130 5 98 
9 
t
BuOH 
t
BuOLi 0.086 102 170 18 32 
10 Benzene 
t
BuONa 0.464 95 100 5 0 
11 H2O KOH 8.9 125 200 28 1 
12 Diglyme (i-PrO)2Al 0.093 123 210 34 Trace 
a 0.111 M benzophenone used. b 0.094 M benzophenone used. 
Walling and Bollyky also investigated the use of different solvents and catalysts in 
the reaction and the results are summarised in Table 12 above. Diglyme, the 
dimethyl ether of diethylene glycol, was reported as the most effective solvent 
allowing higher yields at lower temperatures and pressures than with tert-butanol or 
benzene. Indeed, with excess catalyst, the reaction was complete in only 5 hours at 
the reduced temperature of 78°C and hydrogen pressure of 130 atm. Using LiO
t
Bu 
generated a yield of 32%, but NaO
t
Bu, KOH and (
i
PrO)3Al gave little or no product.  
The reduction of a range of substrates using KO
t
Bu was investigated and it was 
found that the reaction was most effective with aromatic ketones.
119
 Aliphatic 
substrates (acetone and cyclohexene) generated no reduced product. Nitrobenzene 
Development of catalysts for asymmetric hydrogenation                                                     Introduction 
59 
 
was effectively reduced to aniline demonstrating the application of the conditions to 
the reduction of NO2 groups in addition to carbonyl.
119 
In 2002 Berkessel reported further studies into the KO
t
Bu-catalysed hydrogenation 
of ketones.
120
 After initial repetition of the findings reported by Waling and Bollyky 
investigations were carried out to establish a mechanism of the reaction. The reaction 
was found to be irreversible as the reaction of benzhydrol with KO
t
Bu under 45 bar 
hydrogen pressure did not form benzophenone. Increasing the pressure and 
temperature of the reaction was found to increase the rate of reaction. At 100°C the 
conversion to product was found to plateau after a short time at only 15% however at 
210°C quantitative conversion to product was achieved. The reaction was found to 
be first order with respect to benzophenone, hydrogen and KO
t
Bu.
120 
The nature of the alkali metal used as the catalyst was also found to have an effect on 
the reaction.
120
 Use of lithium, sodium, potassium, rubidium and cesium 
benzhydrolates at 135 bar hydrogen and 210°C showed the rate of reaction to 
decrease in the order Cs › Rb ≈ K » Na » Li. This follows the trend of increasing 
covalency of the metal-oxygen bonds, and hence reducing partial charge on the 
metal. A lower charge on the metal makes it less effective at activating the ketone 
towards nucleophilic attack from the hydride of the hydrogen molecule.  
A mechanism for the reaction was proposed as shown in Scheme 41.
120 
 δ 
 
 δ 
 
 
 Scheme 41. Mechanism for base-catalysed hydrogenation of ketones.  
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The mechanism was proposed to proceed via a 6-membered cyclic transition state 
within which both the ketone substrate and alkoxide base are bound to the alkali 
metal. Heterolytic cleavage of the hydrogen molecule occurs to form the final 
product via hydride attack at the carbon centre of the carbonyl group and protonation 
of the alkoxide. Proton transfer to the substrate gives the final product. The cleavage 
of the hydrogen molecule is not thought to be the rate-determining step of the 
reaction and instead it was thought that the formation of the ordered transition state 
was the main factor limiting the reaction rate.
120 
In 2005 Chan and Radom reported further insight into the base-catalysed 
hydrogenation of ketones using computational molecular orbital theory.
121
  
Initially the group looked at the thermodynamics of the reaction and elected to model 
the sodium methoxide-catalysed reduction of formaldehyde at 0°K. The mechanism 
for the reaction was divided into 6 key steps (A-F) as shown in Scheme 42.
121 
 
Scheme 42. Proposed mechanism for sodium methoside-catalysed hydrogenation of formaldehyde. 
 
Sodium methoxide and formaldehyde initially form a strong adduct with both 
oxygen atoms strongly associated to sodium (B). Interaction of the methoxide and 
carbonyl with hydrogen leads to the formation of transition state C which was found 
to have a near linear arrangement of the methoxy oxygen and hydrogen and a highly 
angular arrangement of the carbonyl group and hydrogen. The overall formation of 
C from A was found to have a ΔHA-C of -4 kJ mol
-1
 and thus there is effectively no 
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barrier to the hydrogenation process. From C, a strong complex is formed between 
what will become the alcohol product and the sodium methoxide (D) which then 
dissociates to give the product as a sodium alkoxide (E) before proton exchange via 
a second transition state affords the final alcohol product (F).
121 
Further work looked at the enthalpy and free energy of the reaction at 483.15 K 
(210°C). Findings showed the enthalpy and free energy profiles at 483.15 K to differ 
significantly, for example formation of B has a free energy change of -51 kJmol
-1
 at 
483.15 K whilst at 0 K the change is -109 kJmol
-1
. Formation of C from A has an 
overall free energy change of 65 kJmol
-1
 at 483.15 K and -4 kJmol
-1
 at 0 K. The 
differences are attributed to a significant entropic effect on the reaction which 
supports the theory presented by Berkessel and Walling and Bollyky that the 
formation of an ordered transition state, an entropic effect, is a limiting factor in the 
reaction affecting the size of the energy barrier for the formation of transitions states 
and heterolysis of hydrogen.
121 
Studies into the effect of variables on the reaction were also carried out.
121
 In the 
solution phase, use of group I metals caused the rate of the reaction to increase down 
the group and use of group II metals caused the rate of reaction to decrease down the 
group. Overall group II metals allowed the reaction to proceed with lower energy 
barriers than with group I metals. The effect of the anionic base used in the reaction 
was also investigated. Use of tert-butoxide showed similar catalytic activity to the 
methoxide species showing that the size of the base has little effect on the reaction. 
When benzyloxide analogues were used however, the energy barriers calculated 
were higher than for the methoxides and tert-butoxides, suggesting that aromatic 
alkoxides are less reactive than aliphatic alkoxides. Non-polar solvents gave lower 
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energy barriers for the reaction than polar solvents, however, in practice the metal 
cation in the catalyst is likely to be insoluble in a non-polar solvent and therefore a 
polar solvent would most likely be the solvent of choice for the reaction. It was 
observed that solvents with lower dielectric constants allowed for lower energy 
barriers and hence the most suitable solvent for the reaction was deemed to be a 
polar solvent with a low dielectric constant.  
Different substrates were also investigated, with work focussing on comparing 
aliphatic and aromatic ketones. Previous observations by Walling and Bollyky
119
 and 
also Berkessel
120
 suggested that aromatic ketones were more susceptible to 
hydrogenation than aliphatic ketones. Chan and Radom’s investigations agreed with 
these previous findings with the hydrogenation of acetophenone occurring with a 
lower energy barrier than that of acetone. It was thought that the aromatic ketones 
were more reactive due to the electron-withdrawing phenyl substituent helping to 
activate the carbonyl carbon towards nucleophilic attack from the hydride. 
Resonance effects of the phenyl ring, as shown in Figure 24, can also help stabilise 
an oxygen anion.
121 
 
Figure 24. Resonance stabilisation of charge separated structures of acetophenone. 
1.4.1.1 Asymmetric KOtBu-catalysed hydrogenation of ketones. 
Berkessel also investigated the scope for asymmetric hydrogenation using a chiral 
catalyst and prochiral ketone.
120
 The reduction of prochiral ketone pivalophenone 
with potassium R-1-phenylethanoate catalyst was found to give a 50% yield of the 
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desired alcohol product with an ee. of 12%, the major enantiomer being the R 
enantiomer of the product. In order to ensure that the low ee. was not due to 
racemization of the chiral base used in the catalyst, the alcohol analogue of the base 
was obtained after the reaction and was found to have essentially the same ee. as the 
starting chiral base. The low ee. was therefore attributed to a lack of discrimination 
between the diastereomeric transition states that lead to the final products. 
1.4.2 Iron catalysts for asymmetric hydrogenation of ketones. 
The use of iron catalysts has also been reported for both ATH and APH of ketones as 
well as many other reactions.
122 
An early example of iron-catalysed transfer hydrogenation was reported by 
Bianchini in 1993.
123
 Isostructural trihydride complexes of iron(II), ruthenium(II) 
and osmium(II) were compared for the selective transfer hydrogenation of α, β-
unsaturated ketones. The complexes were of the form 
[MH(H2)(P(CH2CH2PPh2)3)]BPh4 as shown with 117 in Figure 25, and used iso-
propanol or cyclopentanol as the hydrogen source. 
 
Figure 25. Structure of Bianchini’s catalysts. 
 
The use of iron trihydride complex 117 showed limited success for selective 
hydrogenation of the C=O bond over the C=C bond as illustrated in Figure 26.
123 
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Figure 26. Hydrogenation results using catalyst 117. 
 
Hydrogenation of benzylideneacetone (118) was achieved with excellent selectivity 
for hydrogenation of the C=O bond however ketones with terminal or cyclic C=C 
bonds or indeed more hindered C=O bonds as in example 119-121 showed little or 
no selectivity for hydrogenation of the C=O bond over the C=C bond.
123
 When 
applied to the hydrogenation of saturated ketones such as acetophenone, the catalyst 
was highly successful achieving 96% conversion to the racemic alcohol. The use of 
ruthenium and osmium metals with the same ligand system did not offer significant 
improvement to the selectivity for C=O hydrogenation over C=C hydrogenation in 
unsaturated ketones.
123 
An inner sphere mechanism is proposed for the C=O hydrogenation using this 
catalyst. The metal initially loses hydrogen and the ketone co-ordinates to the vacant 
site via the C=O. The hydride is transferred from the metal to the carbon of the 
carbonyl group. The second hydrogen is taken from the solvent alcohol to give the 
desired alcohol product which is then eliminated, and the remaining alkoxide solvent 
co-ordinates to the metal before being eliminated as the carbonyl form.
123
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More recently, Casey has reported the use of catalyst 122 below for both transfer and 
pressure hydrogenation of ketones.
124
 The catalyst shown in Figure 27, is based on 
the ruthenium Shvo catalyst
66-69
 and also Knӧlker’s iron complex.125 
 
Figure 27. Structure of Knӧlker’s iron catalyst (122), used by Casey for hydrogenation applications. 
 
Using iso-propanol as the hydrogen source and a 1 mol% loading of complex 122 at 
75°C, acetophenone was successfully converted to racemic 1-phenylethanol with a 
yield of 87%.
124
 This result compared well with the application of the complex to 
pressure hydrogenation achieving 83% yield of phenyl ethanol from acetophenone 
with hydrogen gas.  The catalytic cycle is analogous to that of the Shvo catalyst as 
shown in Figure 28. 
 
Figure 28. Catalytic cycle for reduction by catalyst 122. 
 
The use of cyclopentadienyl iron carbonyl complexes has also been reported by 
Wills for oxidation of alcohols
126
 and reduction of ketones.
127
 Scheme 43 shows the 
application of asymmetric iron complexes to the ATH of ketones. The tricarbonyl 
complexes are converted into the active iron hydride complexes in situ with use of 
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trimethyl-N-oxide to remove a carbonyl ligand. The complexes show some 
enantioselectivity although enantiomeric excesses were low.
127 
 
Scheme 43. Racemic and asymmetric hydrogenation of acetophenone with achiral and asymmetric 
iron complexes 123-125. 
 
1.4.2.1 Iron-catalysed asymmetric hydrogenation of ketones with 
diaminodiphosphine ligands. 
Gao and Noyori have previously reported the use of diaminodiphosphine ligands 
with ruthenium, rhodium and iridium for ATH of ketones.
61-64
 In 2004, Gao reported 
the application of the ligands to iron-catalysed ATH using [Et3NH][Fe3H(CO)11]  as 
shown in Scheme 44.
128,129
  
 
Scheme 44. ATH of acetophenone using in situ formed iron diaminodiphosphine catalysts. 
 
The ligands proved most successful with aryl alkyl ketones such as acetophenone 
and both complexes in conjunction with 2-propanol as the hydrogen source gave a 
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promising yield and ee. of 92% and 61% respectively for the DPEN based complex 
and 87% and 72% respectively for the cyclohexadiamine based complex in only 4.5 
hours at 45°C.
128,129 
In recent years, Morris and co-workers have reported the use of similar catalysts for 
ATH and APH of ketones.
129
 Work began with preparation of cyclohexadiamine-
diphosphino iron complexes as shown in Figure 29. 
130 
 
Figure 29. Structure of complexes used by Morris. 
 
 
Complex 127 showed some activity for hydrogenation using hydrogen gas achieving 
40% conversion of acetophenone to phenyl ethanol in 27% ee. using 
substrate/catalyst 225/1 and 25 atm. hydrogen at 50°C, however no activity for 
transfer hydrogenation was seen. In contrast, complex 128 was inactive for 
hydrogenation with hydrogen gas, but gave high conversions for the hydrogenation 
of a series of ketones, aldehydes and imines under transfer hydrogenation conditions, 
although the enantioselectivities obtained were low.
130 
 Complex 129 was also active 
for transfer hydrogenation, giving higher ee.’s than for complex 128 but low 
conversions as shown in Scheme 45. 
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Scheme 45. ATH of acetophenone using iron complexes 128 and 129. 
 
It was proposed that during the reaction the imine ligand may be hydrogenated to its 
amine form allowing transfer of a hydride from the iron and proton from the amine 
to the unsaturated substrate.
130
 
Morris has also reported a template synthesis for the preparation of 
diaminodiphosphine iron complexes as shown in Scheme 46.
131
  
 
 
Scheme 46. Preparation of iron complexes using the template method. 
 
It is thought that initially the phosphonium compound is deprotonated to give an 
unstable diphenylphosphinoacetaldehyde which is then trapped by the iron precursor. 
Elimination of water then gives the desired imine form of the co-ordinated ligand. 
Substitution of an acetonitrile ligand with carbon monoxide leads to the desired 
complex.
131 
Complex 130 shown above was applied to the transfer hydrogenation of 
ketones and was found to have greater activity for transfer hydrogenation of ketones 
than the cyclohexadiamine complexes in Figure 29. With a substrate:catalyst:base 
ratio of 2000:1:8 and at room temperature, acetophenone was converted to 1-
phenylethanol with a conversion of 90% and an ee. of 82% in only 30 minutes.
132
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The complex was also found to exhibit high levels of chemoselectivity when applied 
to the transfer hydrogenation of an α,β-unsaturated ketone as shown in Scheme 47, 
with the major product of the reaction being the unsaturated alcohol with only trace 
amounts of the saturated alcohol and ketone being formed.
132 
 
Scheme 47. Reduction of trans-4-phenyl-3-buten-2-one using complex 130. 
 
This demonstrates a high selectivity of the catalyst for C=O bonds rather than non-
polar C=C bonds complying with an outer-sphere mechanism for the reaction with a 
metal hydride and amino proton interacting with the polar C=O bond. 
The use of further iron complexes shown in Figure 30 for APH of acetophenone as 
shown in Scheme 48 was also investigated by Morris.
133
 
 
Figure 30. Structures of iron complexes used for APH of ketones. 
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Scheme 48. Application of complexes 131-135 to APH of acetophenone. 
 
Complexes 131-135 were most active for pressure hydrogenation of acetophenone. It 
was proposed that ligand 131 may convert to the same active species as that formed 
by 132 via conversion from the imine in 131 to an amine due to the slightly 
enhanced activity of 132 over 131. These findings also indicate an importance for the 
presence of the NH functionality in the ligand which again is evidence for an outer-
sphere mechanism as discussed previously. Complexes 134 and 135 show little 
activity and it was proposed that this was due to the bulky amine substituent groups 
blocking the access of the substrate to the iron.
133 
Morris has also reported a series of investigations into the effects of steric hindrance 
and electronics within the ligand by preparation of a range of complexes shown in 
Figure 31 and their application to the ATH of acetophenone shown in Scheme 49.
134
 
Figure 31. Asymmetric iron complexes prepared from a variety of diamines.  
 
 
Scheme 49. Effect of the diamine structure on the enantiomeric excess of the reduction product. 
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The more bulky diamine ligands in complexes 137 and 138 was found to increase the 
catalytic activity of the complex with higher turnover frequencies and also increase 
the enantioselectivity of the reaction. Morris has also looked at the effect of changing 
the phosphorus substituents from phenyl to alkyl groups.
135
 Variations of both the 
ethyldiamine and DPEN derived tetradentate imine ligands with cyclohexyl, 
isopropyl and ethyl groups on the phosphorus as shown in Figure 32 were prepared 
using the previously discussed template method.
135 
 
 
Figure 32. Complexes used to investigate the effect of the phosphine groups of the ligands on the 
reaction. 
 
Complexes 140-143 with tricyclohexyl and triisopropyl phosphine groups were 
found to be inactive to transfer hydrogenation of acetophenone at room temperature 
and 50°C. The complexes with triethylphosphine groups showed some activity at 
room temperature and improved activity at 50°C although complex 145 with DPEN 
was more active than complex 144 as illustrated in Scheme 50. The 
enantioselectivity was lower than with the initial DPEN derived PPh3 complex 
137.
135
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 Scheme 50. Hydrogenation of acetophenone using catalysts 144 and 145. 
It was proposed that dissociation of the phosphine species from the ligand may be 
necessary for the required catalysis to occur. The more electron-donating cyclohexyl 
and iso-propyl groups would make the phosphorus more basic than with the ethyl 
substituent groups and so dissociation of the phosphorus would be less likely.
135 
1.4.2.2 Iron-catalysed transfer hydrogenation of imines. 
Beller and co-workers have recently investigated the application of Iron systems 
such as those discussed above for the asymmetric hydrogenation of N-
(diphenylphosphinyl)-imines.
136
 The reactions use the iron carbonyl hydride cluster 
complex [Et3NH][HFe3(CO)11] as the catalyst precursor and utilise a KOH base and 
2-propanol as the hydrogen donor. The asymmetric nature of the reaction is provided 
by an asymmetric tetradentate ligand such as the diaminodiphosphine ligands used 
initially by Gao
61-64, 128 
and also Morris
129-135
 discussed above. The cyclohexadiamine 
based ligand was found to be most effective, achieving product yields of 85-95% and 
ee.’s of 94-96% in only 30 min at 45°C (Scheme 51).  
 
 
Scheme 51. Iron-catalysed ATH of diphenylphosphinyl imine. 
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The nature of the base used in the reaction is reported as having no effect on the 
reaction, with the use of KOH, NaO
i
Pr and NaO
t
Bu giving comparable yield and ee. 
values. In an absence of base the ee. of the reaction product was found to decrease 
significantly to 45%. Control experiments containing no iron source and no ligand 
gave no amine product.
136 
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2. Results and Discussion. 
2.1 Potassium-catalysed APH of ketones. 
Although highly active, conventional ruthenium, iridium and rhodium-based 
hydrogenation catalysts are expensive and toxic which, particularly on an industrial 
scale, leads to increased costs and the need for extensive purification processes. The 
development of a transition metal free catalytic system for hydrogenation of ketones 
is therefore of great interest. Inspired by work of Walling and Bollyky in 1964
119
 
work began to develop a potassium-based catalyst for ketone hydrogenation.  
Walling and Bollyky reported the KO
t
Bu-catalysed hydrogenation of ketones under 
high temperatures and hydrogen pressures.
119
 It was necessary to use ketones that did 
not contain protons at the α-position in order to prevent enolate formation which 
would inhibit formation of the alcohol product. We proposed that the use of ligands 
may increase the catalytic activity of the system by providing a well defined 
transition state for the reaction (Figure 33), allowing it to proceed under mild 
conditions. The importance of such a transition state in the reaction was reported by 
Berkessel
120
 and Chan and Radom.
121
 
 δ 
 
 δ 
 
 
Figure 33. Proposed cyclic transition states for KOtBu-catalysed hydrogenation of ketones. 
 
Initial work focused on identifying appropriate conditions for the KO
t
Bu-catalysed 
hydrogenation of benzophenone that would give sufficient conversion to products to 
allow analysis by GC, but would also still allow scope for the observation of 
improvements to conversion when using more effective ligands or catalysts. 
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Secondly, conditions should comply with the need to develop a favourable 
hydrogenation process operating under mild conditions. Initial investigations into 
temperature, pressure and KO
t
Bu loading were therefore carried out (Tables 13 and 
14). Triethylene glycol 146 was used as a model for a potential tetradentate ligand. 
Table 13. APH of benzophenone using KOtBu as a catalyst and triethylene glycol 146 as an example 
ligand structure. 
 
 
 
Entry Solvent 
Mol% 
KO
t
Bu 
Mol% 
ligand 
Ligand 
Benzhydrol 
[%]
a 
Time 
[hours] 
1 
t
BuOH 5 0 None None 113 
2 
t
BuOH 20 0 None 5.2% 113 
3 
t
BuOH 40 0 None 6.8% 113 
4 
t
BuOH 20 20 
 
7.3% 113 
     a Determined by GC analysis. 
 
Entries 1 to 3 in Table 13 show the effect on conversion of increasing the catalyst 
loading in the absence of ligand. With 5 mol% KO
t
Bu no product was obtained, 
however with 20 and 40 mol% KO
t
Bu a small conversion to product was seen. Entry 
4 shows a slight improvement to conversion upon the addition of triethylene glycol 
as a potential tetradentate ligand. Increasing the temperature and hydrogen pressure 
to 100°C and 60 bar hydrogen gave a significant increase in conversion, allowing the 
effect of the presence of ligand to be investigated. The results are summarised in 
Table 14. 
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Table 14. APH of benzophenone using KOtBu and triethylene glycol ligand 146 at increased 
temperature and hydrogen pressure. 
 
 
 
Entry Solvent 
Mol% 
KO
t
Bu 
Mol% 
ligand 
Ligand 
Benzhydrol 
[%]
a 
Time 
[hours] 
1 
t
BuOH 20 5 
 
28 136 
2 
t
BuOH 20 10 
 
27 136 
3 
t
BuOH 20 20 
 
39 136 
a Conversions to benzhydrol determined by GC. 
 
The greatest conversion was achieved with 20 mol% ligand, showing increased 
conversion to benzhydrol compared to the use of 5 and 10 mol% ligand, however a 
significant degree of solvent evaporation occurred during the reaction making results 
unreliable. Future reactions were carried out at the lower temperature of 60°C and 
with 60 bar H2 pressure.  
2.1.1 Further ligands for KOtBu-catalysed APH of ketones. 
The addition of a ligand was shown to benefit the reaction and improve conversion. 
Attention turned to investigating the effectiveness of other ligands in the reaction. A 
variety of ligands comprised of different co-coordinating groups were used for 
hydrogenation of benzophenone with KO
t
Bu. The results are shown in Figure 34. 
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Figure 34. Investigations into the effectiveness of different ligand structures for the KOtBu-catalysed 
APH of benzophenone. 
 
Equal aliquots of a bulk solution of KO
t
Bu, 
t
BuOH and benzophenone were used for 
all reactions in order to eliminate error and allow consistency between reactions with 
the ligand used being the only variable. Bis-(2-hydroxyethyl)ethylenediamine (147) 
was the most effective giving 5.1% conversion of benzophenone to benzhydrol. 
Ligand 149 may react with KO
t
Bu to form the potassium salt of the ligand, meaning 
the potassium may not be available to catalyse the hydrogenation reaction. The 
ligands may also either co-ordinate too strongly to the potassium and hinder the 
approach of the ketone or restrict movement and rotation of the system hindering the 
transfer of hydrogen to the ketone, or may not co-ordinate strongly enough, if at all, 
removing any benefit they may otherwise have brought to the reaction. 
It was noted that the evaporation of the solvent seen with the reactions carried out at 
100°C was still occurring at 60°C. An investigation into the use of solvents with 
higher boiling points was therefore carried out as summarised in Table 15. 
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Table 15. Effect of different solvents on the APH of benzophenone. 
 
 
a
Determined by GC analysis. 
 
Ligand 147 was used as this was one of the most effective ligands at this point, 
showing comparable conversion in Table 15, entry 2 to use of triethylene glycol in 
Table 13, entry 4. Each solvent was used in the reaction both with and without ligand 
and for 
t
BuOH and in 2-methyl-2-butanol the conversion was increased upon the 
addition of ligand. Use of 2-methyl-2-butanol in place of 
t
BuOH showed only a 
minor reduction in conversion and significantly less solvent evaporation taking 
place. The use of triethylene glycol seemed to prevent the reaction entirely. Tables 
13 and 14 suggest that triethylene glycol does have some activity as a ligand thus, 
Entry Solvent 
Boiling 
point 
[°C] 
Mol% 
KO
t
Bu 
Mol% 
ligand 
Ligand 
Benzhydrol
a
 
(%)
 
Time 
(hours) 
1 
t
BuOH 83 20 - None 1.9 124 
2 
t
BuOH 
 
83 
 
20 20 
 
7.4 124 
3 
2-methyl-2-
butanol 
102 20 - None 0.8 124 
4 
2-methyl-2-
butanol 
102 20 20 
 
6 124 
5 
Triethylene 
glycol 
125-127 20 - None 0 124 
6 
Triethylene 
glycol 
125-127 20 20 
 
0 124 
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when used as the solvent triethylene glycol may fully saturate the potassium and 
block co-ordination sites preventing the hydrogenation reaction from taking place.  
The effectiveness of other metals as catalysts in the reaction was investigated as 
shown in Scheme 52, however no conversion to benzhydrol was observed. 
 
Scheme 52. Application of Metal(II) salts to the hydrogenation of benzophenone with ligand 147. 
 
Further investigations into the use ligands containing the bis-(2-
hydroxyethyl)ethylenediamine (147) backbone were carried out. The potential for 
asymmetric hydrogenation was also to be investigated so a variety of tetradentate 
asymmetric ligands were prepared. Initial syntheses gave ligands 150 and 151 from 
reaction of DPEN with salicylaldehyde as shown in Scheme 53.
137-139
 In this case the 
terminal hydroxy groups are provided by phenols rather than primary alcohol groups.  
 
Scheme 53. Preparation of tetradentate ligands 161 and 162.
 
Ligands 152-154 were prepared by the coupling of 2 equivalents of norephedrine 
with dibromoethane (152) and dibromopropane (153), and also the coupling of 
ephedrine with dibromoethane (154) as shown in Scheme 54. 
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Scheme 54. Synthesis of tetradentate ligands 152-154. 
 
The reaction is carried out at 100°C in the absence of solvent with the norephedrine 
or ephedrine melting to give a liquid reaction mixture. As the reaction proceeds 
however, the reaction mixture rapidly solidifies causing stirring and thus the mixing 
of unreacted starting materials to cease. 
1
H NMR analysis of crude reaction mixtures 
showed incomplete conversion to product showing approximately 50:50 
product:unreacted amino alcohol. The unreacted amino alcohol starting material and 
product were both highly polar and separation was difficult. Various alterations were 
made to the reaction: changing the number of equivalents of amino alcohol used, 
adding a solvent to prevent solidification of the reaction mixture and also employing 
different purification strategies, however yields were not improved. 
A sufficient amount of each ligand was obtained for application to the hydrogenation 
of benzophenone. The results are summarised in Figure 35. 
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aLigand obtained from Aldrich. bLigand obtained from Acros Organics. % conversions to benzhydrol.  
 
Figure 35. Percentage conversions for APH of benzophenone using a range of tetradentate 
diaminodihydroxy ligands. 
 
The previous use of the unsubstituted ligand 147 gave a conversion of 7.4% (Table 
15, entry 2). Ligands 150 and 151 both gave low conversions, indicating that the 
ligands are less effective, possibly because the phenol groups do not co-ordinate to 
the potassium as well as free hydroxyl groups. This may be due to the delocalised 
aromatic system drawing electron density away from the oxygen. Also the structure 
and rigidity of the aromatic ring may hinder effective co-ordination to the potassium 
ion. It may also be the case that the phenol groups react with the KO
t
Bu to form the 
potassium salt which prevents the catalysis of the hydrogenation reaction. Ligand 
152 was found to be the most effective ligand giving a conversion of almost 14%. 
Ligand 154 with methyl substituted nitrogen atoms gave no conversion to 
benzhydrol. This is assumed to be because the methyl substituted nitrogen does not 
co-ordinate to the potassium. Use of ligand 153 allowed the importance of the chain 
length of the alkyl ‘bridge’ between the two norephedrine components to be 
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investigated, and gave a conversion of 12%, comparing well with 152. Finally the 
use of cyclic crown-type ligands was investigated with the use of cyclen (ligand 155) 
however this was shown to be ineffective as a ligand for APH of ketones. 
In order to establish the potential for APH of ketones, ligands 152-154 were applied 
to the asymmetric hydrogenation of pro-chiral acetophenone. As conversions of 
benzophenone to benzhydrol with KO
t
Bu as the catalyst remained low and also as 
acetophenone would be likely to enolise in the presence of KO
t
Bu, IrCl3 was used as 
the catalyst. IrCl3 is known to be active and selective for APH of ketones
37
 and the 
system was expected to be more active than with KO
t
Bu allowing greater conversion 
and hence accurate ee. determination. The results are shown in Table 16. 
Table 16. APH of acetophenone using ligands 152-154 and IrCl3. 
 
Entry Ligand Conv.
a
 (%) Ee
a
 (%) 
1 
 
98.6 25.5 (R) 
2 
 
37.5 19.9 (R) 
3 
 
15.5 2.7 (R) 
       aDetermined by GC analysis.  
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Ligand 152 shows excellent conversion to the desired alcohol product, however the 
enantiomeric excess of the product obtained is low. Conversion is reduced 
significantly with use of ligand 153 suggesting that the ethylenediamine structure is 
advantageous to the reaction over the propylenediamine structure, allowing enhanced 
co-ordination to the metal centre. The enantioselectivity achieved with ligand 153 is 
also lower than with 152. Use of the N-methyl ligand 154 gave the lowest conversion 
and essentially racemic product. This confirms the need for the presence of NH 
groups within the ligand for effective complex formation. The results show that the 
prepared ligands do not have potential for use in the asymmetric hydrogenation of 
ketones under these reaction conditions. 
 
2.1.2  Reaction mechanism for KOtBu catalysed hydrogenation of ketones. 
With more effective ligands (152 and 153) beginning to emerge for KO
t
Bu-catalysed 
hydrogenation of benzophenone, investigations were made to identify the reaction 
mechanism. The reaction solution from Figure 35 using ligand 153 was analysed by 
mass spectroscopy after the reaction had taken place and both mono and fully 
oxidised derivatives of the ligand as shown in Figure 36 were found to be present. 
 
 
 
Figure 36. Ligand species identified in reaction solution by mass spectrometry. 
 
The presence of oxidised ligand may be evidence of a transfer hydrogenation process 
rather than interaction of the ketone with hydrogen gas. The ligands may transfer 
RMM = 342.5 gmol
-1 
Found m/z 434.2 [M+H]
+ 
RMM = 340.5 gmol
-1 
Found m/z = 430.5 [M+H]
+
  
RMM = 338.4 gmol
-1 
Found m/z = 339.5 [M + H]
+
 
[M+H]
+
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hydrogen from their terminal hydroxyl groups to benzophenone resulting in 
oxidation of the ligand and reduction of benzophenone. The presence of the phenyl 
groups adjacent to the terminal hydroxyl group may help this process with 
delocalisation of the oxygen’s electron density into the aromatic ring weakening the 
O-H bond. Also the resulting carbonyl group in the ligand would provide increased 
conjugation and hence stability making the oxidation process favourable. A proposed 
mechanism for the transfer hydrogenation process is shown in Scheme 55. 
 
Scheme 55. Proposed mechanism for the transfer of hydrogen from ligand 153 to benzophenone. 
 
The mass spectrometry results, showing the presence of the oxidised derivatives of 
the ligand, are not conclusive as ionisation and fragmentation processes occurring in 
the mass spectrometer could also be the reason for the oxidised species being seen. 
In order to obtain conclusive evidence for or against the hydrogen transfer process, 
the hydrogenation of benzophenone with KO
t
Bu and ligand 153 was carried out 
under atmospheric nitrogen rather than pressurised hydrogen (Scheme 56). If 
molecular hydrogen is not involved in the reaction, and it is indeed the ligands that 
are transferring the hydrogen, conversion to benzhydrol should occur to a similar 
extent as under pressurised hydrogen reported in Figure 35. 
 
Scheme 56. Hydrogenation of benzophenone with KOtBu and ligand 153 in the absence of hydrogen. 
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As shown in Scheme 56, the reaction did proceed under nitrogen and a similar 
conversion to that seen in Figure 35 was obtained. This implies that molecular 
hydrogen is not involved in the process and the ligands are transferring the hydrogen 
to the benzophenone. Further evidence for the transfer hydrogenation process can be 
seen when looking back to results obtained in Figure 35. Where the transfer 
hydrogenation process from ligand to ketone is not possible, no conversion to 
benzhydrol was achieved. For example with ligands 150 and 151, where the 
hydroxyl component of the ligand is provided by a phenol, it is not possible to 
oxidise the C-O bond and transfer hydrogen to the benzophenone, possibly due to 
the formation of the potassium phenoxide salt of the ligand. Also with ligand 155 
possessing no hydroxyl groups, no conversion to benzhydrol was achieved.  
The hydrogen transfer process would be stoichiometric with respect to the ligand and 
thus the reaction was therefore repeated with 20 and 100 mol% ligand. In order to 
investigate the importance of the presence of a phenyl group adjacent to the terminal 
hydroxy groups, bis-(2-hydroxyethyl)ethylenediamine (147) was used. To 
investigate the importance of the tetradentate nature of the ligand, the reaction was 
also carried out using 20 and 100 mol% ephedrine 158. The results are summarised 
in Table 17.  
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Table 17. Conversion to benzhydrol using 20 and 100 mol% ligand for transfer hydrogenation. 
 
Entry Solvent 
Mol% 
KO
t
Bu 
Mol% 
ligand 
Ligand 
Benzhydrol 
(%)
a
 
Time 
(hours) 
1
b 
2-methyl-
2-butanol 
20 20 
 
2.1 116 
2 
2-methyl-
2-butanol 
20 100 
 
0.2 116 
3
c 2-methyl-
2-butanol 
20 20 
 
0.8 116 
4 
2-methyl-
2-butanol 
20 100 
 
2.4 116 
aDetermined by GC analysis. b Ligand obtained from Aldrich. cEphedrine obtained from Aldrich. 
 
The conversions obtained for Table 17, entry 1 with 20 mol% of the unsubstituted 
ligand 147 are significantly lower under the absence of hydrogen than previously 
seen for the same ligand (Table 15) suggesting that the absence of the phenyl groups 
reduces the preference for the transfer hydrogenation process relative to reaction 
with hydrogen gas. When the ligand loading was increased to 100 mol%, the 
conversion to benzhydrol was significantly reduced. It is thought that this may be 
due to the increased amount of ligand saturating the potassium, thereby preventing 
co-ordination of the benzophenone and thus the hydrogenation process. Entries 3 and 
4 of Table 17 investigate the importance of the tetradentate nature of the ligand. Use 
of ephedrine at 20 and 100 mol% loadings of ephedrine gave low conversions 
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suggesting tetradentate ligands are more active for the transfer hydrogenation 
process, possibly exhibiting improved co-ordination to the metal centre. 
 
Our aim in this work was to develop convenient conditions for highly active catalytic 
APH of ketones using transition metal-free catalysts. The transfer hydrogenation 
process found to be taking place is not deemed appropriate for further development 
as a viable transition metal-free process for catalytic asymmetric ketone 
hydrogenation. The process is not efficient both in terms of the synthesis of the 
ligands and also because at best, half an equivalent of ligand relative to the substrate 
would be required to achieve full conversion to the alcohol product. The ligands 
were also found to offer no advantage to the reaction in terms of enantioselectivity. 
Indeed, processes involving active non-precious metal catalysts for transfer 
hydrogenation and asymmetric transfer hydrogenation such as the MSPV reduction
43
 
are already prominent in the literature and thus further development of the KO
t
Bu 
system was not investigated. 
 
2.2 Transition metal-catalysed ATH of ketones. 
The use of iron as a catalyst for hydrogenation is appealing due to its high 
availability and low cost and toxicity. In the past Gao has applied the use of iron 
carbonyl complexes and asymmetric diamine-diphosphine ligands to the ATH of 
ketones.
128
 More recently, Morris has used pre-formed iron-diaminodiphosphine 
complexes for ATH and APH of ketones
129-135, 143
 and in 2006 Beller reported the 
use of iron carbonyl complexes and diaminodiphosphine ligands for the asymmetric 
hydrogenation of N-(diphenylphosphinyl)-imines.
136
 Each approach used ligands 
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such as 45 and 126 shown in Figure 37 and their derivatives, achieving excellent 
conversions and enantioselectivities for the conversion of ketones to alcohols. 
 
Figure 37. Examples of diaminodiphosphine ligands used for iron-catalysed hydrogenation of 
ketones. 
 
2.2.1 Iron-catalysed ATH of ketones with aminophosphine ligands. 
We proposed the development of new asymmetric diaminodiphosphine ligands for 
application to the iron-catalysed ATH of ketones. Initially diaminodiphosphine 
ligands derived from proline 159 were prepared as shown in Scheme 57 in order to 
determine the importance of the NH functionality and also determine the effect on 
the enantioselectivity of the reaction of moving the asymmetry from the diamine 
component of the ligand to the phosphine component.  
 
Scheme 57. Synthesis of proline-based aminophosphine ligands. 
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Preparation of mesylate 161 from Boc prolinol 160 allowed substitution with 
diphenyl phosphine followed by addition of borane to give 162. Formation of borane 
complex 162 stabilises the phosphorus to oxidation allowing purification of the 
compound by column chromatography. Removal of the Boc group and borane with 
TFA gave aminophosphine ligand 163 which could then undergo alkylation with 
benzyl bromide or α,α-dibromo-m-xylene to give ligands 164 and 165 respectively. 
The synthesis of 163 proceeded with good yields, however upon alkylation of the 
amine to give 164 and 165, the yields of product were depleted, primarily due to 
isolation and purification of the compounds. Ligand 45 used by Gao was also 
prepared for use in ATH reactions in order to repeat published results and as a 
comparison for the activity of ligands 163-165.  
Preparation of triethylammonium undecacarbonylhydridotriferrate 166 as used by 
Gao
128
 and Beller
136
 was carried out as reported in the literature
144
 and is shown in 
Figure 38. 
 
Previous work within our group has found iron hydrides to be unstable in 
air and moisture and thus full characterisation is difficult however 
1
H
 
NMR analysis 
in degassed deuterated benzene compared well with that reported in the literature by 
Beller
136
 and showed the desired complex to have been formed with presence of the 
Fe-H signal at -15.25 ppm. The 
1
H NMR spectrum obtained is shown in Figure 38. 
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Figure 38. 
1
H NMR spectrum of [Et3NH][HFe3(CO)11] 166 (300 MHz, d6-benzene). 
 
Ligands 45 and 163-165 were applied to the ATH of acetophenone (Table 18).  
Table 18. Application of proline based aminophosphine ligands to iron-catalysed ATH of 
acetophenone. 
 
Entry Ligand Time (hours) Conversion
a
 (%) Ee.
a
 (%) 
1 
 
41 76 32 (R) 
2 
 
87 2 5 (R) 
3 
 
87 4 6 (R) 
4 
 
90 0.3 4 (R) 
       aDetermined by GC analysis. 
[HFe3(CO)11] 
[HNEt3] 
[HN(CH2CH3)3] 
[HN(CH2CH3)3] 
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Ligands 163-165 did not promote hydrogenation with the iron complex. Ligand 45 
which has been used by Gao did show some conversion and enantioselectivity, 
although these did not compare to the literature results where a conversion of 87% 
and an ee. of 72% for ATH of acetophenone was achieved in 4.5 hours under the 
same conditions.
128, 129 
 Analysis of the 
1
H NMR spectrum for the iron complex 
(Figure 38) shows only 0.2:1 iron hydride:Et3NH suggesting that the desired iron 
hydride complex is not forming as readily as expected thus reducing the loading of 
iron hydride present in the ATH reactions affecting the activity of the system. 
 
2.2.2 Ruthenium and rhodium-catalysed ATH of ketones. 
Gao has also used ligand 45 for the rhodium and ruthenium-catalysed ATH of 
ketones.
61
 The use of ligand 45, [Rh(COD)Cl]2 and IPA/KOH gave some conversion 
and enantioselectivity for ATH of acetophenone
63
 however improved results were 
achieved when the pre-formed rhodium complex 49 was used.
62
 A pre-formed Ru 
complex 47 prepared by the reaction of ligand 45 and [RuCl2(DMSO)4] was also 
successfully used for the ATH of ketones.
61
 the results are summarised in Figure 39. 
 
Figure 39. ATH of acetophenone using diamino-diphosphine Rh and Ru complexes. 
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In a similar manner, ligands 163-165 were also applied to rhodium and ruthenium-
catalysed ATH reactions to see if a more active ligand/catalyst precursor 
combination could be developed (Table 19). The ligands and metal precursors were 
used rather than pre-formed complexes in both cases. Reactions were carried out for 
24 hours to allow time for in situ complex formation. 
 
Table 19. Application of proline-based aminophosphine ligands with rhodium and ruthenium 
catalysts. 
 
Entry Ligand 
Time 
(hours) 
Conversion
a
 (%) Ee.
a
 (%) 
1 
2 
 
24 
Rh: 66 
Ru: None 
72 (R) 
- 
3 
4 
 
24 
Rh: <0.5 
Ru: 0.6 
 
 
ND 
ND 
 
5 
6 
 
24 
Rh: 79 
Ru: None 
0.9 (R) 
- 
7 
8 
 
24 
Rh: 13 
Ru: 5.6 
3.0 (R) 
63.7 (R) 
9 
10 
1 
No ligand 24 
Rh: 10 
Ru: None 
Racemic 
- 
aDetermined by GC analysis.  
 
Table 19, entries 1 and 2 show repeats of the reactions reported by Gao shown in 
Figure 39. Table 19, entry 1 compares well with results reported by Gao,
61-63
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achieving improved conversion and enantioselectivity to that reported for the ATH 
of acetophenone with ligand 45 and [Rh(COD)Cl]2, although the reaction time was 
longer than reported by Gao.
63
 Entry 2 also compares well with the literature results, 
with Gao reporting the use of only pre-formed complexes as achieving high yields 
and enantioselectivities.
61
 Use of ligands 163-165 showed no improvement to the 
reported results. Ligands 163 and 165 gave low conversions and enantioselectivity 
and although ligand 165 gave 79% conversion the enantioselectivity was low. 
With ligands 163-165 proving to be inactive to ATH conditions, further ligands were 
prepared including silyl, hydroxy and amide derivatives of ligands 163-165 (Scheme 
58) and also the N-toluenesulfonamide derivative of ligand 159 (Scheme 59) in order 
to investigate the effect of different co-ordination groups on the activity of the 
ligands towards in situ complex formation and the ATH of ketones. 
Reaction of (L)-prolinol with trimethylacetyl chloride gave amide 167 whilst 
protection of the alcohol in (L)-prolinol with TBDMSCl and alkylation if necessary 
gave silyl ligands 168-170. Removal of the silyl group gave aminohydroxy ligands 
171 and 172 (Scheme 58).  
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Scheme 58. Synthesis of proline-based hydroxyamide, aminosilyl and aminohydroxy ligands. 
Initial formation of the p-toluenesulfonamide from 2-aminobenzyl alcohol followed 
by oxidation with MnO2 gave aldehyde 173. The desired tetradentate ligand 174 was 
obtained after reductive amination with (S,S)-DPEN (Scheme 59). 
 
 
 
 
Scheme 59. Synthesis of N-tosyl substituted derivative of ligand 174. 
 
The ligands were applied to the ATH of acetophenone using a variety of metal 
complexes (Table 20).  
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Table 20. Application of ligands with a range of co-ordination groups to rhodium and ruthenium-
catalysed ATH of acetophenone. 
 
Entry Ligand Complex 
Time 
(hours) 
Conversion
a
 
(%) 
Ee.
a
 (%) 
1 
 
 
[Ru(benzene)Cl2]2 24 11 8.9 (R) 
2 
 
[Ru(benzene)Cl2]2 24 1.1 ND 
3 
 
[Ru(benzene)Cl2]2 24 1.7 ND 
4 
 
[Ru(benzene)Cl2]2 24 56.3 1.5 (R) 
5 
6 
7 
 
 
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
 
24 
67.4 
21.1 
1.3 
 
Racemic 
Racemic 
ND 
 
8 
9 
10  
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
24 
65.8 
42.3 
0.79 
Racemic 
Racemic 
Racemic 
11 
12 
13 
 
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
24 
97.0 
41.5 
0.54 
Racemic 
Racemic 
Racemic 
14 
15 
16  
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
24 
5.4 
2.1 
6.5 
26.9 (R) 
13.9 (S) 
46.0 (R) 
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17 
18 
19  
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
24 
96.4 
1.5 
None 
Racemic 
ND 
- 
20 
21 
22 
 
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
 
24 
 
94.3 
1.2 
1.7 
 
Racemic 
ND 
ND 
 
23 
24 
25 
 
 
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
 
 
24 
 
26.8 
None 
1.4 
 
 
6.1 (S) 
- 
ND 
 
 
26 
27 
28 
 
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
[RuCl2(DMSO)4] 
24 
2.8 
0.7 
1.7 
ND 
ND 
ND 
29 
30 
 
[Ru(benzene)Cl2]2 
[Rh(COD)Cl]2 
24 
54.5 
48.3 
Racemic 
4.2 (R) 
31 No ligand [Ru(benzene)Cl2]2 24 98 Racemic 
aDetermined by GC analysis. 
 
In some cases the addition of a ligand improved the conversion of acetophenone to 
phenyl ethanol, however none of the ligands were found to induce high 
enantioselectivity in the reaction. In the case of Table 20, entries 11, 17 and 20 
>90% conversion was achieved, however [Ru(benzene)Cl2]2 itself was shown to be 
highly active for ketone hydrogenation (Table 20, entry 31). It is likely that use of 
ligands 170-172 allows such high conversions to be retained because the ligands are 
not co-coordinating to the ruthenium complex and thus [Ru(benzene)Cl2]2 remains 
available to carry out the transfer hydrogenation process itself. In other cases where 
less or indeed no conversion is achieved with the same ruthenium source, it is likely 
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that the ligands are able to co-ordinate to the ruthenium and in doing so inhibit the 
transfer hydrogenation reaction, possibly blocking all co-ordination sites on the 
metal centre. 
Entries  6, 9 and 12 in Table 20 also show improved conversion of acetophenone to 
phenyl ethanol with [Rh(COD)Cl]2 compared to the absence of ligand (Table 19, 
entry 9), although again no enantioselectivity was achieved. The use of 
[RuCl2(DMSO)4] gave low conversions of acetophenone to phenyl ethanol with all 
ligands. Ligands 167 and 174 with amide and sulfonamide co-coordinating groups 
respectively showed no significant activity with either of the metal precursors used.  
Due to the lack of enantioselectivity achieved with the ligands tested and a variety of 
metal precursors, further studies into their application to ATH of ketones was not 
pursued. 
2.3  Application of tethered ruthenium catalysts to APH of 
carbonyl compounds. 
 
A successful series of catalysts for both ATH and APH of ketones are half-sandwich 
ruthenium complexes such as 55 in Scheme 60 developed by Noyori, incorporating 
an aromatic ligand and asymmetric TsDPEN ligand.
71, 92 
 
 
 
 
 
Scheme 60. Reported ATH70 and APH89 of acetophenone using Noyori's catalyst 55. 
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A variation of this catalyst was developed by Wills et al. in 2005 incorporating a 
three carbon tether between the aromatic and diamine ligand to give 97 shown in 
Scheme 61.
99
 
 
Scheme 61. (S,S)-TsDPEN-3C-tethered ruthenium catalyst 97 for ATH of acetophenone. 
 
The application of complex 97 to the ATH of ketones has been extensively 
studied
99,101,102 
however limited precedent exists for its application to APH of 
ketones,
109
 a process that would be of particular interest to industry. In collaboration 
with Johnson Matthey, work began to assess the scope of 97 for APH of ketones. 
Initially Johnson Matthey had screened a range of reaction conditions to identify 
appropriate catalyst loadings, reaction concentrations and temperatures for the APH 
of acetophenone. They found that concentrations of 0.5 - 1 M and substrate/catalyst 
loadings of 100-1000/1 allowed for full conversion to phenyl ethanol with high 
enantioselectivity in 16 hours at 40-60°C, with the lower catalyst loadings requiring 
the higher temperature.
145
 Initial studies began with repetition of these findings to 
establish appropriate reaction conditions for our reaction set-up prior to assessing the 
catalyst’s scope for APH of a range of ketones. Results of this investigation are 
shown in Table 21. 
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Table 21. Results for APH of acetophenone using (R,R)-TsDPEN-3C-tethered catalyst 97. 
 
Entry Catalyst 
Substrate/ 
catalyst 
[Substrate]
 Temp. 
(°C) 
Conv.
a 
(%) 
Ee
a 
(%) 
1 none - - 40 0.31 N/A 
2 (R,R)-97 100/1 1 mmol [0.5 M] 40 99.9 92.2 (R) 
3 (S,S)-97 100/1 1 mmol [0.5 M] 40 99.9 94.4 (S) 
4 (R,R)-97 500/1 1 mmol [0.5 M] 60 50.4 91.4 (R) 
5 (S,S)-97 500/1 1 mmol [0.5 M] 60 38.0 87.1 (S) 
6
b
 (R,R)-97 500/1 1 mmol [0.5 M] 60 99.9 91.7 (R) 
7
b
 (S,S)-97 500/1 1 mmol [0.5 M] 60 92.3 93.0 (S) 
8
c (R,R)-97 500/1 1 mmol [0.5 M] 60 65.8 92.8 (R) 
9
b (R,R)-97 1000/1 1 mmol [0.5 M] 60 34.7 86.9 (R) 
10
b (S,S)-97 1000/1 1 mmol [0.5 M] 60 39.2 88.3 (S) 
aDetermined by chiral GC. bAcetophenone purified by kugelrohr distillation. cReaction carried out for 
8 hours. 
Full conversion was achieved at a substrate/catalyst (S/C) ratio of 100/1 (1 mol% 
catalyst) at 30 bar H2 and 40°C. With a reduction in catalyst loading to S/C 500/1 
(0.2 mol%) however, even with an increase in temperature to 60°C full conversion 
was not achieved (Table 21, entries 3 and 4). Purification of the acetophenone by 
kugelrohr distillation was found to improve this allowing full conversion to phenyl 
ethanol at S/C 500/1 (Table 21, entry 5 and 6). A reduction in reaction time to 8 
hours at S/C 500/1 showed a significant reduction in conversion to 65.8% 
demonstrating the need for a 16 hour reaction time at this loading. At S/C 1000/1, 
even with distilled acetophenone, full conversion to phenyl ethanol was not achieved 
in contrast to results obtained by Johnson Matthey. Trace impurities remaining in the 
acetophenone or present in the solvent or catalyst itself, may be the cause of this. At 
such low S/C loadings, even trace impurities could poison a sufficient proportion of 
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the catalyst present to reduce conversion. Conditions as in Table 21, entry 3 were 
used to assess the scope of the catalyst for APH of a range of ketones (Figure 40).
145
  
All conversions and enantiomeric excesses determined by chiral GC unless otherwise stated. 
aDetermined by chiral HPLC. bDetermined by Mosher’s method.156 
Figure 40. APH of carbonyl compounds using (R,R)-3C-tethered ruthenium catalyst 97. 
The ketones tested demonstrated good catalyst scope for APH with tethered 
ruthenium catalysts achieving high conversions and enantioselectivities. The results 
also show good tolerance of the catalyst and reaction conditions to a range of 
substituent groups.  
For more sterically encumbered ketones such as 2,2-dimethyl-1-phenyl propanone 
however, a reduction in the conversion and ee. were observed, even with longer 
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reaction times. 1-phenyl propanone however was reduced well along with its α-
hydroxy and α-phenoxy derivatives.  
Both electron donating OMe and electron withdrawing CF3 p-substituent groups 
were tolerated on the aromatic ring of the ketone, however a small reduction in ee. 
was observed with CF3 substituents. This may be due to a loss of electron density in 
the phenyl ring of the ketone due to the electron withdrawing nature of the CF3 
group. This would reduce the favourable π/CH-attraction between catalyst and 
substrate shown in Figure 43 and hence reduce the ee. APH of bicyclic ketones was 
found to give the highest conversions and enantioselectivities.  
Aliphatic ketones such as cyclohexylmethyl ketone performed less well under APH 
conditions with catalyst 97, achieving only 66.8% ee. (S), although this is consistent 
with ATH results.
99
 The low ee. is due to there being only a small energy difference 
between transition states for each enantiomer of product. It should also be noted that 
reduction of cyclohexylmethyl ketone gives the opposite enantiomer of product 
compared to the other substrates tested. This is due to the absence of π/CH-
interactions between the catalyst and the substrate, hence steric factors determine the 
most favourable geometry of the transition state. The ketone is oriented with the 
large cyclohexyl substituent away from the catalyst giving the (S) enantiomer of 
product (Figure 41).  
 
Figure 41. Transition state geometry for APH of aromatic and non-aromatic ketones by the 3C-
tethered ruthenium catalyst 97. 
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Ethyl benzoate and 1-benzylpiperidine-2,6-diene were also subjected to the APH 
conditions however no conversion was seen after 24 hours.  
Determination of the enantiomeric excess and assignment of the stereochemistry of  
2-(morpholin-4-yl)-1-phenylethanol from the APH of 2-morpholino-1-
phenylethanone was achieved using Mosher’s method.146 This technique involves 
the reaction of the obtained alcohol product with (S)-(+)-α-methoxy-α-
trifluoromethylphenylacetyl chloride to give the resulting ester. The ester now has 
two chiral centres, the first resulting from the acetyl chloride which is 
enantiomerically pure and a second from the initial alcohol APH product which may 
or may not be enantiomerically pure. The resulting ester is therefore present as a 
mixture of diastereomers depending on the enantiomeric purity of the APH product. 
Analysis of the ester by 
1
H NMR
 
allows determination of both the enantiomeric 
excess and configuration of the alcohol product by use of the model shown in Figure 
42 and comparison to 
1
H NMR data obtained for the ester formed from a racemic 
sample of the alcohol product. Further details of the analysis carried out is given in 
the Experimental section of this thesis.  
 
Figure 42. Model for assignment of enantiomeric excess and configuration of 2-(morpholin-4-yl)-1-
phenylethanol. 
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In the case of the hydrogenation of 2-morpholino-1-phenylethanone to 2-(morpholin-
4-yl)-1-phenylethanol, comparison of the Mosher’s ester of the asymmetric product 
to the racemic shows the morpholine peaks to be upfield in the 
1
H NMR spectrum 
confirming the presence of the S-enantiomer of the product. Only one set of peaks 
was present in the 
1
H NMR indicating a high enantioselectivity of >95%. 
In order to investigate chemoselectivity for the APH of C=O bond over C=C bonds 
the APH of 4-phenyl-3-buten-2-one 176 was carried out as shown in Scheme 62. 
 
Scheme 62. APH of 4-phenyl-3-buten-2-one with (R,R)-TsDPEN-3C-tethered catalyst 97. 
 
The reaction gave an overall conversion of 79% conversion but poor 
chemoselectivity for reduction of the carbonyl group with 43% conversion to 
products with hydrogenated C=C bonds. This is in contrast to the results achieved 
under ATH conditions with untethered catalyst 57a reported by Wills
73
 where the 
same ketone was reduced with complete conversion, the product comprising of 75% 
of the unsaturated alcohol 177 and 25% saturated alcohol 178.  
The low selectivity between hydrogenation of the C=C and C=O bond in APH is 
likely to be due to there being only a small energy difference between the energy of 
the transition states for each process meaning that there is little discrimination 
between the occurrence of both processes. In the APH reaction reported in Scheme 
62, it was not possible to separate the two alcohol products formed by column 
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chromatography. The alcohol mixture was therefore subjected to hydrogenation with 
Pd/C and atmospheric hydrogen to give only the saturated alcohol which was then 
analysed by chiral HPLC and showed an ee. of only 4.7% (R). Both APH and ATH 
conditions gave low enantioselectivities for the reduction products. 
2.4 Application of further tethered ruthenium catalysts to the APH 
of ketones. 
With the 3C-tethered ruthenium catalyst 97 demonstrating good activity for APH of 
ketones investigations were carried out into the scope of other catalysts for this 
reaction in order to identify a more active catalyst.
 
Three aspects of the catalyst were 
chosen for further study: 
1) The sulfonamide group 
2) The halide ligand 
3) The length of the aryl-diamine tether. 
2.4.1 3C-tethered MsDPEN ruthenium catalyst. 
Initially the (R,R)-3C-tethered-MsDPEN-RuCl catalyst 180, supplied by Johnson 
Matthey, was applied to the APH of acetophenone as shown in Table 22. 
Table 22. Results for APH of acetophenone using (R,R)-MsDPEN-3C-tethered catalyst 180. 
 
 
 
Entry H2 Pressure 
(bar) 
Substrate/ 
catalyst 
[Substrate]
a
 Temp. 
(°C) 
Conv.
b 
(%) 
Ee
b 
(%) 
1 30 500/1 1 mmol [0.5 M] 60 47.3 89.8 (R) 
2 30 1000/1 1 mmol [0.5 M] 60 25.7 83.8 (R) 
3 50 500/1 1 mmol [0.5 M] 60 99.9 91.1 (R) 
4 50 1000/1 1 mmol [0.5 M] 60 60.4 87.8 (R) 
aDistilled acetophenone used. bDetermined by chiral GC.  
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The MsDPEN catalyst was found to be a less active catalyst than the TsDPEN 
catalyst, requiring an increase in pressure to achieve full conversion at S/C 500/1. 
These findings are mirrored in ATH reactions using the MsDPEN catalyst 180. The 
ATH of acetophenone using catalyst 180 as shown in Scheme 63 required 6 hours to 
achieve full conversion, whilst use of TsDPEN catalyst 97 under the same conditions 
required only 2 hours for full conversion. 
 
Scheme 63. ATH of acetophenone using TsDPEN99 (97) and MsDPEN (180) tethered catalysts. 
The reduction in the activity of the MsDPEN catalyst 180 may be due to a loss of 
steric bulk at the sulfonamide group, or indeed a reduction in the electron 
withdrawing nature of the sulfonamide group with a methyl rather than tolyl 
substituent affecting the electronic nature of the ruthenium and hence the Ru-H 
bond. The use of increased H2 pressure was applied to the APH of a range of ketones 
using MsDPEN catalyst 180 (Figure 43). 
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Figure 43. APH of ketones using (R,R)-MsDPEN-3C-tethered ruthenium catalyst 180. 
High conversions and ee.’s were achieved for ATH of the ketones using 50 bar H2 
pressure. 
2.4.2 3C-tethered TsDPEN ruthenium iodo catalyst. 
The second alteration made to the catalyst was to prepare the iodo derivative of 
catalyst 97. Williams, Blacker and co-workers have shown iodo catalysts such as 
[Cp
*
IrI2]2 to be highly active for hydrogen transfer processes for the alkylation of 
amines
147
 and also dynamic kinetic resolution of chiral amines.
148  
Noyori has previously reported a proposed mechanism for APH using untethered 
ruthenium catalysts.
75
 As described in Scheme 30, APH occurs under non-basic 
conditions with loss of chloride by ionisation to form a cationic Ru complex. The 
cationic complex then interacts with hydrogen to form an 18 electron ruthenium 
hydride complex. Hydrogenation of the ketone then occurs via a 6-membered 
pericyclic transition state with transfer of a hydride and proton to the C=O bond. 
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Protonation of the resulting ruthenium complex reforms the cation which then 
continues the catalytic process. 
The ionisation step in the APH mechanism is a significant step in the mechanism, the 
faster the cationic species can be formed, the sooner the catalytic cycle and hence 
hydrogenation of substrate can begin. It has been found that Ru triflate complexes 
show improved activity for APH
75,76,93
 due to rapid and facile ionisation in methanol 
solvent.
93
 The literature also reports the use of silver salts within APH reactions to 
assist with the removal of the chloride
94,149
 however studies carried out by Johnson 
Matthey found the addition of a variety of silver salts was detrimental the APH of 
acetophenone with the tethered catalyst 97 reducing conversions to phenyl ethanol to 
<10% and in some cases <1%.
145 
In order to investigate whether iodide may be a 
better leaving group than chloride in the tethered catalyst improving the rate of 
activation of the catalyst, the tethered (181) and untethered (183) ruthenium iodide 
catalysts were prepared as shown in Scheme 64. X-ray crystallographic structures 
were also obtained for each complex (Figure 44). 
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Scheme 64. Preparation of tethered and non-tethered ruthenium iodide catalysts 181 and 183. 
 
 
 
 
 
 
 
 
Figure 44. Solid state X-ray crystallographic structures of (R,R)-3C-tethered-RuI catalysts 181 (left) 
and 183 (right) with atom labelling. 
 
The X-ray structures are consistent with those reported for the analogous RuCl 
complexes
74, 102
. Each complex was present as a single diastereomer, with the tosyl 
group oriented away from the chloride ligand and π/π-stacking between the tosyl 
group and neighbouring phenyl ring of TsDPEN observed. The Ru-I bond lengths 
were 2.77 and 2.78Ǻ respectively for the tethered (181) and untethered (183) 
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complexes, longer in each case than the analogous RuCl complexes (Ru-Cl 2.43
 
and 
2.44
 Ǻ for the tethered102 (97) and untethered74 (57a) complexes). 
Conversion of the tethered RuCl catalyst (97) to its iodo derivative (181) proceeded 
with excellent product yield and without the need for purification. Formation of the 
untethered iodo catalyst proved to be less trivial with lower yields obtained due to 
the high solubility of both the monomer and its dimer precursor making isolation of 
the complexes more difficult. Conversion of the pre-formed untethered ruthenium 
chloride catalyst 57a into its iodo derivative (183) gave a significantly higher yield 
than formation of the iodo dimer 184 followed by monomer formation. With both 
iodo catalysts in hand a series of APH reactions were carried out with acetophenone 
as the substrate (Table 23). 
Table 23. APH of acetophenone using tethered and untethered ruthenium chloride and iodide 
catalysts 97, 181, 57a and 183. 
 
Entry  Catalyst S
a
/C Temp. 
(°C) 
Time 
(hr.) 
Conv.
b
 
(%) 
Ee
b
 (%) 
1 
(R,R)-untethered 
RuCl catalyst 57a 
100/1 40 16 94.6 94.3 (R) 
2 
(R,R)-untethered RuI 
catalyst 183 
100/1 40 16 67.0 92.7 (R) 
3 
(R,R)-untethered 
RuCl catalyst 57a 
500/1 60 16 9.1 87.3 (R) 
4 
(R,R)-untethered RuI 
catalyst 183 
500/1 60 16 4.4 61.0 (R) 
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5 
(S,S)-tethered RuCl 
catalyst 97 
500/1 60 16 99.8 93.2 (S) 
6 
(S,S)-tethered RuCl 
catalyst 97 
1000/1 60 16 21.0 86.6 (S) 
7 
(S,S)-tethered 
RuI catalyst 181 
500/1 60 16 56.5 92.7 (S) 
8 
(S,S)-tethered 
RuI catalyst 181 
1000/1 60 16 4.6 75.3 (S) 
9 
(S,S)-tethered RuCl 
catalyst 97 
2000/1 60 64.5 39.8 86.3 (S) 
10 
(S,S)-tethered 
RuI catalyst 181 
2000/1 60 64.5 45.2 86.7 (S) 
    aDistilled acetophenone used. bDetermined by chiral GC. 
 
The tethered iodo catalyst 181 was found to be more active than the untethered iodo 
catalyst 182, however both iodo catalysts were less active than their chloro 
counterparts. Interestingly however, with a low catalyst loading and long reaction 
time (Table 23, entries 9 and 10) the activity of the tethered chloro and iodo catalysts 
was comparable in terms of conversion and ee. This suggests that although less 
active than the chloro catalyst, the iodo derivative 181 may exhibit increased 
stability over the chloro catalyst remaining active for longer allowing greater 
conversion over long reaction times than the chloro catalyst 97. The results suggests 
that the ionisation process is not improved with an Ru-I rather than Ru-Cl bond as 
was originally proposed.  
The reaction profile over time for both the tethered chloro and iodo catalyst offers 
further insight into the relative reactivities of the two complexes. Unlike the ATH 
reactions however, when using the sealed Parr reactor for APH reactions it was not 
possible to sample the same reaction at various time points for conversion analysis. 
Sampling APH reactions required cooling and depressurising the reaction before 
opening the reactor to extract a sample and once open, the reaction and all active 
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catalytic intermediates are exposed to air and moisture which may deactivate the 
catalyst. Indeed when initial reactions were sampled this way conversion was found 
to stop after the first sample was taken. Instead several reactions were carried out for 
different lengths of time and the conversion analysed. Each reaction was carried out 
in duplicate to confirm the results and identify anomalous results due to inaccurate 
weighing of catalyst or acetophenone. The same batch of catalyst, acetophenone and 
MeOH was used throughout. The results are shown in Figure 45. 
 
 
Figure 45. Analysis of conversion over time for APH of acetophenone using chloro (97) and iodo 
(181) tethered catalysts. 
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The conversion vs. time graph shows that the ruthenium iodide catalyst 181 is less 
active than the chloro derivative throughout the reaction process. A close up view of 
the first 4 hours of the reaction shown in Figure 46 shows that the initial activation 
period for the catalysts, is much longer for the iodo catalyst than the chloro catalyst.  
 
Figure 46. Analysis of conversion over time for hours 1-4 of the APH of acetophenone using chloro 
(97) and iodo (181) tethered ruthenium complexes. 
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catalyst. Also the formation of HI during the reaction with the iodo catalyst 181 
compared to HCl with the chloro catalyst may be detrimental to the reaction.  
The tethered iodo catalyst 181 was also applied to the ATH of acetophenone. Under 
these conditions, where ionisation of the catalyst is not necessary for formation of 
the active species due to the presence of base, the iodo catalyst 181 performed 
equally to the chloro catalyst 97 (Table 24). 
Table 24. ATH of acetophenone using tethered ruthenium chloride (97) and iodide (181) catalysts. 
 
Entry Catalyst Temp. 
(°C) 
Time 
(hours) 
Conv.
a
 
(%) 
Ee.
a
 (%) 
1 
(R,R)-97 
RuCl 
28 34 92.8 96.5 (R) 
2 
(S,S)-181 
RuI 
28 34 99.6 95.9 (S) 
3 
(R,R)-97 
RuCl 
60 2 99.8 95.0 (R) 
4 
(S,S)-181 
RuI 
60 2 99.4 95.3 (S) 
a
Determined by chiral GC analysis. 
 
For the ATH conditions investigated, both catalysts gave comparable results 
showing no difference in activity upon substitution of the chloride for an iodide in 
the catalyst. The mode of activation for catalysts in ATH processes is loss of the 
halide ligand brought about by the presence of a base such as Et3N or KOH. The loss 
of both chloride and iodide in this way should proceed at equal rates allowing equal 
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formation of the active Ru-hydride species and hence and equal rate of 
hydrogenation taking place.  
2.4.3 4C-tethered ruthenium catalyst. 
The third alteration made to the catalyst was to increase the length of the tether to a 4 
carbon chain. This complex is known and has been reported to give improved results 
for ATH of ketones over the 3 carbon tethered catalyst.
101,102
 
The initial preparation of the catalyst began according to literature procedures
101,102
 
with preparation of the 4-cyclohex-1,4-dienyl)butan-1-ol (185) starting material via 
Birch reduction of 4-phenyl-1-butanol as in Scheme 65. 
 
 
 
Scheme 65. Preparation of 4-cyclohex-1,4-dienyl)butano-1-ol 185. 
 
The next step in the synthesis is to couple the diene to the asymmetric diamine 
ligand, in this case (R,R)-TsDPEN. In the first reported synthesis of this catalyst this 
was achieved via Swern oxidation to afford the aldehyde and then reductive 
amination with TsDPEN to afford the coupled ligand.
99 
Ikariya has published an 
alternative procedure for preparation of tethered diene ligands with conversion of the 
alcohol to a tosylate followed by nucleophilic substitution with the TsDPEN to 
afford the desired diene product.
104
 This process was thus employed for preparation 
of the 4C-tethered ligand 187 as shown in Scheme 66. The ruthenium complex was 
then prepared from ligand 187 according to the reported method.
101,102 
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Scheme 66. Synthesis of (R,R)-TsDPEN-4C-tethered ruthenium catalyst 101. 
 
With the catalyst in hand it was applied to APH of a range of ketones as with the 3C-
tethered catalyst previously. Results are shown in Figure 47. 
 
aConversion and ee. determined by chiral GC unless otherwise stated. bDetermined by chiral HPLC. 
Figure 47. Application of (R,R)-4C-tethered TsDPEN ruthenium catalyst 101 to APH of ketones. 
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APH of ketones with the 4 carbon tethered catalyst 101 proceeded well with high 
activity and enantioselectivity. In most cases however, the 3 carbon catalyst gave the 
best results in terms of conversion, enantioselectivity or both. Only in some cases, 
namely APH of p-trifluoromethylacetophenone, indanone, tetralone and 
chromanone, did the results with 101 match those obtained with 97 in terms of 
conversion and enantioselectivity.  
Under ATH conditions, the improved activity of the 4C-tethered catalyst 101 
compared to its 3C counterpart 97 is reported to be due to the catalyst having a 
higher rate for formation and regeneration of the Ru-H species than 97.
101,102
 The 
results obtained for APH however show the 4C-tethered catalyst 101 to be less active 
than its 3C counterpart.  
This may be due to the different mechanisms for ATH and APH as reported by 
Noyori
75
 and discussed in Schemes 22 and 30. Although in both processes the 
reduction of the ketone occurs via the same cyclic transition state, the formation of 
the Ru-H species occurs by a different pathway for each process. In ATH, the 
presence of base allows the elimination of HCl to give the 16 electron complex 
(Scheme 22), in APH however, the chloride is lost through ionisation generating a 
cationic complex with interacts with molecular hydrogen to form the ruthenium 
hydride species (Scheme 30). In the 4C tethered catalyst 101, the tether is reported to 
be oriented towards the chloride which increases the sterics in this region of the 
catalyst.
102
 The increase in sterics may be a disadvantage under APH conditions, 
inhibiting either the ionisation of the chloride ligand, or the initial co-ordination of 
molecular hydrogen prior to Ru-H formation. Such inhibition would increase the 
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time required for Ru-H formation and regeneration in turn reducing the rate of 
turnover and hence activity of the catalyst. 
2.5 Hydrogenation of aldehydes with tethered ruthenium catalysts. 
The tethered catalysts, particularly the 3C tethered catalyst 97 have shown good 
activity and enantioselectivity for the APH of ketones, however the hydrogenation of 
aldehydes to prepare primary alcohols was also of interest. Initial attempts at the 
hydrogenation of benzaldehyde shown in Scheme 67 gave formation of a second 
product in addition to the desired benzyl alcohol (Figure 48).  
 
 
 
Scheme 67. APH of benzaldehyde using tethered ruthenium catalyst (S,S)-97. 
 
GC conditions: Chrompac cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 100°C, P = 15psi 
H2, det = FID 220°C, inj = 220°C, benzaldehyde 9.6 min., benzyl alcohol 27.1 min. 
Figure 48. Example chrial GC chromatogram of the APH of benzaldehyde as shown in Scheme 67. 
 
 Isolation of the unknown compound at 15.6 min. was achieved by column 
chromatography. 
1
H NMR analysis identified the compound as 
(dimethoxymethyl)benzene (Figures 49 and 50). 
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 GC conditions: Chrompac cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 100°C, P = 15psi 
H2, det = FID 220°C, inj = 220°C, (dimethoxymethyl)benzene 15.6 min. 
 
Figure 49. Chiral GC chromatogram showing isolated unidentified compound at RT 15.6 min. 
 
Figure 50. 
1H NMR of isolated unidentified compound at RT 15.6 min. (CDCl3, 300 MHz). 
 
In order to determine if the formation of the dimethoxy product was characteristic of 
aldehydes in general or was simply isolated to the case of benzaldehyde, 
cinnamaldehyde was also subjected to pressure hydrogenation (PH) conditions as 
shown in Table 25, and Figure 51. 
 
OCH3 
CH 
CHAr 
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Table 25. APH of cinnamaldehyde using catalyst (S,S)-97. 
Entry 
Temp 
(°C) 
Conversion to products
a
 (%) 
  
  
Unknown 
at 26 min. 
1 60 0.3 0.3 7 78.4 13.9 
2 40 16 0.9 1.2 59.2 22.7 
aDetermined by GC. 
 
GC Conditions: Chrompac cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 130°C, P = 15psi 
H2, det = FID 220°C, inj = 220°C, 3-phenylprop-2-enal 11.2 min., 3-phenylpropan-1-ol 20.4 min., 
cinnamaldehyde 21.8 min., unknown product 26.2 min., 3-phenylprop-2-en-1-ol 31.6 min. 
Figure 51. Example GC chromatogram for the APH of cinamaldehyde. 
 
Again an unknown compound was found to form in the reaction (RT = 26.2 min.), 
isolation of this compound and analysis by 
1
H NMR identified it as (3,3-
dimethoxyprop-1-en-1-yl)benzene 189 (Figure 52).  
 
 
Figure 52. (3,3-dimethoxyprop-1-en-1-yl)benzene 189. 
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It was thought that by altering the solvent to a more sterically encumbered alcohol or 
a non alcoholic solvent may prevent formation of such adducts (Table 26). 
Table 26. Investigation into the use of different solvents for the APH of benzaldehyde. 
 
 
 
Entry Solvent 
Conversion to products
a
 (%) 
 
Other 
products  
1 IPA 91.8 0.3 7.9 
2 DCM 98.1 - 1.9 
3 Toluene 96.6 - 3.4 
4 
Cyclo-
hexanol 
95 - 5.0 
5 Dioxane 97.4 0.6 2.0 
6 DMF 93.8 - 6.2 
7 H2O 73.8 - 26.2 
        aDetermined by GC analysis. 
 
Of the solvents tested all gave low conversion to benzyl alcohol but the use of water 
as the solvent gave the highest of these conversions demonstrating a degree of 
tolerance to water for the catalyst. A systematic study was carried out to identify the 
effect of different MeOH/H2O mixtures as the reaction solvent on the conversion of 
benzaldehyde to benzyl alcohol and (dimethoxymethyl)benzene under pressure 
hydrogenation (PH) conditions. The results are shown in Table 27.  
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Table 27. Use of aqueous solvent for the APH of benzaldehyde using (S,S)-97. 
 
Entry Solvent 
Time 
(hours) 
Conversion to products
a
 (%) 
  
 
1 H2O 24 73.8 - 26.2 
2 
MeOH + 
0.2 mol% H2O 
24 5.7 39.5 54.8 
3 
MeOH + 2μL 
H2O 
24 <0.01 38.4 61.6 
4 
75:25 
MeOH:H2O 
24 0.2 <0.01 99.8 
5 
50:50 
MeOH:H2O 
24 0.2 <0.01 99.8 
6 
25:75 
MeOH:H2O 
24 27.8 0.4 71.8 
      aDetermined by GC analysis. 
 
Initially catalytic amounts of water were added to the reaction however no 
improvement to the conversion to benzyl alcohol was seen. With larger amounts of 
water, (Table 27, entries 4 and 5) the formation of (dimethoxymethyl)benzene was 
inhibited and the reaction proceeded with full conversion to benzyl alcohol. Table 
27. entry 6, with 75% water in MeOH shows the water to inhibit the hydrogenation 
reaction with incomplete conversion of benzaldehyde to products in 24 hours, 
although the amount of (dimethoxymethyl)benzene formed remained low. The PH of 
cinnamaldehyde was carried out using conditions as for Table 27, entry 5. 
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Cinnamaldehyde was found to be a more hindered substrate in the initial reductions 
carried out (Table 25) exhibiting lower overall conversion to product than the 
benzaldehyde reduction (Scheme 67) so it was deemed a good substrate to 
investigate the efficacy of the new reaction conditions. The results are shown in 
Scheme 68. 
 
 
 
Scheme 68. APH of cinamaldehyde using (S,S)-97. 
 
Although the reaction showed minimal formation of (dimethoxymethyl)benzene, the 
overall conversion to products for the reaction was 89.3% leaving 10.7% unreacted 
starting material, even with the long reaction time of 24 hours. This shows that the 
addition of water to the MeOH solvent will need to be minimised in order for the 
reaction to remain effective for the PH of more difficult substrates. A further study 
was therefore carried out to determine the minimum amount of water required to 
prevent formation of (dimethoxymethyl)benzene. The results are shown in Table 28.  
 
 
 
 
 
Development of catalysts for asymmetric hydrogenation                                   Results and Discussion 
123 
 
Table 28. APH of benzaldehyde using (S,S)-97 and aqueous solvent. 
 
Entry Solvent 
Time 
(hours) 
Conversion to products
a
 (%) 
  
 
1 
75:25 
MeOH:H2O 
16 19.8 4.6 75.6 
2 
90:10  
MeOH: H2O 
16 <0.01 <0.01 99.9 
3 
95:5 
MeOH:H2O 
16 0.2 - 99.8 
4 
95:5 
MeOH:H2O 
8 0.03 0.03 99.9 
    a
Determined by GC analysis. 
 
The reaction conditions used in Table, 28, entry 4 were deemed to be the best 
conditions for the PH reaction, with short reaction times, minimal amount of water 
and high conversion to the desired alcohol product. With appropriate reaction 
conditions in hand, a sample of 3C-tethered achiral catalyst 190 provided by Johnson 
Matthey was applied to PH of benzaldehyde (Table 29). Use of the achiral catalyst is 
desirable as the hydrogenation of aldehydes does not give chiral products. Thus, the 
presence of expensive enantiomerically pure diamine ligands in the catalyst is not 
required. The achiral catalyst is therefore more cost effective and appropriate to use 
than the asymmetric catalyst 97. 
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Table 29. APH of benzaldehyde with achiral tethered ruthenium catalyst 190 and aqueous solvents. 
 
Entry Solvent 
Substrate/
catalyst 
Temp 
(°C) 
Time 
(hours) 
Conversion to products
a
 (%) 
  
 
1 
95:5 
MeOH:H2O 
500/1 60 8 10.6 13.4 76.0 
2 
95:5 
MeOH:H2O 
500/1 60 4 44.6 32.3 12.3 
3 
95:5 
MeOH:H2O 
1000/1 60 8 48.6 47.2 2.7 
4 
95:5 
MeOH:H2O 
500/1 40 16 40.9 51.7 7.4 
5 
90:10 
MeOH:H2O 
500/1 60 8 17.9 9.2 72.9 
6 
90:10 
MeOH:H2O 
500/1 60 16 0.4 0.1 99.5 
a
Determined by GC analysis. 
 
Initially the achiral catalyst showed reduced activity compared to the (S,S) catalyst. 
Comparison of Table 28, entry 4 and Table 29, entry 1, shows that under the same 
reaction conditions the achiral catalyst gave less conversion to benzyl alcohol and 
also allowed formation of (dimethoxymethyl)benzene. Investigations into reducing 
the reaction time, catalyst loading and temperature were further detrimental to the 
reaction, drastically reducing conversion to the desired product and increasing 
conversion to (dimethoxymethyl)benzene. Increasing the amount of water in the 
solvent and the reaction time was found to correct this achieving almost full 
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conversion to the desired alcohol product (Table 29, entry 6). A range of aldehydes 
were then subjected to APH under these conditions (Table 30). 
Table 30. APH of aldehydes using achiral ruthenium catalyst 190 and aquesous solvent. 
 
Entry Substrate Solvent Time 
(hours) 
Conversion to products
a
 (%) 
1 
 
90:10 
MeOH: H2O 
16 
0.4 
 
99.6 
 
- 
2 
 
90:10 
MeOH: H2O 
16 
0.1 
 
99.8 
Other 0.1 
3 
 
90:10 
MeOH: H2O 
16 
0.8 
 
94.8 
2.8 
 
Other 
1.6 
4 
 
90:10 
MeOH: H2O 
24 
 
0.05 
 
0.06 
96.1 
 
 
 
3.5 
 
 
0.3 
aDetermined by GC analysis. 
 
Good conversion to the desired product was achieved with each aldehyde 
demonstrating tolerance of a variety of aromatic substituents and also good 
chemoselectivity for hydrogenation of the carbonyl group over nitro and alkene 
groups. The hydrogenation of cinnamaldehyde proceeded with greater selectivity for 
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hydrogenation of the C=O bond over the C=C bond than with hydrogenation of 4-
phenyl-3-buten-2-one (Scheme 70). The reduced steric environment of the C=O 
bond in cinnamaldehyde due to the presence of a proton rather than methyl group 
bonded to the carbonyl is thought to give a greater energy difference between 
transition states for C=O and C=C hydrogenation than for 4-phenyl-3-buten-2-one. 
Thus there is a greater preference for hydrogenation of the C=O bond in 
cinnamaldehyde over the C=C bond than in 4-phenyl-3-buten-2-one. 
2.6 Synthesis of tethered ruthenium complexes by aryl substitution 
methodology and application to asymmetric hydrogenation of 
ketones. 
In the previous section, tethered catalysts were successfully applied to the APH of 
ketones and aldehydes demonstrating high activity, enantioselectivity and 
chemoselectivity. Of all the catalysts investigated, the 3C-tethered TsDPEN RuCl 
catalyst 97 proved to be the most active. Although highly active for APH of ketones, 
and also aldehydes in both its chiral and achiral states, the preparation of the catalyst 
is far from ideal requiring a Birch reduction and also a two step ruthenium 
complexation process with formation of the dimer prior to formation of the monomer 
which is used in hydrogenation reactions.
96,97,101,102
 The necessity of the Birch 
reduction also restricts the structure of the tethered catalysts it is possible to form 
using this existing synthesis, limiting substitution on the aryl ring of the catalyst to 
those which can be prepared through the Birch reduction. Reported tethered catalysts 
with aryl substituents have, as a result, been restricted to those containing one or two 
methyl groups (Figure 55).
101,102,104
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Figure 53. Examples of alkyl substituted tethered ruthenium catalysts.  
 
Substituent groups on the aryl ring need to be stable to the Birch reduction 
conditions without hindering the reduction of the aromatic ring. The presence of 
electron donating groups such as alkoxy groups may encourage oxidation of the 
diene formed in the Birch reduction. This would lead to re-aromatisation of the ring 
preventing complexation with ruthenium. Bennett has reported the successful 
preparation of a series of arene ruthenium(II) complexes from a variety of substituted 
dienes including methyl, dimethyl and halogen substituted cyclohexadienes.
150
 In a 
separate report however he reports that attempts to prepare the hexamethylbenzene 
ruthenium chloride dimer were unsuccessful due to the resistance of hexamethyl 
benzene to reduction in order to form its diene derivative for coordination with 
ruthenium.
151
This resistance to reduction suggests that hexamethylbenzene may 
exhibit a strong preference for oxidation due to the electron donation from the six 
methyl substituent groups.  
A further example of this is the reported synthesis of OMe-substituted Noyori type 
complex 193 which requires an 8-9 fold excess of 1-methoxycyclohexa-1,4-diene 
191 in combination with RuCl3 to form the OMe substituted dimer for monomer 
formation with TsDPEN. This reaction is reported in the literature
152, 153
 and further 
confirmed with our own attempts at its synthesis shown in Scheme 69. Initial use of 
1.2 equivalents of diene 191, as used in the reported syntheses of tethered catalysts, 
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gave no formation of the desired dimer 192. Use of 11 equivalents of diene 191 
however gave dimer 192 in a 50% yield (Scheme 69) which was then converted to 
monomer 193. Use of complex 193 for the hydrogenation of acetophenone gave 
>99.9% conversion to phenyl ethanol with an ee. of 94.5% (R) under ATH 
conditions (formic acid:triethylamine 5:2, S/C 100/1, 28°C for 24 hours), but only 
11.8% conversion and 80.2% (R) under APH conditions (30 bar H2 in MeOH, S/C 
500/1 at 60°C for 24 hours). 
 
Scheme 69. Preparation of Noyori-type OMe substituted untethered ruthenium catalyst 204. 
 
Such a large excess of the diene is presumably required due to the electron-rich 
nature of the cyclohexadiene ring, with electron donation from the OMe encouraging 
oxidation to methoxybenzene. Employing a large excess of the diene is therefore 
necessary to ensure that enough diene remains present for complexation with the Ru. 
Whilst this process can be considered far from ideal but acceptable for complexes 
such as 193 which require simple and available diene starting materials, when 
considering the preparation of tethered complexes via a similar route it becomes 
significantly less viable. The use of such large excesses of enantiopure, TsDPEN 
containing diene ligands is not appropriate regarding the cost of such compounds and 
their preparation which involves multiple steps including a Birch reduction as shown 
in Scheme 70. 
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Scheme 70. Example preparations of TsDPEN tethered diene ligand. 
 
The Birch reduction can be avoided, with both Wills
98
 and Ikariya
104
 reporting the 
[4+2] cycloadditions for diene formation as shown in Scheme 71. 
 
Scheme 71. [4+2] cycloadditions for preparation of dienes. 
 
Precedent also exists for [4+2] cylcoadditions involving methoxy substituted 1,3-
butadiene.
154
 However, even with avoidance of the Birch reduction, the issue 
remains with complexing the formed diene ligand with ruthenium.  
Despite the difficulties with the synthesis of such complexes, the preparation and use 
of tethered catalysts possessing aryl substituents remains of significant interest, 
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offering the potential to enhance the interaction between the catalyst and substrates 
in order to improve conversion and enantioselectivity. However, for such potential to 
be investigated, an effective synthesis of such complexes allowing diverse 
substitution of the aryl ring is required. Of particular interest to ourselves was 
preparation of the catalyst via an aryl substitution process, with an electron-poor aryl 
group on a preformed ruthenium dimer being displaced by a more electron-rich aryl 
group of a ligand (Scheme 72).  
 
Scheme 72. Proposed synthesis of tethered ruthenium catalysts by an aryl substitution approach. 
 
This type of reaction is known in the literature however it has not previously been 
applied to the preparation of catalysts with a structure synonymous to the 3C-
tethered TsDPEN RuCl catalyst. There are many reports in the literature of the use of 
aryl substitution in the preparation of complexes involving phosphine ligands as 
shown in Scheme 73.
155
  
 
Scheme 73. Preparation of P-tethered ruthenium complexes by aryl substitution. 
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A review of the literature reveals only two examples of complexes formed via an 
aryl substitution involving nitrogen containing ligands. In 2007 Sadler reported the 
following reaction with tether lengths of 2 and 3 carbons long (Scheme 74).
156 
 
Scheme 74. Preparation of N-tethered ruthenium complexes by aryl substitutions. 
 
In 2009 Ikariya reported the following reaction with tether lengths of 3 and 4 carbons 
long (Scheme 75).
157 
 
Scheme 75. Preparation of N-tethered ruthenium complexes by aryl substitution. 
 
Initially it was thought that 3C-tethered TsDPEN ruthenium chloride complexes 
such as 97 could be prepared in a similar way however past attempts to achieve this 
within our group (carried out by Dr. Silvia Gosiewska) were unsuccessful, either 
with no reaction taking place or with decomposition occurring at higher temperatures 
(Scheme 76). 
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Scheme 76. Previous attempted formations of tethered complexes by aryl substitution in our group. 
Carried out by Dr. Silvia Gosiewska (unpublished result). 
 
These findings showed that unlike the work of Sadler and Ikariya, whereby with a 
ligand containing a single nitrogen atom the nitrogen is first co-ordinated to the 
ruthenium in situ to give an initial complex prior to aryl substitution, in our case with 
a diamine containing ligand, initial co-ordination of both nitrogens to the ruthenium 
inhibits the substitution reaction. It is thought that with both nitrogens co-ordinated 
to the ruthenium the geometry and degree of flexibility of the complex, in particular 
the tethered aryl component, is not of the correct orientation to allow aryl 
substitution to occur. We propose that with only one point of co-ordination between 
the tethered aryl ligand and ruthenium prior to aryl substitution as reported by 
Sadler
156
 and Ikariya
157
, the complex retains flexibility allowing a more favourable 
orientation for aryl substitution to be adopted. An alternative strategy was therefore 
adopted within our group shown in Scheme 77, whereby the ligand 196 and electron 
poor dimer 197 were combined directly rather than attempting the aryl substitution 
on a pre-formed complex.  
 
Scheme 77. Previous attempted synthesis of complex 97 by aryl substitution carried out by Dr. Silvia 
Gosiewska (unpublished result). 
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Under these conditions however, the desired complex was not formed. It was thought 
that the presence of Et3N and a long reaction time at room temperature prior to 
heating may be encouraging formation of the unreactive complex 195 shown in 
Scheme 76, through deprotonation of the tosylated nitrogen which then co-ordinates 
to the ruthenium. Therefore, recent studies in our group carried out by Dr. Soni again 
looked at reacting ligand 196 and dimer 197 directly, however this time the Et3N was 
omitted and the time spent at room temperature before heating was reduced to 30 
min. as shown in Scheme 78. 
 
 
 
Scheme 78. Further attempts at synthesis of complex 97 by aryl substitution (carried out by Dr. Soni). 
 
On this occasion a small amount of product 97 was formed, although by mass 
spectrometry the major component of the reaction mixture was unreacted ligand 196 
rather than complex 195. The absence of base, along with the reduced time at room 
temperature shows inhibition of the formation of complex 195, allowing aryl 
substitution to occur when the reaction was heated. In order to further improve 
conversion to the desired complex, the methoxybenzene derivative of the ligand was 
prepared for use in the aryl substitution reaction as it was felt that the electron rich 
nature of the aromatic ring may bias the system towards displacement of the electron 
poor ethylbenzoate ring and complexation of the methoxybenzene ring to ruthenium 
(Scheme 79). Conversion to complex was improved allowing isolation and 
characterisation of the obtained product.  
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Scheme 79. Synthesis of p-OMe substituted tethered catalyst 199 by aryl substitution (carried out by 
Dr. Soni). 
Additional purification by further column chromatography and recrystallisation of 
the isolated complex was required to give product of sufficient purity for an X-ray 
crystallographic structure to be obtained (Figure 54) and initial ATH reactions to be 
carried out. 
 
Figure 54. X-ray Crystal structure of catalyst 199 obtained by Dr. Soni. 
The X-ray structure compares with that previously reported for complex 97.
99
 The 
complex is a single diastereomer with the tosyl group away from the chloride ligand 
and exhibiting π/π-stacking with the neighbouring phenyl group of TsDPEN. The 
methoxy arene substituent shows a degree of planarity with the aryl ring. 
In an initial screening reaction, Dr. Soni found the catalyst 199 to give >99% 
conversion, 97.9% (R) for ATH of acetophenone using 1 mol% catalyst in formic 
acid triethylamine at 28°C. With the catalyst showing excellent activity for transfer 
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hydrogenation of ketones, it was felt necessary to further optimise its formation. 
Although the product was obtained under reaction conditions shown in Scheme 79, 
high levels of impurities were also formed observed by TLC analysis of the reaction 
product. To purify the product sufficiently for use in catalytic reactions, it was 
necessary to carry out column chromatography followed by multiple 
recrystallisations, a process which was detrimental to the yield of catalyst. It was 
thought that the long reaction time may be contributing to the high levels of 
impurities seen and that a higher temperature may improve this. Dr. Soni repeated 
the synthesis of 199 using chlorobenzene, with its higher boiling point, at 140°C. 
Formation of the complex with no ligand present by TLC was achieved after only 2 
hours, however impurities were still present. Further optimisation of the method was 
required as well as investigations into the application of the methodology to the 
preparation of other tethered ruthenium complexes and their use in APH reactions. 
This work was carried out by myself. 
My initial studies began with identifying the most appropriate synthesis for 
production of ethylbenzoate ruthenium(II)chloride dimer with initial formation of 
cyclohexa-1,4-dienecarboxylic acid, followed by formation of the ethyl ester. The 
ester then undergoes complexation with RuCl3 to give the desired dimer product as 
shown in Scheme 80.  
 
Scheme 80. Synthesis of electron poor Ethylbenzoate ruthenium(II)chloride dimer 197. 
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There are two main methods reported for the production of cyclohexa-1, 4-
dienecarboxylic acid: Birch reduction of benzoic acid
158
 and cycloaddition of 
butadiene with propiolic acid
159
as shown in Scheme 81. 
 
 
 
 
Scheme 81. Synthesis of cyclohexadienecarboxylic acids 200a and b. 
 
Birch reduction of benzoic acid proceeded well on a reasonable scale (8 g benzoic 
acid) giving 75% yield of product 200a. However, along with the associated hazards 
of using sodium metal and ammonia, the reaction was found to be inconsistent with 
different isomers of diene product being formed on different occasions and 
1
H NMR 
analysis showing evidence of decomposition and over reduction of the aromatic ring 
(see Experimental section of this thesis). Formation of 200b by [4+2] cycloaddition 
of 1,3-butadiene and propiolic acid was found to be highly effective forming a single 
isomer of product in an 82% yield. Attempts to carry out the reaction using sulfone, 
which readily decomposes to 1,3-butadiene on heating, instead of 1,3-butadiene 
itself were unsuccessful giving only a 24% yield of the desired product.   
2.6.1 Optimisation of aryl substitution methodology for the preparation of 
tethered ruthenium complexes. 
With a robust synthesis of the dimer 197 in hand, work began to optimise the 
chlorobenzene method for preparation of catalyst 199, as by TLC this method gave 
slightly cleaner product than that obtained from DCM at 90°C, and also was a 
significantly shorter method. Firstly different reaction temperatures were 
investigated (Scheme 82). 
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Scheme 82. Synthesis of p-OMe substituted tethered ruthenium catalyst 210 by aryl substitution. 
 
The reaction was carried out at 90, 120 and 140°C in chlorobenzene for 2 hours after 
the initial 30 min. in DCM at room temperature. The reaction solutions were then 
analysed by TLC and mass spectrometry and the results are described in Figure 55. 
 
 
Figure 55. TLC analysis of complex 199 formation at different temperatures. 
For comparison, the 49 hr., 90°C, DCM reaction was also carried out and analysed 
by TLC along with a sample of the purified catalyst. After 2 hours ligand 209, seen 
by UV light, was present in the 90°C reaction, however none was visible in the 120 
or 140°C reaction. Notably the reaction at 90°C gave significantly cleaner reaction 
product by TLC than the reactions carried out at higher temperatures. In addition, 
209 
standard 
210 
standard 
Chlorobenzene 
      90°C      120°C      140°C 
DCM 90°C 
49 hr. 
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significantly more of the desired complex 199 seemed to be visible by TLC in the 
chlorobenzene reactions than in the DCM reaction. Mass spectrometry confirmed the 
presence of the desired complex in all reactions with a signal at m/z 615.1 [M+H-
Cl]
+
. In order to confirm the most appropriate temperature and reaction time for 
complex formation, further reactions were carried out at 75, 90 and 100°C. At 100°C 
the reaction was found to be complete with no ligand visible by UV after 3 hours, at 
90°C, 5 hours was required for consumption of the ligand  by TLC, however at 75°C 
ligand was still present by TLC after 5 hours. TLC showed more impurities present 
at 100°C than at 75 or 90°C and thus 90°C was deemed to be the most appropriate 
temperature for the reaction giving a good compromise between purity of the product 
obtained and reaction time. 
Further investigations were conducted using different solvents for the reaction 
including chloroform, water, THF, 
i
PrOH, MeCN and xylene at 90°C. After 2 hours, 
TLC and mass spectrometry showed the desired complex to only form in xylene, 
however there were many impurities present thus, chlorobenzene at 90°C was 
deemed the most appropriate conditions for preparation of the methoxy substituted 
catalyst 199.  
2.6.2 Mechanistic insights into the formation of ruthenium complexes by aryl 
substitution. 
With an optimised synthesis of OMe-substituted tethered catalyst 199 via aryl 
substitution in hand, further work was carried out to understand the mechanism of 
formation for the catalyst. It is known from previous studies that the preformed, 
diamine co-ordinated complex 195 does not undergo aryl substitution to the desired 
complex. This was also the case with 202 and its application to the synthesis of 199 
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by aryl substitution as shown in Scheme 83. Reaction of 202 in chlorobenzene at 
90°C showed no evidence of formation of 199 by mass spectrometry after 5 hours. 
 
Scheme 83. Attempted preparation of tethered catalyst 199 from 202. 
 
 
Dr Soni had also found that the absence of base is important for the aryl substitution 
to occur (Schemes 77 and 78). It was therefore possible to propose a mechanism for 
the formation of tethered catalysts via aryl substitution (Scheme 84). 
 
Scheme 84. Proposed mechanism for complexation by aryl substitution. 
 
It is thought that the initial stirring in DCM at room temperature in the absence of 
base allows formation of a coordinative bond between the amino nitrogen of the 
ligand and ruthenium to form complex 203. Upon heating the aryl substitution takes 
place giving intermediate 204, prior to loss of HCl allowing formation of the Ru-
NTs bond to give complex 199. The proposed intermediate 203 is analogous to the in 
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situ formed complexes reported by Sadler
156
 and Ikariya
157
 which are known to 
undergo aryl substitution for complexation with ruthenium. 
An NMR study was carried out whereby the ligand and dimer were combined with 
CDCl3 in an NMR tube and a 
1
H NMR spectrum obtained at various time points. 
The spectra obtained were compared with each other and also with the 
1
H NMR 
spectra of standards of the ligand 198, dimer 197, tethered complex 199, unreactive 
complex 202 and also a sample of the complexation reaction taken after 30 min 
stirring in DCM at RT of dimer 197 and ligand 198. The 
1
HNMR spectra are shown 
in Figure 56.  
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The NMR spectra show rapid consumption of dimer 197 and formation of two 
species upon the mixing of the ligand and dimer in CDCl3 at room temperature 
(spectra 3-9). The formation of the two species is seen most easily by the appearance 
of two peaks at 1.4 and 1.5 ppm in spectra 3-9. These peaks relate to the CH3 group 
in the ethyl ester of species related to dimer 197. Comparison to spectrum 10 shows 
the peak at 1.5 ppm is due to formation of complex 202. Spectra 3-8 show that 
initially the amount of complex 202 present is minimal with the species exhibiting a 
peak at 1.4 ppm present in a greater amount. It is thought that the species generating 
the peak at 1.4 ppm is intermediate 203 (Scheme 84). In spectra 3-5 there is evidence 
of another species under the 1.4 ppm peak, by spectra 7 and 8 the peak has resolved 
to a clean triplet assumed to be the CH3 group in the ethyl ester of intermediate 203.  
Figure 56, spectra 3-8 show that over time, the ratio of complex 202 and the 
presumed intermediate 203 increases, reaching 1:1 in 15 hours, showing increased 
formation of complex 202 which is known to not undergo aryl substitution. 
Spectrum 9 shows the 
1
H NMR spectrum obtained after 30 min. of stirring the ligand 
198 and dimer 197 in DCM at room temperature as in a typical preparation of 
complex 199. The spectrum achieved compares well with spectrum 3 and 4 showing 
minimal formation of complex 202 with a larger amount of 203 present. This 
confirms the importance of a short time frame for the initial stirring of the ligand and 
dimer at room temperature in a complexation reaction to prevent a large amount of 
the unreactive complex 202 forming and allow sufficient reactive material to 
undergo the aryl substitution process. In the case of initial reactions carried out by 
Dr. Gosiewska (Scheme 77) it is likely that in the initial 2 hour stirring period at 
room temperature, a large quantity of the dimer and ligand initially added to the 
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reaction had already formed the unreactive complex 202 leaving less available to 
form the desired tethered complex. Also the use of triethylamine in this earlier 
reaction is likely to have encouraged complex 202 to form more readily through 
deprotonation of the tosylated nitrogen and subsequent co-ordination of the nitrogen 
to ruthenium. 
Within all aryl substitution reactions carried out for preparation of the OMe 
substituted tethered catalyst 199, analysis of the reaction product by mass 
spectrometry shows the presence of ligand 198 (m/z 515 [M+H]
+
) as well as the 
desired complex 199 (m/z 615 [M+H-Cl]
+
), even when TLC showed no ligand to be 
present. An example mass spectrum is shown in Figure 57. 
 
Figure 57. Mass Spectrum of reaction product for formation of complex 199. 
 
It is thought that HCl generated by reaction of the ruthenium dimer 197 with the 
ligand 198 allows formation of the HCl salt of unreacted ligand. The HCl salt (M) of 
the ligand would give the same m/z 515 [M-Cl]
+
 signal in the mass spectrum as the 
free ligand (m/z 515 [M+H
+
]), but would not be observed at the expected Rf of the 
ligand by TLC. Thus TLC analysis would suggest complete consumption of the 
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ligand whilst mass spectrometry would indicate the presence of ligand in its HCl salt 
form. In a separate experiment, (carried out by Dr. Soni), it was found that the HCl 
salt of the ligand does not undergo aryl substitution to form the desired complex 199 
and its presence is hence detrimental to the yield of the desired complex. 
The use of triethylamine is known to be detrimental to the reaction, promoting 
formation of complex 202 (Scheme 77). Use of a weaker base however, may help 
prevent formation of the HCl salt of the ligand but not be strong enough to 
deprotonate the tosylated nitrogen leading to formation of complex 202. A base 
screen was carried out with addition of a range of weak inorganic bases to the 
formation of methoxy substituted tethered complex 199 by aryl substitution. NaOH 
was also screened as a strong base for comparison. The reactions were analysed by 
mass spectrometry after 5 hours and ratios of ligand:complex recorded (Table 31). 
 
Table 31. Addition of inorganic base to the aryl substitution reaction. 
 
Base None Ca(OH)2 Ca(OH)2 NaHCO3 K2CO3 Mg(OH)2 NaOH 
Equiv. 
wrt. 209 
 
- 1 2 1 1 1 1 
Ratio 
209:210 
 
4:1 3:2 3:1 4:1 4:1 6:1 3:1 
Complex 
202 
formed 
No No No No No No Yes 
Ratio refers to relative heights of peaks in mass spectrum. 
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Although mass spectrometry analysis is not quantitative and in this case the ligand is 
known to give a stronger signal than the complex, the spectra obtained provide a 
qualitative measure of amounts of ligand and complex present. Indeed multiple 
preparations of complex 199 using the procedure detailed in Scheme 82 at 90°C each 
achieve a consistent ratio of 4:1 ligand:complex after 5 hours at 90°C. It was also 
possible to observe whether complex 202 formed under each set of conditions with 
presence of a signal at m/z 765.2 for [M+H-Cl]
+
. The results show that the use of 1 
equivalent of Ca(OH)2 was the most beneficial to the reaction, allowing increased 
formation of the desired complex with a ligand:complex ratio of 3:2 (Figure 58) 
which is an improvement on the ratio achieved in the absence of base. 
 
Figure 58. Mass spectrum for addition of 1 equiv. Ca(OH)2 to formation of 199 by aryl substitution. 
 
The use of two equivalents of Ca(OH)2 relative to ligand however gave a ratio of 
only 3:1, an improvement upon the absence of base, but a reduction in conversion 
compared to the use of 1 equivalent. It is likely that the extra equivalent of Ca(OH)2 
is encouraging formation of the unreactive 202 complex or formation of the calcium 
salt of the ligand. The addition of NaHCO3, K2CO3 and Mg(OH)2 was either 
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detrimental to the amount of complex present or had no effect, possibly these bases 
were too strong allowing formation of complex 202,  too weak to prevent formation 
of the salt of the ligand or were allowing formation of metal salts of the ligand. The 
use of NaOH, a strong base, showed some improvement to the conversion to 
complex, however significant levels of complex 202 were formed with a large signal 
at m/z 765.2 [M+H-Cl]
+
 (Figure 59). 
 
Figure 59. Mass spectrum for addition of NaOH to formation of 199 by aryl substitution. 
 
2.6.3 Application of aryl substitution methodology to the preparation of novel 
tethered ruthenium complexes and their application to the 
hydrogenation of ketones. 
Through optimisation of the synthesis and mechanistic studies, the preparation of p-
methoxy substituted complex 199 was now well understood. The preparation of 
further methoxy substituted catalysts by aryl substitution methodology was 
investigated with the catalysts prepared being applied to the APH of ketones. 
Initially the meta-substituted 3,5-dimethoxy catalyst 209 shown in scheme 85 was 
prepared. In the case of this catalyst, unlike with the p-methoxy catalyst, the required 
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alcohol for the TsDPEN coupling reaction is not commercially available and so it 
was synthesised in three steps prior to complex formation as shown in Scheme 85. 
 
Scheme 85. Preparation of 3,5-dimethoxy substituted catalyst 209 by aryl substitution. 
 
Purification of complex 209 by column chromatography and recrystallisation gave 
material of sufficient purity for use in hydrogenation reactions and also for an X-ray 
crystallographic structure to be obtained (Figure 60). 
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Figure 60. X-ray crystallographic structure of catalyst 209. 
The X-ray structure of 209 is consistent with that reported for complex 97.
99
 The X-
ray structure shows 209 to have formed as a single diastereomer with π/π-stacking 
between the tosyl group and neighbouring phenyl ring on TsDPEN. The tosyl group 
is also shown to be oriented away from the chloride ligand. The methoxy arene 
substituent groups show a degree of planarity with the aryl ring. 
Further studies focused on the preparation of an alternative tethered p-methoxy 
substituted catalyst derived from a DPEN-based rather than TsDPEN-based ligand to 
establish the effect of the absence of a sulfonamide substituted diamine on the aryl 
substitution process. It has been shown that with an alkylated amine, such as the 
alkylated TsDPEN ligand used in preparation of the conventional tethered catalyst 
97, the NH functionality is retained upon complexation to the ruthenium, forming a 
coordinative HN-Ru bond.
74
 The tosylated nitrogen however loses the proton upon 
complexation to ruthenium forming a covalent N-Ru bond.
74
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The reaction of (R,R)-DPEN with excess 3-(4’-methoxyphenyl)-propan-1-ol via the 
triflate gave di-substituted ligand 210 which readily underwent complexation by aryl 
substitution in only 1 hour at 90°C in chlorobenzene to give 211 (Scheme 86). 
 
Scheme 86. Synthesis of cationic methoxy substituted tethered catalyst 211. 
 
Complex 211 was obtained as a cationic complex. As expected, in the absence of an 
electron withdrawing sulfonamide group on the diamine the N-H bond is less acidic 
and the proton is retained by the nitrogen during complexation. In complex 211 the 
ruthenium is in its 2+ oxidation state and is thus bound to both nitrogens via 
coordinative bonds leaving the chloride as the only negative ligand in the complex 
giving an overall positive charge for the complex. 
Mass spectrometry analysis of the reaction after 1 hour at 90°C in chlorobenzene 
shows retention of both NH functionalities and the chloride by the complex with a 
[M
+
+ H] peak at m/z 645.2 and no ligand present at m/z 509.3 [M
+
+H] (Figure 61). 
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Figure 61. Mass spectrum of formation of complex 211. 
 
Purification of complex 211 was achieved by column chromatography although 
silica gel was required rather than florisil which was used for the purification of 199 
and 209 as complex 211 was found to decompose on florisil. The complex was 
isolated as an orange/yellow solid with a silica column, but with use of florisil the 
orange/yellow band for complex 211 rapidly become red in colour as it moved 
through the column. Mass spectrometric analysis of the obtained red product showed 
no evidence of the complex. 
With three methoxy substituted tethered catalysts in hand, (199, 209 and 211), each 
was applied to the APH of acetophenone (Table 32). 
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Table 32. Application of complexes 199, 209 and 211 to APH and ATH of acetophenone. 
 
 
Conditions 
  
 
 
Conv.
a
 
(%) 
Ee.
a 
(%) 
Conv.
a
 
(%) 
Ee.
a 
(%) 
Conv.
a 
(%) 
Ee.
a 
(%) 
H2 (30 atm.), 
MeOH, 60°C, 
S/C 500/1, 16 
hours 
99.9
b 
94.0 (R)
b 
99.8
b 
83.5 (R)
b 
0.4 ND 
H2 (30 atm.), 
MeOH, 60°C, 
S/C 100/1, 16 
hours 
Not attempted Not attempted 2 17% (R) 
Formic acid/Et3N 
60°C, S/C 
1000/1, 4 hours 
99.8  96.3 (R)  99.9   88.8 (R) Not attempted 
Formic acid/Et3N 
60°C, S/C 100/1, 
24 hours 
Not attempted Not attempted 1.6    13% (R) 
aDetermined by GC analysis. b Reactions carried out by Dr. Soni. 
Complexes 199 and 209 were found to show high activity for ATH by Dr. Soni and 
also for APH by myself with both complexes achieving excellent conversions and 
high enantioselectivities. The enantioselectivity of complex 209 was found to be 
lower than that of 199 and it is thought that this may be due to the increased sterics 
of the arene ring reducing the ability of the ketone to co-ordinate in a favourable 
manner as shown below in Figure 62. 
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Figure 62. Model for the interaction of acetophenone with catalyst 209 showing the effect of steric 
hindrance on enantioselectivity. 
 
The cationic complex 211 was found to be inactive to hydrogenation both under 
ATH and APH conditions with high catalyst loadings and temperatures. As a 
cationic complex, it may be that substitution of the chloride ligand for a hydride to 
give the active catalytic species is not possible due to the strong retention of the 
chloride by the ruthenium. Indeed in mass spectrometry analysis (Figure 61) the 
chloride was not lost during the ionisation of the complex and it is known that for 
APH to occur the chloride must be lost through an ionisation process to allow the 
complex to interact with hydrogen.  
Cationic half-sandwich ruthenium complexes are known to have biological 
applications, particularly in the area of cancer treatments. Indeed Sadler et al. have 
recently reported photoactivatable cationic pyridyl ruthenium(II) arene complexes to 
be active against cancer cell lines and also the ability of similar complexes to bind to 
DNA.
160 
Work continues within our group to establish the scope for biological 
applications of complex 211 and complexes analogous to it. 
With complexes 199 and 209 demonstrating high activity for APH of acetophenone, 
their application to the APH of a range of ketones was investigated and results are 
shown in Table 33. 
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,Table 33. Application of catalysts 199 and 209 to APH of a range of ketones. 
 
 
Ketone 
Time 
(hr.) 
  
  
Conv.
a
 
(%) 
E.e.
a
 
(%) 
Conv.
a
 
(%) 
E.e.
a
 
(%) 
 
48 99.3 
37.1 
(S) 
40.0 
81.4 
(S) 
 
16 99.9 
93.7 
(R) 
99.9 
79.5 
(R) 
 
16 98.2 
92.4 
(R) 
99.2 
73.5 
(R) 
 
24 >99 
81.8 
(R) 
>99.9 
53.6 
(R) 
 
16 69.6 
84.3 
(R) 
18.8 
72.8 
(R) 
 
48 36.4 
83.3 
(R) 
26.8 
77.6 
(R) 
 
24 99.6
b 94.5
b
 
(S) 
>99.9
b 81.4
b
 
(S) 
 
24 99.7 
90.7 
(S) 
94.2 87.8(S) 
 
48 95.0 
97.7 
(R) 
71.7 
95.2 
(R) 
 
48 99.6 
98.6 
(R) 
59.7 
98.6 
(R) 
 
24 97.6
b 99.6
b
 
(R) 
99.9
b >98.8
b
 
(R) 
aDetermined by GC analysis. bDetermined by HPLC analysis. 
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In most cases the p-OMe substituted catalyst 199 performed equally to the 
unsubstituted catalyst 97 both in terms of conversion and ee. With more sterically 
demanding substrates such as cyclcohexylmethyl ketone and 2,2-
dimethylpropiophenone however conversions and or ee.’s were lower than with the 
unsubstituted catalyst. This may be due to the increased steric hindrance of the 
aromatic ring of the complex disfavouring co-ordination of the complex to the 
ketone for hydrogen transfer as shown in Figure 63. 
 
 
Figure 63. Favoured transition states for APH of acetophenone with catalyst 97 (left) and 199 (right). 
 
With the 3,5-di-OMe substituted complex 209, conversions and ee.’s were reduced 
compared to the unsubstituted complex 97 and p-OMe complex 199 in most cases. 
The main exception to this is with hydrogenation of cyclohexylmethyl ketone for 
which complex 209 gave a significantly higher ee. than complexes 97 and 199. This 
is likely to be due to the increased steric effect of the aromatic ring on the complex 
generating a greater energy difference between transition states for formation of the 
possible enantiomers of product than the unsubstituted catalyst (Figure 64). 
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Figure 64. Transition states for APH of cyclohexylmethyl ketone with catalyst 209 (top) and 97. 
 
2.6.4 Attempted synthesis of further tethered ruthenium complexes by aryl 
substitution methodology. 
In order to assess the scope of the aryl substitution method for the synthesis of 
tethered complexes, the synthesis of a range of further complexes was attempted. 
Dr. Soni achieved the synthesis of the following complexes 212-214, 99 and 100 
using the developed aryl substitution methodology and applied them to the ATH of 
acetophenone as shown in Figure 65. 
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% refers to % conversion to phenyl ethanol and % ee. obtained. 
 
Figure 65. Application of further catalysts prepared by aryl substitution to ATH of acetophenone. 
 
 
Compounds 212-214 are novel, but were found to be less active to hydrogenation 
than the unsubstituted 3C tethered TsDPEN RuCl complex 97.
99
 Complexes 99 and 
100 are known
 
and are reported to be less active than complex 97.
100-102 
My own studies into the scope of the aryl substitution methodology are outlined 
below. Initially the preparation of the pentamethyl substituted 3C tethered complex 
was attempted, as previous attempts within our group to prepare similarly highly 
substituted tethered catalysts via the conventional synthesis akin to that in Scheme 
20 were unsuccessful as formation of the required diene ligand was not achieved. 
With the aryl substitution process formation of a diene is not necessary, hence this 
alternative synthesis of the pentamethyl substituted complex was attempted as shown 
in Scheme 87 
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Scheme 87. Attempted synthesis of pentamethyl substituted tethered catalyst 218 by aryl substitution. 
 
The desired ligand 217 was prepared, however attempts to prepare the desired 
complex 218 via an aryl substitution process were unsuccessful, both using the 
original 90°C 49 hr. DCM method and also the shorter process using chlorobenzene. 
Mass spectrometry showed only ligand and no evidence of the desired complex or 
pentamethyl derivative of complex 195 was seen. Presumably the high degree of 
substitution on the aryl ring is detrimental to the aryl substitution process.  
We were also interested in the scope for preparation of complexes containing 
alternative tethering motifs via the aryl substitution process.  Previously I had 
attempted the synthesis of a complex containing a triazole tether using variations of 
the conventional syntheses of tethered complexes from dienes and ruthenium dimers, 
however no product was obtained (Scheme 88). 
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Scheme 88. Attempted syntheses of triazole tethered catalysts using conventional complexation 
procedures. 
 
The prepared triazole containing diene ligand 224 was found not to undergo 
complexation with RuCl3.xH2O to form dimer 227 or monomer 226 through in situ 
dimer formation. Preparation of an azide-containing Ru dimer 220 was also found 
not to undergo complexation with N-alkyne substituted TsDPEN 223 to form a 
Noyori type complex 221 which could then have undergone Click coupling to form 
the desired complex 226. We therefore applied the optimised aryl substitution 
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methodology to the synthesis of the related complex 229 to see if it could be formed 
in this way, however again the desired complex was not obtained (Scheme 89). 
 
Scheme 89. Attempted synthesis of triazole tethered catalyst 229 by aryl substitution. 
 
Also of interest to us was the incorporation of substituent groups on the tether of the 
complex to create an additional chiral centre within the complex as shown in Scheme 
90, however again, the desired complex 234 was not formed. 
Scheme 90. Attempted synthesis of OMe substituted tethered catalyst 234 by aryl substitution. 
In both cases with an alternative tether (complexes 229 and 234), the aryl 
substitution methodology was unable to generate the desired complex. It is thought 
that the geometry of the tether may be important for the substitution to occur.  
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Previous studies published within our group have found differences in the geometry 
between the 3C and 4C tethered catalyst.
102
 Both complexes exhibit similar geometry 
around the ruthenium centre, however with the 4C tethered catalyst 101, the tether is 
oriented towards the chlorine increasing the sterics. With the 3C tethered catalyst 97 
the tether is oriented away from the chlorine reducing the steric constraints. The 
increased sterics within 4C complex 101 may not be compatible with its formation 
via aryl substitution. This would also suggest why preparation of the OMe and 
triazole containing tethered complexes was also unsuccessful via the aryl substitution 
process, with both tethering motifs giving an increase in steric hindrance.  
 
2.6.5 Preparation of achiral tethered ruthenium catalysts by aryl substitution. 
Also of interest to us was the use of the aryl substitution methodology to make an 
achiral tethered catalyst. Initial attempts to form the p-OMe-substituted achiral 
tethered ligand 235 from N-tosylethylenediamine were unsuccessful with double 
alkylation taking place to give 236 as shown in Scheme 91. 
 
Scheme 91. Attempted synthesis of p-OMe substituted achiral tosylated diamine ligand 235. 
 
Even with the use of reduced equivalents of 3-(4-methoxybenzene)propanol, only 
the di-alkylated diamine and un-alkylated diamine were obtained. The lack of 
aromatic substituent groups on the ethyl chain enhances the nucleophilicity of the 
nitrogen towards reaction with the in situ formed triflate of the starting alcohol. It is 
also likely that once the first alkylation has taken place, the nitrogen becomes more 
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active towards an additional alkylation, this would explain why even with 1:1 
triflate:diamine the product obtained is a 1:1 mixture of unalkylated diamine 235 and 
di-alkylated diamine 236; the mono alkylated diamine being more reactive towards a 
second alkylation than the unalkylated diamine to initial alkylation. Subsequent 
reactions found the di-alkylated diamine 236 ligand not to undergo the aryl 
substitution to give the desired tethered complex 237 as shown in Scheme 92. 
 
Scheme 92. Attempted synthesis of achiral complex 237 by aryl substitution. 
 
The preparation of N-((naphthalene-2-ylsulfonyl)methyl)ethane-1,2-diamine was 
also attempted (Scheme 93) as it was thought that the presence of a large aromatic 
group and hence increased steric hindrance may improve isolation of the ligand and 
complexes derived from it. However, again only di-alkylated product 236b was 
obtained.  
 
Scheme 93. Attempted synthesis of N-((napthalene-2-ylsulfonyl)methyl)ethane-1,2-diamine. 
 
Further attempts to prepare an achiral ligand continued with preparation of N-(2-
(biphenyl-2-yl)methylamino)ethyl)-4-methylbenzenesulfonamide 238 as shown 
below. A reductive amination synthesis would give only the mono-alkylated product 
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and also the additional aromatic ring as part of the tether should help with isolation 
of the ligand and complex by reducing the polarity of the compound. The 
asymmetric 3C tethered catalyst containing an aromatic ring within the tether (99) 
has previously been reported by our group as an active catalyst for ATH of 
ketones.
100
 It was therefore felt that the achiral derivative 239 would also be a good 
candidate as a hydrogenation catalyst (Scheme 94). 
 
Scheme 94. Synthesis of achiral catalyst 239 by aryl substitution. 
 
An increased temperature of 140°C was required to allow complex formation. Initial 
attempts at 90°C showed only complex 240 (Figure 66) by mass spectrometry.  
 
Figure 66. Structure of complex 240. 
 
Increasing the temperature to 120°C showed only a trace amount of complex by 
mass spectrometry after 3 hours and little improvement after leaving the reaction at 
this temperature overnight. Stirring in DCM at 90°C for 49 hours showed only a 
trace amount of complex by mass spectrometry. At 140°C in chlorobenzene, mass 
spectrometry showed a 1:1 ratio of 239:240 after 5 hours and no improvement to this 
after 7 hours so the reaction was cooled and the crude product purified by column 
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chromatography using florisil. The isolated compound was shown to contain the 
desired complex but also impurities by mass spectrometry. Upon recrystallisation 
from hot MeOH and DCM, the small amount of solid obtained was not the desired 
product, with mass spectrometry and TLC analysis showing the product to be in the 
filtrate along with impurities. Further attempts at purification and recrystallisation 
did not show any improvement to the purity of the compound. It is thought that the 
complex remains too polar to allow effective isolation and purification. 
In order to reduce the polarity of the complex, again by incorporating more 
aromaticity and steric bulk to the ligand, the N-((naphthalene-2-
ylsulfonyl)methyl)ethane-1,2-diamine derivative 241 was prepared and 
complexation attempted as shown in Scheme 95. In this case only a trace amount of 
complex 242 was seen to have formed by mass spectrometry. 
 
Scheme 95. Synthesis of achiral complex 242 by aryl substitution. 
 
Despite still containing impurities, complex 239 was applied to the ATH of 
acetophenone. Previous work shows that tethered complexes are slightly less active 
to APH of ketones than ATH. For example, comparison of Table 22, entry 3 with 
Scheme 63 shows that APH required a longer reaction time to achieve full 
conversion than ATH at the same temperature and catalyst loading. We have also 
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found that the purity level of catalyst required for APH is higher than for ATH. With 
some impurities still present in the isolated complex 239 by TLC, ATH of 
acetophenone was carried out to assess its potential activity. For comparison the 
achiral 3C tethered ruthenium monomer 190 (supplied by Johnson Matthey) and 
dimer 243 (prepared according to the synthesis detailed in Scheme 66) were also 
used. The conversion of acetophenone to phenyl ethanol was monitored by GC with 
the results shown in Table 34. The 3C-tethered achiral dimer 243 was stirred at 40°C 
for 3 hours prior to addition of acetophenone to allow in situ monomer formation. 
Table 34. ATH results using achiral dimer 243 and catalysts 190 and 239. 
 
Entry 
Time 
(hr.) 
   
  Conv. (%)
a 
Conv. (%)
a 
Conv. (%)
a 
1 1 12.1 7.5 0.2 
2 2 31.2 18.3 0.6 
3 3 44.7 - - 
4 3.5 - 77.0 0.8 
5 5 83.2 98.3 - 
6 6 - 99.9 - 
7 7 98.0 - - 
8 20 99.9 99.9 - 
9 24 - - 7.6 
aDetermined by GC analysis. 
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Figure 67. Conversion over time for ATH of acetophenone using achiral catalysts. 
Table 34 and Figure 67 show the difference in activity between the conventional 
achiral 3C tethered monomer 190 and monomer 239, showing the latter to be 
inactive to hydrogenation. Figure 67 also shows the similarity in activity of the 
conventional achiral dimer 243 and monomer 190, both achieving full conversion to 
the racemic alcohol in 7 hours, with the reaction proceeding at comparable rates.  
Work continues within the Wills group to develop novel achiral tethered ruthenium 
catalysts that are highly active for ATH and APH processes and are advantageous 
over complex 190 through improved accessibility by use of convenient aryl 
substitution methodology in their preparation. 
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2.6.6 Preparation of polymer supported ruthenium catalysts by aryl 
substitution and application to asymmetric hydrogenation of ketones. 
Within the Wills group there have been many studies into the development of 
polymer supports for tethered ruthenium catalysts in order to establish a catalytic 
system that would allow for improved recovery of the catalyst after reactions and 
allow for recycling of the catalyst, as well as the potential to carry out 
hydrogenations in water through the use of water-soluble polymers. Previously work 
within our group has looked at linking the catalyst to methacrylate based polymer via 
a Click coupling with an alkyne substituted TsDPEN ligand.
161
 With the 
development of the aryl substitution process for tethered catalyst preparation it was 
thought that the catalysts could be linked to the polymer through the aromatic ring, 
again with a Click coupling approach being most appealing due to its robust nature. 
Poly(glycidyl methacrylate), as a well studied and readily available polymer, was 
selected as a basis for further studies. The epoxide functionality could easily be 
converted to an azide group through ring opening of the epoxide with an azide 
nucleophile giving a polymeric substrate for Click coupling to a ligand prior to 
complexation by aryl substitution.
162, 163 
A potential ligand with TsDPEN coupled to an aromatic ring with a 3C tether was 
prepared, with the aromatic ring containing an alkoxy substituent with a terminal 
alkyne for Click coupling (248 in Scheme 96). 
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Scheme 96. Preparation of asymmetric ligand 248 as a substrate for Click coupling. 
Initial small scale scouting reactions found the ligand to undergo complexation by 
aryl substitution to give a tethered complex 249 as shown in Scheme 97. 
 
 
 
Scheme 97. Formation of complex 249 by aryl substitution as a model for polymer supported 
complexation. 
The crude complex 249 was found to show some activity for the ATH of 
acetophenone giving 21.5% conversion to phenyl ethanol with a high ee. of 97.1% 
(R) at a catalyst loading of 1 mol% in formic acid/Et3N at room temperature for 24 
hours. 
Studies also found ligand 248 to undergo successful Click coupling with benzyl 
azide. Further small scale scouting reactions found this product to successfully 
undergo complexation by aryl substitution as shown in Scheme 98. 
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Scheme 98. Formation of complex 251 by aryl substitution as a model for polymer supported 
complexation. 
 
The long alkyl chain between the aromatic ring and alkyne should allow the triazole 
group to be far enough from the complex after Click coupling to not affect the 
activity of the complex. A polymer supported ligand and complex was then prepared 
as shown in Scheme 99. 
 
Scheme 99. Preparation of polymer supported tethered ruthenium catalyst 254. 
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Compound 252 was soluble in THF and DMSO allowing characterisation data to be 
obtained. However compounds 253 and 254 were found to be insoluble in a range of 
solvents tested including THF, DMF, DCM, CHCl3, MeOH, hexane, EtOAc and 
DMSO. Full characterisation data therefore could not be obtained for 253 and 234. 
These compounds were analysed by Infrared Spectroscopy. The azide in 252 gives a 
characteristic absorbance at 2096 cm
-1
 shown in Figure 68, and reduction of this 
signal was taken as an indication of a successful Click coupling having occurred 
(Figure 69). 
 
Figure 68. IR spectrum of azide opened polymer 252. 
 
OH 
CH 
N3 
C=O 
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Figure 69. IR spectrum of polymer supported triazole-linked ligand 253. 
 
After complexation, the reaction mixture was washed with DCM to remove any 
unreacted dimer and this left an orange/brown insoluble solid which was later used 
in hydrogenation reactions to test for catalytic activity (Table 35 and 36). 
The clicked ligand 253 prior to complexation, and indeed the product obtained after 
complexation, were insoluble. In order to reduce the catalyst loading on the polymer 
and increase the solubility and flexibility of the polymer, a 10 mol% loading of 
ligand 248 was used in an initial click reaction followed by a sequential reaction with 
90 mol% hexyne to give complex 256. A second complex (258) was also prepared 
using 30 mol% ligand and 70 mol% hexyne. An even distribution of hexyne and 
ligand is assumed along the polymer backbone (Scheme 100). 
Reduced N3 
Aromatic 
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Scheme 100. Synthesis of polymer supported tethered ruthenium catalysts 256 and 258.  
 
The solubility of the polymer supported ligands and complexes was not improved so 
again, infrared spectroscopy was used to confirm successful Click coupling of the 
ligand and polymer.  
Alternative functionalities were explored for ring opening of the epoxide. It was 
hoped that the epoxide could be opened with the p-OH derivative of the prepared 
ligand, however initial attempts to ring open the epoxide with phenol proved 
unsuccessful. A further survey of the literature showed that epoxides on analogous 
polymer chains had been ring opened with amines.
164
 This approach was therefore 
applied to the preparation of our polymer supported complexes. Hence 90% of the 
epoxide was first opened with diethylamine whilst 10% was opened with sodium 
azide as before to give 260 which was then converted to polymer supported complex 
262 as shown in Scheme 101. It is hoped that the use of diethylamine instead of an 
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additional 90% of clicked alkane chain will help improve the solubility of the 
supported ligands and hence complexes. Diethylamine was chosen as a small and 
available secondary amine that would mean there was no NH functionality in the 
polymer supported ligand to compete with the TsDPEN for complexation to 
ruthenium (Scheme 101). 
 
Scheme 101. Preparation of diethylamine functionalised polymer supported ruthenium tethered 
catalyst 262. 
The addition of diethylamine and reduction in the loading of azide on the polymer 
did not improve the solubility of the polymer supported complex. Compounds 260-
262 remained insoluble allowing only minimal characterization data to be obtained 
for each. The 10% azide functionality of 259 was confirmed by 
1
HNMR analysis as 
shown in Figure 70. 
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Figure 70. 
1H NMR analysis of 259 (300 MHz, d8-THF). 
 
Comparison of the 
1
H NMR of 259 to poly(glycidyl methacrylate) and 252 
confirmed the presence of a 10% loading of azide. The major peaks in the spectrum 
compare well with the spectrum of poly(glycidyl methacrylate) and the smaller set of 
peaks match well with 252. Analysis of the integration of the peaks shows a ratio of 
epoxide:azide of 9:1 as expected. 
The 
1
H NMR spectrum confirms the 10% opening of the epoxide with N3 in 
compound 259. Comparison to the 
1
H NMR spectra for the starting material and 
fully ring opened product shows a 1:9 ratio of epoxide:azide peaks in compound 
259. Infrared spectroscopy also helped confirm the formation of 259 (Figure 71) and 
also 260 (Figure 72). 
THF 
259 
252 
Poly(glycidyl methacrylate) 
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Figure 71. Infrared spectrum of 259. 
 
The small OH and N3 absorbance at 3435 and 2102 cm
-1
 respectively show the 
presence of a small amount of azide opened epoxide in the compound. The weakness 
of the absorbances comply with the expected 10% loading of azide. 
 
Figure 72. Infrared spectrum of 260. 
OH 
CH 
N3 
C=O 
C=O in ring opened 
epoxide 
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N3 
CH 
OH 
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After ring opening the remainder of the epoxide with diethylamine to give 260 the 
size of the OH absorbance relative to that of the N3 has increased suggesting the 
presence of more alcohol in 260 than in 259. The CH signals at 2963-2874 cm
-1
 have 
also increased in intensity, presumably due to the presence of the diethylamine. 
With a variety of polymer supported tethered ruthenium complexes having been 
prepared, a series of hydrogenations of acetophenone were carried out to establish 
the activity of the compounds. ATH and APH conditions were investigated and the 
results are shown in Table 35. 
 
Table 35. ATH and APH of acetophenone using polymer supported tethered catalysts. 
 
 
Entry Catalyst H2 source 
Temp. 
(°C) 
Conv. 
(%)
a Ee. (%)
a,b 
1 254 
Formic 
acid:Et3N 5:2 
28°C 1.3 ND 
2 254 IPA/KOH 28°C 0.4 ND 
3 254 
Water/sodium 
formate 
60°C 6.5 68.3 (R) 
4 256 
Formic 
acid:Et3N 5:2 
28°C 0.61 ND 
5 256 IPA/KOH 28°C 0.71 ND 
6 256 
Water/sodium 
formate 
60°C 32.0 92.7 (R) 
7 
Recovered 
256 from 
entry 6 
Water/sodium 
formate 
60°C 4.3 
Only 1 
enantiomer 
seen by GC 
8 256 H2 , MeOH 60°C 13.1 Racemic 
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9 258 
Water/sodium 
formate 
60°C 16.2 50.2 (R) 
10 258 H2, MeOH 60°C 34.5 Racemic 
11 262 
Formic 
acid:Et3N 5:2 
28°C 6.9 93.0 (R) 
12 262 IPA/KOH 28°C 0.45 ND 
13 262 
Water/sodium 
formate 
60°C 26.3 37.9 (R) 
14 262 H2, MeOH 60°C 79.4 2.7 (R) 
aDetermined by GC analysis. bFor conversions less than 2% the ee. was not determined. 
 
Use of polymer supported ligand 261 and dimer 197 in place of the catalyst under all 
reaction conditions investigated gave no conversion to product. It was also found 
that use of formic acid/Et3N as the hydrogen source caused leaching of the 
ruthenium from the polymer support in all cases with strong colouration of the 
reaction solution occurring. This explains the low activity of all complexes with use 
of formic acid as the hydrogen source. 
Initial reactions using polymer supported complex 254 showed low conversion. 
Improvements to conversion were seen with use of water/sodium formate when 
polymer supported catalyst 256 was used giving 32% conversion, and an ee. of 92.7 
(R) (Table 35, entry 6). Polymer 256 has only a 10% loading of ruthenium complex 
and it is thought that the reduced level of complexation leads to a more flexible 
polymer and also a reduction in steric hindrance allowing for improved conversion. 
The reaction solution was removed from the reaction for Table 35, entry 6 and 
further acetophenone and water/sodium formate mixture added in order to determine 
whether the polymer supported catalyst could undergo reaction cycles. In the second 
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reaction however, only 4.3% conversion to product was obtained over 24 hours 
showing a loss of activity of the catalyst (Table 35, entry 7). Catalyst 256 also 
demonstrated activity for APH of acetophenone (Table 35, entry 8) however to a 
lesser extent than in ATH with water/sodium formate and with no enantioselectivity. 
Polymer supported catalyst 258 was applied to ATH with water/sodium formate and 
APH as these conditions seemed most conducive to hydrogenation occurring. The 
results obtained showed a reduction in conversion with the water/formic acid system, 
but an increase in conversion for APH of acetophenone with hydrogen, although the 
product obtained was racemic.  
Use of polymer supported catalyst 262 showed conversion to product with ATH in 
water/sodium formate and achieved the highest conversion of all at 79.4% with APH 
conditions although again the product obtained was racemic.  
Further ATH reactions were carried out using formic acid/triethylamine and 
IPA/KOH at increased temperatures with those polymer supported catalysts found to 
be most active (256, 258 and 262) (Table 36). 
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Table 36. ATH of acetophenone using polymer supported ruthenium complexes. 
 
 
Entry Catalyst H2 source 
Temp. 
(°C) 
Conv. 
(%)
a Ee. (%)
a 
1 256 
Formic 
acid:Et3N 5:2 
60°C 10.8 87.0 (R) 
2 256 IPA/KOH 80°C 11.3 2.8 (R) 
3 258 
Formic 
acid:Et3N 5:2 
60°C 17.9 82.7 (R) 
4 258 IPA/KOH 80°C 35.2 Racemic 
5 262 
Formic 
acid:Et3N 5:2 
60°C 5.6 82.8 (R) 
6 262 IPA/KOH 80°C 4.6 14.4 (R) 
a
Determined by GC analysis. 
 
The conversions and enantioselectivities achieved were improved compared to the 
equivalent reactions at room temperature reported in Table 35, however the use of 
256 with water/sodium formate (Table 35, entry 6) remains the best ATH result 
when both conversion and the enantiomeric excess of the product obtained are 
considered. 
No conversion was achieved with use of only ruthenium dimer 197 or ligand 261 
under each of the reaction conditions investigated. This confirms that the polymer 
supported catalysts themselves are the source of the hydrogenation taking place and 
that active complexes have successfully been linked to the polymer. 
Development of catalysts for asymmetric hydrogenation                                   Results and Discussion 
179 
 
Due to the low solubility of all the prepared polymer supported catalysts, 
characterisation was difficult. It therefore cannot be determined whether the desired 
complexes were being formed. It may be the case that the desired complexation of 
ruthenium to the supported ligand by aryl substitution is not occurring in its entirety. 
For example it may be that the nitrogens of the TsDPEN coordinate to the ruthenium 
to give a derivative of complex 195 with aryl substitution and displacement of the 
ethylbenzoate not occurring to give complexes such as 263 in Figure 73 which may 
not be highly active or enantioselective for the hydrogenation of ketones. 
 
Figure 73. Potential polymer supported complex obtained from incomplete aryl substitution process. 
 
Work continues within the Wills group to establish more effective polymer 
supported catalysts for ATH and APH applications using aryl substitution 
methodology to achieve complexation. 
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3. Conclusions. 
The application of tetradentate bis-hydroxydiamine ligands derived from 
norephedrine to the KO
t
Bu-catalysed hydrogenation of benzophenone has been 
investigated. Hydrogenation was found to occur via a transfer hydrogenation process 
rather than via interaction of the catalyst and substrate with hydrogen gas. The 
ligands were found to act as hydrogen donors to afford the alcohol product. Although 
hydrogenation of benzophenone was achieved, the transfer hydrogenation process is 
not appropriate for further development due to the low conversions of ketone to 
alcohol achieved and the necessary synthesis of the ligands. 
A series of aminophosphine ligands derived from proline have been prepared and 
applied to the iron-catalysed ATH of acetophenone using [Et3NH][HFe3(CO)11] as 
the catalyst precursor, however no conversion to phenyl ethanol was achieved. This 
was attributed to a lack of Fe-H functionality in the catalyst precursor. The ligands 
were also applied to rhodium and ruthenium-catalysed ATH of acetophenone using 
[Rh(COD)Cl]2, [RuCl2(DMSO)4] and [Ru(benzene)Cl2]2 precursors as well as a 
series of proline based aminoalcohol, aminosilyl and amido ligands. Use of N-
Benzyl-(S)-2-((diphenylphosphino) methylpyrrolidine (163) with [Rh(COD)Cl]2 
gave the most active system giving 79% conversion to phenyl alcohol although the 
reaction was not enantioselective. Dimainodiphosphine ligands reported by Gao
61-64, 
128
 and Morris
 129-135
 with NH functionality and exhibiting asymmetry in their 
diamine components rather than the phosphine exhibit superior activity and 
enantioselectivity for iron, ruthenium and rhodium-catalysed ATH of ketones.  
A series of tethered ruthenium complexes consisting of a tethered aryl-asymmetric 
diamine ligand have been applied to the APH of a range of ketones.
145
 The 3C-
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tethered TsDEPN RuCl catalyst 97 was found to be more active and enantioselective 
than the MsDEPN, iodo and 4C derivatives 180, 181 and 101 respectively.  
The achiral 3C-tethered RuCl catalyst 190 was applied to the hydrogenation of 
aldehydes.
145
 Addition of 10% water to the MeOH reaction solvent was required to 
prevent formation of di-methoxy adducts of the desired alcohol products. The 
hydrogenation was found to proceed with excellent chemoselectivity for 
hydrogenation of the C=O bond over C=C and NO2 functionalities. 
The development and optimisation of a novel synthesis of p-methoxy substituted 
tethered ruthenium catalysts using aryl substitution methodology has been discussed. 
Reaction of N-((1R,2R)-2-(3-(4-methoxyphenyl)propylamino)-1,2-diphenylethyl) 
toluenesulfonamide (198) or N-((1R,2R)-2-(3-(3.5-dimethoxyphenyl)propylamino)-
1,2-(diphenylethyl)toluenesulfonamide (208) with ethylbenzoate ruthenium(II) 
chloride dimer (197) gave the resulting tethered complexes 199 and 209. Application 
of 199 and 209 to the APH of a range of ketones gave excellent conversions to the 
alcohol products with high enantioselectivities. 
A series of poly(methyl methacrylate) supported tethered ruthenium complexes have 
been prepared with a triazole link between the ligand and polymer and using aryl 
substitution methodology for complexation. The activity for ATH and APH of 
acetophenone of such catalysts was generally found to be low. The highest 
conversion (79.4%) was achieved for APH with supported complex 262 although the 
product was racemic (Table 35). The highest ee. of 92.7% (R) was achieved with a 
conversion of 32% for ATH with supported complex 256 (Table 35). The results 
demonstrate potential for the preparation of more active and enantioselective 
supported catalysts for APH and ATH of ketones by the same methodology. 
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4. Future Work. 
The use of aryl substitution methodology has been show to be applicable to the 
synthesis of a range of three carbon tethered ruthenium catalysts, however attempts 
carried out by Dr. Soni and myself to prepare catalysts with four carbon (101), 
triazole (229) and methoxy substituted (234) tethers were unsuccessful. The further 
development of the aryl substitution reaction conditions to allow synthesis of such 
complexes is of interest in order to identify and develop catalysts with improved 
activity for hydrogenation reactions. The 4C tethered catalyst 101 for example is 
known to be more active for ATH of ketones than the 3C catalyst 199.
101, 102, 104
  
Also of interest is the development of the aryl substitution methodology to allow the 
synthesis of a range of achiral tethered ruthenium catalysts. Further studies into the 
aryl substitution reaction conditions, such as the use of weak inorganic bases to 
promote complexation may allow access to such achiral complexes. Further 
investigations to fine tune the electronics of both the ruthenium dimer and 
coordinating ligand may also allow more efficient complexation. 
Although the polymer supported ruthenium complexes reported in this thesis have 
shown limited activity for ATH and APH of ketones, their convenient preparation 
using aryl substitution methodology demonstrates potential for the synthesis of 
further derivatives that may show increased activity and recyclability.  
Modifications that could be made to improve the activity and recyclability of 
polymer supported catalysts include varying the polymer support used. For example, 
the use of co-polymers such as poly(glycidyl methacrylate)/hydroxyethyl 
Development of catalysts for asymmetric hydrogenation                                                     Future Work 
183 
 
methacrylate, which has been shown to be form active supported hydrogenation 
catalysts
116
 could be investigated.  
The use of a range nucleophiles to ring open the epoxide could also be investigated 
and expanded beyond triazole and diamine functionalities as discussed in this thesis. 
Of particular interest is the development of methodology whereby the epoxide can be 
opened with an alcohol such as phenol thus allowing a different mode of attachment 
for the tethered ligand of the catalyst as shown in Figure 74. Studies reported in this 
thesis have shown methoxy substituted tethered catalysts (199 and 209) to be highly 
active for APH of ketones, thus it is proposed that an ether linked supported ligand 
such as 264 may also demonstrate activity for asymmetric hydrogenation of ketones. 
 
Figure 74. Example of potential polymer supported ligand using a phenol link. 
 
The ability to ring-open the epoxide of poly(gylcidyl methacrylate) with an amine 
offers potential for the formation of supported Noyori-type complexes such as that 
shown in Figure 75, through reaction of the epoxide with TsDPEN. During the 
course of my studies, the in situ formation of a polymer supported untethered 
ruthenium catalyst from reaction of supported ligand 261 with [Ru(benzene)Cl2] 
showed potential for ATH of ketones achieving 18.8% conversion with 93.5% ee. 
(R) in 24 hours as shown in Figure 75. 
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Figure 75. Example reaction showing potential for application of such complexes to ATH of ketones 
(right) and proposed structure of supported Noyori-type ruthenium complexes (right). 
 
The successful preparation of cationic tethered ruthenium complex 211 by aryl 
substitution methodology offers potential for investigation into the use of such 
complexes in biological applications. In recent publications, Sadler has reported the 
application of cationic untethered ruthenium complexes to show anti-cancer and 
other biological activities.
160, 165
 The chloride ligand of the complex can be 
substituted for OH2 to allow further substitution for pyridine or a nucleo-base to 
allow interaction with cancer cell lines and DNA.
160, 166
 Ru-OH2 cationic complexes 
have also been shown to be active for reduction of NAD
+
 in the NAD/NADH 
enzymatic pathway.
167 
 The use of aryl substitution methodology could allow access 
to a greater range of cationic ruthenium half sandwich complexes for further 
investigations into the development of these biological applications. 
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5. Experimental. 
5.1 Chemicals.  
All chemicals used in this project were obtained from Sigma Aldrich, Acros 
Organics, Alfa Aesar, TCI and Fischer Scientific. 
5.2 Instrumentation.  
NMR analysis: NMR analysis was carried out on a DPX-300 (300 MHz), DPX-400 
(400 MHz), DRX-500 (500 MHz), AV III-600 (600 MHz) or AV II-700 (700 MHz) 
instrument using deuterated solvents including CDCl3, d6-DMSO, d4-MeOD, d8-
THF, d2-DCM or d6-benzene. 
Mass Spectrometry: All low resolution mass spectrometry data was acquired using a 
Bruker Esquire 2000 (ESI) spectrometer or Bruker HCT + (Ultra)  (ESI) 
spectrometer coupled to an Agilent 1100 HPLC system for sample injection, or an 
Agilent 6130B ESI (quad) mass spectrometer coupled to an Agilent Technologies 
1260 Infinity HPLC system. GC/MS analysis was carried out on a Varian 4000 
GC/MS with chemical ionisation. All high resolution mass spectrometry data was 
obtained using a Bruker micro TOF spectrometer. Methanol was used as the solvent 
for LC/MS and high resolution mass spectrometry, and chloroform for GC/MS.  
 Infrared: Infrared spectroscopy data was acquired using a Perkin Elmer Spectrum 
One, Nicolet Avatar 320 or a Bruker ALPHA FT-IR spectrometer. 
Gas Chromatography: All gas chromatography analysis was carried out using a 
Hewlett Packard 5890 Gas Chromatograph or a Perkin-Elmer 8500 Gas 
Chromatograph. Integration was carried out with a Hewlett Packard HP3396A 
Integrator or a PC running DataApex Clarity software.  
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High Pressure Liquid Chromatography: All HPLC analysis was carried out using a 
Hewlett Packard 1050 Series with a quaternary pump, autosampler and variable 
wavelength detector with integration carried out on a PC running DataApex Clarity 
software or a Gilson HPLC with 805 manometric module, 811b dynamic mixer, 
305/306 pump modules and a Merck Hitachi L-4000 UV detector with integration 
carried out on a Hewlett Packard HP3396A Integrator.  
Polarimetry: All polarimetry was carried out using an Optical Activity Ltd. AA-1000 
Polarimeter with a 2 dm cell using spectrophotemetric grade solvent. 
Melting point analysis: Melting point analysis was carried out on Stuart Melting 
Point SMP10 apparatus. 
5.3  Synthetic and catalytic procedures.  
5.3.1 Synthetic procedures for section 2.1. 
 
N,N-[1,2-Ethanediylbis[imino[(1R, 2R)-1,2-diphenyl-2,1-ethanediyl]]]bis[4-
methylbenzenesulfonamide] (148).  
 
This compound is known in literature and has previously been fully characterised.
36
  
To a nitrogen purged, 2-necked round bottom flask containing (1R,2R)-(-)-N-p-tosyl-
1,2-diphenylethylenediamine ((1R,2R)-(-)-TsDPEN) (1.5 g, 4.1 mmol) was added 
1,2-dibromoethane (0.17 cm
3
, 2.0 mmol). The resulting mixture was then stirred at 
130°C for 6 hours (monitored by TLC: 1:3 hexane:ethylacetate, visualisation by 
UV). The reaction mixture was dissolved in chloroform (30 cm
3
) and washed with 
1M sodium hydroxide solution (20 cm
3
). The product was extracted with chloroform 
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(3 x 40 cm
3
). The chloroform phases were collected and combined, dried over 
MgSO4, filtered and the solvent removed under reduced pressure to give the crude 
product as a white solid. The crude was purified by column chromatography (silica 
gel, 0-100% EtOAc in hexane, TLC: silica plates, 75% EtOAc in hexane, 
visualisation by UV and ninhydrin, product Rf = 0.89) to give the product as a white 
solid (753 mg, 0.996 mmol, 49%). Mp 169-171°C; [α]D
27
 +18.4° (c 0.5, CHCl3) 
(R,R) (lit.
36
 [α]D
20
 +22 (c 0.5 in CHCl3) (R,R)); found (ESI) [M+H]
+
, 759.3055. 
C44H47N4O4S2 requires M, 759.3033; υmax 3271, 3029, 15.98, 14.94, 1453, 1329, 
1149, 1055, 937, 809, 696, 670 cm
-1; δH (300 MHz; CDCl3) 7.24-6.83 (28H, m, 
CHAr); 4.38 (2H, d, J 8.6 Hz, CHNHSO2); 3.71 (2H, d J 8.6 Hz, CHNH); 2.59-2.31 
(10H, dd and s overlapping, 2 x CH2 and 2 x CH3 overlapping); δC (75 MHz, CDCl3) 
142.05 (2 CAr), 138.81 (2 CAr), 137.43 (2 CAr), 136.87 (2 CAr), 128.45 (2 CHAr), 
127.63 (2 CHAr 127.29 (2 CHAr), 127.20 (2 CHAr), 126.84 (2 CHAr), 126.53 (2 
CHAr), 126.35 (2 CHAr), 125.91 (2 CHAr), 67.40 (2 CH), 63.11 (2 CH), 45.74 (2 
CH2), 20.79 (2 CH3); m/z (ESI) 759.2 (M
+
 + 1). Data matches that previously 
reported for this compound.
36
 
 
(1R,2R)-N, N’-Bissalicyl-1,2-diamino-1,2-diphenylethane (150).  
 
This compound is known in the literature but has not previously been fully 
characterised.
137, 138 
 
A solution of (1R,2R)-diphenylethylenediamine (250 mg, 1.17 mmol) dissolved in 
ethanol (1 cm
3
) was slowly added to a stirred solution of salicylaldehyde (440 mg, 
Development of catalysts for asymmetric hydrogenation                                                    Experimental 
188 
 
3.60 mmol) in ethanol (2 cm
3
) in a nitrogen purged, 2-necked round bottom flask. 
The resulting solution was stirred under reflux for 3 hours. After this the solution 
was allowed to cool to room temperature and a yellow precipitate formed which was 
then collected by filtration. The precipitate was dissolved in methanol (3 cm
3
) and 
sodium borohydride (95 mg, 2.5 mmol) was added. The solution was stirred for 2 
hours at room temperature. The solvent was then removed under reduced pressure to 
leave a yellow solid. This was dissolved in dichloromethane (10 cm
3
) and washed 
with saturated sodium carbonate solution (3 x 10 cm
3
). The organic phases were 
collected and combined, dried over MgSO4, filtered and the solvent removed under 
reduced pressure to give the crude product as a yellow solid. The crude was purified 
by column chromatography (silica gel, 1:1 EtOAc:hexane, TLC: silica plate, 1:1 
EtOAc:hexane, visualisation by UV, product Rf = 0.49) to give the product as a 
white solid (260 mg, 0.613 mmol, 52%). Mp 160-163°C; [α]D
22
 + 10.2° (c 0.5, 
CH2Cl2) (R,R) (lit.
138
 [α]D
25
 +48.6 (c 0.01 in CH2Cl2) (R,R)); found (ESI) [M+H]
+
, 
425.2216. C28H29N2O2 requires M, 425.2224; υmax 3250, 3026, 2851, 1587, 1489, 
1454, 1249, 1101, 753, 698 cm
-1; δH (300 MHz, CDCl3) 7.27-7.23 (6H, m, 
CHAr),7.20-7.14 (2H, m, CHAr) 6.95-6.92 (4H, m, CHAr), 6.89-6.86 (2H, m, 
CHAr), 6.79-6.70 (4H, m, CHAr), 4.02 (2H, s, 2 x CH), 3.85 (2H, d, J 13.5 Hz, 2 x 
CH
a
H
b
), 3.59 (2H, d, J 13.5 Hz, 2 x CH
a
H
b); δC (75 MHz, CDCl3) 157.20 (2 CAr), 
136.71 (2 CAr), 128.37 (2 CHAr), 128.01 (2 CHAr), 127.93 (4 CHAr), 127.49 (4 
CHAr), 127.46 (2 CHAr), 121.56 (2 CHAr), 118.69 (2 CHAr), 115.84 (2 CHAr), 
65.74 (2 CH), 49.54 (2 CH2); m/z (ESI) 425.2 (M
+
 + 1). Data matches that previously 
reported for this compound.
137, 138  
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(1R,2R)-N,N’-Bissalicyl-1,2-diaminocyclohexane (151). 
 
This compound is known in the literature but has not previously been fully 
characterised.
138, 139
  
This compound was prepared as for compound 150 using (1R,2R)-
cyclohexanediamine (250 mg, 2.19 mmol), salicylaldehyde (806 mg, 6.60 mmol), 
ethanol (5 cm
3
), sodium borohydride (91 mg, 2.4 mmol) and methanol (3 cm
3
). The 
crude was purified by column chromatography (silica gel, 0-100% EtOAc in hexane, 
TLC: silica plate, 75% EtOAc in hexane, visualisation by UV, product Rf = 0.46) to 
give the product as an orange solid (255 mg, 0.782 mmol, 36%). Mp 94-96°C; [α]D
22
 
– 37.3° (c 0.5, CH2Cl2) (R,R) (lit.
138
 [α]D
25
-26.6 (c 0.01 in CH2Cl2) (R,R)); found 
(ESI) [M+H]
+
, 327.2069, C20H26N2O2 requires M, 327.2067; υmax 3302, 3147, 2929, 
2852, 1592, 1447, 1403, 1254, 1096, 854, 750, 725 cm
-1; δH (300 MHz, CDCl3) 
7.63–7.57 (2H, m, CHAr), 7.42-7.40 (2H, m, CHAr), 7.26-7.19 (4H, m, CHAr), 4.41 
(4H, dd, J, 13.9 and 23.1 Hz, 2 x CH
a
H
b
), 2.89 – 2.86 (2H, m, C6H10), 2.60-2.56 
(2H, m, C6H10), 2.16-2.12 (2H, m, C4H10), 1.71-1.57 (4H, m, C6H10); δC (75 MHz, 
CDCl3) 157.34 (2 CAr), 128.22 (2 CHAr), 127.69 (2 CHA), 122.28 (2 CAr) 118.62 
(2 CHAr), 115.82 (2 CHA), 59.09 (2 CH), 49.06 (2 CH2), 29.82 (2 CH2), 23.54 (2 
CH2); m/z (ESI) 327.2 (M
+
 + 1).  Data matches that previously reported for this 
compound.
138, 139  
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N,N’-Bis[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-1,2-diaminoethane (152).  
 
This compound is known in the literature but has not previously been fully 
characterised.
140, 141
  
(1R,2S)-Norephedrine (1.0 g, 6.6 mmol) in a nitrogen purged 2-necked round bottom 
flask was stirred at 100°C until it had completely melted. To this was then added 1,2-
dibromoethane (413 mg, 2.20 mmol) and the resulting mixture was connected to a 
condenser and stirred at 100°C overnight. It should be noted that the reaction 
mixture solidified within approx. 15 mins. After 2 hours, the reaction was cooled to 
room temperature and the reaction solid was dissolved in water (10 cm
3
) with 
heating. The aqueous solution was washed with chloroform (15 cm
3
), and then the 
aqueous phase was basified with the addition of 2M sodium hydroxide solution. The 
product was then extracted with chloroform (4 x 15 cm
3
). The organic phases were 
collected, combined and dried over MgSO4 before being filtered and then the solvent 
removed under reduced pressure to give the crude product as an off white solid. 
1
H 
NMR (CDCl3, 300MHz) analysis showed the desired product to be present at a 
conversion of 55%. Further purification was achieved by dissolving the crude in 
dichloromethane and adding 5 cm
3
 1M hydrochloric acid. The product was extracted 
into the aqueous layer (3 x 15 cm
3
 1M hydrochloric acid). The aqueous layer phases 
were combined and basified with saturated NaHCO3 solution. The product was then 
extracted into DCM (3 x 15 cm
3
). The organic phases were combined, dried over 
MgSO4, filtered and the solvent removed under reduced pressure to give the product 
as a white solid (186 mg, 0.567 mmol, 26%). Mp 108-110°C; [α]D
36 
+10° (c 0.7, 
EtOH) (1R,2S) (lit.
141
 [α]D
25
 +6.9 (c 0.72 in EtOH) (1R,2S)); found (ESI) [M+H]
+
, 
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329.2221, C20H29N2O2 requires M, 329.2224; υmax 3266, 3081, 2963, 2920, 2828, 
1447, 1284, 1120, 1005, 739, 698 cm
-1
;
 δH (300 MHz, CDCl3) 7.29-7.15 (12H, m, 
CHAr and 2 x NH overlapping), 4.64 (2H, d, J 3.9 Hz, 2 x CH(C6H5)), 2.82-2.78 
(4H, m, 2 x CHCH3 and 2 x OH overlapping), 2.66-2.60 (4H, m, 2 x CH2NH), 0.79 
(6H, d, J 6.5 Hz, 2 x CH3); δC (75 MHz, CDCl3) 141.53 (2 CAr), 128.12 (4 CHAr), 
127.15 (2 CHAr), 126.18 (4 CHAr), 73.88 (2 CH), 58.53 (2 CH), 46.90 (4 CH2), 
14.74 (2 CH3); m/z (ESI) 329.2 (M
+
 + 1). Data matches that previously reported for 
this compound.
140, 141
  
 
N,N’-Bis[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-1,2-diaminopropane (153).  
 
This compound is novel.  
Prepared as for ligand 152 using (1R,2S)-Norephedrine (1.0 g, 6.6 mmol) and  1,3-
dibromopropane (666 mg, 3.30 mmol) instead of 1,2- dibromoethane. The purified 
product was obtained as a white solid (404 mg, 1.18 mmol, 36%). Mp 98- 100°C; 
[α]D
36
 + 5.0 (c 0.5, EtOH); found (ESI) [M+H]
+
, 343.2379, C21H31N2O2 requires M, 
343.2380; υmax 3065, 2969, 2871, 1488, 1449, 1200, 1144, 1102, 1089, 996, 897, 
748, 698 cm
-1; δH (300 MHz, CDCl3) 7.24-7.14 (10H, m, CHAr), 4.86 (2H, d, J 3.4 
Hz, 2 x CHOH), 3.43 (4H, br s, 2 x NH and 2 x OH overlapping), 2.89-2.72 (6H, m, 
2 x CH2CH2 and 2 x CHNH overlapping), 1.68 (2H, quin, J 6.3 Hz, CH2CH2CH2), 
0.78 (6H, d, J 6.5 Hz, 2 x CH3); δC (75 MHz, CDCl3) 140.72 (2 CAr), 127.49 (4 
CHAr), 126.44 (2 CHAr), 125.44 (4 CHAr), 72.45 (2 CH), 58.24 (2 CH), 45.36 (2 
CH2), 28.59 ( 2 CH2), 12.83 (2 CH3); m/z (ESI) 343.2 (M
+
 + 1).  
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N,N’-Bis[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]-1,2-dimethylaminoethane 
(154).  
 
This compound is known in the literature but has not previously been fully 
characterised.
142
  
This was prepared as for ligand 152 (1R,2S)-ephedrine (1.0 g, 6.1 mmol) instead of 
(1R,2S)-norephedrine and 1, 2-dibromoethane (564 mg, 3.00 mmol).. The purified 
product was achieved as a white solid (247 mg, 0.694 mmol, 23%). Mp 68-71°C; 
[α]D
34
 +59.4 (c 1, CHCl3) (1R,2S) (lit.
142
 [α]D
34
 +16.9 (c 1.0 in CHCl3) (1R,2S)); 
found (ESI) [M+H]
+
, 357.2541, C22H33N2O2 requires M, 357.2537; υmax 2965, 2856, 
2806, 1448, 1335, 1194, 1047, 758, 701, 638 cm
-1; δH (300 MHz, CDCl3) 7.26-7.19 
(8H, m, CHAr), 7.13-7.08 (2H, m, CHAr), 5.12 (2H, d, J 3.1 Hz, 2 x CHOH), 3.20 
(2H, d, J 11.3, 2 x CH
a
H
b
), 2.81-2.73 (2H, m, 2 x CHNCH3), 2.38 (6H, s, 2 x 
CH3N), 2.07 (2H, d, J 11.3, 2 x CH
a
H
b
), 0.68 (6H, d, J 6.7 Hz, 2 x CH3); δC (75 
MHz, CDCl3) 141.87 (2 CAr), 128.03 (4 CHAr), 126.67 (2 CHAr), 125.81 (4 
CHAr), 76.72 (2 CH), 64.17 (2 CH), 51.43 (4 CH2), 43.83 (2 CH3), 6.04 (2 CH3); 
m/z (ESI) 357.2 (M
+
 + 1). Data matches that previously reported for this 
compound.
142 
 
General procedure 1: hydrogenation of benzophenone using 20 mol% KO
t
Bu 
and 20 mol% ligand and hydrogen gas.  
To benzophenone (164 mg, 0.901 mmol) in a small pyrex test tube was added 
KO
t
Bu (20 mg, 0.18 mmol), ligand (0.18 mmol) and solvent (either 
t
BuOH or 2-
methyl-2-butanol) (2.25 cm
3
). A micro stirrer was added to the test tube which was 
then placed inside the Parr Reactor. The reactor was purged with hydrogen gas and 
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then charged to the desired pressure. The reaction was then stirred at the required 
temperature for the required time (approx. 5 days).  
When multiple ligands were tested in the same experiment, a bulk solution of 
benzophenone, KOtBu and solvent was prepared and divided into equal aliquots 
(2.25 cm
3
) in separate pyrex test tubes and 1 ligand (0.18 mmol) was added to each.  
The reaction solution was filtered through silica with EtOAc and the filtrate analysed 
by GC. 
 
5.3.2 Synthetic procedures for section 2.2. 
 
(1S,2S)-N,N-Bis(2-(diphenylphosphino)benzyl)cyclohexane-1,2-diamine (45). 
 
This compound is known in the literature but has not previously been fully 
characterised.
63
 
To (S,S)-1,2-diaminocyclohexane (19 mg, 0.17 mmol) and Na2SO4 (142 mg, 1.00 
mmol) was added anhydrous DCM (1.5cm
3
). To the resulting solution was then 
added σ-(diphenylphosphino)benzaldehyde (100 mg, 0.344 mmol). The solution was 
then stirred at room temperature for 24 hours. After this the reaction was filtered and 
the solvent removed under reduced pressure to leave an orange solid. To this was 
then added anhydrous THF (2 cm
3
) and the solution cooled to 0°C. To the cooled 
solution was then added 2M LiAlH4 solution in THF (1.0 mmol, 0.50 cm
3
). The 
reaction was stirred overnight. After this, water was slowly added to the reaction and 
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the THF was removed under reduced pressure. The product was then extracted with 
Et2O (3 x 15 cm
3
). The Et2O phases were combined, dried over Na2SO4 and filtered. 
The solvent was then removed under reduced pressure to leave the crude product as a 
yellow oil (59 mg, 0.08 mmol, 47%). Further purification was not necessary. [α]D
32
 + 
6.4° (c 0.25 in CHCl3) (S,S); (found (EI): M
+
 + H + O2, 695.2959 C44H45N2O2P2 
requires M,695.2951); υmax 3051, 2925, 2853, 1710, 1433, 1357, 1180, 1090, 1026, 
878, 741. 694 cm
1; δH (300 MHz, CDCl3) 7.52-7.48 (2H, m, CHAr), 7.33-7.18 (24H, 
m, CHAr), 6.91-6.81 (2H, m, CHAr), 4.02 (2H, dd, J 1.5 and 13.4 Hz, CH
a
H
b
N), 
3.83 (2H, dd, J 1.5 and 13.4 Hz, CH
a
H
b
N), 2.29 (2H, br s, NH), 2.15-2.12 (2H, m, 
CH), 2.02-1.96 (2H, m, CH2), 1.62-1.57 (2H, m, CH2), 1.11-1.04 (2H, m, CH2), 
0.92-0.85 (2H, m, CH2); δC (75 MHz, CDCl3) 136.30 (2 CAr, d, JCP 4.6 Hz), 136.17 
(2 CAr, d, JCP 4.6 Hz), 135.49 (2 CAr), 134.85 (2 CAr, d, JCP 13.4 Hz), 133.42 (4 
CHAr), 133.15 (4 CHAr), 132.75 (2 CHAr), 128.65 (CHAr), 128.41 (2 CHAr), 
128.33 (2 CAr), 128.10 (2 CHAr), 128.03 (4 CHAr), 127.98 (4 CHAr), 127.88 (2 
CHAr), 126.41 (2 CHAr), 60.35 (2 CH), 48.26 (2 CH2), 30.65 (2 CH2), 24.29 (2 
CH2); δp (300MHz, CDCl3) -17.0; m/z (ESI) 663.2 (M
+
 + 1). Data matches that 
previously reported for this compound.
63 
 
(1S,2S)-N,N-Bis(2-(diphenylphosphino)benzyl)-1,2-diphenylethane-1,2-diamine 
(159). 
 
This compound is known in the literature but has not previously been fully 
characterised.
62 
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This compound was prepared as for compound 45 using (S,S)-DPEN (53 mg, 0.25 
mmol), Na2SO4 (213 mg, 1.50 mmol), anhydrous DCM (2 cm
3
), σ-
(diphenylphosphino)benzaldehyde (145 mg, 0.500 mmol), anhydrous THF (3 cm
3
) 
and 2M LiAlH4 solution in THF (0.75 cm
3
, 1.5 mmol). Purification of the crude 
product by recrystallisation was attempted but gave no improvement to the purity of 
the products. [α]D
32
 + 0.9 (c 0.5 in CHCl3) (S,S); HRMS not obtained due to purity of 
product achieved; υmax 3053, 2905, 1708, 1586, 1434, 1179, 1118, 1027, 742, 693 
cm
1; δH (300MHz, CDCl3) 7.48-7.44 (2H, m, CHAr), 7.30-7.13 (34H, m, CHAr), 
6.85-6.79 (2H, m, CHAr), 4.00 (2H, s, CH), 3.67-3.66 (2H, m, CH
a
H
b
), 3.59-3.57 
(2H, m, CH
a
H
b
), 2.09 (2H, br s, NH); δC (75MHz, CDCl3) 144.15 (2 CAr), 139.78 (2 
CAr), 136.28 (2 CAr), 136.04 (2 CAr), 135.19 (2 CAr), 133.41 (4 CHAr), 133.29 (2 
CHAr, s), 133.14 (4 CHAr), 131.74 (2 CHAr), 131.40 (4 CHAr), 131.26 (4 CHAr), 
128.27 (2 CHAr), 128.15 (2 CAr), 127.94 (4 CHAr), 127.85 (4 CHAr), 127.53 (2 
CHAr), 126.48 (2 CHAr), 66.89 (2 CH), 52.64 (2 CH2); δp (300MHz, CDCl3) -16.6; 
m/z (ESI) 777.1 (M
+
 + 17). (For procedure see reference 155). Data matches that 
previously reported for this compound.
62 
 
Boc-(L)-prolinol (160). 
 
This compound is known in the literature and has previously been fully 
characterised.
168, 169 
A solution of N-Boc-(L)-proline (900 mg, 4.18 mmol) in anhydrous THF (8 cm
3
) 
was cooled to 0°C with an ice bath. To the cooled solution was then added dropwise 
borane dimethyl sulfide complex 2M in THF (4.2 cm
3
, 8.4 mmol). The solution was 
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stirred at 0°C for 5 hours and then at room temperature overnight. The reaction was 
followed by TLC (1:1 EtOAc:petroleum ether, visualisation by KMnO4, product Rf 
0.59). After this, water was slowly added to the reaction followed by EtOAc (15 
cm
3
). The organic phase was separated and the aqueous phase washed with further 
EtOAc (2 x 15 cm
3
). The organic phases were combined and washed with brine, 
saturated Na2HCO3 solution and finally water. The organic phase was dried over 
Na2SO4, filtered and the solvent removed under reduced pressure to leave the 
product as a white solid (756 mg, 3.76 mmol, 90%). Further purification was not 
necessary. Mp 61-63°C, [α]D
25
 -67.5 (c 0.5 in CHCl3) (S) (lit.
168
 [α]D
26
 -52.7 (c 1.05 
in CHCl3) (S)); (found (EI): M
+
+Na, 224.1261 C10H19NNaO3 requires M, 224.1257); 
υmax 3432, 2979, 2932, 2872, 1656, 1392, 1478, 1455, 1392, 1365, 1161, 1127, 1054, 
907, 864, 775 cm
-1
 ; δH (300MHz, CDCl3) 4.78 (1H, br s, OH), 3.91 (1H, br s, 
CHN), 3.60-3.48 (2H, br m, CH2OH ), 3.42-3.34 (1H, br m, NCH
a
H
b
), 3.28-3.20 
(1H, br m, NCH
a
H
b
), 1.97-1.88 (1H, m, CH2), 1.80-1.71 (2H, m, CH2), 1.53-1.46 
(1H, m, CH2), 1.42 (9H, s, (CH3)3); δC (75 MHz, CDCl3) 164.16 (1 C=O), 79.57 (1 
C), 67.03 (1 CH2), 59.54 (1 CH), 46.91 (1 CH2), 28.06 (1 CH2), 27.82 (3 CH3), 23.42 
(1 CH2); m/z (ESI) 224.1 (M
+
 + 23) and 425.0 (M2
+
 + 1). Data matches that 
previously reported for this compound.
168, 169
 
Boc-(S)-2-Methylsulfonyloxymethylpyrrolidine (161). 
 
This compound is known in the literature but has not previously been fully 
characterised.
170, 171
 For procedure see reference 172. 
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To a solution of N-Boc-(L)-prolinol 160 (756 mg, 3.76 mmol) was added anhydrous 
DCM (19 cm
3
) and triethylamine (577 mg, 5.70 mmol). The resulting solution was 
stirred and to it was slowly added methanesulfonyl chloride (653 mg, 5.70 mmol). 
The reaction was stirred at room temperature and monitored by TLC (silica gel 
plates, 1:1 EtOAc:petroleum ether, visualisation by KMnO4, product Rf 0.65). Once 
complete, the solvent was removed under reduced pressure. To the residue was 
added EtOAc (15 cm
3
) and water (10 cm
3
). The organic phase was separated and the 
aqueous phase washed with further EtOAc (2 x 15 cm
3
). The organic phases were 
combined and then washed with brine and saturated NaHCO3 solution. The organic 
phases was then dried over Na2SO4, filtered and the solvent removed under reduced 
pressure to leave the crude product  as a pale yellow oil (703 mg, 2.52 mmol, 67%). 
Further purification was not necessary. [α]D
25
 -47.1 (c 0.5 in CHCl3) (S); (found (EI): 
M
+
 - C5H8O2 + H, 180.0688 C16H14NO3S requires M, 180.0689); υmax 2973, 1752, 
1686, 1391, 1353, 1167, 1109, 956, 907, 814, 772 cm
-1
 ; δH (100 MHz, CDCl3)  
4.29-4.20 (1H, br m, CHN), 4.18-4.03 (2H, br s, CH2N), 3.36 (2H, br s, CH2OSO2), 
3.01 (3H, s, CH3SO2 ), 2.10-1.77 (4H, m, CH2), 1.47 (9H, s, (CH3)3);  δC (400MHz, 
CDCl3) 164.10 (1 C=O), 79.15 (0.5 C), 79.56 (0.5 C), 68.93 (0.5 CH2), 68.88 (0.5 
CH2), 55.09 (1 CH3), 46.36 (1 CH2), 46.02 (0.5 CH2), 36.75 (0.5 CH), 36.31 (0.5 
CH) 27.80 (3 CH3), 27.14 (0.5 CH2), 23.10 (0.5 CH2), 22.23 (0.5 CH2); m/z (ESI) 
180.1 (M
+
 - 100, + 1) and 302.1 (M
+
 + 23). Data matches that previously reported for 
this compound.
170, 171
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Boc-(S)-2-((diphenylphosphino)methyl)pyrrolidine borane complex (162). 
 
This compound is novel. 
To Boc-(S)-2-Methylsulfonyloxymethylpyrrolidine 161 (2.31 g, 8.27 mmol) was 
added anhydrous, degassed THF (40 cm
3
). The resulting solution was cooled to -
25°C with an ice/NaCl bath and stirred. Potassium diphenylphosphide solution 0.5M 
in THF (33.2 cm
3
, 16.6 mmol) was added to the solution dropwise. To the resulting 
vivid orange solution was then added borane dimethyl sulfide complex 2M in THF 
(8.3 cm
3
, 16.6 mmol). The reaction was allowed to warm to room temperature and 
stirred overnight. After this the reaction solution was filtered through celite and the 
solvent removed under reduced pressure to leave the crude as a cloudy oil. The crude 
was purified by column chromatography (silica gel, 0-50% EtOAc in petroleum 
ether, TLC: silica plate, 20% EtOAc in petroleum ether, visualisation by KMnO4, Rf 
product = 0.55) to give the pure product as a white solid (2.03 g, 5.30 mmol, 64%). 
Mp 83-84°C; [α]D
26
 -19.8  (c 0.5 in CHCl3) (S); (found (EI): M
+
 +Na, 406.2084 
C22H31BNNaO2P requires M, 406.2082); υmax 2973, 2378, 1679, 1393, 1363, 1170, 
1107, 1061, 734, 692 cm
-1
 ; δH (500 MHz, CDCl3) mixture of rotomers 7.98-7.88 
(1H, m, CHAr), 7.77-7.73 (1H, m, CHAr), 7.69-7.63 (2H, m, CHAr), 7.51-7.37 (6H, 
m, CHAr), 4.18 (0.5H, br s, CHN), 4.03 (0.5H, br s, CHN), 3.42-3.37 (0.5H, m, 
CH2PPh2), 3.34-3.19 (2H, m, CH2N), 2.88-2.82 (0.5H, m, CH2PPh2), 2.35-2.25 
(0.5H, m, CH2PPh2), 2.12-2.06 (0.5H, m, CH2PPh2), 1.96-1.87 (1H, m, CH2), 1.85-
1.81 (1H, m, CH2), 1.77-1.68 (1.5H, m, CH2), 1.60 (0.5H, br s, CH2), 1.48-1.42 (9H, 
m, C(CH3)3), 1.24-0.72 (3H, br s, BH3); δC (75 MHz, CDCl3) 153.58 (1 C=O), 
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132.24 (CHAr), 131.99 (CHAr), 131.51 (CHAr), 131.27 (CHAr), 130.62 (CHAr), 
130.32 (CHAr), 128.91 (2 CAr), 128.33 (2 CHAr), 128.20 (2 CHAr), 53.15 (CH), 
45.65 (CH2, d JCP, 42 Hz), 30.52 (C), 30.20 (CH2), 29.16 (CH2, d, JCP, 31 Hz), 28.00 
(3 CH3), 23.71 (CH2, d, JCP, 65 Hz); δp 10.6 (br s); m/z (ESI) 406.2 (M
+
 + 23). (For 
procedure see reference 173) 
 
(S)-2-((Diphenylphosphino)methyl)pyrrolidine (163). 
 
This compound is known in the literature and has not previously been fully 
characterised.
169, 174, 175 
To Boc-(S)-2-((diphenylphosphino)methyl)pyrrolidine borane complex 162 (600 mg, 
1.57 mmol) at 0°C was added degassed TFA (19 cm
3
, 250 mmol). The resulting 
clear, brown solution was stirred at 0°C for 2 hours. After this, the reaction was 
quenched at 0°C by the slow addition of saturated K2CO3 solution until 
effervescence ceased. After this the solution was brought to pH 7 by addition of 1M 
HCl solution. The product was then extracted with DCM (3 x 20 cm
3
) to give the 
crude product as a pale yellow viscous oil (416 mg, 1.54 mmol, 98%). Further 
purification was not necessary. [α]D
26
 - 5.4  (c 0.5 in CHCl3) (lit.
175
 [α]D
25
 -13.0 (c 
1.0 in CHCl3) (S)); (found (EI): M
+
 +H, 270.1402 C17H21NP requires M, 270.1406); 
υmax 2974, 2760, 1670, 1434, 1173, 1124, 831, 798, 740, 720 694 cm
-1; δH (300MHz, 
CDCl3) 8.17 (1H, br s, NH), 7.36-7.21 (10H, m, CHAr), 3.33-3.06 (3H, m, CH2N 
and CHN overlapping), 2.67 (1H, dd, J 13.5 and 6.1 Hz, CH
a
H
b
), 2.34 (1H, dd, J 
13.5 and 9.0 Hz, CH
a
H
b
), 2.13-2.04 (1H, m, CH2), 2.01-1.92 (1H, m, CH2), 1.86-
1.62 (2H, m, CH2);  δC (100MHz, CDCl3) 136.79 (CAr, d, JCP  11.3 Hz), 136.11 
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(CAr, d, JCP 11.3 Hz), 132.87 (2 CHAr, d, JCP 19.3 Hz), 132.51 (2 CHAr, d, JCP 
19.3Hz), 130.99 (CHAr, d, JCP 9.7 Hz), 130.55 (CHAr, d JCP 9.7 Hz), 129.22 (2 
CHAr, d, JCP 9.5 Hz), 128.75 (2 CHAr, t, JCP 6.3 Hz), 116.64 (CH2, d, JCP 293.9 
Hz), 58.32 (CH, d, JCP 20.3 Hz), 44.71 (CH2), 31.27 (CH2) 23.67 (CH2); δp (121 
MHz, CDCl3) -22.40 (s); m/z (ESI) 270.1 (M
+
 + 1). Data matches that previously 
reported for this compound.
169, 174, 175
 
N-Benzyl-(S)-2-((diphenylphosphino)methylpyrrolidine (164). 
 
This compound is known in the literature
176, 177
 but has not previously been fully 
characterised.
 
NaH (60% in mineral oil) (76 mg, 1.9 mmol) was washed in anhydrous hexane (3 
cm
3
) to remove the oil. The hexane was removed via a needle and syringe with 
cotton wool and filter paper secured to the end of the needle. Any residual hexane 
was then removed under vacuum and the flask cooled to 0°C with an ice bath. 
Anhydrous THF (6 cm
3
) was added and the resulting solution stirred. To it was then 
added (S)-2-((diphenylphosphino)methyl)pyrrolidine 163 (135 mg, 0.501 mmol) and 
the reaction stirred for 40 min at 0°C. After this benzyl bromide (64 mg, 0.37 mmol) 
was added and the reaction solution heated and stirred at reflux for 2.5 hours. After 
this the reaction was cooled to room temperature and water and EtOAc were added. 
The product was extracted with EtOAc (3 x 10 cm
3
). The EtOAc phases were 
combined, dried over Na2SO4, filtered and the solvent removed under reduced 
pressure to leave the crude as an orange oil. The crude was purified by column 
chromatography (silica gel, 0-75% EtOAc in petroleum ether, TLC: silica plate, 1:1 
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EtOAc:petroleum ether, visualisation by KMnO4, Rf product = 0.60) to give the 
product as a colourless oil (68 mg, 0.19 mmol, 51%). [α]D
30
 -94.9  (c 1 in CHCl3) 
(S); (found (EI): M
+
 + H, 360.1873 C24H27NP requires M, 360.1876); υmax 3054, 
2936, 2787, 1433, 1117, 738, 694 cm
-1
 ; δH (300MHz, CDCl3) 7.50-7.42 (4H, m, 
CHAr), 7.35-7.29 (6H, m, CHAr), 7.27-7.22 (5H, m, CHAr), 4.04 (1H, d, J 12.8 Hz, 
CH
a
H
b
), 3.17 (1H, d, J 12.8 Hz, CH
a
H
b
), 2.90 (1H, t, J 7.7 Hz, CH2N), 2.62 (1H, dt, 
J 13.1 and  3.4 Hz, CH2N), 2.46 (1H, m, CHN), 2.07 (3H, m, CH2), 1.67 (3H, m, 
CH2); δC (100MHz, CDCl3) 139.41 (2 CAr, d, JCP 12.8 Hz), 138.18 (CAr), 138.64 
(CAr, d, JCP 12.8 Hz), 133.12 (2 CHAr, d, JCP 19.1 Hz), 132. 59 (2 CHAr, d, JCP 
19.1 Hz), 129.04 (2 CHAr), 128.76 (CHAr), 128.54 (CHAr), 128.36 (2 CHAr, d, JCP 
3.0 Hz), 128.41 (2 CHAr, d, JCP 3.0 Hz), 128.18 (CHAr), 126.84 (CHAr), 61.64 
(CH, d, JCP 18.7 Hz), 58.22 (CH2), 53.84 (CH2), 34.10 (CH2, d, JCP 13.3 Hz), 31.90 
(CH2, d, JCP 7.8 Hz), 22.15 (CH2); δp (300MHz, CDCl3) -21.8; m/z (ESI) 360.1 (M
+
 
+ 1) and 376.1 (M
+
 + 17).  
 
1,3-Bis-((S)-2-((Diphenylphosphino)methylpyrrolidin-1-yl)methyl)benzene 
(165). 
 
This compound is novel. 
This compound was prepared as for 164 using NaH (60% in mineral oil) (120 mg, 
3.00 mmol), anhydrous THF (9 cm
3
), (S)-2-((diphenylphosphino)methyl)pyrrolidine 
163 (200 mg, 0.742 mmol) and α,α-dibromo-m-xylene (79 mg, 0.30 mmol). The 
crude was purified by column chromatography (silica gel, 0-100% EtOAc in 
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petroleum ether, TLC: silica plate, 1:1 EtOAc:petroleum ether, visualisation by 
KMnO4, Rf product = 0.1) to give the product as a yellow oil (24 mg, 0.038 mmol, 
13%). [α]D
30
 – 24.6  (c 0.5 in CHCl3) (S); (found (EI): M
+
 + H, 641.3211 C42H47N2P2 
requires 641.3209; υmax 2922, 2791, 1655, 1434, 1159, 1118, 906, 798, 738, 694 cm
-
1
 ; δH (300MHz, CDCl3) 7.47-7.39 (9H, m, CHAr), 7.33-7.28 (11H, m, CHAr), 7.16-
7.14 (2H, m, CHAr), 7.10-7.04 (2H, m, CHAr),  4.00 (2H, d, J 12.8Hz, CH
a
H
b
Ph), 
3.09 (2H, d, J 12.8Hz, CH
a
H
b
Ph
 
), 2.88-2.83 (2H, m, CH
a
H
b
PPh2), 2.64-2.58 (2H, m, 
CH
a
H
b
PPh2), 2.47-2.39 (2H, m, CHN), 2.10-1.93 (6H, m, CH2), 1.63 (6H, m, CH2);  
δC (75 MHz, CDCl3) 138.52 (2 CAr), 137.88 (2 CAr), 132.59 (CHAr), 132.33 
(CHAr), 132.06 (CHAr), 131.82 (CHAr), 129.10 (2 CAr), 128.99 (CHAr), 128.14 (2 
CHAr), 127.91 (2 CHAr), 127.81 (4 CHAr), 127.76 (4C), 127.71 (CHAr), 127.38 
(CHAr), 126.99 (2 CHAr), 61.24 (2 CH), 57.69 (2 CH2), 53.25 (2 CH2), 33.42 (2 
CH2, d, JCP 13.2 Hz), 31.25 (2 CH2, d, JCP 7.6 Hz), 21.47 (CH2); δP (300MHz, 
CDCl3) -21.6; m/z (ESI) 641.2 (M
+
 + 1). 
 
Tetraethylammonium undecacarbonylhydridotriferrate (166). 
[Et3NH] [HFe3(CO)11]. 
This compound is known in the literature.
128, 136
 Full characterisation is difficult due 
to the air sensitive nature of the compound, but NMR data has been previously 
reported.
136 
To degassed water (1 cm
3, 18 mmol) and degassed triethylamine (349 μL, 2.5 
mmol). To this was then added Fe(CO)5 (460 μL, 3.5 mmol). The reaction was 
connected to a reflux condenser and stirred vigorously at 80°C for 20 hours. After 
this the reaction was cooled to room temperature. The reaction was filtered under 
nitrogen and washed with degassed, distilled water. The residue was then dried under 
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vacuum. The product, a red dark red solid was stored under nitrogen. δH (300MHz, 
C6D6) 1.90 (1H, br s, NH), 1.40 (2H, br q, CH2), 0.00 (3H, br t, CH3) and -15.25 
(0.2H, s, FeH). Data matches that previously reported for this compound although 
the integral of the FeH signal was expected to be 1.
136 
 
General procedure 2: asymmetric transfer hydrogenation with [Et3NH] 
[HFe3(CO)11].
128, 129
 
The reaction was carried out under an argon atmosphere. To [Et3NH] [HFe3(CO)11] 
166 (3 mg, 0.005 mmol), KOH (1.6 mg, 0.03 mmol), acetophenone (60 mg, 0.5 
mmol) and anhydrous, degassed iso-propanol (1 cm
3
) all taken from a freshly 
prepared stock solution, was added the required ligand (3mol% for a tetradentate 
ligand, 6mol% for a bidentate ligand). The resulting solution was stirred under argon 
at 45°C. The reaction solution was filtered through silica with 1:1 EtOAc:petroleum 
ether 40-60°C. The filtrate was analysed by GC. 
 
(S)-(2-(Hydroxymethyl)pyrrolidine)-N-2,2-dimethylpropan-1-one (167). 
 
This compound is known in the literature but has not previously been fully 
characterised.
178
 
To a nitrogen purged, dried flask was added (L)-prolinol (202 mg, 2.00 mmol) in 
chloroform (1.5 cm
3
) that had been dried over molecular sieves. The resulting 
solution was cooled to 0°C and to it was added Et3N (405 mg, 4.00 mmol) followed 
by the dropwise addition of trimethylacetyl chloride (265 mg, 2.20 mmol). The 
resulting solution was allowed to warm to room temperature and stirred overnight. 
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Chloroform (10 cm
3
) and saturated NaHCO3 aq. (10 cm
3
) was added. The 
chloroform phase was collected and washed with further NaHCO3 (aq.) followed by 
saturated NaCl (aq.) before being dried over MgSO4, filtered and the solvent 
removed under reduced pressure to give the crude product as an orange oil. The 
crude was purified by column chromatography (silica gel, 0-100% EtOAc in 
petroleum ether, TLC: silica plate, 1:1 EtOAc:petroleum ether, visualisation by 
KMnO4, product Rf = 0.12) to give the product as a white solid (191 mg, 1.0 mmol, 
50%). Mp 78-79°C; [α]D
34
 -55.5 (c 1 in CHCl3) (S); (found (ESI): M
+
 + H, 208.1304. 
C10H19NNaO2 requires M, 208.1308); υmax 3388, 2956, 2872, 1589, 1410, 1365, 
1225, 1155, 1053, 752 cm
-1; δH (300 MHz, CDCl3) 5.02 (1H, br s, OH), 4.14-4.06 
(1H, m, CHN), 3.68-3.60 (1H, m, CH2N), 3.42-3.38 (2H, m, CH2OH), 3.33-3.25 
(1H, m, CH2N), 1.98-1.70 (2H, m, CH2), 1.65-1.53 (1H, m, CH2), 1.43-1.35 (1H, m, 
CH2), 1.26 (9H, s, (CH3)3); δC (75 MHz, CDCl3) 178.08 (1C=O), 66.11 (CH), 61.40 
(CH2), 47.77 (CH2), 38.39 (C(CH3)3), 26.83 (3 CH3), 26.4 (CH2), 24.6 (CH2); m/z 
(ESI) 186.2 (M
+
 + 1), 208.1 (M
+
 + 23). Data matches that previously reported for 
this compound.
178 
 
(S)-2-((tert-Butyldimethylsilyloxy)methylpyrrolidine (168). 
 
This compound is known in the literature but has not previously been fully 
characterised.
179 
To (L)-prolinol (303 mg, 2.99 mmol) was added triethylamine (405 mg, 4.00 mmol). 
To this was then added anhydrous Et2O (5 cm
3
), anhydrous THF (5 cm
3
) and the 
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solution cooled to 0°C. TBDMSCl (603 mg, 4.00 mmol) was then added. The 
resulting solution was allowed to warm to room temperature and stirred overnight. 
After this 5 cm
3
 of 50% K2CO3 solution (aq.) was slowly added to the reaction. The 
organic phase was separated and washed with saturated NaHCO3 solution (aq.) and 
brine. The organic phase was dried over Na2SO4, filtered and the solvent removed 
under reduced pressure to leave the crude product (179) as an orange oil. (634 mg, 
2.94 mmol, 98%). Further purification was not necessary. [α]D
20
 – 1.8  (c 0.25 in 
CHCl3) (S); (found (EI): M
+
 + H, 216.1779 C11H26NOSi requires 216.1778; υmax 
2953, 2927, 2855, 1462, 1406, 1252, 1090, 832, 771, 664 cm
-1; δH (300MHz, CDCl3) 
3.59-3.45 (2H, m, CH2OSi), 3.14-3.06 (1H, m, CHN), 2.98-2.90 (1H, m, CH2N), 
2.82-2.74 (1H, m, CH2N), 2.64 (1H, br s, NH), 1.76-1.64 (3H, m, CH2), 1.46-1.38 
(1H, m, CH2), 0.87 (9H, s, (CH3)3), 0.3 (6H, s, 2 x CH3);  δC (75 MHz, CDCl3) 65.34 
(CH2), 59.85 (CH), 46.36 (CH2), 27.35 (CH2), 25.88 (3 CH3), 25.40 (2 CH2), 18.27 
(C), -5.42 (CH3); m/z (ESI) 216.2 (M
+
 + H). Data matches that previously reported 
for this compound.
179
 
 
(S)-1-Benzyl-2-((tert-butyldimethylsilyloxy)methyl)pyrrolidine (169). 
 
This compound is known in the literature but has not previously been fully 
characterised.
179
 
This compound was prepared as for compound 175 using NaH (60% in mineral oil) 
(88 mg, 2.20 mmol) anhydrous THF (8 cm
3
), O-(tert-butyldimethylsilyl)prolinol 168 
(120 mg, 0.557 mmol) and benzyl bromide (89 mg, 0.56 mmol) The crude product 
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was purified by column chromatography (silica gel, 0-20% EtOAc in petroleum 
ether, TLC: silica plate, 1:1 EtOAc:petroleum ether, visualisation by KMnO4, 
product Rf = 0.81) to give the product as a colourless oil (80 mg, 0.26 mmol, 46%). 
[α]D
30
 -26.5° (c 0.5 in CHCl3) (S); (found (EI): M
+
 + H, 306.2249 C18H32NOSi 
requires M, 306.2248); υmax 2955, 2927, 2856, 2787, 2361, 1461, 1252, 1076, 834, 
774, 735, 697 cm
-1; δH (300MHz, CDCl3)7.24-7.14 (5H, m, CHAr), 4.04 (1H, d, J 
13.3 Hz, CH
a
H
b
Ar), 3.57 (1H, dd, J 9.9 and 5.4 Hz, CH
a
H
b
OSi), 3.42-3.32 (2H, m 
(dd and d overlapping), CH
a
H
b
Ar and CH
a
H
b
OSi overlapping), 2.87-2.81 (1H, m, 
CH2N), 2.65-2.56 (1H, m, CHN), 2.19-2.10 (1H, m, CH2N), 1.86-1.77 (1H, m, CH2), 
1.64-1.51 (3H, m, CH2), 0.81 (9H, s, (CH3)3), 0.04 (6H, s, CH3);  δC (75MHz, 
CDCl3) 139.25 (CAr), 128.40 (2 CHAr), 127.53 (2 CHAr), 126.14 (CHAr), 66.56 
(CH2), 64.46 (CH), 59.39 (CH2), 54.21 (CH2), 27.82 (CH2), 25.36 (3 CH3), 22.22 
(CH2), 17.71 (C), -5.95 (2 CH3); m/z (ESI) 306.2 (M
+
 + 1). Data matched that 
previously reported for this compound.
179 
 
1,3-Bis-((S)-2-((tert-butyldimethylsilyloxy)methyl)pyrrolidine)methyl)benzene 
(170). 
 
This compound is novel. 
Prepared as for 169 using NaH (60% in mineral oil) (112 mg, 2.80 mmol), 
anhydrous THF (9 cm
3
), O-(tert-butyldimethylsilyl)prolinol 168 (150 mg, 0.696 
mmol) and α,α-dibromo-m-xylene (46 mg, 0.28 mmol). The crude product was 
purified by column chromatography (silica gel, 0-20% EtOAc in petroleum ether, 
TLC: silica plate, 1:1 EtOAc:petroleum ether, visualisation by KMnO4, product Rf = 
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0.56) to give the product as a colourless oil (54 mg, 0.10 mmol, 36%). [α]D
32
 -22.3° 
(c 0.3 in CHCl3) (S); (found (EI): M
+
 + H, 533.3967 C30H57N2O2Si2 requires M, 
533.3953); υmax 2953, 2927, 2855, 2784, 1461, 1360, 1251, 1083, 834, 774, 704, 665 
cm
-1; δH (300MHz, CDCl3) 7.24 (1H, s, CHAr), 7.20-7.15 (3H, m, CHAr), 4.06 (2H, 
d, J 12.8 Hz, 2 x CH
a
H
b
Ar
 
), 3.62 (2H, dd, J 10.0 and 5.3 Hz, 2 x CH
a
H
b
OSi), 3.46-
3.36 (4H, m (d and dd overlapping), 2 x CH
a
H
b
Ar and 2 x CH
a
H
b
OSi overlapping),  
2.90-2.85 (2H, m, CH2N), 2.68-2.60 (2H, m, CHN), 2.20 (2H, q, J 8 Hz, CH2N), 
1.94-1.82 (2H, m, CH2), 1.71-1.52 (6H, m, CH2), 0.87 (18H, s, 2 x (CH3)3), 0.02 
(12H, s, 4 x CH3); δC (75 MHz, CDCl3) 139.06 (2 CAr), 128.96 (1 CHAr), 127.31 
(CHAr), 126.89 (2 CHAr), 66.56 (2 CH2), 64.48 (2 CH), 59.39 (2 CH2), 54.20 (2 
CH2), 27.87 (2 CH2), 25.36 (6 CH3), 22.23 (2 CH2), 17.71 (2 C), -5.9 (4 CH3); m/z 
(ESI) 533.3 (M
+
 + 1). (For procedure see reference 169-171). 
 
(S)-(1-benzylpyrrolidin-2-yl)methanol (171). 
 
This compound is known and has previously been fully characterised.
180
 
To a nitrogen purged flask, dried by heating under vacuum was added(S)-1-benzyl-2-
(tert-butyldimethylsilyloxy)methylpyrroliodine 169 (76 mg, 0.25 mmol) and 
anhydrous THF (4 cm
3
). The solution was cooled to 0°C and TBAF 1M solution in 
THF (0.4 cm
3
, 0.4 mmol) was added. The solution was stirred at O°C and monitored 
by TLC (1:1 EtOAc:pet ether, visualisation by KMnO4, product Rf = 0.51). 
Additional TBAF (0.2 cm
3
, 0.2 mmol) was added after 2 hours and the solution was 
allowed to warm to room temperature and stirred for an hour. Once complete by 
TLC the reaction was quenched by the slow addition of saturated Na2HCO3 solution 
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(aq.). The reaction was washed with water (10 cm
3
) and extracted with Et2O (3 x 10 
cm
3
). The Et2O phases were combined, dried over Na2SO4, filtered and the solvent 
removed under reduced pressure to leave the crude product as an orange oil. The 
crude was purified by column chromatography (silica gel, 0-100% EtOAc in 
petroleum ether, TLC: as above) to give the pure product as a yellow oil, (33 mg, 
0.17 mmol, 68%). [α]D
34
 -43.3 (c 0.8 in CHCl3) (S) (lit.
180
 [α]D
20
 -24 (c 0.4 in CHCl3) 
(S));  (found (ESI): M
+
 + H, 192.1384. C12H18NO requires M, 192.1383); υmax 3330, 
2956, 2872, 2791, 1452, 1074, 1028, 737, 698 cm
-1; δH (400 MHz, CDCl3) 7.33-7.26 
(5H, m, CHAr), 4.02 (1H, d, J 13.0 Hz, CH
a
H
b
Ar), 3.68 (1H, dd, J 11.0 and 3.4 Hz, 
CH
a
H
b
OH), 3.49-3.43 (2H, m, CH
a
H
b
Ar and CH
a
H
b
OH overlapping), 3.06-3.01 (1H, 
m, CH
a
H
b
N), 2.96-2.64 (2H, br s and m overlapping, CHN and OH overlapping), 
2.39-2.33 (1H, m, CH
a
H
b
N), 1.98-1.81 (2H, m, CH2), 1.77-1.69 (2H, m, CH2); δC 
(100 MHz, CDCl3) 139.24 (CAr), 128.98 (2 CHAr), 128.46 (2 CHAr), 127.38 
(CHAr), 64.71 (CH), 61.67 (CH2), 58.64 (CH2), 54.39 (CH2), 27.65 (CH2), 23.48 
(CH2); m/z (ESI) 192.1 (M
+
 + 1). Data matches that previously reported for this 
compound.
180
 
 
1,3-Bis-((S)-2-((pyrrolidin-1-yl)methanol)methyl)benzene (172). 
 
This compound is novel. 
The compound was prepared as for (S)-(1-benzylpyrrolidin-2-yl)methanol 171 using  
(S)-1-((1,2R)-3-(((2R)-2-((tert-butyldimethylsilyloxy)methyl)cyclopentyl)methyl)- 
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benzyl)-2-((tert-butyldimethylsilyloxy)methyl)pyrrolidine 170 (512 mg, 0.96 mmol), 
anhydrous THF (3 cm
3
) and TBAF 1M solution in THF (2.9 cm
3
, 2.9 mmol). The 
crude product was purified by column chromatography (silica gel, 0-50% MeOH in 
DCM followed by flushing with 100% MeOH, TLC: silica plate, 20% MeOH in 
DCM, visualisation by KMnO4, product Rf = 0) to give the pure product as an 
orange/yellow oil (64 mg, 0.21 mmol, 22%). [α]D
34
 -47.8 (c 0.5 in CHCl3) (S); 
(found (ESI): M
+
 + H, 305.2220. C18H29N2O2 requires M, 305.2224); υmax 3323, 
2948, 2871, 2793, 1443, 1351, 1079, 1038, 905, 753, 704 cm
-1; δH (300 MHz, 
CDCl3) 7.27-7.16 (4H, m, CHAr), 3.89 (2H, d, J 13.0 Hz, CH
a
H
b
Ar), 3.57 (2H, dd, J 
10.7 and 3.6 Hz, CH
a
H
b
OH), 3.40-3.35 (4H, m, CH
a
H
b
Ar and CH
a
H
b
OH 
overlapping), 2.99-2.93 (2H, m, CH
a
H
b
N), 2.84-2.44 (4H, m and br s overlapping, 
CHN and OH overlapping), 2.33-2.25 (2H, m, CH
a
H
b
N), 1.95-1.75 (4H, m, CH2), 
1.72-1.64 (4H, m, CH2); δC (100 MHz, CDCl3) 139.35 (2 CAr), 129.15 (1 CHAr), 
128.40 (1 CHAr), 127.63 (2 CHAr), 64.49 (2 CH), 61.93 (2 CH2), 58.73 (2 CH2), 
54.67 (2 CH2), 27.84 (2 CH2), 23.51 (2 CH2); m/z (ESI) 305.2 (M
+
 + 1), 327.2 (M
+
 + 
23). 
 
2-N-Tosylbenzaldehyde (173). 
 
This compound is known in the literature and has previously been fully 
characterised.
181, 182
 
To 2-aminobenzyl alcohol (1 g, 8 mmol) was added anhydrous chloroform (8 cm
3
), 
pyridine (800 μL, 9.89 mmol) and p-toluenesulfonyl chloride (1.6 g, 8.4 mmol). The 
resulting solution was stirred for 3 hours at room temperature. After this the solvent 
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was removed under reduced pressure to give a brown solid. This was dissolved in 
EtOAc and washed with saturated NH4Cl solution (aq.). The EtOAc phases were 
combined, dried over Na2SO4, filtered and the solvent removed under reduced 
pressure to give an off-white solid. This was then purged with nitrogen and to it was 
added anhydrous DCM (40 cm
3
) and MnO2 (5.6 g, 64 mmol). The resulting black 
solution was stirred at room temperature for 1.5 hours before being filtered through 
celite and the solvent removed from the filtrate under reduced pressure to leave the 
crude product as an off-white solid. This was purified by column chromatography 
(silica gel, 3:1 petroleum ether:EtOAc, TLC: silica plate, 25% EtOAc in petroleum 
ether, visualisation by KMnO4, product Rf = 0.50) to give the product as a white 
solid (430 mg, 1.56 mmol, 20%). Mp 135°C; (found (EI): M
+
 + Na, 298.0509 
C14H13N2NaO3S requires M, 298.0508); υmax 3119, 2849, 2766, 1662, 1581, 1493, 
1455, 1404, 1337, 1291, 1150, 1087, 929, 811, 758, 657 cm
-1; δH (300 MHz, CDCl3) 
10.80 (1H, s, NH), 9.82 (1H, s, COH), 7.77 (2H, d, J 8.3 Hz, CHArSO2), 7.70 (1H, 
d, J 8.0 Hz, CHAr), 7.59 (1H, dd, J 7.5 Hz and 1.7 Hz, CHAr), 7.51 (1H, t, J 8.0 Hz 
and 1.7 Hz, CHAr), 7.24 (2H, d, J 8.3 Hz, CHArSO2), 7.16 (1H, td, J 7.5 and 0.75 
Hz, CHAr), 2.36 (3H, s, CH3).  δC (75MHz, CDCl3) 195.10 (C=O), 146.89 (CAr), 
144.25 (CAr), 139.90 (CAr), 136.32 (CAr), 136.18 (CHAr), 135.84 (CHAr), 129.79 
(2 CHAr), 127.27 (2 CHAr), 123.00 (CHAr), 117.70 (CHAr), 21.6 (CH3); m/z (ESI) 
276.0 (M
+
 + 1) and 298.0 (M
+
 + 23). Data matches that previously reported for this 
compound.
 181, 182 
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(1S,2S)-N, N-Bis(2-N-tosylbenzyl)-1,2-diphenylethane-1,2-diamine (174). 
 
This compound is novel. 
To 2-N-tosylbenzaldehyde 173 (430 mg, 1.56 mmol) was added Na2SO4 (680 mg, 
4.79 mmol) and anhydrous DCM (7 cm
3
). To this was then added (S,S)-DPEN (170 
mg, 0.801 mmol). The resulting bright yellow solution was stirred at room 
temperature for 24 hours. After this, the reaction solution was filtered and the solvent 
removed under reduced pressure to leave a bright yellow solid. The solid was 
dissolved in anhydrous THF (8 cm
3
) and cooled to 0°C. LiAlH4 solution 2M in THF 
(2.4 cm
3
, 4.8 mmol) was then added dropwise. The solution was stirred overnight 
and allowed to warm to room temperature. After this the reaction was cooled to 0°C 
and water was slowly added. The THF was removed under reduced pressure. The 
aqueous residue was then extracted with Et2O (4 x 20 cm
3
). The Et2O phases were 
combined, dried over Na2SO4, filtered and the solvent removed under reduced 
pressure to leave the product as a pale yellow, viscous oil (198 mg, 0.27 mmol, 
59%). Further purification was not necessary. Mp 87°C; [α]D
32
 + 13.2° (c 0.5 in 
CHCl3) (S, S); (found (EI): M
+
 + H, 731.2740 C42H43N4O4S2 requires M, 731.2734); 
υmax 2970, 2901, 1707, 1586, 1493, 1330, 1155, 1090, 931, 812, 756, 700, 656 cm
-1
; 
δH (700MHz, CDCl3) 7.49-7.46 (6H, m, CHArSO2 and CHAr overlapping), 7.25-
7.19 (10H, m, CHAr in DPEN, NHTs and CHAr), 7.10 (4H, d, J 7.7 Hz, CHArCH3), 
6.99 (4H, d, J 6.8 Hz, CHAr in DPEN), 6.94 (2H, t, J 7.0 Hz, CHAr), 6.81 (2H, d, J 
7.0 Hz, CHAr), 3.78 (2H, s, CH), 3.33 (2H, d, J 13.0 Hz, CH
a
H
b
), 3.23 (2H, d, J 13.0 
Hz, CH
a
H
b
), 2.32 (6H, s, CH3) ; δC (175 MHz, CDCl3) 143.29 (2 CAr), 138.60 (2 
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CAr, s), 137.62 (2 CAr), 137.43 (2 CAr), 129.77 (2 CHAr), 129.49 (4 CHAr), 
128.63 (2 CHAr), 128.57 (4 CHAr), 128.50 (2 CAr), 128.99 (4 CHAr), 127.74 (2 
CHAr), 126.90 (4 CHAr, s), 124.40 (2 CHAr), 121.76 (2 CHAr), 67.61 (2 CH), 
50.44 (2 CH2), 21.48 (2 CH3); m/z (ESI) 731.1 (M
+
 + 1) and 753.0 (M
+
 + 23).  
 
General procedure 3: rhodium and ruthenium-catalysed transfer 
hydrogenation of acetophenone.
 
To a nitrogen purged, dried test tube containing the desired ligand (0.002 mmol, 1 
mol% for tetradentate ligands and 0.004 mmol, 2 mol% for bidentate ligands) was 
added from a stock solution, acetophenone (24 mg, 0.2 mmol), anhydrous IPA (2 
cm
3
), KOH (0.11 mg, 0.0020 mmol) and either [Rh(COD)Cl]2 (0.99 mg, 0.002 
mmol) or [Ru(benzene)Cl2]2 (1.0 mg, 0.002 mmol). The resulting solution stirred 
under nitrogen at 82°C. The reaction solution was filtered through silica with 1:1 
EtOAc:petroleum ether 40-60°C. The filtrate was analysed by GC. 
 
5.3.3 Synthetic procedures for Section 2.3 
  
2-morpholino-1-phenylethanone. 
 
This compound is known in the literature and has previously been fully 
characterised. 
183
 
To a dried, nitrogen purged flask was added 2-bromoacetophenone (1.0 g, 5.0 
mmol). To this was then added anhydrous DCM (20 cm
3
) and the resulting solution 
was stirred and Et3N (1.01 g, 10 mmol) was added followed by morpholine (436 mg, 
5 mmol). The reaction was stirred at room temperature overnight. The reaction was 
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washed with saturated NaHCO3 solution and brine. The organic phase was dried 
over Na2SO4, filtered and the solvent removed under reduced pressure to give the 
crude product as a yellow oil. The crude was purified by column chromatography 
(silica gel, 0-100% EtOAc in petroleum ether, TLC: silica gel, 1:1 EtOAc:petroleum 
ether, visualisation by KMnO4, product Rf = 0.36) to give the product as a yellow oil  
(556 mg, 2.7 mmol, 54%). The product was unstable at room temperature and 
decomposed to its enamine over time. (Found (ESI): M
+
 + H, 206.1181 C12H16NO2 
requires M, 206.1176); υmax 2968, 2906, 2814, 1691, 1451, 1278, 1215, 1112, 971, 
864, 759, 691 cm
-1; δH (400 MHz, CDCl3) 8.04-8.01 (2H, m, CHAr), 7.63-7.57 (1H, 
m, CHAr), 7.51-7.46 (2H, m, CHAr), 3.85 (2H, s, CH2CO), 3.82-3.79 (4H, m, 2 x 
CH2CH2N), 2.65-2.62 (4H, m, 2 x OCH2CH2); δC (75 MHz, CDCl3) 196.09 (C=O), 
135.94 (CAr), 133.35 (CHAr), 128.59 (2 CHAr), 128.07 (2 CHAr), 66.81 (2 CH2), 
64.69 (CH2), 53.88 (2 CH2); m/z (ESI) (M
+
 + 1), (M
+
 + 23). Data matches that 
previously reported for this compound.
183
 
 
1-Benzylpiperidine-2,6-dione. 
 
This compound is known in the literature and has previously been fully 
characterised.
184 
To a dried, nitrogen purged flask was added glutaric anhydride (571 mg, 5.00 mmol) 
and anhydrous THF (10 cm
3
). The resulting solution was stirred and to it was added 
benzylamine (643 mg, 6.00 mmol). The reaction was stirred for 30 min at room 
temperature. The solvent was removed under reduced pressure. The residue was 
dissolved in EtOAc (10 cm
3
) and the solution was washed with 1 M HCl (aq.) (10 
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cm
3
). The EtOAc phase was collected and the aqueous phase washed with a further 2 
portions of EtOAc. The EtOAc phases were combined and washed with brine before 
being dried over MgSO4, filtered and the solvent removed under reduced pressure to 
leave the crude intermediate. To the intermediate, at room temperature and under 
nitrogen was then added Et3N (759 mg, 7.50 mmol) and acetic anhydride (5 cm
3
). 
The reaction was then connected to a reflux condenser and stirred at 80°C for 1 hour. 
The reaction was then cooled to room temperature and dried under reduced pressure. 
The residue was dissolved in EtOAc (10 cm
3
) and the resulting solution was washed 
with 1 M HCl (aq.) and brine. The EtOAc phase was dried over MgSO4, filtered and 
the solvent removed by evaporation to leave the crude product as an orange oil. The 
crude was purified by column chromatography (silica gel, 0-100% EtOAc in 
petroleum ether 40-60, TLC: 1:1 EtOAc:petroleum ether, visualisation by KMnO4, 
product Rf = 0.53) to give the product as a white solid (596 mg, 2.9 mmol, 58%). 
Mp 54°C; (found (ESI): M
+
 + H, 204.1015 C12H14NO2 requires M, 204.1019); υmax 
2964, 1668, 1422, 1354, 1228, 1168, 1133, 1013, 717, 703 cm
-1; δH (400 MHz, 
CDCl3) 7.35-7.33 (2H, m, CHAr), 7.29-7.22 (3H, m, CHAr), 4.93 (2H, s, NCH2), 
2.64 (4H, t, J 6.5 Hz, 2 x CH2CH2), 1.94-1.87 (2H, quin, J 6.5 Hz,CH2CH2CH2); δC 
(100 MHz, CDCl3) 172.54 (2 C=O), 137.44 (CAr), 128.54 (2 CHAr), 128.35 (2 
CHAr), 127.31 (CHAr), 42.56 (CH2), 32.72 (2 CH2), 16.98 (CH2); m/z (ESI) 204.1 
(M
+
 + 1), 226.1 (M
+
 + 23). Data matches that previously reported for this 
compound.
184 
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General procedure 4: pressure hydrogenation of ketones catalysed by tethered 
ruthenium catalysts (S/C 500/1). 
To an oven dried test tube was added the catalyst (1.2 mg, 0.002 mmol) and ketone 
(1 mmol). To the test tube was then added anhydrous MeOH (2 cm
3
) and the tube 
was transferred to the Parr reactor which was then sealed and purged with H2 before 
being charged with H2 to 30 bar. The reactor was then heated to 60°C and the 
reactions stirred at this temperature and pressure for the required time. The reactions 
were cooled, the pressure released and the reaction mixture filtered through silica 
with 1:1 EtOAc:petroleum ether 40-60. The filtrate was then analysed by GC. The 
remainder of the filtrate was concentrated under vacuum to leave the alcohol product 
which was then analysed by 
1
H and 
13
C NMR and its optical rotation obtained. 
Where necessary the product was purified by column chromatography (silica gel, 0-
50% EtOAc in petroleum ether 40-60) to remove residual starting material. 
5.3.4 Synthetic procedures for Sections 2.4 and 2.5. 
 
 
N-[(1S, 2S)-1, 2-Diphenyl-2-(3-phenypropylamino)ethyl)-4-
methylbenzenesulfonamide)ruthenium(II)iodide monomer (181). 
 
This compound is novel. 
To an argon purged flask was added (S,S)TsDPEN 3C tethered RuCl 97 catalyst (40 
mg, 0.060 mmol) and KI (25 mg, 0.15 mmol). To this was then added 50% v/v 
EtOH/H2O (4 cm
3
). The resulting orange solution was stirred under reflux at 80°C 
for 2 hours. After this the reaction solution which had become a red/purple colour 
was cooled to room temperature and filtered. The collected precipitate was dried to 
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give a red/purple solid (42 mg, 0.059 mmol, 98%). Purification was not necessary. 
Mp 170°C (decomposed); [α]D
28
 +565 (c 0.1 in CHCl3) (S, S); (found (ESI): M
+
 - I 
+H, 585.1161 C30H32N2O2RuS requires M, 585.1151); υmax 3495, 3212, 2940, 1455, 
1263, 1128, 1084, 936, 905, 806, 701, 659 cm
-1; δH (400 MHz, CDCl3) 7.17 (2H, d, J 
7.6 Hz, CHAr in tosyl), 7.12-7.07 (3H, m, CHAr), 6.82-6.76 (5H, m, CHAr), 6.66 
(H, t, J 7.5 Hz, CHAr), 6.59 (2H, d, J 7.6 Hz, CHAr in tosyl), 6.48 (1H, t, J 5.6 Hz, 
CHAr-Ru), 6.25 (1H, t J, 5.6 Hz, CHAr-Ru), 6.10 (1H, t J 5.6 Hz, CHAr-Ru), 5.60 
(1H, d, J 5.6 Hz, CHAr-Ru), 5.05 (1H, d, J 5.6 Hz, CHAr-Ru), 4.81-4.78 (1H, m, 
NH), 4.09 (1H, d, J 11.0 Hz, CHNTs), 3.69 (1H, t, J 11.0 Hz, CHNH), 2.80-2.74 
(1H, m, CH2NH), 2.64-2.52 (2H, m, CH2CH2NH), 2.29-2.24 (4H, m and s 
overlapping, CH in CH2NH and CH3 overlapping), 2.19-2.10 (1H, m, CH2ArRu), 
1.99-1.93 (1H, m, CH2ArRu); δC (100 MHz, CDCl3) 142.40 (CAr), 139.16 (CAr), 
138.50 (CAr), 136.51 (CAr), 129.20 (2 CHAr), 128.68 (CHAr), 128.26 (2 CHAr), 
128.03 (4 CHAr), 127.19 (2 CHAr), 126.81 (2 CHAr), 126.27 (CHAr), 98.87 (CAr-
Ru), 93.44 (CHAr-Ru), 89.61 (CHAr-Ru), 81.98 (CHAr-Ru), 79.36 (CHAr-Ru), 
77.44 (CHAr-Ru), 77.20 (CH), 70.00 (CH), 48.57 (CH2), 29.59 (CH2), 26.08 (CH2), 
21.25 (CH3); m/z (ESI) 585.0 (M
+
 + 1); X-ray crystallography data is given in 
Appendix 2. For procedure see reference 185. 
 
N-[(1R,2R)-2-(Amino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide(p-
cymene)ruthenium(II)chloride monomer (57a). 
 
This compound is known and has previously been fully characterised.
74 
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To a nitrogen purged, dried round bottom flask, was added [(p-cymene)RuCl2]2 (50 
mg, 0.080 mmol) was added (R,R)TsDPEN (59 mg, 0.16 mmol). To this was then 
added Et3N (32 mg, 0.32 mmol) and degassed anhydrous IPA (5 cm
3
). The resulting 
orange solution was stirred at reflux (80°C) for 1 hour. After this the reaction was 
cooled to room temperature, and the solvent removed under reduced pressure to 
leave an orange solid. The solid was washed with water and filtered. The solid was 
dried and then recrystallised from hot MeOH to give the product as an orange solid 
(75 mg, 0.12 mmol, 75%).  Mp 182-184°C; [α]D
27 
-45 (c 0.01 in CHCl3) (R,R) (lit.
186
 
[α]D
29
 -80.5 (c 1.05 in CHCl3) (R,R)); (found (ESI): M
+
 + H, 601.1468. 
C31H35N2O2RuS requires M, 601.1465); υmax 3216, 1452, 1265, 1126, 1083, 913, 
806, 696, 572 cm
-1; δH (400 MHz, CDCl3) 6.98-6.96 (5H, m, CHAr), 6.72-6.68 (5H, 
m, CHAr), 6.56 (2H, t J 7.7 Hz, CHAr), 6.38-6.37 (2H, m, CHAr), 5.90 (1H, br s, 
CHAr-Ru), 5.80 (1H, br s, CHAr-Ru), 5.73-5.70 (2H, m, CHAr-Ru), 3.73 (1H, d J 
10.5 Hz, CHNTs), 3.61-3.56 (1H, m, CHNH2), 3.24-3.11 (1H, m, NH2), 3.11-3.09 
(1H, m, CH(CH3)2), 2.31 (3H, s, p-CH3(C6H4)SO2), 2.21 (3H, s, 
i
Pr(C6H4)CH3), 1.63 
(1H, br s, NH2), 1.20 (6H, d J 6.0 Hz, (CH3)2CH); δC (100 MHz, CDCl3) 143.34 
(CAr), 139.74 (CAr), 138.89 (CAr), 138.67 (CAr), 129.03 (CHAr), 127.83 (2 
CHAr), 127.78 (2 CHAr), 127.30 (4 CHAr), 126.70 (2 CHAr), 126.56 (2 CHAr), 
125.87 (CHAr), 93.89 (CAr-Ru), 85.63 (CHAr-Ru), 82.00 (CHAr-Ru), 80.11 
(CHAr-Ru), 71.60 (CHAr-Ru), 69.39 (CHAr-Ru), 46.18 (CH), 30.54 (2 CH3), 22.15 
(CH3), 18.84 (CH3); m/z (ESI) 601 (M
+
 -35 + 1,). Data matches that previously 
reported for this compound.
74
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N-[(1R,2R)-2-(Amino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide(p-
cymene)ruthenium(II)iodide monomer (183). 
 
This compound is novel. 
Method A: 
To an argon purged flask was added [Ru(p-cymene)Cl2]2 182 (50 mg, 0.080 mmol) 
was added KI (133 mg, 0.80 mmol) followed by 50% v/v EtOH/H2O. The resulting 
red solution was then stirred under reflux at 80°C for 2 hours. The reaction solution 
which had become purple, was cooled to room temperature and filtered. The 
collected precipitate was dried to give a purple solid [Ru(p-cymene)I2]2 (184) (68 
mg, 0.070 mmol). To the purple solid (60 mg, 0.060 mmol) in an argon purged, dried 
flask was then added (R,R)TsDPEN (44 mg, 0.12 mmol), followed by Et3N (24 mg, 
0.24 mmol) and anhydrous IPA (5 cm
3
). The resulting purple solution was stirred 
under reflux at 80°C for 1 hour. After this the reaction was cooled to room 
temperature and the solvent removed under reduced pressure. The residue was then 
washed with 1 cm
3
 of water before again being dried to leave the crude as a purple 
solid. The solid was recrystallised from hot MeOH to leave the purified product as a 
purple/red solid (26 mg, 0.035 mmol, 29% based on mmol Ru). For procedure see 
reference 185. 
Method B: 
To Noyori RuCl complex 57a (130 mg, 0.216 mmol) was added KI (83 mg, 0.50 
mmol) and anhydrous IPA (10 cm
3
). The reaction was stirred at reflux (80°C) for 2 
hours and then cooled to room temperature. The solid was collected by filtration to 
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give the product as a red solid (67 mg, 0.10 mmol, 46%). For procedure see 
reference TT. Mp 198°C (decomposed); [α]D
28
 +13 (c 0.05 in CHCl3) (R,R); (found 
(ESI): M
+
 - I + H, 601.1466. C31H36N2O2RuS requires M, 601.1465); υmax 3494, 
3213,2935, 1455, 1263, 1128, 1084, 1059, 937, 906, 806, 701, 659 cm
-1; δH (400 
MHz, MeOD) 7.14-7.11 (5H, m, CHAr), 6.93-6.90 (2H, m, CHAr), 6.86-6.79 (3H, 
m, CHAr), 6.69-6.61 (4H, m, CHAr), 5.74-5.72 (1H, m, CHAr-Ru), 5.68-5.65 (2H, 
m, CHAr-Ru), 5.57 (1H, br s, CHAr-Ru), 4.61 (1H, br s, NH2), 4.01-3.98 (1H, m, 
CHNTs), 3.78-3.75 (1H, m, CHNH2), 3.34 (2H, br s, MeOH, CH(CH3)2 and NH2 
overlapping), 2.56 (3H, s, p-CH3(C6H4)SO2), 2.27 (3H, s, 
i
Pr-(C6H4)-CH3), 1.42 (6H, 
d  J, 6.8 Hz, CH(CH3)2); δC (150 MHz, d6-DMSO) δC (150 MHz, DMSO) 140.35 
(CAr), 139.79 (CAr), 138.99 (CAr), 135.03 (CAr), 129.45 (2 CHAr), 129.28 
(CHAr), 128.63 (4 CHAr), 128.12 (2 CHAr), 127.32 (2 CHAr), 126.83 (2 CHAr), 
126.56 (CHAr), 88.25 (CHAr-Ru), 86.45 (CHAr-Ru), 73.77 (CHAr-Ru), 72.04 
(CHAr-Ru), 55.39 (CAr-Ru), 40.53 (CAr-Ru), 40.42 (CH), 40.39 (CH), 33.46 (2 
CH3), 24.46 (CH), 23.63 (CH3), 21.21 (CH3); m/z (ESI) 601.0 (M
+
 + 1); X-ray 
crystallographic data given in Appendix 2. For procedure see reference 185.
 
4-(Cyclohexa-1,4-diphenyl)butan-1-ol (185). 
 
This compound is known in the literature and has previously been fully 
characterised.
101 
A 1L, 3-necked round bottom flask was connected to a condenser and pressure 
equalising dropping funnel. The flask and condenser were then cooled to -78°C with 
a dry ice/acetone mixture and maintained at this temperature throughout the reaction. 
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The system was purged with nitrogen and then to the addition funnel was added 4-
phenyl-1-butanol (10g, 66.7 mmol) and anhydrous EtOH (30 cm
3
). To the round 
bottom flask was then added ammonia gas which condensed to a volume of 250cm
3
. 
The ethanolic solution of 4-phenyl-1-butanol was added to the flask dropwise with 
stirring. During the addition a white precipitate began to form in the reaction 
solution, additional EtOH was added in 2-3 cm
3
 portions to help maintain stirring 
and dissipate the precipitate. A total of 20 cm
3
 of additional EtOH was added in this 
way during the course of the 4-phenyl-1-butanol addition. Once all of the alcohol 
had been added, sodium was added to the reaction slowly. Upon addition of sodium, 
blue flecks appeared in the reaction solution and copper coloured droplets formed on 
the reaction surface. Sodium was added until the reaction solution was a 
homogenous intense, dark blue colour. Stirring was continued and when the blue 
colour faded (initially quickly over 2-5 mins) additional sodium was added, now in 
larger pieces (500 mg) until the blue colour persisted. A total of 10g of sodium was 
added. The reaction was then slowly warmed to room and stirred overnight. 
Saturated NaHCO3 solution (200 cm
3
) was slowly added to the reaction, initially 
dropwise in case of any unreacted sodium. The resulting solution was then extracted 
with DCM (4 x 50 cm
3
). The DCM layers were collected, combined and dried over 
MgSO4 before being filtered and the DCM then removed under reduced pressure to 
leave the product as a colourless oil (9.92g, 65 mmol, 98%). υmax 3318, 2932, 2859, 
2820, 1632, 1428, 1053, 957, 959 cm
-1δH (400 MHz, CDCl3) 5.75-5.68 (2H, m, 
HC=CH), 5.44-5.43 (1H, m, HC=CCH2), 3.66-3.63 (2H, m, CH2), 2.72-2.67 (2H, m, 
CH2), 2.62-2.57 (2H, m, CH2), 2.02-1.95 (3H, m, CH2 and OH), 1.61-1.46 (4H, m, 2 
x CH2); δC (75 MHz, CDCl3) 134.10 (CC=C), 123.70 (HC=C) 123.68 (HC=C), 
117.88 (HC=C), 62.22 (CH2), 36.54 (CH2), 31.79 (CH2), 28.23 (CH2), 26.12 (CH2), 
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22.80 (CH2); m/z (CI) 153.2 (M
+
 + 1). Data matches that previously reported for this 
compound.
101
 The compound was stored under nitrogen at < 0°C. 
 
4-(Cyclohexa-1,4-dien-1-yl)buty-4-methylbenzenesulfonate (186). 
 
This compound is novel. 
To a nitrogen purged, oven dried 2-necked round bottom flask was added 4-
(cyclohexa-1,4-diphenyl)butan-1-ol 185 (456 mg, 3 mmol) and anhydrous toluene (5 
cm
3
). To this was then added triethylamine (455 mg, 4.5 mmol), 1-methylimidazole 
(369 mg, 4.5 mmol). The reaction solution was then degassed and stirred. To the 
reaction solution, under a flow of nitrogen was added 4-methylbenzenesulfonyl 
chloride (858 mg, 4.5 mmol). The reaction was then stirred overnight. Once deemed 
complete by TLC (silica plate, 25% EtOAc in petroleum ether, visualisation by 
KMnO4, product Rf = 0.6) 2M HCl aq. solution (4 cm
3
) was added to the reaction 
solution which was then stirred. The product was extracted with DCM (3 x 10 cm
3
) 
and the DCM phase washed with brine (10 cm
3
) and water (10 cm
3
), dried over 
MgSO4, filtered and the solvent removed under reduced pressure to leave the crude 
as a yellow oil. The crude product was purified by column chromatography (silica 
gel, 0-25% EtOAc in petroleum ether, TLC: as above) to give the product as a 
colourless oil (768 mg, 2.5 mmol, 83%). (found (ESI): M
+
 + Na, 329.1175 
C17H22NaO3S requires M, 329.1182); υmax 2972, 1356, 1173, 1097, 955, 918, 813, 
774, 660, 579, 555, 520 cm
-1; δH (400 MHz, CDCl3) 7.72-7.70 (2H, d, J 8.0 Hz, 
CHAr), 7.28-7.26 (2H, d, J 8.0 Hz, CHAr), 5.61 (2H, s, HC=CH), 5.27 (1H, s, 
CH2C=CH), 3.97-3.94 (2H, t, J 6.4 Hz, CH2OTs), 2.61-2.55 (2H, m, CH=CHCH-
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2CH), 2.46-2.41 (2H, m, CH2C=CH), 2.37 (3H, s, CH3), 1.85-1.81 (2H, m, 
CH=CCH2(CH2)3), 1.59-1.52 (2H, m, CH2CH2OTs), 1.39-1.31 (2H, m, 
CH=CCH2CH2); δC (100 MHz, CDCl3) 144.68 (CAr), 134.08 (CC=C), 133.23 
(CAr), 129.83 (2 CHAr), 127.89 (2 CHAr ), 124.26 (HC=C), 124.20 (HC=C), 
118.93 (HC=C), 70.55 (CH2), 36.60 (CH2), 28.75 (CH2), 28.38 (CH2), 26.73 (CH2), 
22.97 (CH2), 21.65 (CH3); m/z (ESI) 328.9 (M
+
 + 23), 306.9 (M
+
 + 1). 
 
N-(1R,2R)-(2-(4-(Cyclohexa-1,4-dienyl)butyl)-1,2-diphenylethyl)-4-
methylbenzenesulfonamide (187). 
 
This compound is known in the literature and has previously been fully 
characterised.
101
 
To a nitrogen purged, oven dried flask connected to a reflux condenser was added 
the 4-(cyclohexa-1,4-dien-1-yl)buty-4-methylbenzenesulfonate 186 (306 mg, 1.00 
mmol) and anhydrous toluene (5 cm
3
). To this was then added N,N-
diisopropylethylamine (194 mg, 1.50 mmol) and (R,R)-TsDPEN (403 mg, 1.10 
mmol). The resulting solution was degassed and then stirred at 135°C overnight. 
After this the reaction solution was concentrated under reduced pressure to leave the 
crude product as a yellow/orange oil. The crude product was purified by column 
chromatography (silica gel, 0-50% EtOAc in petroleum ether 40-60, TLC: silica 
plate, 25% EtOAc in petroleum ether, visualisation by KMnO4, product Rf = 0.55) to 
give the product as a viscous colourless oil (441 mg, 0.88 mmol, 88%). [α]D
26
 -12.1 
(c 1.0 in CHCl3) (R, R) (lit.
101
 [α]D
25
 -15.6 (c 0.5 in CHCl3) (R,R)); (δH (400 MHz, 
CDCl3) 7.38-7.36 (2H, d, J 8.0 Hz, CHAr), 7.15-7.12 (3H, m, CHAr), 7.07-7.01 (5H, 
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m, CHAr), 6.95-6.90 (4H, m, CHAr), 6.32 (1H, br s, NH), 5.71-5.69 (2H, m, 
HC=CH), 5.36 (1H, br s, C=CH), 4.24-4.22 (1H, d, J 8.0, CHNHTs), 3.61-3.59 (1H, 
d, J 8.0, CHNH) 2.70-2.66 (2H, m, CHCH2CH=CH), 2.56-2.51 (2H, m, CH2C=CH), 
2.42-2.36 (1H, m, CH2), 2.34 (3H, s, CH3), 2.29-2.26 (1H, m, CH2) 1.90-1.87 (2H, 
m, CH2), 1.40-1.32 (4H, m, 2 x CH2); δC (100 MHz, CDCl3) 142.68 (CAr), 139.40 
(CAr), 138.40 (CAr), 137.09 (CAr), 134.70 (CC=C), 129.09 (2 CHAr), 128.30 (2 
CHAr), 127.90 (2 CHAr), 127.59 (2 CHAr), 127.44 (CHAr), 127.39 (2 CHAr), 
127.25 (CHAr), 127.15 (2 CHAr), 124.35 (HC=C), 124.32 (HC=C), 118.50 (HC=C), 
67.86 (CH), 63.08 (CH), 47.04 (CH2), 37.20 (CH2), 29.64 (CH2), 28.87 (CH2), 26.77 
(CH2), 24.76 (CH2), 21.45 (CH3);m/z (ESI) 501.2 (M
+
 + 1). Data matches that 
previously reported for this compound.
101
 
 
N-[(R,R)-1,2-Diphenyl-2-(4-phenylbutylamino)-ethyl]-4-
methylbenzenephonamide ammonium chloride ruthenium dimer (188). 
 
This compound is known in the literature and has previously been fully 
characterised.
101
 
To a nitrogen purged, oven dried flask connected to a reflux condenser was added 
(R,R)-N-(4-(cyclohexa-1,4-dienyl)butyl)-1,2-diphenyl-N’-tosylethane-diamine 187 
(1.00 g, 2.00 mmol) and anhydrous DCM (30 cm
3
). The resulting solution was then 
stirred and cooled to 0°C with an ice/water bath. To the cooled solution was then 
added dropwise 2M HCl in Et2O solution (3 cm
3
, 6 mmol). The reaction solution 
was then stirred at room temperature for 30 min and became a yellow colour. 
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Volatile material was removed under reduced pressure to leave the HCl salt as an off 
white solid. To the salt was then added RuCl3.xH2O (418 mg, 1.60 mmol assuming 
RuCl3.3H2O) and EtOH (40 cm
3
). The resulting brown/black solution was stirred at 
reflux overnight. After this the reaction was cooled to room temperature and filtered 
to collect a brown/black precipitate. The precipitate was washed with Et2O and dried 
to give the clean product as a brown/black solid (1.05 g, 0.74 mmol, 93%). Mp 
247°C (decomposed); δH (400 MHz, d6-DMSO) 9.59 (2H, br s, NHH), 9.10 (2H, br 
s, NHH), 8.77 (2H, d, J 9 Hz, NHH), 7.20 (8H, d, J 8 Hz, CHAr), 7.13-7.11 (6H, m, 
CHAr), 6.90 (4H, d, J 8 Hz, CHAr), 6.80-6.78 (2H, m, CHAr), 6.72-6.70 (8H, m, 
CHAr), 5.91 (4H, t, J 5.0 Hz, CHAr-Ru), 5.67-5.64 (6H, m, CHAr-Ru), 4.69 (2H, t, 
J, 9.0 Hz, CH), 4.45 (2H, t, J 9.0 Hz, CH), 2.64-2.61 (4H, m, CH2), 2.34-2.31 (4H, 
m, CH2), 2.12 (6H, s, CH3), 1.70-1.56 (4H, m, CH2), 1.47-1.41 (4H, m, CH2); δH 
(100 MHz, d6-DMSO) 142.00 (2 CAr), 137.88 (2 CAr), 135.66 (2 CAr), 131.58 (2 
CAr), 129.15 (4 CHAr), 128.81 (4 CHAr), 128.63 (4 CHAr), 128.28 (2 CHAr), 
127.78 (4 CHAr), 127.54 (4 CHAr), 127.12 (2 CHAr), 126.26 (4 CHAr), 107. 15 
(CAr-Ru), 88.91 (4 CHAr-Ru), 84.91 (4 CHAr-Ru), 83.15 (2 CHAr-Ru), 64.27 (2 
CH), 60.64 (2 CH), 45.21 (2 CH2), 31.75 (2 CH2), 25.66 (2 CH2), 24.41 (2 CH2), 
20.85 (2 CH3). Data matches that previously reported for this compound.
101 
 
N-[(R,R)-1,2-Diphenyl-2-(4-phenylbutylamino)-ethyl]-4-
methylbenzenesulfonamide)ruthenium(II)chloride (101). 
 
This compound is known in the literature and has previously been fully 
characterised.
101
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To a nitrogen purged, oven dried flask connected to a reflux condenser was added N-
[(R,R)-1,2-diphenyl-2-(4-phenylbutylamino)-ethyl]-4-methylbenzenesulfonamide 
ammonium chloride ruthenium dimer 188 (1.00 g, 0.90 mmol). To this was then 
added anhydrous IPA (40 cm
3
) and triethylamine (425 mg, 4.20 mmol). The solution 
was stirred at reflux for 90 min. The reaction was cooled to room temperature and 
volatile material was removed under reduced pressure to leave a brown/beige solid. 
The solid was dissolved in DCM and washed with brine. The DCM phase was dried 
over MgSO4, filtered and the solvent removed under reduced pressure to leave the 
crude product as a brown solid (849 mg, 1.3 mmol, 72%). [α]D
26
 -250 (c 0.01 in 
CHCl3) (R,R) (lit.
101
 [α]D
27
 -333 (c 0.0096 in CHCl3) (R,R)); found (ESI): [M
+
 - Cl + 
H], 599.1308 C31H33N2O2RuS requires M, 599.1308); υmax 3204, 3025, 2922, 1453, 
1270, 1125, 1082, 970, 904, 807, 697, 655 cm
-1; δH (400 MHz, CDCl3) 7.17 (2H, d, J 
8 Hz, CHAr) 7.03-6.99 (3H, m, CHAr), 6.75 (3H, d, J 8.0 Hz, CHAr), 6.63 (4H, d, J 
8.0 Hz, CHAr), 6.49 (2H, d, J 7.0 Hz, CHAr), 6.21 (1H, t, J 5.0 Hz, CHAr-Ru), 
6.02-5.94 (2H, m, CHAr-Ru), 5.41 (1H, d, J 5.0 Hz, CHAr-Ru), 5.33 (1H, d, J, 5.0 
Hz, CHAr-Ru), 4.21-4.16 (1H, m, NH), 3.93 (1H, d, J 11.0 Hz, CHNHTs), 3.68-3.63 
(1H, m, CHNH), 3.27-3.22 (1H, m, CH2), 3.3.13-3.10 (1H, m, CH2), 2.60-2.58 (2H, 
m, CH2), 2.23-2.17 (4H, m, CH3 and CH2), 2.01-1.99 (1H, m, CH2), 1.81-1.78 (1H, 
m, CH2), 1.71-1.67 (1H, m, CH2); δC (100 MHz, CDCl3) 141.35 (CAr), 138.31 
(CAr), 138.18 (CAr), 135.68 (CAr), 127.92 (2 CHAr), 127.48 (2 CHAr), 127.06 (2 
CHAr), 126.93 (2 CHAr), 126.46 (1 CHAr), 126.24 (2 CHAr), 125.81 (2 CHAr), 
125.19 (CHAr), 97.56 (CAr-Ru), 86.31 (CHAr-Ru), 84.71 (CHAr-Ru), 83.87 (1C 
CHAr-Ru), 83.37 (CHAr-Ru), 78.89 (CHAr-Ru), 78.00 (CH), 68.62 (CH), 50.85 
(CH2), 29.06 (CH2), 24.63 (CH2), 23.24 (CH2), 20.21 (CH3); m/z (ESI) 599.1 (M
+
 + 
1 - 35). Data matches that previously reported for this compound.
101 
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Pressure hydrogenation of ketones and aldehydes catalysed by tethered 
ruthenium catalysts (S/C 500/1). 
This was carried out according to General procedure 4. 
 
5.3.5 Synthetic procedures for Section 2.6. 
Methoxybenzene ruthenium(II)chloride dimer (192). 
 
This compound is known in the literature but has not previously been fully 
characterised.
152, 153
 
To a nitrogen purged flask was added RuCl.3H2O (261 mg, 1 mmol) and MeOH 
(13.5 cm
3
). To this was then added 1-methyl-1,4-cyclohexadiene (1.22 g, 11 mmol) 
and the reaction was stirred at reflux for 6 hours. The reaction solution was cooled to 
room temperature and filtered to give a black solid (138 mg, 0.25 mmol, 50%).  δH 
(400 MHz, d6-DMSO) 6.21 (2H, t, J 6 Hz, CHAr-Ru), 5.59 (2H, d, J 6.0 Hz, CHAr-
Ru), 5.42 (1H, t, J 6.0 Hz, CHAr-Ru), 3.97 (3H, s, CH3); δC (100 MHz, DCMSO) 
140.43 (2 CAr-Ru), 94.10 (4 CHAr-Ru), 74.39 (2 CHAr-Ru), 65.19 (4 CHAr-Ru), 
57.20 (2 CH3). 
 
N-[(1R,2R)-2-(Amino)-1,2-diphenylethyl]-4-methylbenzenesulfonamide 
methoxybenzene ruthenium(II)iodide monomer (193). 
 
This compound is novel. 
Development of catalysts for asymmetric hydrogenation                                                    Experimental 
227 
 
To a nitrogen purged, dried flask was added methoxybenzene ruthenium(II)chloride 
dimer 192 (100 mg, 0.180 mmol) was added (R,R)TsDPEN (147 mg, 0.400 mmol) 
and triethylamine (152 mg, 1.50 mmol). To this was then added anhydrous IPA (5 
cm
3
) and the reaction was stirred at 80°C for 1 hour. The reaction was cooled to 
room temperature. The solvent was removed under reduced pressure and the residue 
washed with water before being dried to leave the crude product. The crude was 
recrystallised from MeOH to give the pure product as an orange solid (72 mg, 0.12 
mmol, 33%). Mp decomposed 240°C; [α]D
25 
+1220 (c 0.0025 in CHCl3) (R,R); 
(found (ESI): M
+
 + H, 575.0962 C28H29N2O3RuS requires M, 575.0943); υmax 3289, 
3229, 3058, 3029, 1524, 1454, 1273, 1262, 1039, 924, 809, 759, 698, 674, 657 cm
-1
; 
δH (400 MHz, d6-DMSO) weak spectrum, some impurities present. 7.13-7.11 (2H, 
m, CHAr), 6.86-6.81 (3H, m, CHAr), 6.69-6.57 (5H, m, CHAr), 6.10-6.06 (1H, m, 
CHAr-Ru), 5.86-5.77 (1H, m, CHAr-Ru), 5.50-5.48 (1H, m, CHAr-Ru), 5.33-5.31 
(1H, m, CHAr-Ru), 5.15-5.14 (1H, m, CHAr-Ru), 4.06 (2H, br s, NH2), 3.97 (3H, s, 
CH3), 3.93-3.91 (1H, m, CH), 3.76-3.73 (1H, m, CH), 2.23 (3H, s, CH3); δC (150 
MHz, DMSO) weak spectrum, quaternary carbons not observed, some impurities 
present. 128.09 (2 CHAr), 127.65 (CHAr), 127.51 (2 CHAr), 127.05 (2 CHAr), 
126.64 (CHAr), 126.36 (2 CHAr), 114.22 (CAr-Ru), 108.54 (CHAr-Ru), 104.75 
(CHAr-Ru), 101.73 (CHAr-Ru), 97.28 (CAr-Ru), 68.12 (CH), 64.87 (CH), 62.11 
(CH3), 20.75 (CH3); m/z (ESI) 575.0 (M
+
 + 1 – 35). 
 
 
 
Development of catalysts for asymmetric hydrogenation                                                    Experimental 
228 
 
Cyclohexa-2,5-dienecarboxylic acid (200a).  
 
This compound is known in the literature but has not previously been fully 
characterised.
158
  
A dried, nitrogen purged flask was connected to a condenser which was cooled to -
78°C with dry ice and acetone. The flask was then also cooled to -78°C. To the 
cooled flask was added ammonia gas which condensed to give liquid ammonia (120 
cm
3
). To the ammonia was then added dropwise via needle and syringe benzoic acid 
(8.0 g, 0.065 mol) in dry EtOH (40 cm
3
). After addition was complete sodium was 
added to the reaction slowly in small portions. Initially the reaction solution became 
a dark blue colour upon addition of sodium but the colour then faded. Addition of 
sodium was continued until the dark colour persisted. In total 15 g, 0.65 mol sodium 
was added to the reaction. Additional EtOH was also added to the reaction 
periodically to help maintain stirring. Once the dark colour persisted the reaction was 
stirred at -78°C for a further 3 hours and was then allowed to warm to room 
temperature overnight. Chilled, distilled water was slowly added to the reaction until 
all of the white solid had dissolved. The solution was acidified to pH 1 with HCl 
(aq.). The product was then extracted with Et2O (4 x 20 cm
3
). The Et2O phases were 
combined, dried over MgSO4, filtered and the solvent removed under reduced 
pressure to leave the product as an orange oil (6.02 g, 0.049 mol, 75%). δH (400 
MHz, CDCl3) 5.95-5.91 (2H, m, HC=CHCH2), 5.86-5.82 (2H, m, CH=CHCH2), 
3.83-3.76 (1H, m, CHCOOH), 2.74-2.68 (2H, m, CH2). The product was seen to 
rapidly decompose by 
1
H NMR and also unexpected isomers of product were 
obtained from subsequent preparation of the product (Figure 76). Further 
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characterisation was not carried out and a more robust synthesis of the product was 
sought. 
 
Figure 76. 1. 1H NMR for obtained product after 24 hours at room temperature in air. 2. 1H NMR of 
expected product. 3. 1H NMR of unexpected product. 
 
Cyclohexa-1,4-dienecarboxylic acid (200b). 
 
Method A: A pre-weighed round bottom flask was purged with N2 and cooled to -
78°C with a dry ice/acetone bath. To a 300 cm
3
 glass Parr reactor insert was added 
propiolic acid (8.6 g, 123 mmol) and the insert was then also cooled to -78°C. To a 
100 g cylinder of 1,3-butadiene was fitted a brass hose adapter and to the adapter 
was fitted a suba seal through which a cannula was inserted. All joints were wrapped 
with parafilm to avoid leaks. 1,3-Butadiene gas was then added to the cooled round 
bottom flask in which it condensed. The flask was weighed periodically until the 
Decomposed  product 
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required amount of liquid 1,3-butadiene had been collected (10 g, 185 mmol). The 
1,3-butadiene was then quickly poured into the glass insert containing the propiolic 
acid. The insert was then sealed in the Parr reactor. The reaction was stirred and 
allowed to warm to room temperature over 30 min. After this the reaction 
temperature was increased by 10°C every 30 min until a temperature of 110°C was 
reached. The pressure change was carefully monitored during this time. The reaction 
was stirred at 110°C overnight. After this the reaction was allowed to cool to room 
temperature and the pressure released. The reaction was then removed from the 
reactor and the product was present as a yellow crystalline solid (12.5 g, 101 mmol, 
82%). Purification was not necessary. The reaction gave only the expected isomer A 
of the product. For procedure see reference 159. 
Method B: To a dried, nitrogen purged flask was added butadiene sulfone (1.77g, 
15.0 mmol), propiolic acid (701 mg, 10.0 mmol) and anhydrous xylene (3 cm
3
). The 
mixture was stirred at reflux for 3 hours. After this the reaction was cooled and 
distilled by kugelrohr distillation (0.2 torr, 35°C) to give a colourless oil (400 mg) 
and a yellow solid (300 mg). The solid was found to be the desired product (2.4 
mmol, 24%). 
Method A is considered the most appropriate synthesis as it gives a high yield 
without the need for purification and gave only the expected isomer of product. 
Mp 108-109°C; υmax 2972, 2631, 2531, 1686, 1655, 1424, 1286, 1081, 931, 911, 641 
cm
-1; δH (300 MHz, CDCl3) 9.15 (1H, br s, OH),  7.08 (1H, s, CH=CCOOH), 5.78-
5.74 (1H, m, =CHCH2CCOOH), 5.65-5.61 (1H, m, CH=CHCCOOH), 2.88 (4H, s, 
2CH2); δC (75 MHz, CDCl3) 171.86 (C=O), 138.58 (CC=C), 126.55 (HC=C), 123.67 
(HC=C), 121.47 (HC=C), 26.58 (CH2), 24.12 (CH2). Data matches that previously 
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reported for this compound.
159
 The product was directly converted to the more stable 
ethyl ester (201) for storage. 
Ethyl cyclohexa-1, 4-dienecarboxylate (201). 
 
This compound is known in the literature but has not previously been fully 
characterised.
187 
To cyclohexa-1, 4-dienecarboxylic acid 200b (6 g, 48 mmol) in a dried, nitrogen 
purged flask connected to a condenser, was added dry EtOH (42 cm
3
) and 95% 
sulfuric acid (2.8 cm
3
). The solution was stirred at reflux for 18 hours before being 
cooled to room temperature. The pH of the solution was adjusted to pH 8 with 
NaOH (aq.). DCM (20 cm
3
) was then added to the solution along with saturated 
NaCl solution (aq.) (20 cm
3
). The DCM phase was removed and the aqueous phase 
washed with a further DCM (3 x 20 cm
3
). The DCM phases were combined, dried 
over Na2SO4, filtered and the solvent removed under reduced pressure to give the 
product as an orange oil (4.6 g, 30 mmol, 62%). Purification was not necessary. 
(Found (ESI): M
+
 + H, 153.0905 C9H12O2 requires M, 153.0910); υmax 3034, 2982, 
1709, 1679, 1641, 1430, 1394, 1243, 1080, 1049, 967, 742, 651 cm
-1; δH (300 MHz, 
CDCl3) 6.96-6.95 (1H, m, CH=CCOOH), 5.79-5.62 (2H, m, CH=CH), 4.20 (2H, q, J 
7.1 Hz, CH2CH3), 2.91-2.85 (4H, m, CH2), 1.29 (3H, t, J 7.1 Hz, CH2CH3); δC (75 
MHz, CDCl3) 166.30 (C=O), 135.47 (CH), 127.18 (C), 123.73 (CH), 121.60 (CH), 
59.61 (CH2), 26.33 (CH2), 24.45 (CH2), 13.59 (CH2). The compound was stored 
under nitrogen at <0°C. 
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Ethylbenzoate ruthenium(II)chloride dimer (197). 
 
This compound is known in the literature but has not previously been fully 
characterised.
156, 157 
To ethyl cyclohexa-1, 4-dienecarboxylate 212 (1.60 g, 10.5 mmol) in a dried, 
nitrogen purged flask connected to a condenser, was added RuCl3.xH2O (679 mg, 
2.60 mmol assuming 3 H2O). Dry EtOH (40 cm
3
) was then added and the reaction 
was stirred at reflux for 18 hours. After this the reaction was cooled and filtered. The 
solid was washed with hexane and Et2O to leave the product as an orange solid (735 
mg, 1.1 mmol, 42%). υmax 3079, 1721, 1513, 1469, 1397, 1286, 1268, 1105, 1021, 
977, 864, 770, 677 cm
-1
;
 δH (300 MHz, d6-DMSO) 7.69 (2H, d, J 6.0Hz, CHAr-Ru), 
6.29 (1H, t, J 6.0Hz, CHAr-Ru) 6.04 (2H, t, J 6.0 Hz, CHAr-Ru), 4.34 (2H, q, J 7.0 
Hz, CH2), 1.31 (3H, t, J 7.0 Hz, CH3); δC (100 MHz, d6-DMSO) 163.85 (C=O), 
92.45 (CHAr-Ru), 91.81 (CHAr-Ru), 85.20 (CHAr-Ru), 82.47 (C), 62.09 (CH2), 
14.24 (CH3). Data matches that previously reported for this compound.
156, 157 
5.3.5.1 Synthesis of primary alcohol precursors for tethered ligands. 
3-(3,5-dimethoxyphenyl)-prop-2-enoic acid (205). 
 
This compound is known in the literature but has not previously been fully 
characterised.
188 
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To a dried, nitrogen purged flask was added 3,5-dimethoxybenzaldehyde (1.00 g, 
6.00 mmol) was added malonic acid (3.06 g, 29.4 mmol), piperidine (2.5 cm
3
) and 
anhydrous pyridine (11 cm
3
). The solution was stirred at reflux (90°C) for 18 hours. 
After this the reaction was allowed to cool to room temperature before being poured 
into chilled distilled water (10 cm
3
) and acidified with addition of 6M HCl (aq.) 
whilst stirring until a white precipitate formed. The white solid was collected by 
filtration to give the product (860 mg, 4.10 mmol, 68%). Mp 178°C; (found (ESI): 
M
+
 + Na, 231.0630 C11H12NaO4 requires M, 231.0628); υmax 3670, 2971, 2901, 
2360, 1683, 1631, 1592, 1431, 1283, 1206, 1161, 1056, 926, 837, 807 and 669 cm
-1
; 
δH (400 MHz, DMSO-d6) 12.41 (1 H, br s, OH), 7.52 (1 H, d J, 16 Hz, CH=CH), 
6.87 (2H, d J, 2.3 Hz, CHAr), 6.59-6.55 (2H, m, CH=CH and CHAr overlapping), 
3.78 (6H, s, 2 x CH3); δC (100 MHz, DMSO-d6) 167.55 (C=O), 160.66 (2 CAr), 
143.94 (HC=), 136.19 (CAr), 119.81 (HC=), 106.01 (2 CHAr), 102.38 (CAr), 55.33 
(2 CH3); m/z (ESI) 208.8 (M
+
 + 1), 230.7 (M
+
 + 23). 
 
3-(3,5-Dimethoxyphenyl)propanoic acid (206). 
 
This compound is known in the literature and has previously been fully 
characterised.
189, 190 
To a dried, nitrogen flask was added 3-(3,5-dimethoxyphenyl)-prop-2-enoic acid 205 
(840 mg, 4.00 mmol) and 10% palladium on carbon (218 mg, 0.200 mmol). To this 
was then added methanol (40 cm
3
). A balloon of hydrogen was connected to the 
reaction flask and the flask purged with hydrogen. The reaction was then stirred at 
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room temperature under 1 atm. hydrogen overnight. After this the reaction was 
filtered over celite and the solvent removed under reduced pressure to leave the 
product as an orange oil (657 mg, 3.10 mmol, 78%). (found (ESI): M
+
 + Na, 
233.0783. C11H14NaO4 requires M, 233.0781); υmax 2936, 2838, 1705, 1594, 1458, 
1429, 1351, 1291, 1204, 1147, 1066, 922, 831 and 691 cm
-1; δH (300 MHz, CDCl3) 
9.99 (1H, br s, OH), 6.43-6.30 (3H, m, CHAr), 3.75 (6H, s, OCH3), 2.88 (2H, t, J 7.7 
Hz, CH2COOH), 2.64 (2H, t, J 7.7 Hz, ArCH2); δC (75 MHz, CDCl3) 178.43 (C=O), 
160.24 (2 CAr), 142.04 (CAr), 105.71 (CHAr), 97.63 (CHAr), 54.65 (2 CH3), 35.07 
(CH2), 30.34 (CH2); m/z (ESI) 210.8 (M
+
 + 1), 232.7 (M
+
 + 23). Data matches that 
previously reported for this compound.
189, 190 
 
3-(3,5-Dimethoxylphenyl)propan-1-ol (207). 
 
 
 
 
This compound is known in the literature but has not previously been 
characterised.
191 
To a dried, nitrogen purged flask was added 3-(3,5-dimethoxyphenyl)propanoic acid 
206 (627 mg, 3.00 mmol) and anhydrous THF (7.5 cm
3
). The solution was stirred 
and cooled to 0°C. To the cooled solution was added dropwise LiAlH4 (1M in THF) 
(7.5 cm
3
, 7.5 mmol). The reaction was allowed to warm to room temperature and 
monitored by TLC (silica plate, 20% EtOAc in petroleum ether 40-60°, product Rf = 
0.2, starting material Rf = 0.1, visualisation by UV). Once complete (after 3.5 
hours), the reaction was cooled to 0°C and water was slowly and carefully added to 
quench the reaction. THF was then removed under reduced pressure to leave a 
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cloudy white solution. The product was then extracted with Et2O (3 x 15 cm
3
) and 
the Et2O phases were combined, dried over Na2SO4, filtered and the solvent removed 
under reduced pressure to leave the crude product as a pale yellow oil (501 mg). The 
crude was purified by column chromatography (silica gel, 0-50% EtOAc in 
petroleum ether, TLC: as above) to give the product as a colourless oil (456 mg, 
77%). (found (ESI): M
+
 + Na, 219.0097. C11H16NaO3 requires M, 219.0989); υmax 
3320, 2936, 2837, 1593, 1458, 1427, 1345, 1291, 1203, 1146, 1041, 926, 829 and 
694 cm
-1; δH (400 MHz, CDCl3) 6.37 (2H, s, CHAr), 6.31 (1H, s, CHAr), 3.78 (6H, 
s, CH3), 3.68 (2H, t, J 6.3 Hz, CH2OH), 2.67-2.63 (2H, m, ArCH2), 1.92-1.85 (2H, 
m, CH2CH2), 1.41 (1H, br s, OH); δC (100 MHz, CDCl3) 160.82 (CAr), 144.29 
(CAr), 106.52 (2 CHAr), 97.83 (CHAr), 62.29 (CH2), 55.27 (CH2), 34.01 (CH2), 
32.44 (CH2); m/z (ESI) 196.8 (M
+
 + 1), 218.8 (M
+
 + 23). 
 
(Pentamethylbenzylidene)propanedioic acid (215).  
 
This compound is known but has not previously been published in the literature.
 
Prepared as for 3-(3,5-dimethoxyphenyl)-prop-2-enoic acid 205 using 
pentamethylbenzaldehyde (530 mg, 3.00 mmol), malonic acid (1.54 g, 14.8 mmol), 
pyridine (5.5 cm
3
) and piperidine (1.2 cm
3
). The desired product was obtained in 
quantitative yield (785 mg, 3.00 mmol, 100%). Mp 158°C; (found (ESI): M
+
 + Na, 
285.1093. C15H18NaO4 requires M, 285.1097); υmax 3330, 2973, 2883, 2643, 2362, 
1671, 1561, 1425, 1243, 1047, 880 and 704 cm
-1; δH (400 MHz, DMSO) 7.69 (1H, s, 
CH), 2.17 (3H, s, ArCH3), 2.14 (6H, s, 2 x ArCH3), 2.07 (6H, s, 2 x ArCH3); δC (100 
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MHz, DMSO) 166.49 (C=O), 166.83 (C=O), 143.44 (CAr) 134.05 (CAr), 132.03 
(CAr), 131.52 (CAr), 131.06 (CAr), 129.70 (CAr), 17.58 (2 CH3), 16.42 (CH3), 
15.98 (2 CH3); m/z (ESI) 262.8 (M
+
 + 1), 284.9 (M
+
 + 23). 
 
3-(Pentamethylphenyl)propan-1-ol (216). 
 
This compound is known in the literature but has not previously been fully 
characterised.
192, 193 
To a dried, nitrogen purged flask was added (pentamethylbenzylidene)propanedioic 
acid 215  (1.0 g, 3.8 mmol), 10% palladium on carbon (202 mg, 0.190 mmol) and 
methanol (38 cm
3
). A balloon of hydrogen was connected to the reaction flask and 
the flask purged with hydrogen. The reaction was then stirred at room temperature 
under 1 atm. hydrogen overnight. After this the reaction was filtered over celite and 
the solvent removed under reduced pressure to leave the saturated product as a white 
solid (956 mg, 3.60 mmol). δH (400 MHz, CDCl3) 3.25-3.19 (3H, m, CH and CH2 
overlapping), 2.17 (6H, s, 2 x CH3), 2.15 (3H, s, CH3), 2.13 (6H, s, 2 x CH3); δC (100 
MHz, CDCl3) 170.99 (2C, s), 132.37 (1C, s), 132.28 (1C, s), 131.87 (1C, s), 131.71 
(2C, s), 131.69 (2C, s), 52.24 (1C, s), 29.21 (1C, s), 16.66 (2C, s), 16.61 (1C, s), 
16.50 (2C, s); m/z (ESI) 286.9 (M
+
 + 23). This solid was then transferred to a flask 
connected to a bubbler. The flask was heated at 180°C to remove CO2 until bubbling 
ceased. The flask was then cooled to leave the mono-acid product as a beige solid 
(740 mg, 3.40 mmol). δH (300 MHz, CDCl3) 10.67 (1H, br s, OH), 3.14-3.11 (2H, m, 
CH2COOH), 2.60-2.49 (2H, m, CH2CH2), 2.34 (6H, s, 2 x CH3), 2.29 (9H, s, 3 x 
CH3); δC (75 MHz, CDCl3) 178.94 (C=O), 133.43 (CAr), 132.68 (CAr), 132.24 (2 
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CAr), 131.21 (2 CAr), 33.79 (CH2), 25.55 (CH2), 16.36 (CH3), 16.29 (2 CH3), 15.77 
(2 CH3); m/z (ESI) 242.9 (M
+
 + 23). To the solid was then added anhydrous THF 
(6.6 cm
3
). The solution was stirred and cooled to 0°C and to it was added dropwise 
LiAlH4 solution (1M in THF) (6.6 cm
3
, 6.6 mmol). The reaction was allowed to 
warm to room temperature and was monitored by TLC (silica plate, 25% EtOAc in 
petroleum ether, visualisation by KMnO4, product Rf = 0.48). Once complete, the 
reaction was cooled to 0°C and water was slowly added to quench the reaction. The 
THF was then removed under reduced pressure to leave a cloudy white solution. The 
product was then extracted with Et2O (3 x 15 cm
3
). The Et2O phases were combined 
and dried over Na2SO4, filtered and the solvent removed under reduced pressure to 
leave the crude product as a pale yellow solid. The crude product was purified by 
column chromatography (silica gel, 0-50% EtOAc in petroleum ether, TLC: as 
above) to give the product as a white solid (246 mg, 31% over 3 steps). Mp 111-
112°C; (found (ESI): M
+
 + Na, 229.1564 C14H22NaO requires M, 229.1563); υmax 
3252, 2921, 2859, 1442, 1363, 1158, 1048, 994, 729 cm
-1; δH (300 MHz, CDCl3) 
3.77 (2H, t, J 6.3 Hz, CH2), 2.82-2.76 (2H, m, CH2OH), 2.28 (6H, s, 2 x CH3), 2.26 
(3H, s, ArCH3), 2.25 (6H, s, 2 x CH3), 1.81-1.72 (2H, m, CH2CH2), 1.68 (1H, br s, 
OH); δC (75 MHz, CDCl3) 135.12 (CAr), 132.06 (CAr), 132.03 (2 CAr), 131.12 (2 
CAr), 62.53 (CH2), 32.36 (CH2), 26.34 (CH2), 16.29 (CH2), 16.26 (2 CH2), 15.82 (2 
CH2); m/z (ESI) 229.1 (M
+
 + 23). Data matches that previously reported for this 
compound.
192, 193
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(R)-Ethyl-3-hydroxy-3-(4-methoxyphenyl)propanoate (230). 
 
This compound is known in the literature but has not previously been fully 
characterised.
194, 195 
Ethyl-4-methoxybenzoylacetate (666 mg, 3.00 mmol) was added to a nitrogen 
purged, dry schlenk tube. To it was added (R,R) TsDPEN 3C tethered RuCl 
monomer (9 mg, 0.015 mmol) and degassed formic acid:triethylamine 5:2 complex 
(1.5 cm
3
). The reaction was stirred at 28°C for 5 hours. After this the reaction 
solution was filtered through silica with 1:1 EtOAc:petroleum ether 40-60 solution to 
remove the catalyst. The filtrate was dried under reduced pressure to leave the 
product as a colourless oil (647 mg, 2.9 mmol, 97%). Purification was not necessary. 
[α]D
30
 + 41.1 (c 1.0 in CHCl3) >99.0% (R,R,R) (lit.
194
 [α]D
25
 + 25.7 (c 1.4 in CHCl3) 
>99% (R,R,R)); (found (ESI): M
+
 + H, 247.0947 C12H16NaO4 requires M, 247.0941); 
υmax 3439, 2982, 2838, 1727, 1613, 1514, 1465, 1372, 1302, 1244, 1172, 1111, 1030, 
831 cm
-1; δH (400 MHz, CDCl3) 7.29 (2H, d, J 8.7 Hz, CHAr), 6.88 (2H, d, J 8.7 Hz, 
CHAr), 5.09-5.05 (1H, m, CH), 4.17 (2H, q, J 7.2 Hz, CH2CH3), 3.79 (3H, s, CH3), 
3.25 (1H, d, J 3.3 Hz, OH), 2.78-2.64 (2H, m, CH2CH), 1.26 (3H, t, J 7.2 Hz, 
CH3CH2); δC (100 MHz, CDCl3) 172.43 (C=O), 159.20 (CAr), 134.78 (CAr), 126.99 
(2 CHAr), 113.92 (2 CHAr), 69.98 (CH), 60.84 (CH), 55.29 (CH3), 43.38 (CH2), 
14.17 (CH3); m/z (ESI) 247.1 (M
+
 + 23). Data matches that previously reported for 
this compound.
194, 195
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(R)-Ethyl-3-methoxy-3-(4-methoxyphenyl)propanoate (231). 
 
This compound is novel. 
To (R)-ethyl-3-hydroxy-3-(4-methoxyphenyl)propanoate 230 (530 mg, 2.40 mmol) 
in a dried, nitrogen purged flask was added anhydrous DCM (5 cm
3
). To this was 
then added MeI (1.69 g, 12.0 mmol). The solution was stirred for 15 min at room 
temperature before Ag2O (2.78 g, 12.0 mmol) was added. The reaction was then 
stirred at room temperature overnight. After this further MeI (1.69 g, 12.0 mmol) 
was added to the reaction which was then stirred at room temperature for a further 
hour. Et2O (10 cm
3
) was then added to the reaction. The organic phase was washed 
with saturated NH4Cl aq. solution, dried over MgSO4, filtered and the solvent 
removed under reduced pressure to give the crude as a colourless oil. The crude 
product was purified by column chromatography (silica gel, 0-30% EtOAc in 
petroleum ether, TLC: silica plate, 30% EtOAc in petroleum ether, visualisation by 
KMnO4, product Rf = 0.66) to give the product as a colourless oil (279 mg, 1.2 
mmol. 50%). [α]D
23
 +57.2 (c 1.0 in CHCl3) (R); (found (ESI): M
+
 + H, 261.1102 
C13H18NaO4 requires M, 261.1097); υmax 2937, 2825, 1732, 1612, 1512, 1465, 1373, 
1304, 1244, 1155, 1096, 1030, 831 cm
-1; δH (400 MHz, CDCl3) 7.65 (2H, d, J 8.6 
Hz, CHAr), 6.89 (2H, d, J 8.6 Hz, CHAr), 4.60-4.56 (1H, m, CHOCH3), 4.14 (2H, q, 
J 7.0 Hz, CH2CH3), 3.81 (3H, s, p-CH3(C6H4)SO2), 3.19 (3H, s, OCH3), 2.80 (1H, dd 
J, 15.2 and 9.0 Hz, CHCH
a
H
b
), 2.55 (1H, dd, J 15.2 and 5.0 Hz, CHCH
a
H
b
), 1.23 
(3H, t, J 7.2 Hz, CH3CH2); δC (100 MHz, CDCl3) 171.04 (C=O), 159.41 (CAr), 
132.57 (CAr), 127.91 (2 CHAr), 113.92 (2 CHAr), 79.62 (CH), 60.50 (CH2), 56.56 
(CH3), 55.26 (CH3), 43.51 (CH2), 14.18 (CH3); m/z (ESI) 261.1 (M
+
 + 23). 
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(R)-3-methoxy-3-(4-methoxyphenyl)propan-1-ol (232). 
 
This compound is novel. 
To (R)-ethyl-3-methoxy-3-(4-methoxyphenyl)propanoate 231 (259 mg, 1.1 mmol) in 
a dried, nitrogen purged flask was added anhydrous THF (2.2 cm
3
). The solution was 
then cooled to 0°C with an ice bath and to it was added dropwise LiAlH4 solution 
(1M in THF) (2.2 cm
3
, 2.2 mmol). The reaction was then stirred at room temperature 
overnight. After this the reaction was cooled to 0°C and water was added dropwise 
to quench the reaction. The THF was then removed under reduced pressure and to 
the residue was added water. The product was extracted in EtOAc (3 x 10 cm
3
). The 
EtOAc phases were combined, dried over Na2SO4, filtered and the solvent removed 
under reduced pressure to leave the product as a colourless oil (212 mg, 1.08 mmol, 
98%). Purification was not necessary. [α]D
26
 +112.1 (c 0.5 in CHCl3) (R); (found 
(ESI): M
+
 + H, 219.0993 C11H16NaO3 requires M, 219.0992); υmax 3295, 2935, 1611, 
1511, 1455, 1424, 1246, 1173, 1098, 1031, 893, 829, 808, 699, 668, 637 cm
-1; δH 
(400 MHz, CDCl3) 7.23 (2H, d, J 8.7 Hz, CHAr), 6.90 (2H, d, J 8.7 Hz, CHAr), 
4.35-4.32 (1H, m, CHOCH3), 3.81 (p-CH3(C6H4)SO2), 3.76-3.74 (2H, m, CH2OH), 
3.20 (3H, s, OCH3), 2.70 (1H, br s, OH), 2.09-2.00 (2H, ArCH2), 1.87-1.78 (2H, m, 
CH2CH2OH); δC (100 MHz, CDCl3) 159.23 (CAr), 133.46 (CAr), 127.76 (2 CHAr), 
113.92 (2 CHAr), 83.32 (CH), 61.14 (CH2), 56.37 (CH3) 55.28 (CH3), 40.34 (CH2); 
m/z (ESI) 219.1 (M
+
 + 23).  
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5.3.5.2 Synthesis of tethered aryl-diamine ligands. 
 
General procedure 5: preparation of tethered aryl-diamine ligands. 
To a dried, nitrogen purged flask was added the required aryl-3C-primary alcohol 
(1.6 eq.), anhydrous DCM (5cm
3
 per mmol sulfonated diamine) and 2,6-lutidine (2.1 
eq.). The solution was cooled to 0°C and to it was added dropwise a solution of 
trifluoromethanesulfonic anhydride (1.7 equiv.) in anhydrous DCM (1 cm
3
 per mmol 
of sulfonated diamine). The reaction became pink in colour and was stirred for 30 
min at 0°C and then at room temperature for 60 min. After this the reaction was 
cooled to 0°C and to it was added dropwise a solution of sulfonated diamine (1 eq.), 
triethylamine (2.4 eq.) and anhydrous DCM (1 cm
3
 per mmol of sulfonated diamine). 
The reaction became yellow/orange and was stirred at 0°C for 30 min and then at 
room temperature overnight. The reaction was diluted with DCM and saturated 
NaHCO3 (aq.) solution was added. The product was then extracted with DCM (3 x 
20 cm
3
). The DCM phases were washed with saturated NaHCO3 (aq.) solution, brine 
and water sequentially. The DCM phase was dried over MgSO4, filtered and the 
solvent removed under reduced pressure to give the crude as a yellow oil. The crude 
was purified by column chromatography (silica gel, 0-100% EtOAc in petroleum 
ether) to give the clean ligand products for complex formation. For procedure see 
reference 145. 
N-((1R,2R)-2-(3-(4-Methoxyphenyl)propylamino)-1,2-diphenylethyl)-4-
methylbenzenesulfonamide (198). 
 
This compound is novel.  
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This compound was prepared according to general procedure 5 using 3-(4-
methoxyphenyl)propan-1-ol (500 mg, 3.00 mmol), 2,6-lutidine (418 mg, 3.90 
mmol), trifluoromethanesulfonic anhydride (900 mg, 3.20 mmol), (R,R)-TsDPEN 
(606 mg, 1.90 mmol), Et3N (455 mg, 4.50 mmol) and DCM (2 cm
3
 followed by 2 
cm
3
). The product was purified by column chromatography as in the general 
procedure. TLC: silica plate, 30% EtOAc in petroleum ether, product Rf = 0.57 with 
visualisation by UV and KMnO4, 2,6-lutidine Rf = 0.40 with visualisation by UV 
only, 2,6-lutidine elutes with the product. The fractions containing the product were 
collected and dried under reduced pressure to give a white solid. The solid was 
washed with pentane and filtered to remove 2,6-lutidine and leave the product as a 
white solid (962 mg, 1.87 mmol, 98% based on 696 mg, 1.9 mmol (1R,2R)-N-p-
tosyl-1,2-diphenylethylenediamine). Mp 101°C; [α]D
30
 -21.0 (c 1.0 in CHCl3) (R,R); 
(found (ESI): M
+
 + H, 515.2369 C31H35N2O3S requires M, 515.2363); υmax 3303, 
2928, 1511, 1454, 1327, 1243, 1158, 1035, 916, 808, 698, 669 cm
-1; δH (400 MHz, 
CDCl3) 7.37 (2H, d, J 8.4 Hz, CHAr), 7.12-7.11 (3H, m, CHAr), 7.04-6.98 (7H, m, 
CHAr), 6.94-6.88 (4H, m, CHAr), 6.89 (2H, d, J 8.4 Hz, CHAr), 6.29 (1H, br s, 
NH), 4.25 (1H, d, J 7.8 Hz, CH), 3.77 (3H, s, CH3), 3.59 (1H, d, J 7.8 Hz, CH), 2.50-
2.38 (3H, m, CH2), 2.31-2.25 (4H, m, CH3 and CH2 overlapping), 1.68-1.63 (2H, m, 
CH2); δC (100 MHz, CDCl3) 157.79 (CAr), 142.72 (CAr), 139.34 (CAr), 138.40 
(CAr), 137.11 (CAr), 133.86 (CAr), 129.24 (2 CHAr), 129.12 (2 CHAr), 128.32 (2 
CHAr), 127.94 (2 CHAr), 127.58 (2 CHAr), 127.47 (CHAr) 127.44 (2 CHAr), 
127.28 (CHAr), 127.14 (2 CHAr), 113.80 (2 CHAr), 67.79 (CH), 63.12 (CH), 55.29 
(CH3), 46.47 (CH2), 32.38 (CH2), 31.72 (CH2), 21.46 (CH3); m/z (ESI) 515.1 (M
+
 + 
1). 
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N-((1R,2R)-2-(3-(3.5-Dimethoxyphenyl)propylamino)-1,2-diphenylethyl)-4-
methylbenzeneulphonamide (208). 
 
This compound is novel.  
This compound was prepared according to general procedure 5 using 3-(3,5-
dimethoxyphenyl)propan-1-ol 207 (400 mg, 2.00 mmol), 2,6-lutidine (279 mg, 2.60 
mmol), trifluoromethanesulfonic anhydride (590 mg, 2.10 mmol), (R,R)-TsDPEN 
(458 mg, 1.25 mmol), Et3N (304 mg, 3.00 mmol) and DCM (1.3 cm
3
 followed by 
1.3 cm
3
). The product was purified by column chromatography as in the general 
procedure. TLC: silica gel, 1:1 EtOAc:petroleum ether, product Rf = 0.68 with 
visualisation by UV and KMnO4, 2,6-lutidine Rf = 0.36 with visualisation by UV 
only. 2,6-lutidine elutes with the product. The fractions containing the product were 
collected and dried under reduced pressure to give a colourless oil. Pentane was 
added and the mixture stirred. The pentane was then decanted and residual pentane 
removed under reduced pressure to leave the clean product as a colourless oil (377 
mg, 0.69 mmol, 55% based on 458 mg, 1.25 mmol (1R,2R)-N-p-tosyl-1,2-
diphenylethylenediamine). [α]D
30
 -14.8 (c 1.0 in CHCl3) (R, R); (found (ESI): M
+
 + 
H, 545.2471 C32H37N2O4S requires M, 545.2469); υmax 3259, 2937, 1595, 1455, 
1324, 1204, 1147, 1055. 924, 813, 760, 697cm
-1; δH (400 MHz, CDCl3) 7.37 (2H, d, 
J 8.3 Hz, CHAr), 7.13-7.12 (3H, m, CHAr), 7.04-7.01 (5H, m, CHAr), 6.94-6.88 
(4H, m, CHAr), 6.30-6.29 (1H, m, CHAr), 4.25 (1H, d, J 8.1 Hz, CH), 3.77 (6H, s, 
CH3), 3.60 (1H, d, J 8.1 Hz, CH), 2.52-2.41 (3H, m, CH2), 2.32-2.30 (4H, m, CH3 
and CH2 overlapping), 1.73-1.65 (2H, m, CH2); δC (100 MHz, CDCl3) 160.8 (2 
CAr), 144.3 (CAr), 142.7 (CAr), 139.3 (CAr), 138.3 (CAr), 137.1 (CAr), 129.1 (2 
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CHAr), 128.3 (2 CHAr), 127.9 (2 CHAr), 127.6 (2 CHAr), 127.5 (2 CHAr), 127.4 
(CHAr), 127.3 (CHAr), 127.1 (2 CHAr), 106.4 (2 CHAr), 97.9 (CHAr), 67.7 (CH), 
63.1 (CH), 55.3 (CH3), 46.60 (CH2), 33.70 (CH2), 31.3 (CH2), 21.4 (CH3); m/z (ESI) 
545.2 (M
+
 + 1). 
(1R,2R)-N,N-Bis(3-(4-methoxyphenyl)propyl)-1,2-diphenylethane-1,2-diamine 
(210). 
 
This compound is novel. 
To a nitrogen purged, dried flask was added 3-(4-methoxyphenyl)propan-1-ol (416 
mg, 2.50 mmol) was added 2,6-lutinine (321 mg, 3.00 mmol) and anhydrous DCM 
(5 cm
3
). The solution was cooled to 0°C and to it as added a solution of Tf2O (759 
mg, 2.70 mmol) in anhydrous DCM (1 cm
3
). The reaction was stirred at 0°C for 30 
min and then at room temperature for 60 min. After this the reaction was again 
cooled to 0°C and to it was added a solution of (R,R)-DPEN (212 mg, 1.00 mmol) 
and Et3N (354 mg, 3.5 mmol) in anhydrous DCM (1 cm
3
). The reaction was stirred 
at 0°C for 30 min and then at room temperature overnight. After this DCM was 
added and the reaction washed with saturated NaHCO3 solution (aq.). (3 x 10 cm
3
). 
The organic phase was dried over Na2SO4, filtered and the solvent removed under 
reduced pressure to leave the crude as a yellow oil. The crude product was purified 
by column chromatography (silica gel, 0-50% EtOAc in petroleum ether, TLC: silica 
gel, 30% EtOAc in petroleum ether, product Rf = 0.18 visualisation by UV and 
KMnO4, 2,6-lutidine Rf = 0.38 visualisation by UV, 2,6-lutidine elutes before 
product) to give the product as a white solid (326 mg, 0.64 mmol, 64% based on 
(R,R)-DPEN). [α]D
26
+4.4 (c 0.5 in CHCl3) (R,R); (found (ESI): M
+
 + H, 509.3164 
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C34H41N2O2 requires M, 509.3163); υmax 2931, 2834, 1510, 1452, 1243, 1035, 830, 
810, 731, 698, cm
-1; δH (300 MHz, CDCl3) 7.17-7.12 (6H, m, CHAr), 7.07-7.02 (8H, 
m, CHAr), 3.77 (6H, s, CH3), 3.63 (2H, s, CHN), 2.57-2.36 (8H, m, ArCH2 and 
CH2NH overlapping), 1.79-1.69 (4H, m, CH2CH2CH2N); δC (75 MHz, CDCl3) 
157.06 (2 CAr), 141.00 (2 CAr), 133.76 (2 CAr), 128.67 (4 CHAr), 127.32 (4 
CHAr), 127.28 (4 CHAr), 126.22 (2 CHAr), 113.09 (4 CHAr), 68.66 (2 CH), 54.65 
(2 CH3), 46.45 (2 CH2), 31.97 (2 CH2), 31.44 (2 CH2); m/z (ESI) 509.3 (M
+
 + 1). 
 
4-Methyl-N-((1R,2R)-2-(3-(2,3,4,5,6-pentamethylphenyl)propylamino)-1,2-
diphenylethyl)benzenesulfonamide (217). 
 
This compound is novel. 
This compound was prepared according to general procedure 5 using 3-
(pentamethylphenyl)propan-1-ol 216 (106 mg, 0.50 mmol), 2,6-lutidine (75 mg, 0.70 
mmol), trifluoromethanesulfonic anhydride (141 mg, 0.50 mmol), (R,R)-TsDPEN 
(110 mg, 0.30 mmol), Et3N (81 mg, 0.80 mmol) and DCM (0.3 cm
3
 followed by 1 
cm
3
). The product was purified by column chromatography as in the general 
procedure. TLC: silica gel, 30% EtOAc in petroleum ether, product Rf = 0.58 with 
visualisation by UV and KMnO4, 2,6-lutidine Rf = 0.30 with visualisation by UV 
only, 2,6-lutidine elutes with the product. The fractions containing the product were 
collected and dried under reduced pressure to give a colourless oil. Pentane was 
added and the mixture stirred. A white solid precipitated out and was collected by 
filtration to give the product as a white solid (77 mg, 47% based on 110 mg, 0.3 
mmol (1R,2R)-N-p-tosyl-1,2-diphenylethylenediamine).). Mp 152-153°C; [α]D
26
 -19 
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(c 0.5 in CHCl3) (R,R); (found (ESI): M
+
 + H, 555.3049. C35H43N2O2S requires M, 
555.3040); υmax 2988, 2901, 1452, 1331, 1154, 1066, 1055, 906, 804, 767, 696 cm
-1
; 
δH (400 MHz, CDCl3) 7.38 (2H, d, J 8.3 Hz, CHAr), 7.14-7.13 (3H, m, CHAr), 7.03-
7.01 (5H, m, CHAr), 6.94-6.92 (4H, m, CHAr), 4.27 (1H, d, J 8.1 Hz, CH), 3.68 
(1H, d, J 8.1 Hz, CH), 2.62-2.51 (4H, m, CH2), 2.31 (3H, s, CH3), 2.22 (3H, s, CH3), 
2.21 (6H, s, 2 x CH3), 2.19 (6H, s, 2 x CH3), 1.57-1.51 (2H, m, CH2); δC (100 MHz, 
CDCl3) 142.74 (CAr), 142.34 (CAr), 137.08 (CAr), 135.68 (CAr), 132.66 (CAr), 
132.58 (2 CAr), 131.58 (2 CAr), 129.12 (2 CHAr), 128.43 (CHAr), 127.95 (CHAr), 
127.71 (CHAr), 127.62 (4 CHAr), 127.31 (CHAr), 127.13 (2 CHAr), 67.66 (CH), 
62.98 (CH), 47.36 (CH2), 29.87 (CH2), 28.25 (CH2), 21.45 (CH3), 16.90 (CH3), 
16.86 (2 CH3), 16.45 (2 CH3); m/z (ESI) 555.3 (M
+
 + 1). 
 
N-((1R,2R)-2-((R)-3-methoxy-3-(4-methoxyphenyl)propylamino)-1,2-
diphenylethyl)-4-methylbenzeneaulfonamide (233).  
 
This compound is novel. 
This compound was prepared according to general procedure 5 using (R)-3-methoxy-
3-(4-methoxyphenyl)propan-1-ol 232 (196 mg, 1.00 mmol), 2,6-lutidine (139 mg, 
2.10 mmol), trifluoromethanesulfonic anhydride (309 mg, 1.10 mmol), (R,R)-
TsDPEN (231 mg, 0.63 mmol), Et3N (152 mg, 2.40 mmol) and DCM (0.67 cm
3
 
followed by 0.67 cm
3
). The product was purified by column chromatography as in 
the general procedure. TLC: silica gel, 30% EtOAc in petroleum ether , product Rf = 
0.62 with visualisation by UV and KMnO4, 2,6-lutidine Rf = 0.36 with visualisation 
by UV only, 2,6-lutidine elutes with the product. The fractions containing the 
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product were collected and dried under reduced pressure to give a colourless oil. 
Pentane was added and the mixture stirred. The pentane was decanted and residual 
pentane was removed under reduced pressure to leave the clean product as an orange 
oil (270 mg, 0.5 mmol, 79% based on 231 mg, 0.63 mmol N-(2-aminoethyl)-4-
methylbenzenesulfonamide). Mp 125-126°C; [α]D
28
 +7.6 (c 1.0 in CHCl3) (R, R, R); 
(found (ESI): M
+
 + H, 545.2480. C32H37N2O4S requires M, 545.2469); υmax 3279, 
2923, 1452, 1330, 1246, 1153, 1074, 1027, 826, 698, 666 cm
-1; δH (400 MHz, 
CDCl3) 7.38 (2 H, d, J 7.5 Hz, CHAr), 7.13-7.01 (10 H, m, CHAr) 6.96-6.94 (2 H, 
m, CHAr), 6.89-6.83 (4H, m, CHAr), 4.22 (1 H, d, J 8 Hz, CHNTs), 4.02 (1H, dd, J 
8 and 5 Hz, CHOCH3), 3.80 (3 H, s, ArOCH3), 3.55 (1H, d, J 8 Hz, CHNH), 3.09 (3 
H, s, CHOCH3), 2.49-2.41 (1 H, m, CH2), 2.37-2.31 (4 H, m, SO2ArCH3 and 
CH2NH overlapping), 1.91-1.82 (1 H, m, CH2CHOCH3), 1.73-1.67 (1 H, m, 
CH2CHOMe); δC (100 MHz, CDCl3) 142.63 (CAr), 139.36 (CAr), 138.42 (CAr), 
137.10 (CAr), 133.71 (2 CAr), 129.10 (2 CHAr), 128.26 (2 CHAr), 127.87 (2 
CHAr), 127.75 (2 CHAr), 127.66 (2 CHAr), 127.42 (2 CHAr), 127.40 (CHAr), 
127.25 (CHAr), 127.16 (2 CHAr), 113.83 (2 CHAr), 82.56 (CH3), 67.94 (CH), 63.18 
(CH), 56.31 (CH), 55.27 (CH3), 44.59 (CH2), 37.96 (CH2), 21.45 (CH3); m/z (ESI) 
545.3 (M
+
 + 1). 
 
Attempted synthesis of N-(2-(3-(4-methoxyphenyl)propylamino))ethyl)-4-
methylbenzenesulfonamide (235). 
 
This compound would be novel. 
Attempts to prepare this compound were carried out according to general procedure 
5 using 3-(4-methoxyphenyl)propan-1-ol (500 mg, 3.00 mmol), 2,6-lutidine (418 
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mg, 3.90 mmol), trifluoromethanesulfonic anhydride (900 mg, 3.20 mmol), N-(2-
aminoethyl)-4-methylbenzenesulfonamide (407 mg, 1.90 mmol), Et3N (455 mg, 4.50 
mmol) and DCM (13.6 cm
3
). The product was purified by column chromatography 
as in the general procedure. TLC: silica gel, 30% EtOAc in petroleum ether, product 
Rf = 0.36 with visualisation by UV and KMnO4, 2,6-lutidine Rf = 0.42 with 
visualisation by UV only. The product elutes after 2,6-lutidine, no pentane wash is 
necessary. The product was obtained as a yellow oil but was found to be the di-
alkylated product shown below rather than the expected mono-alkylated product. 
(123 mg, 0.24 mmol, 24% base on 279 mg, 1.30 mmol N-(2-aminoethyl)-4-
methylbenzenesulfonamide).  
Reducing the number of equivalents of 3-(4-methoxyphenyl)propan-1-ol to 1 
equivalent relative to N-(2-aminoethyl)-4-methylbenzenesulfonamide gave no 
improvement with the di-alkylated N-(2-(bis(3-(4-methoxyphenyl)propylamino)) 
ethyl)-4-methylbenzenesulfonamide still being the major product formed in the 
reaction. 
 
N-(2-(bis(3-(4-methoxyphenyl)propylamino))ethyl)-4-
methylbenzenesulfonamide (236).  
 
(Found (ESI): M
+
 + H, 511.2627 C29H38N2O4S requires M, 511.2625); υmax 2936, 
1510, 1463, 1324, 1242, 1158, 1091, 1033, 812, 660 cm
-1; δH (300 MHz, CDCl3) 
7.72 (2H, d, J 8.1 Hz, CHArSO2), 7.23 (2H, d, J 8.1 Hz, CHArCH3), 7.03 (4H, d, J 
8.7 Hz, CHArOCH3), 6.82 (4H, d, J 8.7 Hz, CHArCH2), 3.78 (6H, s, OCH3), 2.91 
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(2H, t, J 5.8 Hz, SO2NCH2), 2.45-2.38 (9H, m, CH3ArSO2, CH2CH2CH2NH and 
SO2NCH2CH2N overlapping), 2.31-2.26 (CH2Ar), 1.62-1.51 (CH2CH2CH2); δC (75 
MHz, CDCl3) 177.17 (2 CAr), 142.71 (CAr), 136.08 (CAr), 133.31 (2 CAr), 129.08 
(CHAr), 128.55 (4 CHAr ), 126.53 (2 CHAr), 113.18 (4 CHAr), 54.65 (2 CH3), 
52.41 (2 CH2), 51.78 (CH2), 39.79 (2 CH2), 32.06 (CH2), 28.15 (2 CH2), 20.91 (2 
CH3); m/z (ESI) 511.3 (M
+
 + 1). 
 
N-((Naphthalene-2-ylsulfonyl)methyl)ethane-1, 2-diamine. 
 
This compound is known in the literature but has not previously been fully 
characterised.
196 
To ethylene diamine (1.2 g, 20 mmol) in anhydrous DCM (5 cm
3
) was added a 
solution of 2-napthalenesulfonyl chloride (453 mg, 2.00 mmol) in anhydrous DCM 
(5 cm
3
). The resulting solution was stirred at room temperature for 30 min. Water 
was added to the reaction and the organic phase was separated and washed with 
further water. The aqueous washings were then combined and washed with DCM. 
The organic phases were combined, dried over Na2SO4, filtered and the solvent 
removed under reduced pressure to give the product as a white solid (270 mg, 1.1 
mmol, 55%). Purification was not necessary. Mp 129-131°C; (found (ESI): M
+
 + H, 
251.0851 C12H15N2O2S requires M, 251.0849); υmax 3363, 2849, 1594, 1314, 1151, 
1125, 960, 746, 654 cm
-1; δH (400 MHz, CDCl3) 8.44 (1H, s, CHAr), 7.96-7.93 (2H, 
m, CHAr), 7.90-7.83 (2H, m, CHAr), 7.65-7.57 (2H, m, CHAr), 3.02-2.99 (2H, m, 
CH2), 2.80-2.77 (5H, m, CH2 and NH2 and NH overlapping); δC (100 MHz, CDCl3) 
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136.78 (CAr), 134.78 (CAr), 132.17 (CAr), 129.55 (CHAr), 129.24 (CHAr), 128.76 
(CHAr), 128.37 (CHAr), 127.91 (CHAr), 127.56 (CHAr), 122.31 (CHAr), 45.43 
(CH2), 40.98 (CH2); m/z (ESI) 251.0 (M
+
 + 1). This compound is known in the 
literature but has not previously been fully characterised.
196 
 
 
N-(2-(Bis(3-(4-methoxyphenyl)propyl)amino)ethyl)naphthalene-2-sulfonamide 
(236b). 
 
This compound is novel.  
This compound was prepared according to general procedure 5 using 3-(4-
methoxyphenyl)propan-1-ol (266 mg, 1.60 mmol), 2,6-lutidine (225 mg, 2.10 
mmol), trifluoromethanesulfonic anhydride (478 mg, 1.70 mmol), N-((naphthalene-
2-ylsulfonyl)methyl)ethane-1, 2-diamine (250 mg, 1.00 mmol), Et3N (243 mg, 2.40 
mmol) and DCM (7.3 cm
3
). The product was purified by column chromatography as 
in the general procedure. TLC: 30% EtOAc in petroleum ether, product Rf = 0.21 
with visualisation by UV and KMnO4, 2,6-lutidine Rf = 0.31 with visualisation by 
UV. Product elutes after 2,6-lutidine, no pentane wash required. Product obtained as 
a yellow oil (110 mg, 0.2 mmol, 25% based on 250 mg, 1 mmol sulfonated diamine). 
Mp 53°C; (found (ESI): M
+
 + H, 547.2624 C32H39N2O4S requires M, 547.2625); υmax 
2949, 2909, 2850, 2833, 1510, 1326, 1241, 1157, 1031, 810, 746, 657 cm
-1; δH (400 
MHz, CDCl3) 8.43 (1H, br s, CHAr), 7.93-7.87 (3H, m, CHAr), 7.82-7.80 (1H, m, 
CHAr), 7.65-7.57 (2H, m, CHAr), 6.96 (4H, d, J 8.4 Hz, CHArOCH3), 6.78 (4H, d, J 
8.4 Hz, CHArCH2), 5.30 (1H, br s, NH), 3.77 (6H, s, CH3), 2.96 (2H, t, J 5.6 Hz, 
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CH2NHSO2), 2.44 (2H, t, J 5.6 Hz, SO2HNCH2CH2N), 2.36 (4H, t, J 7.6 Hz, 
CH2CH2CH2N), 2.28-2.25 (4H, m, ArCH2), 1.55 (4H, quin, J 7.6 Hz, CH-
2CH2CH2N); δC (100 MHz, CDCl3) 157.80 (2 CAr), 136.54 (CAr), 134.79 (CAr), 
133.82 (2 CAr), 132.18 (CAr), 129.49 (CHAr), 129.26 (CHAr), 129.15 (4 CHAr), 
128.78 (CHAr), 128.45 (CHAr), 127.95 (CHAr), 127.59 (CHAr), 122.44 (CHAr), 
113.80 (4 CHAr), 55.28 (2 CH3), 53.00 (CH2), 52.46 (CH2), 40.42 (2 CH2), 32.63 (2 
CH2), 28.67 (2 CH2); m/z (ESI) 547.3 (M
+
 + 1). 
 
N-(2-(Biphenyl-2-yl)methylamino)ethyl)-4-methylbenzenesulfonamide (238). 
 
This compound is novel. 
To biphenylcarboxaldehyde (182 mg, 1.00 mmol) was added activated molecular 
sieves (1 g) and anhydrous MeOH (6 cm
3
). To this was added TsEN (246 mg, 1.10 
mmol) and acetic acid (50 μL). The reaction was stirred at room temperature for 5 
hours and then NaBH3CN (251 mg, 4.00 mmol) was added and the reaction stirred at 
room temperature overnight. After this the reaction was filtered and the solid washed 
with DCM. The filtrate and DCM washings were combined and dried under reduced 
pressure. The residue was then dissolved in anhydrous DCM and washed with 1M 
NaOH (aq.) solution. The DCM phase was separated, dried over Na2SO4, filtered and 
the solvent removed under reduced pressure to give the product as a pale yellow 
viscous oil (134 mg, 0.35 mmol, 70%). Purification was not necessary. (found (ESI): 
M
+
 + H, 381.1632 C22H25N2O2S requires M, 381.1631); υmax 3272, 2858, 1477, 
1450, 1322, 1155, 1091, 814, 775, 750, 703 cm
-1; δH (300 MHz, CDCl3) 7.67 (2H, d, 
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J 8.1 Hz, SO2CHAr), 7.43-7.11 (13H, m, CHAr and NH overlapping), 3.58 (2H, s, 
ArCH2N), 2.84 (2H, dd, J 6.5 and 4.8 Hz, CH2NHSO2), 2.50 (2H, dd, J 6.5 and 4.8 
Hz, CH2NH), 2.40 (3H, s, CH3); δC (75 MHz, CDCl3) 142.64 (CAr), 141.24 (CAr), 
140.53 (CAr), 136.39 (CAr), 136.22 (CAr), 129.57 (CHAr), 129.04 (2 CHAr), 
128.50 (CHAr), 128.27 (2 CHAr), 127.68 (2 CHAr), 126.95 (CHAr), 126.62 (CHAr 
), 126.55 (CHAr), 126.49 (2 CHAr), 50.06 (CH2), 46.65 (CH2), 41.60 (CH2), 20.92 
(CH3); m/z (ESI) 381.0 (M
+
 + 1). 
 
N-(2-(Biphenyl-2-yl)methylamino)ethyl)naphthalene-2-sulfonamide (241). 
 
This compound is novel. 
To biphenylcarboxaldehyde (91 mg, 0.5 mmol) was added activated molecular 
sieves (500 mg ) and anhydrous MeOH (3 cm
3
). To this was added N-((naphthalene-
2-ylsulfonyl)methyl)ethane-1,2-diamine (138 mg, 0.55 mmol) and acetic acid (50 
μL). The reaction was stirred at room temperature for 5 hours and then NaBH3CN 
(126 mg, 2 mmol) was added and the reaction stirred at room temperature overnight. 
The reaction was filtered and the solid washed with DCM. The filtrate and DCM 
washings were combined and dried under reduced pressure. The residue was then 
dissolved in anhydrous DCM and washed with 1M NaOH (aq.) solution. The DCM 
phase was separated, dried over Na2SO4, filtered and the solvent removed under 
reduced pressure to give the product as a pale yellow oil (134 mg, 0.350 mmol, 
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70%). Purification was not necessary. (found (ESI): M
+
 + H, 417.1635 C25H25N2O2S 
requires M, 417.1631); υmax 3286, 2912, 1451, 1435, 1320, 1154, 1074, 747, 702, 
656 cm
-1; δH (300 MHz, CDCl3) 8.38-8.37 (1H, , m, CHAr), 7.92-7.86 (3H, m, 
CHAr), 7.75-7.71 (1H, m, CHAr), 7.65-7.55 (2H, m, CHAr), 7.37-7.17 (11H, m, 
CHAr and NH overlapping), 3.55 (2H, s, CH2), 2.87 (2H, dd, J 6.4 and 4.7 Hz, 
CH2NSO2), 2.48 (2H, dd, J 6.4 and 4.7 Hz, CH2NH); δC (75 MHz, CDCl3) 141.84 
(CAr), 141.12 (CAr), 136.97 (CAr), 136.59 (CAr), 134.76 (CAr), 132.15 (CAr), 
130.18 (CHAr), 129.47 (CHAr), 129.24 (CHAr), 129.09 (CHAr), 128.86 (2 CHAr), 
128.77 (CHAr), 128.43 (CHAr), 128.28 (2 CHAr), 127.93 (CHAr), 127.57 (2 
CHAr), 127.21 (CHAr), 127.17 (CHAr), 122.37 (CHAr), 50.63 (CH2), 47.23 (CH2), 
42.27 (CH2); m/z (ESI) 417.1 (M
+
 + 1). 
 
5.3.5.3 Synthesis of tethered ruthenium complexes by aryl substitution 
methodology. 
 
General procedure 6 and 7: preparation of tethered ruthenium complexes by 
aryl substitution methodology. 
General procedure 6: 
To a pressure tube was added the required aryl-3C-TsDPEN ligand (2eq.), 
ethylbenzoate ruthenium(II)chloride dimer (1 eq.) and anhydrous DCM (4.5 cm
3
 per 
mmol of ligand). The tube was then flushed with N2 and then sealed. The reaction 
was stirred for 30 min. at room temperature and then at 90°C for 48 hours. The 
reaction was allowed to cool to room temperature and the solvent was removed 
under reduced pressure to give the crude as a dark brown solid. The crude was 
purified by column chromatography and then recrystallised from minimal hot 
methanol with DCM.  
Development of catalysts for asymmetric hydrogenation                                                    Experimental 
254 
 
General procedure 7: 
To a nitrogen purged round bottom flask was added the required aryl-3C-TsDPEN 
ligand (2 eq.), ruthenium dimer (1 eq.) and dry DCM (1.3 cm
3
 per 0.05 mmol 
ligand). The solution was stirred at room temperature for 1 hour. The DCM was 
removed under reduced pressure to give an orange/red solid. Chlorobenzene (3.3 cm
3
 
per 0.05 mmol ligand) was then added. The reaction was connected to a reflux 
condenser, purged with nitrogen and stirred at 90°C until deemed complete by TLC. 
Once complete the reaction was cooled and the chlrorbenzene removed under 
reduced pressure to give the crude as an orange/brown solid. The crude product was 
purified by column chromatography and recrystallisation from minimal hot methanol 
and DCM. 
N-((1R,2R)-2-(3-(4-methoxyphenyl)propylamino)-1,2-diphenyl)-4-methyl 
benzenesulfonamide) ruthenium chloride (199). 
 
This compound is novel. 
The compound was prepared according to general procedures 6 and 7 using N-
((1R,2R)-2-(3-(4-methoxyphenyl)propylamino)-1,2-diphenylethyl)-4-
methylbenzenesulfonamide 198 (300 mg, 0.58 mmol), ethylbenzoate 
ruthenium(II)chloride dimer 197 (187 mg, 0.29 mmol) and anhydrous DCM (9 cm
3
) 
for general procedure 6, and  N-((1R,2R)-2-(3-(4-methoxyphenyl)propylamino)-1,2-
diphenylethyl)-4-methylbenzene sulfonamide 198 (100 mg, 0.20 mmol), 
ethylbenzoate ruthenium(II)chloride dimer 197 (64 mg, 0.10 mmol) and anhydrous 
DCM (5.2 cm
3
), chlorobenzene (13.2 cm
3
) for general procedure 7. In each case the 
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crude product was purified by column chromatography (florisil 200 mesh, 0-10% 
MeOH in DCM, TLC: silica plate, 5% MeOH in DCM, visualisation in natural light, 
product Rf = 0.40 orange) to give the product was an orange solid. This was then 
further purified by recrystallisation from the minimal hot MeOH and DCM to give 
the product as orange crystals. 
General procedure 6: 150 mg, 40% after column chromatography, 16 mg, 0.025 
mmol, 6% from 2 recrystallisations. 
General procedure 7: 103 mg, 80% after column chromatography, 31 mg, 0.05 
mmol, 25% from 2 recrystallisations. 
Mp 261°C (decomposed); [α]D
30
 -670 (c 0.01 in CHCl3) (R,R); (found (ESI): [M
+
 + 
H – Cl], 615.1255 C31H33N2O3RuS requires M, 615.1257); υmax 3194, 3027, 3938, 
1534, 1495, 1466, 1454, 1270, 1256, 1128, 1082, 1039, 1012, 938,  905, 812, 69, 
656 cm
-1
; δH (400 MHz, CDCl3) 7.29-7.27 (2H, m, CHAr), 7.16-7.11 (3H, m, 
CHAr), 6.85-6.77 (2H, m, CHAr), 6.75-6.73 (3H, d, J 8.3 Hz, CHAr), 6.64-6.60 (2H, 
t, J 7.5 Hz, CHAr), 6.55-6.53 (2H, m, CHAr), 5.57 (1H, d, J 6.0 Hz, CHAr-Ru), 5.47 
(1H, 6.0 Hz, CHA-Ru), 5.35 (1H, d, J 6.0 Hz, CHAr-Ru), 5.22 (1H, d, J 6.0 Hz, 
CHAr-Ru), 4.33 (1H, d, J 11.2 Hz, CHNTs), 4.08-4.03 (1H, br m, NH(CH2)3), 3.99 
(3H, s, OCH3), 3.56 (1H, t, J 11.2 Hz, CHNH), 2.81-2.75 (1H, m, NCH2CH2CH2), 
2.49-2.39 (2H, m, NCH2CH2CH2Ar), 2.32-2.25 (1H, m, NCH2CH2CH2), 2.21 (3H, s, 
SO2ArCH3), 2.12-2.00 (2H, m, NCH2CH2CH2); δC (100 MHz, CDCl3) 143.83 (CAr), 
138.67 (CAr), 138.42 (CAr), 136.40 (CAr), 134.69 (CAr), 128.72 (2 CHAr), 128.68 
(2 CHAr), 128.34 (CHAr), 127.73 (4 CHAr), 127.06 (2 CHAr), 126.88 (2 CHAr), 
126.01 (CHAr), 91.20 (CAr-Ru), 84.72 (CHAr-Ru), 81.46 (CHAr-Ru), 78.77 
(CHAr-Ru), 72.17 (CHAr-Ru), 68.94 (CH3), 65.49 (CH), 56.84 (CH), 49.41 (CH2), 
30.32 (CH2), 27.32 (CH2), 21.16 (CH3); m/z (ESI) 615.1 (M
+
 + 1 – 35). 
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Addition of inorganic base to aryl substitution complexation:  
To a nitrogen purged, dried flask was added N-((1R,2R)-2-(3-(4-
methoxyphenyl)propylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide 198 
(100 mg, 0.2 mmol) and ethylbenzoate ruthenium(III)chloride dimer 197 (64 mg, 0.1 
mmol). To this was then added Ca(OH)2 (15 mg, 0.2 mmol) and anhydrous DCM 
(5.2 cm
3
). The resulting solution was then stirred at room temperature for 30 min 
before the DCM was removed under reduced pressure and replaced with 
chlorobenzene (13.2 cm
3
).  The reaction was stirred at 90°C for 5 hours. The reaction 
was cooled and the solvent removed under vacuum. The residue was washed with 
water and dried to leave the crude product as a black solid. The crude product was 
purified by column chromatography and recrystallisation as above, however only 1 
recrystallisation was required, to give the product (199) as an orange solid (118 mg, 
91% after column chromatography, 43 mg, 0.066 mmol, 33% from 1 
recrystallisation). Data matched that reported above. 
 
N-((1R,2R)-2-(3-(3,5-Dimethoxyphenyl)propylamino)-1,2-diphenylethyl)-4-
methylbenzenesulfonamide) ruthenium chloride (209). 
 
This compound is novel.  
The compound was prepared according to the general procedures using N-((1R,2R)-
2-(3-(3.5-dimethoxyphenyl)propylamino)-1,2-diphenylethyl)-4-
methylbenzeneulphonamide 208 (220 mg, 0.40 mmol), ethylbenzoate 
ruthenium(II)chloride dimer  197 (130 mg, 0.20 mmol) and anhydrous DCM (6 cm
3
) 
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for general procedure 6, and  N-((1R,2R)-2-(3-(3.5-dimethoxyphenyl)propylamino)-
1,2-diphenylethyl)-4-methylbenzeneulphonamide 208 (200 mg, 0.36 mmol), 
ethylbenzoate ruthenium(II)chloride dimer 197 (116 mg, 0.18 mmol) and anhydrous 
DCM (9 cm
3
) and chlorobenzene (23 cm
3
) for general procedure 7. In each case the 
crude product was purified by column chromatography (florisil 200 mesh, 0-10% 
MeOH in DCM, TLC: silica plate, 5% MeOH in DCM, visualisation in natural light, 
product Rf = 0.43 orange) to give the product as an orange solid. This was then 
further purified by recrystallisation from minimal hot MeOH and DCM to give the 
product as orange crystals.  
General procedure 6: 220 mg ligand, 238 mg after column chromatography, 16 mg, 
0.06 mmol, 15% from 2 recrystallisations. 
General procedure 7: 200 mg ligand, 130 mg after column chromatography, 96 mg, 
0.14 mmol, 39% from 1 recrystallisation. 
 
Mp 672°C (decomposed); [α]D
30
 -10.3 (c 0.02 in CHCl3) (R,R); (found (ESI): M
+
 + 
H - Cl, 645.1357 C32H35N2O4RuS requires M, 645.1363); υmax 3676, 2988, 2901, 
1542, 1407, 1394, 1265, 1125, 1078, 1066, 1056, 895, 833, 691 cm
-1
; δH (400 MHz, 
CDCl3) 7.46 (2H, d, J 8.3 Hz, CHAr), 7.14-7.06 (3H, m, CHAr), 6.85 (3H, d, J 8.0 
Hz, CHAr), 6.78-6.72 (4H, m, CHAr), 6.65 (2H, d, J 7.3 Hz, CHAr), 5.89 (1H, s, 
CHAr-Ru), 4.77 (2H, d, J 15.2 Hz, CHAr), 4.41-4.38 (1H, m, NH (CH2)3), 4.17 (3H, 
s, OCH3), 4.16 (3H, s, OCH3), 4.07 (1H, d, J 10.8 Hz, CHNTs), 3.76 (1H, t, J 11.7 
Hz, CHNH(CH2)3), 2.71-2.58 (3H, m, CH2), 2.25 (3H, s, SO2ArCH3), 2.21-2.04 (2H, 
m, CH2), 1.90-1.86 (1H, m, CH2); δC (100 MHz, CD2Cl2) 143.57 (CAr), 140.15 
(CAr), 139.32 (CAr), 137.23 (CAr), 136.16 (CAr), 135.61 (CAr), 129.46 (2 CHAr), 
128.94 (2 CHAr), 128.51 (CHAr), 127.97 (4 CHAr), 127.82 (2 CHAr), 127.26 (2 
CHAr), 126.57 (CHAr), 96.96 (CAr-Ru), 78.74 (CHAr-Ru), 69.55 (CHAr-Ru), 
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65.39 (CHAr-Ru), 57.50 (CH3), 57.47 (CH3), 56.46 (CH) 53.94 (CH), 48.35 (CH2), 
29.92 (CH2), 25.86 (CH2), 21.27 (CH3); m/z (ESI) 645.1 (M
+
 + 1 - 35). X-ray 
crystallography data is given in Appendix 2. 
 
Cationic tethered ruthenium complex (211). 
 
This compound is novel. 
This compound was prepared according to general procedure 7 using (1R,2R)-N,N-
Bis(3-(4-methoxyphenyl)propyl)-1,2-diphenylethane-1,2-diamine 210 (200 mg, 0.40 
mmol), ethylbenzoate ruthenium(II)chloride dimer 197 (129 mg, 0.20 mmol), DCM 
(10.3 cm
3
) and chlorobenzene (26.7 cm
3
). It was only necessary to stir the reaction in 
chlorobenzene at 90°C for 1 hour before complete consumption of the ligand was 
observed by TLC. The crude product was purified by column chromatography (silica 
gel, 0-30% MeOH in DCM, TLC: silica plate, 5% MeOH in DCM, visualisation in 
natural light, product Rf = 0.48 yellow) to give the product as a yellow/orange solid 
(158 mg, 0.24 mmol, 60%). Mp 85°C; [α]D
28
 +210 (c 0.01 in CHCl3) (R, R); (found 
(ESI): M
+
, 645.1820. C34H40ClN2O2Ru requires M, 645.1822); υmax 3059, 2928, 
1511, 1454, 1244, 1177, 1029, 1005,  805, 763, 701 cm
-1; δH (400 MHz, CDCl3) 8.72 
(1H, br s, NH), 7.96 (1H, br s, NH), 7.12-7.06 (6H, m, CHAr), 6.86-6.81 (4H, m, 
CHAr), 6.75-6.68 (4H, m, CHAr), 5.69-5.67 (1H, m, CHAr-Ru), 5.45-5.43 (1H, m, 
CHAr-Ru), 5.18-5.16 (1H, m, CHAr-Ru), 5.10-5.09 (1H, m, CHAr-Ru), 4.39 (1H, br 
s, CHNH), 3.95-3.86 (1H, m, CHNH), 3.60 (3H, s, CH3OAr-Ru), 3.05-3.02 (2H, m, 
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CH2), 2.87 (2H, br s, CH2), 2.33-2.30 (4H, m, CH2), 2.17 (3H, s, CH3OAr(CH2)3N), 
1.91 (1H, br s, CH2), 1.72-1.59 (3H, m, CH2); δC (100 MHz, CDCl3) 157.67 (CAr), 
137.78 (CAr), 136.34 (CAr), 135.04 (CAr), 134.73 (CAr), 132.78 (CAr), 129.07 (2 
CHAr), 129.00 (2 CHAr), 128.93 (2 CHAr), 128.76 (CHAr), 128.56 (2 CHAr), 
128.26 (2 CHAr), 127.52 (CHAr), 113.65 (2 CHAr), 100.47 (CAr-Ru), 86.98 (CAr-
Ru), 86.75 (CHAr-Ru), 75.53 (CHAr-Ru), 71.31 (CHAr-Ru), 70.10 (CHAr-Ru), 
66.97 (CH), 56.69 (CH), 55.24 (CH3), 53.38 (CH2), 32.31 (CH2), 31.82 (CH2), 30.12 
(CH2), 30.09 (CH3), 29.14 (CH2), 27.74 (1C, s); m/z (ESI) 645.2 (M
+
). 
 
Achiral 3C-tethered dimer 243. 
 
This compound is known in the literature and has been fully characterised.
145 
The batch of dimer 252 used in this thesis had been prepared previously in our group 
according to literature procedures and was fully characterised in agreement with the 
literature.
145
 
 
Achiral tethered ruthenium complex (239). 
 
This compound is novel. 
This compound was prepared according to general procedure 7 using N-(2-
(Biphenyl-2-yl)methylamino)ethyl)-4-methylbenzenesulfonamide 238 (100 mg, 0.28 
mmol), ethylbenzoate ruthenium(II)chloride dimer 197 (84 mg, 0.14 mmol), DCM 
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(6.5 cm
3
) and chlorobenzene (17 cm
3
). It was necessary to stir the reaction at 140°C 
in chlorobenzene for 7 hours after the initial 30 min in anhydrous DCM. The crude 
product was purified by column chromatography (floristic 200 mesh, 0-10% MeOH 
in DCM, TLC: silica plate, 5% MeOH in DCM, visualisation in natural light, 
product Rf = 0.65) to give the product as a brown/orange solid (50 mg). Mass 
spectrometry showed 2:1 complex:ligand. Attempts were made to recrystallise the 
product from hot MeOH and DCM however the product was found to remain in 
solution. The solid was removed by filtration and the filtrate dried under reduced 
pressure to give the product as a brown solid (27 mg, 0.055 mmol, 20%). The 
product contained impurities and minimal data was obtained. 
1
H NMR analysis 
showed the presence of resonances expected in the product although the peaks were 
broad and impurities were present: δH (400 MHz, CDCl3) 7.64-7.22 (CHAr and 
impurities), 6.33 (1H, s, CHAr-Ru), 6.13 (1H, s, CHAr-Ru), 5.39 (1H, s, CHAr-Ru), 
2.41 (2H, br s, NCH2), 2.41 (2H, br s, NCH2), 1.26 (3H, s, CH3); m/z (ESI) 481.1  
(M
+
+H-Cl). 
 
N-((1R,2R)-2-(3-(4-methoxyphenyl)propylamino)-1,2-diphenylehtyl)-4-
methylbenzenesulfonamide)-η6-(ethyl benzoate) ruthenium chloride (p-OMe-
202). 
 
This compound is novel.  
To a nitrogen purged, dried flask was added ligand N-((1R,2R)-2-(3-(4-
methoyphenyl)propylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide  198 
(50 mg, 0.1 mmol) and ethylbenzoate ruthenium(II)chloride dimer 197 (32 mg, 0.05 
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mmol). To this was then added triethylamine (20 mg, 0.2 mmol) and anhydrous iso-
propanol (4 cm
3
). The resulting solution was stirred at reflux under nitrogen for 2 
hours. The reaction was cooled to room temperature and the solvent and 
triethylamine were removed under reduced pressure to leave an orange/brown solid. 
The solid was purified by column chromatography (florisil 200 mesh, 0-5% MeOH 
in DCM, TLC: 5% MeOH in DCM, visualisation in natural light, product Rf = 0.35) 
to give a red solid (33 mg, 0.04 mmol, 40%). Mp 210°C (decomposed 170°C); [α]D
28
 
-30 (c 0.005 in CHCl3) (R,R); (found (ESI): M
+
 + H, 765.1944 C40H43N2O5RuS 
requires M, 765.1942); υmax 3028, 2923, 1729, 1512, 1454, 1268, 1125,1103, 1082, 
903, 817, 806, 697, 576 cm
-1; δH (400 MHz, CDCl3) 7.18 (2H, d, J 8.0 Hz, CHAr), 
7.04-6.92 (6H, m, 5 x CHAr and CHAr-Ru ); 6.75-6.65 (6H, m, CHAr), 6.60 (1H, br 
s, CHAr), 6.54 (2H, t, J 7.5 Hz, CHAr), 6.39 (2H, d, J 7.5 Hz, CHAr), 6.29 (1H, t, J 
5.8 Hz, CHAr-Ru), 6.11-6.09 (1H, m, CHAr-Ru), 5.86 (1H, d, J 5.8 Hz, CHAr-Ru), 
5.10 (1H, t, J 5.8 Hz, CHAr-Ru), 4.59-4.51 (1H, m, CH2CH3), 4.41-4.34 (1H, m, 
CH2CH3), 4.01 (1H, d, J 11.0 Hz, CH), 3.82 (1H, t, J 11.0 Hz, NH), 3.70 (3H, s, 
OCH3), 3.55-3.49 (1H, m, CH), 3.31-3.22 (1H, m, CH2), 2.75-2.67 (1H, m, CH2), 
2.64-2.57 (1H, m, CH2), 2.24-2.16 (1H, m, CH2), 2.13 (3H, s, S(O2)CH3), 2.02-1.97 
(1H, m, CH2), 1.86-1.79 (1H, m, CH2), 1.45 (3H, t, J 7.2 Hz, CH2CH3); δC (100 
MHz, CDCl3) 166.50 (C=O), 158.22 (CAr), 142.04 (CAr), 139.35 (CAr), 138.30 
(CAr), 136.60 (CAr), 132.79 (CAr), 129.53 (2 CHAr), 128.87 (2 CHAr), 128.63 
(CHAr), 128.33 (CHAr), 127.84 (2 CHAr), 127.50 (4 CHAr), 126.86 (2 CHAr), 
126.28 (2 CHAr), 114.08 (2 CHAr), 94.96 (CHAr-Ru), 93.73 (CHAr-Ru), 89.25 
(CHAr-Ru), 81.08 (CHAr-Ru), 79.21 (CHAr-Ru), 79.13 (CHAr-Ru), 75.38 (CAr-
Ru), 69.69 (CH), 62.76 (CH2), 55.35 (CH3), 53.48 (CH2), 32.08 (CH2 ), 30.56 (CH2), 
21.20 (CH3), 14.44 (CH3); m/z (ESI) 765.2 (M
+
 + 1). 
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5.3.5.4 Attempted syntheses of triazole tethered ruthenium complexes. 
 
[(1R,2R)-1,2-Diphenyl-N-(prop-2-ynylamino)ethyl]-4-
methylbenzenesulfonamide (223) 
 
This compound is known in the literature and has previously been fully 
characterised.
54 
To a dried, argon purged flask was added (R,R)TsDPEN (733 mg, 2.00 mmol) and 
anhydrous K2CO3 (719 mg, 5.20 mmol). To this was then added anhydrous MeCN 
(15 cm
3
) and finally propargyl bromide solution (80% in toluene) (327 mg, 2.20 
mmol). The reactions was stirred at room temperature overnight. The reaction 
solution was filtered and the acetonitrile was removed under reduced pressure. The 
residue was dissolved in chloroform and washed with water. The organic phase was 
then dried over MgSO4, filtered and the solvent removed under reduced pressure to 
leave the crude product as an off-white solid. The crude was purified by column 
chromatography (silica gel, 0-50% EtOAc in petroleum ether, TLC: silica plate, 1:1 
EtOAc:petroleum ether, visualisation by KMnO4, product Rf = 0.7) to give the pure 
product as a white solid (457 mg, 1.13 mmol, 57%). Mp 128-129°C; [α]D
28
 -70.7 (c 
0.5 in CHCl3) (R,R) (lit.
54
 [α]D
27
 -66.7 (c 0.5 in CHCl3) (R,R)); (found (ESI): M
+
 + H, 
405.1633 C24H25N2O2S requires M, 405.1631); υmax 3676, 3193, 2987, 2901, 1439, 
1331, 1153, 1076, 916, 810, 697, 670 cm
-1; δH (400 MHz, CDCl3) 7.39 (2H, d, J 8.3 
Hz, CHArSO2), 7.11-7.09 (3H, m, CHAr) 7.04-6.94 (7H, m, CHAr) 6.90-6.87 (2H, 
m, CHAr), 6.17-6.15 (1H, m, NHTs), 4.37 (1H, t, J 7.0 Hz, CHNHTs), 4.04 (1H, d, J 
7.5 Hz, CHNHCH2), 3.38 (1H, dd, J 17.0 and 2.5 Hz, CH
a
H
b
CCH), 3.02 (1H, dd, J 
17.0 and 2.5 Hz, CH
a
H
b
CCH), 2.27 (3H, s, CH3), 2.22 (1H, t, J 2.4 Hz, CH2CCH), 
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2.07 (1H, br s, NHCH2); δC (100 MHz, CDCl3) 142.17 (CAr), 137.56 (2 CAr 136.37 
(CAr), 128.53 (2 CHAr), 127.67 (2 CHAr), 127.38 (4 CHAr), 127.02 (CHAr), 
126.65 (2 CHAr), 126.61 (1 CHAr), 126.44 (2 CHAr), 80.86 (C), 71.40 (CH), 65.23 
(CH), 62.67 (CH), 34.98 (CH2), 20.80 (CH3); m/z (ESI) 405.1 (M
+
 + 1), 427.0 (M
+
 + 
23). Data matches that previously reported for this compound.
54 
 
3-(Azidomethyl)-6-methylcyclohexa-1,4-diene (225). 
 
This compound is novel. 
To an argon purged, dried flask was added (4-methylcyclohexa-1,4-dien-1-
yl)methanol previously prepared in our group (248 mg, 2.00 mmol) and anhydrous 
THF (8 cm
3
). The solution was cooled to 0°C and to it was added 
diphenylphosphoryl azide (660 mg, 2.40 mmol) and, dropwise, DBU (364 mg, 2.40 
mmol). The reaction was stirred at 0°C for 1 hour and then at room temperature 
overnight. The reaction was heated to 40°C for 3 hours before being allowed to cool 
to room temperature. Et2O (10 cm
3
) and H2O (5 cm
3
) were then added to the 
reaction. The aqueous phase was extracted with Et2O (2 x 10 cm
3
). The Et2O extracts 
were collected and combined before being dried over Na2SO4, filtered and the 
solvent removed under reduced pressure to leave the crude as a pale yellow oil. The 
crude was purified by column chromatography using a short silica gel column to 
minimise decomposition of the azide on the silica (silica gel, 0-10% EtOAc in 
petroleum ether, TLC: silica plate, 1:1 EtOAc:petroleum ether, visualisation by 
KMnO4, product Rf = 0.89) to give the purified product as a pale yellow oil (151 mg, 
1 mmol, 51%). υmax 3675, 2969, 2901, 2358, 2342, 2090, 1441, 1242, 1065, 950, 
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783, 668 cm
-1; δH (400 MHz, CDCl3) 5.74-5.73 (1H, s, CH), 5.44-5.43 (1H, s, CH), 
3.69 (2H, s, CH2), 2.66 (4H, s, 2 x CH2), 1.69 (3H, s, CH3) ; δC (100 MHz, CDCl3) 
130.86 ( C), 192.87 (C), 123.96 (CH), 117.94 (CH), 57.15 (CH2), 31.37 (CH2), 28.32 
(CH2), 22.94 (CH3); m/z (CI) 107.2 (M
+
 - 42) weak spectrum, compound does not 
ionise readily, HRMS data could not be obtained.  
  
N-((1-((4-Methylcyclohexa-1,4-dienyl)methyl)-1H-1,2,3-triazol-4-
yl)methylamino)-1,2-diphenyl)-4-methylbenzenesulfonamide (224). 
 
This compound is novel. 
To an argon purged dried flask was added the ([(1R,2R)-1,2-diphenyl-N-(prop-2-
ynylamino)ethyl]-4-methylbenzenesulfonamide 223 (113 mg, 0.280 mmol) and 
degassed anhydrous THF (4 cm
3
) and degassed distilled water (4 cm
3
). Under a flow 
of argon the 3-(azidomethyl)-6-methylcyclohexa-1,4-diene 225 (50 mg, 0.34 mmol), 
Cu(OAc)2 (11 mg, 0.060 mmol) and sodium-(L)-ascorbate (22 mg, 0.11 mmol). The 
reaction turned from blue to cloudy white and was stirred at room temperature for 48 
hours.  EtOAc was then added to the reaction followed by ammonium hydroxide 
(36%) solution (aq.). The EtOAc phase was collected and washed with further 
ammonium hydroxide solution (3 x 10 cm
3
).  The ammonium hydroxide solution 
was then extracted with EtOAc (3 x 10 cm
3
). The EtOAc phases were combined, 
dried over Na2SO4, filtered and the solvent removed under reduced pressure to leave 
the crude product as a pale blue oil. The crude product was purified by column 
chromatography (silica gel, 0-5% MeOH in DCM, TLC: silica plate, 5% MeOH in 
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DCM, visualisation by KMnO4, product Rf = 0.49) to give the product as a white 
solid (100 mg, 0.18 mmol, 64%). Mp 160-161°C; [α]D
29
 -25.8 (c 0.25 in CHCl3) 
(R,R); (found (ESI): M
+
 + H, 554.2592. C32H36N5O2S requires M, 554.2584 error -
1.4 ppm); υmax 3331, 3028, 2817, 2360, 2342, 1453, 1325, 1152, 1052, 911, 813, 
697, 666 cm
-1; δH (400 MHz, CDCl3) 7.35 (2H, d, J 7.5 Hz, CHArSO2), 7.13-7.11 
(3H, m, CHAr), 7.04-6.98 (7H, m, CHAr), 6.90 (2H, d, J 7.5 Hz, CHArSO2), 6.29 
(1H, br s, NHTs), 5.73 (1H, s, NCH2C=CH), 5.38 (1H, s, H3CC=CH), 4.82 (2H, s, 
NNCH2CH=CH), 4.32 (1H, d, J 7.8, CH
a
H
b
NHCH), 3.76 (2H, d, J 7.8 Hz, 
CH
a
H
b
NHCH), 3.72 (1H, d J, 13.8 Hz, CHNHTs), 3.59 (1H, d J, 13.8, CHNHCH2), 
2.68-2.64 (2H, m, CH2CH=CCH3), 2.49-2.43 (2H, m, H3CCCH2), 2.31 (3H, s, 
ArCH3), 1.68 (3H, s, CH3C=CH); δC (100 MHz, CDCl3) 146.51 (CAr), 142.74 
(CAr), 138.71 (CAr), 138.23 (CAr), 137.02 (CAr), 130.78 (CAr), 129.68 (CAr), 
129.12 (2 CHAr), 128.37 (2 CHAr), 127.94 (2 CHAr), 127.67 (2 CHAr), 127.61 
(CHAr), 127.49 (2 CHAr), 127.28 (CHAr), 127.06 (2 CHAr), 124.95 (HC=), 121.42 
(HC=), 117.64 (HC=), 67.15 (CH), 63.09 (CH), 56.10 (CH2), 42.31 (CH2), 31.46 
(CH2), 27.74 (CH2), 22.91 (CH3), 21.43 (CH3); m/z (ESI) 554.1 (M
+
 + 1), 576.2 (M
+
 
+ 23). 
 
Attempted synthesis of N-((1R, 2R)-2-((1-(4-methylbenzyl)-1H-1, 2, 3-triazol-4-
yl)methylamino)-1,2-diphenyl)-4-methylbenzenesulfonamide 
ruthenium(II)chloride dimer, hydrochloride salt (227). 
 
This compound would be is novel.  
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To an argon purged, dried flask at 0°C was added N-((1-((4-methylcyclohexa-1, 4-
dienyl)methyl)-1H-1, 2, 3-triazol-4-yl)methyl)-1, 2-diphenylethane-1, 2-diamine 224 
(50 mg, 0.090 mmol) and EtOH (1.7 cm
3
) and concentrated HCl (aq.) (36%) (12 
μL). The resulting solution was stirred at 60°C for 30 min. A solution of RuCl3.xH2O 
(18 mg, 0.070 mmol) in EtOH (1.7 cm
3) and water (56 μL) was added to the 
reaction. The reaction was then stirred at 75°C overnight. After this the reaction was 
cooled to room temperature and hexane was added and the solution stirred for 5 min 
before being filtered.  The solid was washed with additional hexane before being 
dried to give the product as a brown solid (27 mg), however no evidence of the 
desired complex was seen by mass spectrometry or NMR.  
 
4-Methylbenzylazide ruthenium(II)chloride dimer (220). 
 
This compound is novel. 
To an argon purged, dried flask was added 4-methylbenzylbromide 
ruthenium(II)chloride dimer previously prepared in our group (100 mg, 0.140 mmol) 
and NaN3 (27 mg, 0.42 mmol). To this was then added anhydrous, degassed DCM (6 
mL). The reaction was cooled at room temperature for 48 hours. After this the 
reaction was filtered and the solid washed with water and then further DCM before 
being dried under vacuum to leave the solid as a red/brown solid (67 mg,  0.11 
mmol, 79%). The product was found to be unstable in air and sensitive to shocks 
with agitation using a spatula causing the compound to violently decompose. It was 
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stored therefore used directly in subsequent reactions without purification. Minimal 
characterisation data was obtained. υmax 3676, 2987, 2901, 2362, 2050, 1406, 1380, 
1250, 1229, 1066, 1057, 889 cm
-1; δH (400 MHz, DMSO) 6.23-6.20 (3H, m, CHAr-
Ru), 5.90-5.88 (2H, m, CHAr-Ru), 4.43 (2H, s, CH2), 2.20 (3H, s, CH3). 
 
Attempted synthesis of N-((1R, 2R)-2-((1-(4-methylbenzyl)-1H-1, 2, 3-triazol-4-
yl)methylamino)-1,2-diphenyl)-4-methylbenzenesulfonamide 
ruthenium(II)chloride dimer (222). 
 
This compound would be novel. 
To a nitrogen purged, dried flask containing 4-methylbenzylazide 
ruthenium(II)chloride dimer (55 mg, 0.085 mmol) was added N-((1-((4-
methylcyclohexa-1,4-dienyl)methyl)-1H-1,2,3-triazol-4-yl)methyl)-1,2-
diphenylethane-1,2-diamine 224 (69 mg, 0.17 mmol), Cu(OAc)2 (6 mg, 0.035 mmol) 
and sodium (L) ascorbate (14 mg, 0.070 mmol). To this was then added degassed 
THF/water 1/1 (4 mL) and the reaction stirred at room temperature for 48 hours. 
After this EtOAc (10 mL) was added followed by ammonium hydroxide (aq.) (35%) 
(10 mL). The EtOAc phase was separated and washed with further ammonium 
hydroxide (aq.) (35%) (10 mL). The ammonium hydroxide phases were combined 
and washed with EtOAc. The EtOAc phases were combined, dried over Na2SO4, 
filtered and the solvent removed under reduced pressure to give a black solid (101 
mg) however the desired product was not observed by mass spectrometry or NMR. 
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Attempted synthesis of N-[(1R, 2R)-1, 2-diphenyl-2-(prop-2-ynylamino)ethyl)]-
4-methylbenzenesulfonamide-(4-methylbenzylazide)ruthenium(II)chloride 
(221). 
 
This compound would be novel. 
To 4-methylbenzylazide ruthenium(II)chloride dimer 220 (6 mg, 0.09 mmol) was 
added [(1R,2R)-1,2-diphenyl-N-(prop-2-ynylamino)ethyl]-4-methylbenzene 
sulfonamide 223 (73 mg, 0.18 mmol) and anhydrous, degassed IPA (10 mL). To this 
was then added triethylamine (36 mg, 0.36 mmol) and the reaction was stirred at 
reflux for 1 hour. After this the reaction was cooled to room temperature and the 
solvent removed under reduced pressure. The residue was washed with water and 
dried under vacuum to leave the crude product as a black solid (123 mg, 0.18 mmol). 
No evidence of the desired complex was seen by mass spectrometry or NMR 
analysis. 
 
Attempted synthesis of N-((1R,2R)-2-((1-(4-methylbenzyl)-1H-1, 2, 3-triazol-4-
yl)methylamino)-1,2-diphenyl)-4-methylbenzenesulfonamide 
ruthenium(II)chloride monomer (226). 
 
This compound would be novel. 
To a nitrogen purged, dried schlenk tube was added N-((1-((4-methylcyclohexa-1,4-
dienyl)methyl)-1H-1,2,3-triazol-4-yl)methylamino)-1,2-diphenyl)-4-
methylbenzenesulfonamide 224 (110 mg, 0.200 mmol) and anhydrous toluene (0.6 
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cm
3
). To the stirred solution at 50°C was added HCl (aq.) (37%) (25 μL). The 
solution was heated to 75°C and RuCl3.3H2O (44 mg, 0.16 mmol) in water (50 μL) 
was added followed by IPA (0.3 cm
3
). The reaction was stirred at 75°C overnight. 
After this the reaction was cooled to 0°C and toluene (0.9 cm
3
) and N,N-
diisopropylethylamine (145 μL, 0.83 mmol) was added with stirring. The reaction 
was allowed to warm to room temperature and was then heated at 80°C for 30 min 
before being again cooled to room temperature. DCM (1.5 mL) was added and the 
reaction solution was filtered over neutral alumina which was then washed with 
DCM. The filtrate was dried under reduced pressure. IPA (1.5 mL) was then added 
and the solution stirred at room temperature for 1 hour after which it was filtered and 
the solid dried to give a black solid (85 mg). No evidence of the desired product was 
seen by mass spectrometry or NMR analysis.  
 
Benzyl azide. 
 
This compound is known in the literature and has been fully characterised.
197
 
To a nitrogen purged flask was added sodium azide (215 mg, 3.30 mmol) in DMSO 
(5 cm
3
). To this was then added a solution of benzyl bromide (513 mg, 3.00 mmol) 
in DMSO (2.5 cm
3
). The reaction was stirred at room temperature overnight. After 
this water was added to the reaction and the product extracted into Et2O (3 x 15 
cm
3
). The Et2O phases were combined, dried over MgSO4, filtered and the solvent 
removed under reduced pressure to leave the product as a colourless oil (303 mg, 
2.30 mmol, 77%). Purification was not necessary. υmax 2090, 1496, 1454, 1253, 
1201, 876, 735, 694 cm
-1; δH (400 MHz, CDCl3) 7.41-7.31 (5H, m, CHAr), 4.33 (2H, 
Development of catalysts for asymmetric hydrogenation                                                    Experimental 
270 
 
s, CH2); δC (100 MHz, CDCl3) 135.39 (CAr), 128.87 (2 CHAr), 128.34 (CHAr), 
128.25 (2 CHAr), 54.84 (CH2); m/z (CI) 91.0 (M
+
 - 42). Data matches that reported 
for this compound.
197
 
 
N-((1R,2R)-2-((1-benzyl-1H-1,2,3-triazol-4-yl)methylamino)-1,2-diphenyl)-4-
methylbenzenesulfonamide (228). 
 
 
This compound is known in the literature and has previously been fully 
characterised.
54
 
To a nitrogen purged, dried flask was added [(1R,2R)-1,2-diphenyl-N-(prop-2-
ynylamino)ethyl]-4-methylbenzene sulfonamide 223 (202 mg, 0.5 mmol), degassed 
dry THF (6.5 cm
3
) and degassed water (6.5 cm
3
). To the stirred solution was then 
added Cu(OAc)2 (18 mg, 0.10 mmol), sodium ascorbate (40 mg, 0.20 mmol) and 
benzyl azide (80 mg, 0.60 mmol). The reaction was stirred at room temperature for 
48 hours. During this time, the reaction solution turned from blue to cloudy white in 
colour. After 48 hours, EtOAc was added to the reaction followed by ammonium 
hydroxide (35% aq.). The EtOAc phase was collected and washed with further 
ammonium hydroxide. The EtOAc phase was dried over Na2SO4, filtered and the 
solvent removed under reduced pressure to give the crude product as an off white 
solid. The crude product was purified by column chromatography (silica gel, 0-10% 
MeOH in DCM, TLC: silica plate, 5% MeOH in DCM, visualisation by KMNO4, 
product Rf = 0.52) to give the product as a white solid (60 mg, 0.11 mmol, 22%). 
Mp 190°C; [α]D
30
 -26.4 (c 0.5 in CHCl3) (R,R) (lit.
54
 [α]D
29
 -21.3 (c 0.5 in CHCl3) 
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(R,R)); (found (ESI): M
+
 + H, 538.2272 C31H32N5O2S requires M, 538.2271); υmax 
3345, 2976, 1454, 1433, 1323, 1151, 1077, 1051, 933, 812, 714, 694, 662 cm
-1; δH 
(400 MHz, CDCl3) 7.38-7.33 (5 H, m, CHAr), 7.27-7.25 (2 H, m, CHAr), 7.23 (1H, 
s, NH), 7.11-7.09 (3H, m, CHAr), 7.04-6.94 (7H, m, CHAr), 6.89-6.87 (2H, m, 
CHAr), 6.25 (1H, br s, NH), 5.50-5.42 (2H, m, CH2), 4.31 (1H, d, J 7.7 Hz, CH
a
H
b
), 
3.74 (1H, d, J 7.7 Hz, CH
a
H
b
), 3.70 (1H, d, J 14.2 Hz, CH
a
H
b
), 3.56 (1H, d, J 14.2 
Hz, CH
a
H
b
), 2.30 (3H, s, CH3); δC (100 MHz, CDCl3) 146.75 (CAr), 142.74 (CAr), 
138.68 (CAr), 138.25 (CAr), 137.01 (CAr), 129.13 (4 CHAr), 128.74 (CHAr), 
128.37 (2 CHAr), 128.10 (2 CHAr), 127.94 (2 CHAr), 127.66 (2 CHAr), 127.61 
(CHAr), 127.47 (2 CHAr), 127.29 (CHAr), 127.05 (2 CHAr), 121.59 (CHAr), 71.83 
(C), 67.12 (CH), 65.93 (CH), 63.08 (CH), 54.10 (CH2), 42.26 (CH2), 21.44 (CH3); 
m/z (ESI) 538.2 (M
+
 + 1). Data matches that previously reported.
54 
Attempted synthesis of triazole tethered monomer 229 using aryl substitution. 
 
This compound would be novel. 
The attempted preparation of this compound was carried out according to the general 
procedure 7 using N-((1R,2R)-2-((1-benzyl-1H-1,2,3-triazol-4-yl)methylamino)-1,2-
diphenyl)-4-methylbenzenesulfonamide 228 (28 mg, 0.05 mmol), ethylbenzoate 
ruthenium(II)chloride dimer 197 (16 mg, 0.025 mmol), DCM (1.3 cm
3
) and 
chlorobenzene (3.3 cm
3
). After 5 hours at 90°C no evidence of the formation of the 
desired monomer 229 was seen by mass spectrometry. 
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5.3.5.5 Synthesis of polymer supported ligands and ruthenium complexes. 
 
Hex-5-ynyl-4-methylbenzenesulfonate (244). 
 
This compound is known in the literature but has not previously been fully 
characterised.
198 
To a dried, nitrogen purged flask was added 5-hexyn-1-ol (392 mg, 4.00 mmol) was 
added anhydrous DCM (24 cm
3
). The solution was then cooled to 0°C and to it was 
added DMAP (49 mg, 0.4 mmol), tosyl chloride (915 mg, 4.8 mmol) and 
triethylamine (486 mg, 4.8 mmol). The resulting colourless solution was then 
allowed to warm to room temperature and stirred overnight. Saturated NH4Cl (aq.) 
solution was added to quench the reaction and the mixture extracted with EtOAc (3 x 
15 cm
3
), dried over Na2SO4, filtered and the solvent removed under reduced pressure 
to leave the product as a faint yellow oil (790 mg, 3.10 mmol, 78%). Purification 
was not necessary. (found (ESI): M
+
 + Na, 275.0713 C13H16NaO3S requires M, 
275.0712); υmax 3289, 2958, 1354, 1172, 1097, 1009, 930, 814, 661 cm
-1; δH (300 
MHz, CDCl3) 7.80 (2H, d, J 8.0, CHAr), 7.35 (2H, d, J 8.0 Hz, CHAr), 4.06 (2H, t, J 
6.2 Hz, CH2OSO2Ar), 2.45 (3H, s, CH3), 2.17 (2H, td, J 6.9 and 2.7 Hz, HCCCH2), 
1.93 (1H, t, J 2.6 Hz, HCCCH2), 1.83-1.73 (2H, m, CH2CH2OSO2), 1.61-1.51 (2H, 
m, HCCH2CH2CH2); δC (100 MHz, CDCl3) 144.79 (CAr), 133.08 (CAr), 129.87 (2 
CHAr), 127.88 (2 CHAr), 83 40 (CH), 69.94 (CH2), 68.99 (C), 27.76 (CH2), 24.22 
(CH2), 21.64 (CH3), 17.73 (CH2); m/z (ESI) 275.0 (M
+
 + 23). Data matches that 
previously reported for this compound.
198 
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Ethyl-3-(4’-hydroxyphenyl)propanoate (245). 
 
This compound is known in the literature and has previously been fully 
characterised.
199 
To 3-(4-hydroxyphenyl)propionic acid (664 mg, 4.00 mmol) was added ethanol (4 
cm
3
) and catalytic H2SO4 (98%) (22μL). The solution was stirred at room 
temperature overnight. The ethanol was removed under reduced pressure and water 
was added to the residue which was then extracted with EtOAc (3 x 10 cm
3
), dried 
over Na2SO4, filtered and the solvent removed under reduced pressure to leave the 
product as a colourless oil (625 mg, 3.2mmol, 80%). Purification was not necessary. 
(found (ESI): M
+
 + Na, 217.0843. C11H14NaO3 requires M, 217.0835); υmax 3368, 
2981, 1703, 1514, 1445, 1372, 1205, 1101, 1035, 828 cm
-1; δH (400 MHz, CDCl3) 
7.02 (2H, d, J 8.3 Hz, CHAr), 6.74 (2H, d, J 8.3 Hz, CHAr), 6.45 (1H, br s, OH), 
4.12 (2H, q, J 7.0 Hz, OCH2), 2.86 (2H, t, J 7.7 Hz, CH2CH2CO), 2.58 (2H, t, J 7.7 
Hz, CH2CH2CO), 1.22 (3H, t, J 7.0 Hz, CH3); δC (100 MHz,CDCl3) 173.88 (C=O), 
154.38 (CAr), 132.18 (CAr), 129.39 (2 CHAr), 115.41 (2 CHAr), 60.78 (CH2), 36.37 
(CH2), 30.15 (CH2), 14.16 (CH3); m/z (ESI) 217.1 (M
+
 + 23). Data matches that 
previously reported for this compound.
199 
 
Ethyl-3-(4-(hex-5-ynyloxy)phenyl)propanoate (246). 
 
This compound is novel. 
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To a nitrogen purged, dried flask was added ethyl-3-(4-hydroxyphenyl)propanoate 
245 (543 mg, 2.80 mmol), K2CO3 (1.16 g, 8.40 mmol), NaI (42 mg, 0.28 mmol) and 
anhydrous acetonitrile (17 cm
3
). To this was then added hex-5-ynyl-4-
methylbenzenesulfonate 244 (857 mg, 3.40 mmol). The reaction was stirred at reflux 
(80°C) overnight. After this the reaction was cooled to room temperature and the 
acetonitrile was removed under reduced pressure. Water was added to the residue 
and the mixture was extracted with EtOAc (3 x 15 cm
3
). The EtOAc was dried over 
Na2SO4, filtered and the solvent removed under reduced pressure to leave the crude 
product as an orange oil. The crude product was purified by column chromatography 
(silica gel, 0-50% EtOAc in petroleum ether, TLC: 30% EtOAc in petroleum ether, 
visualisation by KMnO4, product Rf 0.70) to give the product as a white solid (788 
mg, 2.90 mmol, 85%). (Found (ESI): M
+
 + H, 275.1644 C17H23O3 requires M, 
275.1642); υmax 3291, 2938, 1729, 1511, 1240, 1176, 1038, 826, 636 cm
-1; δH (300 
MHz, CDCl3) 7.09 (2H, d, J 8.6 Hz, CHAr), 6.79 (2H, d, J 8.6 Hz, CHAr), 4.10 (2H, 
q, J 7.1 Hz, CH2CH3), 3.93 (2H, t, J 6.2 Hz, CH2OAr), 2.89-2.84 (2H, m, 
CH2COEt), 2.58-2.53 (2H, m, CH2CH2CO2Et), 2.25 (2H, td, J 7.0 and 2.6 Hz, 
HCCCH2), 1.95 (1H, t, J 2.6 Hz, HCCCH2), 1.90-1.83 (2H, m, CH2CH2CH2OAr ), 
1.74-1.64 (2H, m, HCCCH2CH2), 1.21 (3H, t, J 7.1 Hz, OCH2CH3); δC (75 MHz, 
CDCl3) 172.38 (C=O), 156.84 (CAr), 131.98 (CAr), 128.62 (2 CHAr), 113.83 (2 
CHAr), 83.50 (CH), 68.03 (C), 66.62 (CH2), 59.75 (CH2), 29.52 (CH2), 27.70 (CH2), 
24.44 (CH2), 17.54 (CH2), 13.62 (CH3); m/z (ESI) 275.1 (M
+
 + 1), 297.1 (M
+
 + 23). 
For procedure see reference 200. 
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Ethyl-3-(4-(hex-5-ynyloxy)phenyl)propan-1-ol (247). 
 
This compound is novel. 
To ethyl-3-(4-(hex-5-ynyloxy)phenyl)propanoate 246 (590 mg, 2.15 mmol) was 
added anhydrous THF (4.3 cm
3
) and the solution cooled to 0°C. LiAlH4 (1M in 
THF) (4.3 cm
3
, 4.3 mmol) was then added dropwise. The reaction was stirred at 
room temperature and monitored by TLC (1:1 EtOAc:petroleum ether 40-60, Rf 
product = 0.42) until complete (2 hr). At this point the reaction was again cooled to 
0°C and water was added dropwise to quench the reaction. The THF was removed 
under reduced pressure and the product extracted from the residue with EtOAc (3 x 
15 cm
3
). The EtOAc phases were combined, dried over Na2SO4, filtered and the 
solvent removed under rotary evaporation to leave the crude as a colourless oil (408 
mg, 1.76 mmol, 70%). Purification was not necessary. Mp 28-29°C; (found (ESI): 
M
+
 + Na, 255.1359 C15H20NaO2 requires M, 255.1356); υmax 3284, 2942, 2870, 
1510, 1242, 1175, 1053, 1032, 1006, 817, 634 cm
-1; δH (400 MHz, CDCl3) 7.09 (2H, 
d, J 8.5 Hz, CHAr), 6.81 (2H, d, J 8.5 Hz, CHAr), 3.95 (2H, t, J 6.3 Hz, CH2OAr), 
3.65 (2H, t, J 6.4 Hz, CH2OH), 2.64 (2H, t, J 7.5 Hz, ArCH2), 2.27 (2H, td, J 7.0 and 
2.5 Hz, HCCCH2), 1.97 (1H, t, J 2.6 Hz, HCCCH2), 1.93-1.81 (4H, m, 
CH2CH2CH2OAr and CH2CH2OH overlapping), 1.75-1.67 (2H, m, HCCCH2CH2), 
1.59 (1H, br s, OH); δC (100 MHz, CDCl3) 157.24 (CAr), 133.83 (CAr), 129.31 (2 
CHAr), 114.46 (2 CHAr), 84.18 (CH), 68.66 (C), 67.32 (CH2), 62.26 (CH2), 34.45 
(CH2), 31.16 (CH2), 28.36 (CH2), 25.09 (CH2), 18.18 (CH2); m/z (ESI) 255.1 (M
+
 + 
23). 
Development of catalysts for asymmetric hydrogenation                                                    Experimental 
276 
 
N-((1R, 2R)-2-(3-(4-(Hex-5-ynyloxy)phenyl)propylamino)-1, 2-diphenylethyl)-4-
methylbenzenesulfonamide (248). 
 
This compound is novel. 
This compound was prepared according to general procedure 5 using 3 ethyl-3-(4-
(hex-5-ynyloxy)phenyl)propan-1-ol 247 (400 mg, 1.72 mmol), 2,6-lutidine (353 mg, 
3.30 mmol), trifluoromethanesulfonic anhydride (787 mg, 2.80 mmol), (R,R)-
TsDPEN (403 mg, 1.10 mmol), Et3N (263 mg, 2.60 mmol) and DCM (8 cm
3
). The 
product was purified by column chromatography as in the general procedure. TLC: 
silica gel, 30% EtOAc in petroleum ether, product Rf = 0.36 with visualisation by 
UV and KMnO4, 2,6-lutidine Rf = 0.29 with visualisation by UV, 2,6-lutidine elutes 
with the product). The fractions containing the product were collected, combined and 
dried under reduced pressure to give a white solid. The solid was then washed with 
pentane to remove residual 2,6-lutidine. The mixture was filtered and the solid dried 
to give the product as a white solid (524 mg, 0.900 mmol, 82% based on 403 mg, 1.1 
mmol N-(2-aminoethyl)-4-methylbenzenesulfonamide)). Mp 123-124°C; [α]D
27
 -25.2 
(c 0.25 in CHCl3) (R,R); (found (ESI): M
+
 + H, 581.2833 C36H41N2O3S requires M, 
581.2832); υmax 3286, 3248, 2915, 1510, 1454, 1434, 1316, 1242, 1160, 1031, 808, 
700 cm
-1; δH (400 MHz, CDCl3) 7.37 (2H, d, J 8.5 Hz, CHArSO2), 7.13-7.11 (3H, m, 
CHAr), 7.05-6.88 (12H, m, CHAr and NHSO2 overlapping), 6.78 (2H, d, J 8.5 Hz, 
CHArSO2), 6.28 (1H, br s, NH), 4.25 (1H, d, J 7.8 Hz, CHNSO2), 3.95 (2H, t, J 5.0 
Hz, CH2OAr), 3.59 (1H, d, J 7.8 Hz, CHN), 2.51-2.38 (3H, m, ArCH2 and CH2N 
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overlapping), 2.31 (3H, s, CH3), 2.29-2.24 (3H, m, HCCCH2 and CH2N 
overlapping), 1.96 (1H, t, J 2.6 Hz, HCCCH2), 1.92-1,85 (2H, m, CH2CH2CH2OAr), 
1.75-1.61 (4H, m, CH2CH2N and HCCCH2CH2); δC (100 MHz, CDCl3) 157.20 
(CAr), 142.70 (CAr), 139.33 (CAr), 138.39 (CAr), 137.09 (CAr), 133.79 (CAr), 
129.21 (2 CHAr), 129.10 (2 CHAr), 128.31 (2 CHAr), 127.93 (2 CHAr), 127.58 (2 
CHAr), 127.46 (CHAr), 127.41 (2 CHAr), 127.29 (CHAr), 127.13 (2 CHAr), 114.39 
(2 CHAr) 84.18 (C), 68.64 (CH), 67.77 (CH), 67.29 (CH2), 63.09 (CH), 46.45 (CH2), 
32.37 (CH2), 31.71 (CH2), 28.37 (CH2), 25.11 (CH2), 21.46 (CH3), 18.19 (CH2); m/z 
(ESI) 581.3 (M
+
 + 1). 
(R,R)-3C-tethered monomer with o-hexyne substituent (249) 
 
 
This compound is novel. 
This compound was prepared as for general procedure 7 using N-((1R, 2R)-2-(3-(4-
(hex-5-ynyloxy)phenyl)propylamino)-1,2-diphenylethyl)-4-methylbenzene 
sulfonamide 248 (116 mg, 0.2 mmol), ethylbenzoate ruthenium(II)chloride dimer 
197 (64 mg, 0.1 mmol), DCM (5 cm
3
) and chlorobenzene (13.4 cm
3
). After 5 hours 
at 90°C mass spectrometry analysis showed the desired monomer 248:249 2:1 (m/z  
681.2 [M
+
 + H - Cl]). Due to the small scale of the reaction, the product was not 
purified. The reaction was carried out as proof of concept for aryl substitution with 
this ligand structure prior to preparing the polymer supported derivative 253. 
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N-((1R,2R)-2-(3-(4-(4-(3-Benzyl-3H-1,2,3-triazol-4-yl)butoxy)phenyl) 
propylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide (250). 
 
This compound is novel. 
To a nitrogen purged flask was added the N-((1R,2R)-2-(3-(4-(hex-5-
ynyloxy)phenyl)propylamino)-1,2-diphenylethyl)-4-methylbenzenesulfonamide 248 
(116 mg, 0.200 mmol), Cu(OAc)2 (7 mg, 0.04 mmol) and sodium-(L)-ascorbate (16 
mg, 0.08 mmol) and degassed solution of 1/1 THF/water (5 cm
3
). To the stirred 
solution was then added benzyl azide (32 mg, 0.24 mmol). The reaction became a 
blue colour when stirred and then became cloudy white. The reaction was stirred at 
room temperature for 48 hours. After this EtOAc (10 cm
3
) was added followed by 
ammonium hydroxide (35%) solution. The EtOAc was separated and aqueous phase 
extracted with further EtOAc (2 x 10 cm
3
). The EtOAc phases were combined and 
washed with further ammonium hydroxide (35%) solution. The EtOAc phases were 
dried over Na2SO4, filtered and the solvent removed under reduced pressure to leave 
the product as a white solid (140 mg, 0.19 mmol, 95%). Purification was not 
necessary. Mp 123-124°C; [α]D
27
 -25.2 (c 0.25 in CHCl3) (R,R); (found (ESI): M
+
 + 
H, 714.3481 C43H48N5O3S requires M, 714.3472); υmax 2925, 1510, 1454, 1324, 
1241, 1155, 1047, 811, 698 cm
-1; δH (400 MHz, CDCl3) 7.38-7.34 (4H, m, CHAr), 
7.25-7.21 (3H, m, CHAr), 7.13-7.10 (3H, m, CHAr), 7.04-7.00 (5H, m, CHAr), 
6.97-6.88 (6H, m, CHAr), 6.75 (2H, d, J 8.5 Hz, CHAr), 6.30 (1H, br s, NH), 5.46 
(2H, s, ArCH2NNN), 4.25 (1H, d, J 7.9 Hz, CHNHSO2), 3.93 (2H, t, J 5.7 Hz, 
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CH2OAr), 3.59 (1H, d, J 7.9 Hz, CHNH), 2.76 (2H, t, J 7.0 Hz, CH2CNNN), 2.49-
2.38 (3H, m, CH2Ar and CHHNH), 2.31-2.24 (4H, m, CH3 and CHHNH 
overlapping), 1.84-1.81 (4H, m, CH2CH2CH2CH2OAr), 1.69-1.61 (2H, m, 
CH2CH2NH); δC (100 MHz, CDCl3) 157.18 (CAr), 148.42 (CAr), 142.72 (CAr), 
139.31 (CAr), 138.40 (CAr), 137.09 (CAr), 133.76 (CAr), 129.21 (2 CHAr), 129.12 
(2 CHAr), 129.09 (2 CHAr), 128.64 (CHAr), 128.31 (2 CHAr), 128.01 (2 CHAr), 
127.93 (2 CHAr), 127.58 (2 CHAr), 127.45 (2 CHAr), 127.28 (CHAr), 127.11 (2 
CHAr), 120.72 (CHAr), 114.37 (2 CHAr), 82.82 (CH), 67.76 (CH), 67.52 (CH2), 
65.19 (C), 63.14 (CH), 62.18 (C), 54.01 (CH2), 46.44 (CH2), 32.37 (CH2), 31.70 
(CH2), 28.88 (CH2), 25.98 (CH2), 25.46 (CH2), 21.46 (CH3); m/z (ESI) 714.3 (M
+
 + 
1).  
 
(R,R)-3C-tethered ruthenium monomer with triazole linker (251). 
 
This compound is novel. 
This compound was prepared as for general procedure 7 using N-((1R,2R)-2-(3-(4-
(4-(3-benzyl-3H-1,2,3-triazol-4-yl)butoxy)phenyl)propylamino)-1,2-diphenylethyl)-
4-methylbenzenesulfonamide 250 (36 mg, 0.05 mmol), ethylbenzoate 
ruthenium(II)chloride dimer 197 (16 mg, 0.025 mmol), DCM (1.3 cm
3
) and 
chlorobenzene (3.3 cm
3
). After 5 hours mass spectrometry analysis showed the 
desired monomer 251:250 3:1 (m/z 814.2 [M
+
 + H - Cl]). Due to the small scale of 
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the reaction, the product was not isolated. The reaction was carried out as proof of 
concept for aryl substitution with this ligand structure prior to preparing the polymer 
supported derivative 253.  
Azido opened polymer (252). 
 
This compound is known in the literature and has previously been fully 
characterised.
201 
To poly(glycidyl methacrylate) Mn~20,000 (568 mg, 4 mmol epoxide) was added 
NaN3 (780 mg, 12 mmol) and NH4Cl (636 mg, 12 mmol). To this was then added 
anhydrous DMF (40 cm
3
). The reaction was stirred at 50°C for 24 hours. The 
reaction was cooled to room temperature and water was added until a white 
precipitate formed. The precipitate was collected by filtration and dried to give the 
product as a white solid (565 mg, 3.3 mmol repeat units, 83%). Mp 250°C 
(decomposed); υmax 3427, 2987, 2096, 1720, 1251, 1149, 1089, 747 cm
-1; δH (300 
MHz, THF) 4.71 (1H, br s, OH), 3.87-3.84 (3H, m, COOCH2 and CH overlapping), 
3.25 (2H, br s, CH2N3), 1.86-1.78 (2H, m, CH2CCH3), 0.99-0.83 (3H, m, CH2CCH3); 
δC (75 MHz, THF) 176.71 (C=O), 68.29 (CH), 66.11 (CH2), 53.79 (CH2), 44.71 
(CH2), 16.78 (CH3). 
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Ligand functionalised polymer (253). 
 
This compound is novel. 
To a nitrogen purged flask was added the azido opened polymer 252 (45 mg, 0.20 
mmol N3) and N-((1R,2R)-2-(3-(4-(hex-5-ynyloxy)phenyl)propylamino)-1,2-
diphenylethyl)-4-methylbenzenesulfonamide 248 (113 mg, 0.20 mmol). To this was 
then added Cu(OAc)2 (7 mg, 0.04 mmol) and sodium-(L)-ascorbate 16 mg, 0.08 
mmol followed by degassed THF/water 1/1 (5 cm
3
). The reaction was stirred at room 
temperature for 48 hours. A blue precipitate formed and was collected by filtration. 
This was washed with ammonium hydroxide (aq.) and dried to give the product as a 
blue/green insoluble gel (147 mg, 0.19 mmol clicked ligand). υmax 3375, 2987, 2901, 
2103 (weak N3 signal), 1726, 1241, 1152, 1077, 1056, 810, 698, 665, 548 cm
-1
. 
 
 
Polymer supported (R,R)-3C-tethered Ru complex (254). 
 
This compound is novel. 
To a nitrogen purged flask was added the ligand functionalised polymer 253 (100 
mg, 0.13 mmol ligand) was added the ethylbenzoate ruthenium(II)chloride dimer 
197 (42 mg, 0.065 mmol). To this was then added anhydrous DCM (3.4 cm
3
) and the 
solution was stirred at room temperature for 30 min. The DCM was removed under 
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reduced pressure and was replaced with chlorobenzene (8.6 cm
3
) and the reaction 
was stirred at 90°C for 5 hours. The chlorobenzene was removed under vacuum to 
leave the product as a red/brown insoluble solid. This was washed with further DCM 
to remove unreacted ethylbenzoate ruthenium(II)chloride dimer to give the product 
(97 mg, 0.11 mmol Ru catalyst, 85%). MP 234°C (decomposed); υmax 3406, 2931, 
1720, 1510, 1445, 1269, 1156, 1106, 1049, 810, 744, 699 cm
-1
; 
 
1:9 ligand:hexyne functionalised polymer (255). 
 
This compound is novel. 
To a nitrogen purged flask was added the azido opened polymer (97 mg, 0.50 mmol 
N3) and N-((1R,2R)-2-(3-(4-(hex-5-ynyloxy)phenyl)propylamino)-1,2-diphenylethyl) 
-4-methylbenzenesulfonamide 253 (29 mg, 0.05 mmol) and hexyne (37 mg, 0.45 
mmol). To this was then added Cu(OAc)2 (18 mg, 0.1 mmol) and sodium-(L)-
ascorbate (40 mg, 0.2 mmol) and THF/water 4/1 (10 cm
3
). The reaction was stirred 
at room temperature for 48 hours. After this the product had separated from solution 
as a blue/green jelly. This was removed, washed with ammonium hydroxide (aq.) 
(35%) and dried to give the product as an insoluble blue gel (103 mg, 0.035 mmol 
ligand/0.32 mmol clicked hexyne, 70%). υmax 3265, 2954, 2931, 2871, 1728, 1453, 
1149, 1058, 809, 701, 665, 549 cm
-1
. 
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1:9 (R,R)-3C-tethered Ru complex:hexyne functionalised polymer (256). 
 
 
This compound is novel. 
To a nitrogen purged flask was added 1:9 ligand:hexyne functionalised polymer 255 
(100 mg, 0.034 mmol ligand) was added ethylbenzoate ruthenium(II)chloride dimer 
197 (11 mg, 0.017 mmol) and anhydrous DCM (0.9 cm
3
). The reaction was stirred at 
room temperature for 30 min before the DCM was removed under reduced pressure. 
Chlorobenzene (2.2 cm
3
) was added and the reaction stirred at 90°C for 5 hours. 
After this the reaction was cooled to room temperature, filtered and the solid dried to 
give the product as a red/brown solid. This was washed with further DCM to remove 
unreacted ethylbenzoate ruthenium(II)chloride dimer to give the product (70 mg, 
0.021 mmol Ru catalyst, 62%). υmax 3230, 3079, 2930, 1722, 1443, 1396, 1367, 
1288, 1268, 1149, 1105, 1054, 771, 746, 700, 665 cm
-1
. 
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3:7 ligand:hexyne functionalised polymer (257). 
 
This compound is novel. 
To a nitrogen purged flask was added the azido opened polymer (93 mg, 0.5 mmol 
N3) and N-((1R,2R)-2-(3-(4-(hex-5-ynyloxy)phenyl)propylamino)-1,2-diphenylethyl) 
-4-methylbenzenesulfonamide 248 (87 mg, 0.15 mmol) and hexyne (29 mg, 0.35 
mmol). To this was then added Cu(OAc)2 (18 mg, 0.1 mmol) and sodium-(L)-
ascorbate (40 mg, 0.2 mmol) and THF/water 4/1 (10 cm
3
). The reaction was stirred 
at room temperature for 48 hours. After this the product had separated from solution 
as a blue/green jelly. This was removed, washed with ammonium hydroxide (aq.) 
(35%) and dried to give the product as an insoluble blue gel (180 mg, 0.13 mmol 
ligand/0.30 mmol clicked hexyne, 87%). υmax 3272, 2930, 2869, 1727, 1454, 1242, 
1152, 1055, 810, 699, 665, 548 cm
-1
. 
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3:7 (R, R)-3C-tethered Ru complex:hexyne functionalised polymer (258). 
 
This compound is novel. 
This compound was prepared as for 256 using 3:7 ligand:hexyne functionalised 
polymer 257 (180 mg, 0.13 mmol ligand), ethylbenzoate ruthenium(II)chloride 
dimer 197 (42 mg, 0.065 mmol), anhydrous DCM (1.2 cm
3
) and chlorobenzene (2.8 
cm
3
) to give the product (189 mg, 0.12 mmol Ru catalyst, 92%). υmax 3687, 3674, 
2972, 2901, 1723, 1394, 1251, 1056, 861, 679, 565 cm
-1
. 
 
10% azido opened poly(glycidyl methacrylate) (259). 
 
This compound is novel. 
To a nitrogen purged flask was added poly (glycidyl methacrylate) Mn 20,000 (568 
mg, 4 mmol epoxide) was added NaN3 (26 mg, 0.4 mmol) and NH4Cl (21 mg, 0.4 
mmol). To this was then added anhydrous DMF (40 cm
3
). The reaction was stirred at 
50°C overnight. The reaction was cooled to room temperature and DMF removed 
under vacuum. The residue was then washed with water and dried to leave a viscous, 
sparingly soluble colourless gel (330 mg, 0.23 mmol N3/2.0 mmol epoxide, 58%). 
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υmax 3435 (weak), 2932, 2102 (weak), 1728 (weak), 1665, 1386, 1255, 1148, 1091, 
658 cm
-1; δH (400 MHz, THF) 4.61 (0.1H, br s, OH), 4.17 (0.9H, br s, COOCH
a
H
b
), 
3.89-3.84 (0.3H, m, COOCH2 and CHOH overlapping), 3.70 (0.9H, br s, 
COOCH
a
H
b
), 3.24 (0.2H, br s, CH2N3), 3.10 (0.9H, br s, COOCH2CH ), 2.66 (0.9H, 
br s, CH
a
H
b
O in epoxide), 2.51 (0.9H, br s, CH
a
H
b
O in epoxide), 1.91-1.81 (2H, 
CH2CCH3), 1.00-0.84 (3H, m, CH3); δC (100 MHz, DMSO) quaternary carbon 
CC=O not observed 162.28 (1C, s), 143.17 (1C, s), 65.70 (1C, s), 65.45 (1C, s), 
48.57 (1C, s), 48.49 (1C, s), 43.79 (1C, s), 39.96 (1C, s), 35.75 (1C, s), 30.67 (1C, s). 
 
1:9 azido:diethylamine functionalised poly(glycidyl methacrylate) (260). 
 
This compound is novel. 
To a nitrogen purged flask connected to a condenser was added 10% azide opened 
poly (glycidyl methacrylate) 259 (230 mg, 1.44 mmol epoxide/0.16 mmol N3) was 
added DMSO (2.5 cm
3
) and diethylamine (124 mg, 1.7 mmol). The reaction was 
stirred at 60°C overnight. After this the reaction was cooled to room temperature and 
the DMSO removed under vacuum with gentle heating to leave the product as a 
straw coloured, insoluble, viscous gel (280 mg, 0.15 mmol N3/1.4 mmol 
diethylamine, 97%). υmax 3386, 2965, 2931, 2101, 1724, 1438, 1385, 1269, 1152, 
1020, 952 cm
-1
. For procedure see reference 164.
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1:9 ligand:diethylamine functionalised polymer (261). 
 
This compound is novel. 
To a nitrogen purged flask was added 1:9 azide:diethylamine opened poly (glycidyl 
methacrylate) 260 (280 mg, 0.15 mmol N3/1.4 mmol diethylamine) and N-((1R, 2R)-
2-(3-(4-(hex-5-ynyloxy)phenyl)propylamino)-1,2-diphenylethyl)-4-
methylbenzenesulfonamide 248 (87 mg, 0.15 mmol). To this was then added 
Cu(OAc)2 (5.5 mg, 0.03 mmol) and sodium-(L)-ascorbate (12 mg, 0.06 mmol) 
followed by THF/water 4/1 (3 cm
3
). The reaction was stirred at room temperature for 
48 hours. The reaction was filtered and the solid was washed with ammonium 
hydroxide (aq.) (35 %) and dried to leave a blue/green insoluble solid (250 mg, 0.09 
mmol clicked ligand/0.81 mmol diethylamine, 75%). υmax 3344, 2968, 2936, 1726, 
1453, 1386, 1374, 1241, 1151, 1060, 811, 700 cm
-1
. 
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1:9 (R,R)-3C-tethered Ru complex:diethylamine functionalised polymer (262). 
 
This compound is novel. 
This compound was prepared as for 256 using 1:9 ligand:diethylamine 
functionalised polymer 261 (250 mg, 0.09 mmol clicked ligand), ethylbenzoate 
ruthenium(II)chloride dimer 197 (29 mg, 0.045 mmol), anhydrous DCM (0.8 cm
3
) 
and chlorobenzene (2 cm
3
) to give the product (141 mg, 0.05 mmol Ru/0.45 mmol 
diethylamine, 56%). υmax 3374, 2967, 1724, 1665, 1453, 1386, 1266, 1151, 1084, 
997, 746, 700 cm
-1
. 
 
5.3.6 Analysis of reduction products. 
All products are known in the literature and have previously been fully characterised. 
All data matches that reported for each compound.  
GC Sample preparation: A small amount of the reaction solution was removed by 
syringe and filtered through a narrow column of silica with 1:1 EtOAc:petroleum 
ether 40-60. The filtrate was dried under reduced pressure. 2 mg of the residue was 
then dissolved in EtOAc (1 cm
3) and 1 μL of this solution was injected on the GC. 
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HPLC Sample preparation: A small amount of the reaction solution was removed by 
syringe and filtered through a narrow column of silica with 1:1 EtOAc:petroleum 
ether 40-60. The filtrate was dried under reduced pressure. 2 mg of the residue was 
then dissolved in 90:10 Hexane:IPA (1 cm
3) and 20 μL of this was injected on the 
HPLC system. 
 
Benzhydrol. 
 
GC analysis : BP20 (WAX) polyethylene glycol 25m x 0.22mm x 0.25μm, helium 
carrier gas, P=15 psi; T=190°C; ketone 11.4 min., alcohol 23.6 min. 
δH (300 MHz, CDCl3) 7.41-7.31 (8H, m, CHAr), 7.29-7.26 (2H, m, CHAr), 5.86 
(1H, d, J 3.6 Hz, OH), 2.21 (1H, d, J 3.6 Hz, CH). Data matches that previously 
reported for this compound.
202, 203 
 
(R)-1-Phenylethanol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 115°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 9.2 min., R isomer 14.2 min., S isomer 15.6 min. 
[α]D
24
 +64.5 (c 1.0 in CHCl3) 96.7% ee. (R) (lit.
96
 [α]D
27
 +54.9 (c 1.0 in CHCl3) 96% 
ee. (R)); δH (400 MHz, CDCl3) 7.37-7.31 (4H, m, CHAr), 7.28-7.24 (1H, m, CHAr), 
4.87 (1H, q, J 6.5 Hz, CH), 2.00 (1H, br s, OH), 1.48 (3H, d, J 6.5 Hz, CH3). 
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(R)-1-(4’-Methoxyphenyl)ethanol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 130°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 12.6 min., R isomer 30.8 min., S isomer 33.0 min. 
[α]D
30
 +46.6 (c 1.0 in CHCl3) 91.7% ee. (R) (lit.
96
 [α]D
27
 +32.3 (c 1.0 in CHCl3) 90% 
ee. (R)); δH (400 MHz, CDCl3) 7.32-7.30 (2H, m, CHAr), 6.91-6.89 (2H, m, CHAr), 
4.85 (1H, q, J 6.4 Hz, CH), 3.82 (3H, s, OCH3), 2.28 (1H, br s, OH), 1.49 (3H, d, J 
6.3 Hz, CH3). 
 
(R)-1-(4’-Trifluoromethylphenyl)ethanol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 130°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 6.9 min., R isomer 13.4 min., S isomer 14.8 min. 
[α]D
28
 +33.5 (c 1.0 in CHCl3) 92.4% ee. (R) (lit.
204
 [α]D
22
 +29.3 (c 1.0 in CHCl3) 
>99% ee. (R));δH (400 MHz, CDCl3) 7.62-7.60 (2H, m, CHAr), 7.48-7.46 (2H, m, 
CHAr), 4.93 (1H, q, J 6.5 Hz, CH), 2.97 (1H, br s, OH), 1.49 (3H, d, J 6.5 Hz, CH3). 
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(R)-1-Phenylpropan-1-ol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 115°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 15.7 min., R isomer 25.0 min., S isomer 26.8 min. 
[α]D
26
 +47.6 (c 1.0 in CHCl3) 89.7% ee. (R) (lit.
99
 [α]D
20
 +47.0 (c 1.4 in CHCl3) 95% 
ee. (R)); δH (300 MHz, CDCl3) 7.37-7.25 (5H, m, CHAr), 4.57 (1H, t, J 6.6 Hz, CH), 
2.03 (1H, br s, OH), 1.86-1.66 (2H, m, CH2), 0.90 (3H, t, J 7.4 Hz, CH3). 
 
(R)-1-(3’,5’-Bis(trifluoromethyl)phenyl)ethanol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 120°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 4.8 min., R isomer 12.8 min., S isomer 12.2 min. 
[α]D
31
 +16.5 (c 1.0 in CHCl3) 81.8% ee. (R) (lit.
105
 [α]D
28
 +11.9 (c 1.0 in CHCl3) 
96% ee. (R)); δH (300 MHz, CDCl3) 7.81-7.78 (3H, m, CHAr), 5.00 (1H, q, J 6.3 Hz, 
CH), 2.92 (1H, br s, OH), 1.51 (3H, d, J 6.6 Hz, CH3). 
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(S)-2-phenoxy-1-phenylethanol. 
 
Enantiomeric excess and conversion determined by HPLC analysis: IB column, 0.46 
x 25 cm, 0.7 cm
3
/min, 95:5 Hexane:2-propanol, RT, ketone 14.2 min, R isomer 17.1 
min, S isomer 22.4 min. Ketone UV response is 12.35 times greater than for the 
alcohol. [α]D
29
 +52.2 (c 1.0 in CHCl3) 94.5% ee. (S) (lit.
105
 [α]D
30
 +58.8 (c 1.0 in 
CHCl3) 95% ee. (S)); δH (300 MHz, CDCl3) 7.45-7.24 (7H, m, CHAr), 6.98-6.89 
(3H, m, CHAr), 5.10 (1H, dd, J 8.8 and 3.3 Hz, CH), 4.10-4.07 (1H, m, CH2), 4.02-
3.96 (1H, m, CH2), 2.90 (1H, br s, OH). 
 
(S)-1-phenylethane-1,2-diol. 
 
Enantiomeric excess and conversion determined by GC analysis: CP-ChiraSil-DEX 
CB 25 m x 0.25 mm x 0.25 μm, T = 140°C, P = 18psi He, det = FID 220°C, inj = 
220°C, ketone 8.6 min, S isomer 31.3 min, R isomer 33.3 min. [α]D
27
 +64.5 (c 0.5 in 
CHCl3) 90.3% ee. (S) (lit.
104
 [α]20 +63 (c 1.0 in CHCl3) 96% ee. (S)); δH (300 MHz, 
CDCl3) 7.31-7.25 (5H, m, CHAr),4.74-4.70 (1H, m, CH), 3.96 (1H, br s, OH), 3.68-
3.53 (3H, m, CH2 + OH). 
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1-Phenyl-2,2-dimethyl-1-propanol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 125°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 13.9 min., R isomer 29.4 min., S isomer 30.0 min. 
[α]D
29
 +12.7 (c 1.0 in CHCl3) 75.9% ee. (R) (lit.
204
 [α]D
20
 +12.2 (c 1.0 in CHCl3) 
45% ee. (R)); δH (300 MHz, CDCl3)  7.31-7.25 (5H, m, CHAr), 4.39 (1H, s, CH), 
1.86 (1H, br s, OH), 0.92 (9H, s, (CH3)3). 
 
1-Tetralol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 120°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 41.3 min., R isomer 54.3 min., S isomer 54.6 min. 
[α]D
26
 -34.2 (c 0.5 in CHCl3) 99.0% ee. (R) (lit.
96
 [α]D
27
 -32.3 (c 1.0 in CHCl3) 98% 
ee. (R)); δH (300 MHz, CDCl3) 7.43-7.39 (1H, m, CHAr), 7.23-7.17 (2H, m, CHAr), 
7.10-7.07 (1H, m, CHAr), 4.75-7.74 (1H, m, CH), 2.86-2.65 (2H, m, CH2 + OH), 
2.02-1.70 (5H, m, CH2). 
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(R)-2,3-dihydroinden-1-ol. 
 
Enantiomeric excess and conversion determined by GC analysis: Chrompac 
cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 100°C, P = 15psi H2, det = 
FID 220°C, inj = 220°C, ketone 66.9 min., R isomer 84.8 min., S isomer 84.0 min. 
[α]D
26
 -31.6 (c 1.0 in CHCl3) 97.5% ee. (R) (lit.
96
 [α]D
27
 -30.5 (c 1.0 in CHCl3) 84% 
ee. (R)); δH (300 MHz, CDCl3) 7.41-7.39 (1H, m, CHAr), 7.25-7.21 (3H, m, CHAr), 
5.21 (1H, m, CH), 3.08-2.98 (1H, m, CH2), 2.85-2.74 (1H, m, CH2), 2.51-2.40 (1H, 
m, CH2), 1.97-1.86 (2H, m, OH + CH2). 
 
 
(R)-3,4-Dihydrochromen-4-ol. 
 
Enantiomeric excess and conversion determined by HPLC analysis: IB column, 0.46 
x 25 cm, 1 cm
3
/min, 95:5 Hexane:2-propanol, RT, ketone 6.6 min, S isomer 8.6 min, 
R isomer 9.4 min. Ketone UV response is 20.12 times greater than for the alcohol. 
[α]D
27
 +66.5 (c 1.0 in CHCl3) 99.0% ee. (R) (lit.
205
 [α]D
31
 +60.1 (c 0.2 in CHCl3) 
96% ee. (R)); δH (300 MHz, CDCl3) 7.27-7.24 (1H, m, CHAr), 7.19-7.13 (1H, m, 
CHAr), 6.90-6.85 (1H, m, CHAr), 6.81-6.78 (1H, m, CHAr), 4.67 (1H, t, J 4.1 Hz, 
CH), 4.21-4.15 (2H, m, CH2), 2.76 (1H, br s, OH), 2.13 (1H, s, CH), 2.09-1.90 (2H, 
m, CH2). 
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(S)-2-(morpholin-4-yl)-1-phenylethanol. 
 
Conversion determined by 
1
H NMR. Enantiomeric excess determined by Mosher’s 
method
146 
>95% (S). [α]D
24
 +48.2 (c 0.3 in MeOH) >95% ee. (S) (lit.
206 [α]D
26
 +41.8 
(c 5.07 in MeOH) 89% ee. (S))
 ; δH (400 MHz, CDCl3) 7.38-7.26 (5H, m, CHAr), 
4.76 (1H, dd J, 10.4 and 3.4 Hz, CH), 3.76 (5H, m, CH2OCH2 and OH overlapping), 
2.75 (2H, m, CH2), 2.54-2.45 (4H, m, -CH2NCH2-). 
 
Figure 77. Mosher's ester derivatives and configuration model. 
 
Mosher’s ester of (S)-2-(morpholin-4-yl)-1-phenylethanol. 
 
To a solution of (S)-2-(morpholin-4-yl)-1-phenylethanol) (5 mg, 0.024 mmol) in 
anhydrous DCM (1 cm
3
) was added triethylamine (5 mg, 0.048 mmol) and DMAP 
(0.3 mg, 0.0024 mmol). To the solution and at 0˚C was then added (S)-(+)-MTPA-Cl 
(8 mg, 0.03 mmol). The reaction was then stirred overnight at room temperature. 
After this volatile material was removed under reduced pressure to leave the crude 
which was then analysed by 
1
H NMR. 
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1
H NMR key peaks for ee. determination: Major isomer δH (400 MHz, CDCl3) L
3
: 
2.83 (1H, dd, J 13.7 and 9.9 Hz, CH2CHOH), 2.65-2.61 (2H, m, NCH2CH2O), 2.55 
(1H, dd, J 13.6 and 3.0 Hz, CH2CHOH), 2.38-2.33 (1H, m, NCH2CH2O). 
Determination of ee.: Only 1 enantiomer visible by NMR so ee. > 95%. 
Determination of configuration: Product is the (S) enantiomer. Comparison to the 
Mosher’s esters of the racemic alcohol and asymmetric reduction product shows that 
in the 
1
H NMR of the
 
asymmetric product the L
3
 signals present are upfield. 
 
Mosher’s ester of racemic 2-(morpholin-4-yl)-1-phenylethanol.  
The racemic alcohol was prepared by NaBH4 reduction of the ketone. The Mosher’s 
ester was then prepared as above. 
1
H NMR key peaks: δH (400 MHz, CDCl3) L
3
: 
2.93-2.81 (1H, m, CH2-CHOH), 2.74-2.71 (1H, m, N-CH2CH2O),  2.65-2.61 (1H, m, 
N-CH2CH2O), 2.57-2.54 (1H, m, CH2-CHOH), 2.48-2.43 (1H, m, N-CH2CH2O), 
2.38-2.33 (1H, m, N-CH2CH2O). 
 
 
 
 
 
 
 
Figure 78. 
1H NMR spectra for Mosher's esters of 2-(morpholin-4-yl)-1-phenylethanol. 
Racemic 
Asymmetric 
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(S)-1-Cyclohexylethanol. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 75°C, P = 15psi H2, det = FID 220°C, inj = 220°C, ketone 
40 min., alcohol 80 min. [α]D
26
 +3.7 (c 1.0 in CHCl3) 81.4% ee. (S) (lit.
207
 [α]D
22
 
+2.7 (c 0.5 in CHCl3) 75% ee. (R)); δH (300 MHz, CDCl3) 3.54 (1H, q, J 6.2 Hz, 
CH), 1.87-1.83 (1H, m, CH), 1.79-1.73 (2H, m, CH2), 1.69-1.65 (3H, m, CH + CH2), 
1.32-1.14 (7H, m, CH2 + OH), 1.07-0.93 (2H, m, CH2). 
Enantiomeric excess determined by GC for the acetate derivative of reduction 
product: Chrompac cyclodextrin-β-236M-19 50m x 0.25 mm x 0.25 μm, T = 115°C, 
P = 15psi H2, det = FID 220°C, inj = 220°C, R isomer 14.5 min., S isomer 13.3 min. 
Preparation of acetate derivative: The reduction product (10 mg) was dissolved in 1 
cm
3
 of DCM. To this was then added acetic anhydride (20 μL) and DMAP (3 
crystals). The reaction was stirred over night and then volatiles were removed under 
reduced pressure. A small amount of the residue was diluted in EtOAc and then 
injected on the GC. 
 
4-Phenylbut-3-en-2-ol. 
 
Conversion determined by 
1
H NMR. δH (300 MHz, CDCl3) 7.38-7.17 (5H, m, 
CHAr), 6.55 (1H, d J, 15.9 Hz, CH=CHCHOH), 6.25 (1H, dd, J 15.9 and 6.4 Hz, 
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CH=CHCHOH), 4.51-4.42 (1H, m, CHOH), 1.94 (1H, br s, OH), 1.36 (3H, d, J 13.0 
Hz, CH3). 
Enantiomeric excess determined by conversion of the unsaturated/saturated alcohol 
product mixture into 4-phenylbutan-2-ol and analysis by HPLC as detailed below. 
4-Phenylbutan-2-ol. 
 
To 4-phenylbut-3-en-2-ol: 4-phenylbutan-2-ol 1:1 mixture (45 mg, 0.30 mmol) was 
added anhydrous MeOH (1 cm
3
) and 10% Pd/C (18 mg, 0.015 mmol Pd). The flask 
was connected to a balloon of hydrogen (1 atm.), purged with hydrogen and stirred at 
room temperature overnight. The reaction was filtered through celite with EtOAc 
and the filtrate dried under reduced pressure to give the product as a colourless oil 
(29 mg, 0.2 mmol, 67%). Enantiomeric excess determined by HPLC analysis: IB 
column, 0.46 x 25 cm, 0.8 cm
3
/min, 95:5 Hexane:2-propanol, RT, ketone 7.0 min, R 
isomer 8.9 min, S isomer 10.9 min. [α]D
28
 +0.67 (c 0.3 in CHCl3) 4.7% ee. (S) (lit.
208
 
[α]25 +7.9 (c 1.0 in CHCl3) 33% ee. (S); δH (400 MHz, CDCl3) 7.30 – 7.25 (2H, m, 
CHAr), 7.21-7.16 (3H, m, CHAr), 3.87-3.79 (1H, m, CHOH), 2.80-2.63 (2H, m, 
CH2CHOH), 1.80-1.74 (2H, m, CH2CH2CHOH), 1.40 (1H, br s, OH), 1.23 (3H, d, J 
6.3 Hz, CH3). 
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Benzyl alcohol. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 100°C, P = 15psi H2, det = FID 220°C, inj = 220°C, 
benzaldehyde 9.6 min., (dimethoxymethyl)benzene 15.6 min., benzyl alcohol 27.1 
min. δH (300 MHz, CDCl3) 7.33-7.22 (5H, m, CHAr), 4.55 (2H, s, CH2), 3.04 (1H, 
br s, OH). 
 
(Dimethoxymethyl)benzene. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 100°C, P = 15psi H2, det = FID 220°C, inj = 220°C, 
(dimethoxymethyl)benzene 15.6 min. δH (400 MHz, CDCl3) 7.46-7.44 (2H, m, 
CHAr), 7.38-7.32 (3H, m, CHAr), 5.39 (1H, s, CH), 3.33 (6H, s, OCH3) 
 
(4-Methoxyphenyl)methanol. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 135°C, P = 15psi H2, det = FID 220°C, inj = 220°C, 4-
methoxybenzaldehyde 10.1 min., (4-methoxyphenyl)methanol 21.9 min. δH (400 
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MHz, CDCl3) 7.30-7.28 (2H, m, CHAr), 6.90-6.89 (2H, m, CHAr), 4.62 (2H, s, 
CH2), 3.81 (3H, s, CH3), 1.62 (1H, br s, OH). 
 
(4-Bromophenyl)methanol. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 150°C, P = 15psi H2, det = FID 220°C, inj = 220°C, 4-
bromobenzaldehyde 9.5 min., (4-bromophenyl)methanol 18.5 min. δH (400 MHz, 
CDCl3) 7.50-7.46 (2H, m, CHAr), 7.25-7.22 (2H, m, CHAr), 4.65 (2H, s, CH2), 1.78 
(1H, br s, OH). 
 
(4-Nitrophenyl)methanol. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 180°C, P = 15psi H2, det = FID 220°C, inj = 220°C, 4-
nitrobenzaldehyde 7.9 min., (4-aminophenyl)methanol 9.7 min., (4-
nitrophenyl)methanol 23.2 min. δH (300 MHz, CDCl3) 8.23-8.20 (2H, m, CHAr), 
7.55-7.52 (2H, m, CHAr), 4.84 (2H, s, CH2), 2.00 (1H, br s, OH). 
 
3-Phenylprop-2-en-1-ol. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 130°C, P = 15psi H2, det = FID 220°C, inj = 220°C, 
cinnamaldehyde 21.8 min., 3-phenylprop-2-enal 11.2 min, 3-phenylpropan-1-ol 20.4 
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min., (3,3-dimethoxyprop-1-en-1-yl)benzene 26.2 min., 3-phenylprop-2-en-1-ol 31.6 
min. δH (400 MHz, CDCl3) 7.38-7.23 (5H, m, CHAr), 6.60 (1H, d, J 16.1 Hz, CH), 
6.38-6.31 (1H, m, CH), 4.30 (2H, d, J 5.5 Hz, CH2), 1.85 (1H, br s, OH). 
 
 
(3,3-Dimethoxyprop-1-en-1-yl)benzene. 
 
Conversion determined by GC analysis: Chrompac cyclodextrin-β-236M-19 50m x 
0.25 mm x 0.25 μm, T = 130°C, P = 15psi H2, det = FID 220°C, inj = 220°C, (3,3-
dimethoxyprop-1-en-1-yl)benzene 26.2 min. δH (400 MHz, CDCl3) 7.46-7.38 (2H, 
m, CHAr), 7.34-7.25 (3H, m, CHAr), 6.72 (1H, d, J 16.0 Hz, CH), 6.15 (1H, dd, J 
16.0 and 4.9 Hz, CH), 4.96 (1H, d, J 4.9 Hz, CH), 3.38 (6H, s, OCH3). 
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7. Appendix 1-Hydrogenation of imines using Frustrated 
Lewis Pair catalysts. 
7.1 Introduction: Frustrated Lewis Pairs. 
 
Several systems have been reported for non-metal catalysed hydrogenation reactions. 
MacMillan has developed a series of imidazolidinone catalysts which have been 
applied to ATH of α,β-unsaturated carbonyl compounds 209, 210 reactions as well as 
many other transformations.
211-214
 Corey, Bakshi and Shibata have reported the ATH 
of ketones using an oxaborolidine catalyst and stoichiometric borane.
215
  
More recently, the non-metal-catalysed pressure hydrogenation of imines has been 
reported by Stephan 
217-218
 using Frustrated Lewis Pairs (FLPs) as the catalytic 
species. FLPs are combinations of Lewis acids and bases that are sterically prevented 
from forming a Lewis acid-base adduct meaning that the Lewis acid and base 
components remain available to interact with other molecules.
219
 Conventionally the 
interaction of a Lewis acidic borane and Lewis basic phosphine would result in 
formation of a dative bond between the lone pair of electrons on the phosphorus and 
the empty p-orbital of the boron, with FLPs this interaction is prevented due to steric 
hindrance.  
 
Scheme 102. Reactivity of 'classical' (A) and 'frustrated' (B) Lewis pairs. 
 
Scheme 102 A shows the classical interaction of a borane with a non-sterically 
hindered tertiary phosphine. The THF group on the boron is replaced with the 
phosphine which joins to the boron via a dative bond. Scheme 102 B shows a 
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‘frustrated’ interaction where, due to steric hindrance, direct interaction between the 
phosphorus and boron atoms is prevented. Instead, nucleophilic substitution occurs 
on the borane species at the carbon para to the boron and the displaced fluorine 
migrates to the boron to give the zwitterionic phosphonium borate product. Due to 
the charges on the phosphorus and boron, they each retain their respective Lewis 
basicity and acidity, allowing interaction with other molecules. 
Stephan has reported the application of FLPs to hydrogen activation.
220 
Phosphinoborane 265 readily cleaves hydrogen to form phosphonium borate 266. 
Upon heating hydrogen is reformed and liberated as illustrated in Scheme 103. 
 
 
 
 
 
Scheme 103. Activation of hydrogen by phosphine-borane. 
 
The process was thought to involve activation of molecular hydrogen by the boron 
Lewis acid and protonation of the phosphorus Lewis base. The mechanism of 
hydrogen activation was investigated by Guo and Li
221
 who report the process to 
involve the formation of an ‘encounter complex’ (Scheme 104) between two 
phosphinoborane molecules held together by hydrogen bonding. The hydrogen 
molecule inserts between the boron and phosphorus at one end of the encounter 
complex and cleaves to form an ion pair complex. The process repeats with the other 
boron-phosphorus pair in the complex interacting with a second molecule of 
hydrogen. Final dissociation of the complex leads to the formation of two 
phosphonium borate complexes. 
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Scheme 104. 'Encounter complex' mechanism of hydrogen activation by FLPs. 
 
Papai and co-workers also investigated the method of hydrogen activation by 
FLPs.
222
 Investigations into the mechanism found no dative P-B bond  but a weakly 
bound, non-covalent [R3P]...[B(C6F5)3] complex was observed. It was thought that 
this complex was a reactive intermediate in the activation process and also that it 
may provide a pre-organised active centre for H-H bond activation. The group 
suggested that the complex represented an energetically strained species which 
lowered the barrier to hydrogen activation. 
The ability of the FLP system to activate hydrogen lead to its application to metal-
free catalysed hydrogenation of imines via proton and hydride transfer from the 
phosphonium borate to the polar C=N bond of the imine.
216-220, 223
 A mechanism for 
the reaction has been proposed and is shown in Scheme 105.
218-221, 223 
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Scheme 105. Mechanism of imine hydrogenation with phosphinoborane FLPs. 
 
Initially the phosphinoborane interacts with hydrogen to form the phosphonium 
borate species. A proton is then transferred from the phosphorus to the nitrogen of 
the imine. Hydride transfer from the boron to the imino carbon atom followed by 
coordination of the nitrogen to the boron then occurs before the amine product is 
released to reform the phosphinoborane. 
Phosphinoborane FLP catalysts have been successfully applied to the Pressure 
hydrogenation of a series of imines as shown in Table 37.
218 
Table 37. Application of FLP phosphinoborane catalysts 267 and 268 to pressure hydrogenaiton of 
imines. 
 
Entry R
1
 R
2
 Catalyst 
Temp. 
(°C) 
Time 
(hours) 
Yield 
(%) 
1 Ph 
t
Bu 267 80 1 79 
2 Ph 
t
Bu 268 80 1 98 
3 Ph SO2Ph 267 120 10.5 97 
4 Ph SO2Ph 268 120 16 87 
5 Ph CHPh2 267 140 1 88 
6 Ph CH2Ph 267 120 48 5 
7 Ph CH2Ph(B(C6F5)3) 267 120 46 57 
8 PhCHCHPhNPh 267 120 1.5 98 
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A sterically hindered imine could itself act as the Lewis base, removing the need for 
the phosphine.
220
 The imine acts in the same way as the hindered phosphine in 
Scheme 105. Acting as a Lewis base, the imine is able to accept a proton from the 
cleaved hydrogen molecule. This is followed, as before, by hydride transfer from the 
borate to give the hydrogenated product. 
In similar work Repo and co-workers reported the activation of hydrogen by amines 
and B(C6F5)3.
224 
Reaction of 2,2,6,6-tetramethylpiperidine with B(C6F5)3 under 
atmospheric hydrogen afforded 95% yield of  ammonium borate 259. The process 
proceeds via a 6-membered transition state 260 shown in Figure 79. 
 
Figure 79. Cleavage of hydrogen by amines and B(C6F5)3. 
Soos has reported the use of amine  Lewis bases in the FLP-catalysed hydrogenation 
of imines finding DABCO to be particularly successful (Scheme 106).
225 
  
Scheme 106. Hydrogenation of imines with DABCO and hindered borane. 
 
FLPs were successfully applied to catalytic hydrogenation of imines, nitriles and 
aziridines, however aldehydes were found to only react stoichiometrically. Both 
Stephan
218
 and Repo
224
 have reported hydrogenation of benzaldehyde with 
phosphinoborane and amine/borane FLP systems respectively. In both cases, 
benzaldehyde underwent hydride attack to form an alkoxide bound to the boron as 
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shown in Scheme 107,  however due to the reduced basicity of oxygen compared to 
nitrogen, protonation of oxygen to yield the alcohol product was not achieved. 
 
Scheme 107. Attempted hydrogenation of benzaldehyde with FLPs. 
 
7.1.1.1 Asymmetric hydrogenation of imines with FLP catalysts. 
The first example of asymmetric hydrogenation of imines using FLP catalysts was 
reported by Klankermayer.
226
 Chiral borane 156 (Figure 80) derived from (+)-α-
pinene was applied to the asymmetric hydrogenation of N-(1-
phenylethylidene)aniline. The reaction gave complete conversion to product with an 
ee. of 13%, thus illustrating the scope for APH of imines with this system.  
 
Figure 80. Chiral borane derived from (+)-α-pinene. 
 
More recently, Klankermayer has reported the use of other asymmetric boranes for 
asymmetric hydrosilylylation
227
 and APH of imines as shown in Scheme 
108
228
achieving increased enantioselectivity. 
 
Scheme 108. APH of N-(1-phenylethylidene)aniline using FLP catalst 262
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7.2 Results and Discussion. 
 
The development of metal free catalysts for hydrogenation and asymmetric 
hydrogenation was also investigated during the course of my studies. The initial 
synthesis of asymmetric boranes focused on the condensation of diols with boronic 
acids to give dioxaborolanes (Scheme 109).
229, 230
 An asymmetric derivative was 
prepared by asymmetric Sharpless dihydroxylation of stilbene followed by in situ 
coupling with the boronic acid (Schemes 110).
231
 
 
Scheme 109. Preparation of achiral dioxaborolane 263 
 
 
Scheme 110. Preparation of asymmetric dioxaborolane 264. 
 
Application of boranes 263 and 264 to the hydrogenation of imines was found to be 
unsuccessful with no significant formation of amine achieved. Attempts to repeat 
literature reactions using commercially available tris(pentafluorophenyl)borane were 
also unsuccessful with NMR analysis of reaction solutions showing hydrolysis of the 
imine substrates to be occurring preferentially to hydrogenation (Tabel 38). 
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Table 38. APH of imines using boron catalysts. 
 
 
Entry R R’ Catalyst 
H2 
(bar) 
Temp. 
(°C) 
Time 
(hr) 
Conv. to 
amine
a
 (%) 
1
b
 Me Ph B(C6F5)3 10 mol% 10 80 15 99 
2 Me Ph B(C6F5)3 10 mol% 10 80 26 None 
3 Me Ph B(C6F5)3 10 mol% 15 100 48 None 
4
c Me Ph B(C6F5)3 10 mol% 10 80 23 None 
5 Me Ph 263 10 mol% 5 80 26 Trace 
6 Me Ph 263 10 mol% 5 80 64 None 
7 Me Ph 26410 mol% 5 80 26 Trace 
8 Me Ph  264 10 mol% 5 80 64 None 
9 H Ts B(C6F5)3 10 mol% 20 80 24 None 
10 H Ph 
B(C6F5)3 10 mol%, 
DABCO 10 mol% 
5 RT 24 None 
11
d
 H 
tBu 
B(C6F5)2Mes 10 mol%, 
DABCO 10 mol% 
4 RT 42 100 
12
e
 Me Ph B(C6F5)3 20 mol% 20 80 24 15.3 
aDetermined by 1H NMR. bReaction reported in literature.226  c4Ǻ molecular sieves used in reaction 
dReaction reported in literature.225. e4Ǻ molecular sieves used, reaction set up and sealed under argon. 
Initial hydrogenations were carried out on Phenyl-(1-phenylethylidene)amine (Table 
38 entries 2-8) as a comparison to the literature result for the same imine (entry 1).
226
 
Repetition of the literature reaction (entry 2) and also the use of increased H2 
pressure, temperature and reaction time (entry 3) showed no conversion of imine to 
its amine prodict. The addition of 4Ǻ molecular sieves to remove water from the 
reaction also showed no improvement (entry 4). Application of boranes 263 and 264 
to the reaction showed no improvement with only a trace of the desired amine 
product seen by GC analysis of the reaction solution (entries 5-8). Use of less 
sterically encumbered imines as substrates and also the addition of DABCO which 
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has been shown in the literature to promote hydrogenation if imines (entry 11)
225
 
also showed no improvement to the conversion to amine product (entries 9-10). 
Despite attempts to exclude water from the reaction solutions and reagents it was 
necessary for the reaction solutions to be open to the air briefly whilst the Parr 
reactor was sealed before being purged with hydrogen. This brief exposure may 
allow sufficient moisture into the reaction to allow imine hydrolysis rather than 
hydrogenation. Only in one case (Table 38, entry 12), where the reaction solution 
was prepared with rigorous exclusion of water and set up under a flow of argon, was 
hydrogenation of the imine achieved. The conversion to amine was low at only 
15.3% and 
1
H NMR analysis also showed evidence of hydrolysis of the imine. The 
aim of this work was to develop an active, robust, metal free catalyst that is 
accessible and convenient to use for asymmetric hydrogenation of imines, the need 
for stringent moisture and air exclusion does not fit with this criteria and so work on 
the development of this type of catalyst was halted at this point. 
Development of catalysts for asymmetric hydrogenation                                                       Appendix 2 
323 
 
8. Appendix 2-X-ray crystallography data. 
 
X-ray crystallography data of N-[(1S, 2S)-1, 2-Diphenyl-2-(3-phenypropyl 
amino)ethyl)-4-methylbenzenesulfonamide)ruthenium(II)iodide monomer 181. 
 
Crystal data: C31H35IN2O3RuS, M = 743.64,  Monoclinic, space group P2(1), a = 
11.7063(2), b = 9.65672(16), c = 13.5915(3) A , α = 90°, β = 98.9689(17)°, γ = 90°, 
U = 1517.66(5) A
3
 (by least squares refinement on 8297 reflection positions), T 
=298(2)K, λ = 0.71073 A, Z =  2, D(cal) = 1.627 Mg/m3, F(000) = 744.  mu(MoK-α) 
= 1.636 mm
-1
. Crystal character: brown block. Crystal dimensions 0.24 x 0.12 x 0.12 
mm. 
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X-ray crystallography data of N-[(1R,2R)-2-(Amino)-1,2-diphenylethyl]-4-
methylbenzenesulfonamide(p-cymene)ruthenium(II)iodide monomer 183. 
 
Crystal data: C31H35IN2O2RuS, M = 727.64, Orthorhombic, space group 
P2(1)2(1)2(1), a = 8.8762(6), b = 13.4321(7), c = 26.712(3) A , α = 90°, β = 90°, γ = 
90°, U = 3184.7(4) A
3
 (by least squares refinement on 9388 reflection positions), T 
=298(2)K, λ = 0.71073 A, Z =  4, D(cal) = 1.518 Mg/m3, F(000) = 1456. mu(MoK-
α) =  1.555 mm-1. Crystal character: brown block. Crystal dimensions 0.24 x 0.12 x 
0.04 mm. 
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X-ray crystallography data of N-((1R,2R)-2-(3-(4-methoxyphenyl)propylamino)-
1,2-diphenyl)-4-methylbenzenesulfonamide) ruthenium chloride 209. 
 
Crystal Data: C32 H35 Cl N2 O4 Ru S, M = 680.20,  Orthorhombic, space group 
P2(1)2(1)2(1), a = 7.58370(10), b = 10.22300(10), c = 38.6764(3) A, α = 90°,β = 
90°, γ = 90°, U = 2998.51(5) A3 (by least squares refinement on 12912 reflection 
positions), T =150(2)K, λ = 1.54178 A, Z =  4, D(cal) = 1.507 Mg/m3, F(000) = 
1400.  mu(MoK-α) = 6.026 mm-1. Crystal character: orange plate. Crystal 
dimensions 0.40 x 0.10 x 0.01 mm. 
